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Summary 
 
 
Transition metal fragments displaying switching behaviour are appealing materials, which may be 
used in a functional way in research and technology. Some molecular species containing transition 
metal ions may exhibit a crossover between states having a different magnetic moment, the magnetic 
interconversion between the low-spin and high-spin state in FeIII systems which can be triggered by 
a change in temperature, pressure or by light irradiation.  
The research presented in this thesis focuses on using substituted derivatives of R-salicylaldehyde 
4R’-thiosemicarbazone (H2L, H2-R-thsa-R’) for generating FeIII spin crossover. The aim was to 
design mononuclear FeIII compounds with a view of studying their structural features and magnetic 
properties. The results present the full structural analysis of differently charged FeIII-bis(ligand) 
complexes, these include: (i) (cation+)[FeIII(L2‒)2]·x(solvent), (ii) [FeIII(HL‒)(L2‒)]·x(solvent) and 
(iii) [FeIII(HL‒)2](anion‒)·x(solvent). The studies discuss several influences on the structural features 
and the magnetic properties of the reported FeIII compounds, these include: the nature of the anion 
or cation associated with the FeIII complex, the degree of solvation of the complex and the variations 
in the ligand substituents.  
The magnetic studies of the (cation+)[FeIII(L2‒)2]·x(solvent) compounds have presented one high-
spin compound ((CH3)2NH2[Fe(3-OEt-thsa)2]) and four low-spin compounds (Cs[Fe(3-OEt-thsa-
Me)2]·CH3OH, Cs[Fe(5-Br-thsa)2], NH4[Fe(thsa)2] and NH4[Fe(5-Br-thsa)2]), of which NH4[Fe(5-
Br-thsa)2] revealed a fraction of the FeIII ions convert into the high-spin state. Three [FeIII(HL‒)(L2‒
)]·x(solvent) compounds have been studied, of which a rare two-step spin transition has been 
observed for [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]·H2O, while the isostructural compounds [Fe(H-
thsa-Me)(thsa-Me)]·H2O undergoes an incomplete spin transition and [Fe(H-3-OEt-thsa-Me)(3-
OEt-thsa-Me)]·H2O remains in the high-spin state. It was recognised that the steric and electronic 
features imposed by the R,R’-substituents may have an impact on the spin state of FeIII cations, and 
affect at which temperature the spin transition occurs. Furthermore, the FeIII cation of both [FeIII(HL‒
)2](anion‒)·x(solvent) compounds, [Fe(H-5-Br-thsa-Et)2](NO3)·H2O and [Fe(H-4-OH-
thsa)2]4·(SO4)2·9H2O, were found to be in the high-spin state.  
Collectively, the described research has provided new insight into this family of FeIII bis(R-
salicylaldehyde 4R’-thiosemicarbazone) compounds and provides a strong foundation for further 
studies.   
 
Keywords: FeIII, spin-crossover, R-salicylaldehyde 4R’-thiosemicarbazone, intermolecular 
interactions, two-step spin transition 
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z + 1; (ii) –x, –y + 1, –z + 1.] 
Figure 3.2.3 χMT vs T plot of Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH. [The sample was heated 
(▲) and subsequently cooled (▼).] 
Figure 3.3.1 The molecular structure and atom-numbering scheme for Cs[Fe(5-Br-
thsa)2]. Displacement ellipsoids are drawn at 50% probability level. 
Figure 3.3.2 A projection showing the unit cell of Cs[Fe(5-Br-thsa)2]. The Cs+ cation has 
been omitted for clarity. Displacement ellipsoids are drawn at the 50% probability level. 
Dashed lines indicate hydrogen bonds. [Symmetry codes: (iv) x, –y + 1/2, z + 1/2; (v) –
x + 1, y – 1/2, –z + 3/2; (vi) x, –y + 3/2, z + 1/2; (vii) –x + 2, y + 1/2, –z + 3/2; (viii) –x 
+ 2, y + 1/2, –z + 1/2; (ix) –x + 1, y – 1/2, –z + 1/2.]  
Figure 3.3.3 χMT vs T plot of Cs[Fe(5-Br-thsa)2]. [The sample was heated (▲) and 
subsequently cooled (▼).] 
Figure 3.4.1 The molecular structure and atom-numbering scheme for NH4[Fe(thsa)2]. 
The N atom of the NH4+ cation has been omitted from the figure for clarity. 
Displacements ellipsoids are drawn at the 50% probability level. 
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Figure 3.4.2 A projection showing the unit cell of NH4[Fe(thsa)2]. The N atom of the 
ammonium cation has been omitted for clarity. Displacement ellipsoids are drawn at the 
50% probability level. Dashed lines indicate hydrogen bonds. [Symmetry codes: (i) x – 
1/2, 1/2 – y, z – 1/2; (ii) x – 1/2, 1/2 – y, 1/2 + z.] 
Figure 3.4.3 χMT vs T plot of NH4[Fe(thsa)2]. [The sample was heated (▲) and 
subsequently cooled (▼).] 
Figure 3.5.1 The molecular structure and atom-numbering scheme for NH4[Fe(5-Br-
thsa)2]. The N atom of the NH4+ cation, and alternative orientation for O1′, S1′, C2′, C3′ 
and C4′ have been omitted from the figure for clarity. Displacements ellipsoids are drawn 
at the 50% probability level. [Symmetry code: (i) –x, y, –z –1/2.] 
Figure 3.5.2 A projection showing the unit cell of NH4[Fe(5-Br-thsa)2]. The N atom of 
the NH4+ cation, and alternative orientation for O1’, S1’, C2’, C3’ and C4’ have been 
omitted for clarity. Displacements ellipsoids are drawn at the 50% probability level. 
Dashed lines indicate hydrogen bonds. [Symmetry codes: (i) 1/2 + x, 3/2 – y, –1 – z; (ii) 
1/2 + x, 3/2 – y, –1 – z.] 
Figure 3.5.3 χMT vs T plot of NH4[Fe(5-Br-thsa)2]. [The sample was heated (▲) and 
subsequently cooled (▼).] 
Figure 3.5.4 DSC curves obtained for NH4[Fe(5-Br-thsa)2] in the temperature range 100-
300 K, measured at a scan rate of 5 K min-1. 
Figure 3.6.1 The molecular structure and atom-numbering scheme for (CH3)2NH2[Fe(3-
OEt-thsa)2]. Displacement ellipsoids are drawn at the 50 % probability level.  
Figure 3.6.2 A projection showing the unit cell of (CH3)2NH2[Fe(3-OEt-thsa)2]. 
Displacement ellipsoids are drawn at 50% probability level. Dashed lines indicate 
hydrogen bonds. 
Figure 3.6.3 χMT vs T plot of (CH3)2NH2[Fe(3-OEt-thsa)2]. [The sample was heated (▲) 
and subsequently cooled (▼).] 
Figure 3.6.4 Temperature dependence of the molar magnetic susceptibility, χM, for the 
compound (CH3)2NH2[Fe(3-OEt-thsa)2] in the range 5-150 K. Points are the 
experimental data; solid red line represents the least-squares fit of the data to Equation 
(1), where D = 0.80 cm-1 and g = 2.20.  
Figure 4.1.1 Molecular structure of the R-salicylaldehyde 4R’-thiosemicarbazone 
ligands (i) H2-3-OEt-thsa-Me and (ii) H2-thsa-Me. 
Figure 4.2.1 The molecular structure and atom-numbering scheme of [Fe(H-thsa-
Me)(thsa-Me)]∙H2O, whereby the ligand bound to Fe1 atom are related by the symmetry 
operation: (i) –x + 1, –y + 1, z. The hydrogen atom bound to N2 and N2i atoms has a site 
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occupancy factor of 0.5, i.e. the atom is disordered over the N2 and N2i sites (50:50). 
Displacement ellipsoids are drawn at the 50% probability level.  
Figure 4.2.2 A projection showing the unit cell of [Fe(H-thsa-Me)(thsa-Me)]∙H2O. The 
disordered H2O molecule has been omitted for clarity. Displacement ellipsoids are drawn 
at the 50% probability level. Dashed lines indicate hydrogen bonds. [Symmetry codes: 
(i) –x + 1, –y + 1, z; (ii) x – 1/2, –y + 1, z + 1/2] 
Figure 4.2.3 χMT vs T plot of [Fe(H-thsa-Me)(thsa-Me)]·H2O (left). The sample was 
warmed (▲) and then subsequently cooled (▼) in the temperature region of 5-300 K, at 
a rate of 2 K min-1. DSC curves (right) obtained for [Fe(H-thsa-Me)(thsa-Me)]∙H2O at a 
scan rate of 5 K min-1.  
Figure 4.2.4 χMT vs T plot of [Fe(H-thsa-Me)(thsa-Me)]·H2O. The sample was warmed 
(▲) in the temperature region of 200–400 K, at a rate of 2 K min-1. 
Figure 4.3.1 The molecular structure and atom-numbering scheme for the asymmetric 
unit of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O. The two H2O molecules has been 
omitted for clarity. Displacement ellipsoids are drawn at the 50% probability level. 
Figure 4.3.2 A projection of the unit cell of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-
Me)]∙H2O. Displacement ellipsoids are drawn at the 50% probability level.  
Figure 4.3.3 χMT vs T plot of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]·H2O in the 
temperature range of 5 – 300 K, measured at a rate of 2 K min-1. (i) The heating mode is 
shown on the left and represented by the symbol (∆) and (ii) the cooling mode on the 
right is represented by the symbol (▼). 
Figure 4.3.4 DSC curves obtained for [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O in 
the temperature range 150-350 K, measured at a scan rate of 5 K min-1. 
Figure 4.3.5 Temperature dependence of the molar magnetic susceptibility, χM, for the 
compound [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]·H2O in the range 5-150 K. Points 
represent the cooling mode experimental data; solid red line represents the least-squares 
fit of the data to Equation (1), where D = 2.85 cm-1 and g = 2.18.  
Figure 4.4.1 The molecular structure and atom-numbering scheme for [Fe(H-5-Cl-thsa-
Me)(5-Cl-thsa-Me)]∙H2O, whereby the second ligand bound to Fe1 atom is generated by 
the symmetry operation (i) –x + 1, –y + 1, z. The hydrogen atom bound to N2 and N2i 
atoms has a site occupancy factor of 0.5, i.e. the atom is disordered over the N2 and N2i 
sites (50:50). The H2O molecule has been omitted for clarity. Displacement ellipsoids are 
drawn at the 50% probability level.  
Figure 4.4.2 A projection showing the unit cell of [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-
Me)]∙H2O. The disordered H2O molecule has been omitted for clarity. The displacement 
ellipsoids are drawn at the 50% probability level. 
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Figure 4.4.3 Hydrogen bonding system of [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O in 
the a direction. An alternative orientation for H1WA and H1WB has been omitted for 
clarity. The displacement ellipsoids are drawn at the 50% probability level. [Symmetry 
codes: (i) –x + 1, –y + 1, z; (ii) –x + 3/2, y, z + 1/2; (iii) x + 1/2, –y + 1, z + 1/2; (iv) –x 
+ 3/2, y, z – 1/2.] 
Figure 4.4.4 χMT vs T plot of [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]·H2O. The sample 
was warmed (▲) and then subsequently cooled (▼) in the temperature region of 5–320 
K, at a rate of 2 K min-1. 
Figure 4.4.5 DSC curves obtained for [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]·H2O in the 
temperature range 200-350  K, measured at a scan rate of 5 K min-1. 
Figure 4.5.1 Atom labelling of the benzene ring of the R-salicylaldehyde 4R’-
thiosemicarbazone ligand. 
Figure 5.1.1 Molecular structure of the R-salicylaldehyde 4R’-thiosemicarbazone 
ligands (i) H2-5-Br-thsa-Et and (ii) H2-4-OH-thsa  
Figure 5.2.1 The molecular structure and atom-numbering scheme for [Fe(H-5-Br-thsa-
Et)2](NO3)∙H2O. Displacement ellipsoids are drawn at the 50% probability level. 
Figure 5.2.2 A projection showing the hydrogen bonding interactions of [Fe(H-5-Br-
thsa-Et)2](NO3)∙H2O. Displacement ellipsoids are drawn at the 50% probability level. 
Dashed lines indicate hydrogen bonds. [Symmetry codes: (i) x + 1, –y + 1/2, –z + 3/2; 
(ii) x – 1/2, y, –z + 1; (iii) x, –y + 1/2, –z + 3/2.] 
Figure 5.2.3 A projection showing the unit cell of [Fe(H-5-Br-thsa-Et)2](NO3)∙H2O. 
Displacement ellipsoids are drawn at the 50% probability level. 
Figure 5.2.4 χMT vs T plot of [Fe(H-5-Br-thsa-Et)2](NO3)·H2O in the temperature range 
5-300 K. The data were measured at a rate of 2 K min-1.  
Figure 5.2.5 Temperature dependence of the molar magnetic susceptibility, χM, for the 
compound [Fe(H-5-Br-thsa-Et)2](NO3)·H2O in the range 5-300 K. Points are the 
experimental data; solid red line represents the least-squares fit of the data to Equation 
(1), where D = 2.12 cm-1 and g = 2.22.  
Figure 5.3.1 The molecular structure and atom-numbering scheme of the Fe1 unit for 
[Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O. Displacement ellipsoids are drawn at the 50% 
probability level.  
Figure 5.3.2 The molecular structure of the asymmetric unit of [Fe(H-4-OH-
thsa)2]4∙(SO4)2∙9H2O. 
Figure 5.3.3 A projection of selected hydrogen bonding ring systems within the 
asymmetric unit of [Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O. Displacement ellipsoids are drawn 
at the 50% probability level.  
147 
 
 
 
 
149 
 
 
149 
 
153 
 
163 
 
165 
 
167 
 
 
 
168 
 
170 
 
171 
 
 
 
173 
 
 
174 
 
178 
 
 
16 
 
Figure 5.3.4 χMT vs T plot of [Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O in the temperature range 
5-300 K. the data were measured at a rate of 2 K min-1. 
Figure 5.3.5 Temperature dependence of the molar magnetic susceptibility, χM, for the 
compound [Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O in the range 5-300 K. Points are the 
experimental data; solid red line represents the least-squares fit of the data to Equation 
(1), where D = 2.78 cm-1 and g = 2.10. 
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1.0 Introduction 
1.1 Introduction to the spin-crossover phenomenon  
The spin-crossover phenomenon which occurs in 3d4-3d7 transition metal systems is described as a 
change in spin state (low-spin to high-spin) due to an external perturbation [1]. Spin transitions can 
be caused by a change in temperature, pressure or light irradiation [1].  
In order to describe the occurrence of a spin transition of a metal complex, one has to consider crystal 
field theory. For the purpose of this thesis, the crystal field considerations will be explained with 
respect to an octahedral transition metal complex. Firstly, if we consider an isolated metal ion or one 
exposed to a spherical crystal field, all five d-orbitals have the same energy, i.e. the d-orbitals of the 
transition metal ion are energetically degenerate. However, when the transition metal ion is part of 
a complex system, so bound to six ligand donor atoms in octahedral symmetry, the ion is now 
exposed to a non-spherical octahedral crystal field. A rise in energy to form the degenerate doublet, 
the eg set, is due to the energy of the dz2 and the dx2-y2 orbitals increasing due to the repulsion between 
electrons in their d-orbitals and the ligand atoms, considered as negative point charges, along the 
metal-ligand direction. However, the energy of the electrons in the remaining orbitals, the dxy, dyz 
and dxz orbitals, that lie between the metal ligand axes are less affected by the crystal field, thus the 
energy is decreased to form a degenerate triplet, the t2g set, at a lower energy with respect to the 
spherical crystal field. This splitting of the d-orbitals is illustrated in Figure 1.1.  
 
Figure 1.1 The effect of the splitting of the d-orbitals when placing a metal ion into an octahedral 
crystal field (∆o splitting energy of the octahedral crystal field). 
 
Due to the splitting of the d-orbitals into the eg and t2g subsets when the 3d4-d7 transition metal ion is 
exposed to an octahedral crystal field there are two possible arrangements of the electrons in the 
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ground state i.e low-spin or high-spin state. The energy gap or difference between the eg and t2g levels 
is the octahedral crystal field strength, ∆o, and can be affected dependent upon the ligand bound to 
the metal ion. The two configurations of the electronic ground states are classed as the high-spin and 
low-spin state, as displayed in Figure 1.2 for the d5 metal ion.  
  
Figure 1.2 The two possible ground state electronic configurations for a d5 metal ion in an octahedral 
crystal field. 
 
The low-spin state is the ground state when the crystal field is strong and the energy required to pair 
electrons in the lower energy t2g orbitals is less than that required to promote it to a higher energy eg 
orbital, i.e. the electrons occupy the orbitals of lower energy. The high-spin state arrangement for 
the d5 ion contains the maximum amount of unpaired electrons. The arrangement of the electrons in 
the high-spin state d5 ion is when the energy required to promote electrons to a higher energy eg 
orbital is less than the energy to pair the electrons in the lower energy t2g orbitals. This is when ∆o is 
smaller than P (the spin pairing energy), the d-orbitals will each contain one electron prior to spin-
pairing of electrons within the same orbital, in accordance with Hund’s Rule. The low-spin state has 
the minimum spin possible for the complex system and the high-spin state possesses the maximum 
spin, with respect to the two configurations of the electronic ground states of 3d4-d7 metal ions. If 
the energy difference between the high-spin and low-spin states reaches the thermal energy, kBT, 
where kB is the Boltzmann constant and T is temperature, then the compound can interconvert 
between spin states on the application of an external perturbation. This interconversion of the 
electrons between the eg and t2g orbitals of the low-spin and high-spin states is known as a spin-
crossover, as illustrated in Figure 1.3. 
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Figure 1.3 Spin-crossover dependent upon external perturbations of temperature (T), pressure (p) or 
light irradiation (hν) for octahedral compounds of FeIII, a 3d5 system. The high-spin and low-spin 
form differ in electronic population of the 3d orbitals with an associated alteration of the magnetic 
and structural characteristics. 
 
Spin-crossover is observed in FeIII systems (3d5), whereby the significant difference is the spin of 
the high and low-spin states. For octahedral FeIII the ground state terms for S = 5/2 (high-spin) and 
S = 1/2 (low-spin) configuration of the 3d5 electronic system are described as being the sextet 6A1 
and the doublet 2T2, respectively. (The theoretical treatment of the crystal field of the present FeIII 
system is similar to that of the FeII system which is described in detail by Hauser [2].) It is widely 
recognised that the splitting by the octahedral crystal field is both sensitive to the nature of the ligand 
and the metal-donor atom bond distances. The latter causes a relative displacement of potentials 
wells for the low-spin (2T2 doublet) and high-spin (6A1 sextet) configurations along the symmetric 
stretch vibration, as represented in Figure 1.4 [2].  
The horizontal displacement of the potential wells corresponds to the population of the anti-bonding 
eg orbitals in the high-spin state, which gives rise to the lengthening of the metal-donor atom 
distances when switching from the low-spin to the high-spin state. Furthermore, the vertical 
displacement corresponds to the difference of the zero-point energies of the high-spin and low-spin 
configurations; this is defined as ∆E°(HL). It is realised that for the possibility for the thermal spin 
transition to occur ∆E°(HL) has to be of the order of kBT (thermal energy). For spin-crossover active 
metal complexes with the electronic configuration of 3d5, at low temperatures, the spin-crossover 
centre is usually found to be in the low-spin state (S = 1/2), and upon increasing the temperature the 
metal ion transitions into the high-spin state (S = 5/2).  
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Figure 1.4 The potential wells for the high-spin (6A1) and the low-spin (2T2) states as a function of 
the FeIII-donor atom distance, along the symmetric metal-ligand stretching vibration (r(M-L) where 
M = metal cation and L = ligand). The change in metal-ligand bond distance (i.e. the horizontal 
displacement of the wells) is represented by ∆r(HL), and ∆E°(HL) represents the zero point energy 
difference between the two spin states. (Adapted from reference [2]). 
 
Spin transitions can occur both in solution and in the solid state, and for the basis of this thesis only 
spin transitions of solids will be discussed. Spin-crossover of FeIII ions can be represented by their 
high-spin fraction (γHS) vs. a dependent variable, such as temperature. The most common types of 
spin transition curves are illustrated in Figure 1.5. [1]; these are: 
(i) A gradual smooth and continuous change of γHS over the temperature range; 
(ii) The transition is abrupt, whereby the transition can occur in a very narrow temperature 
range; 
(iii) An abrupt transition with hysteresis; 
(iv) Spin transition with steps; 
(v) Spin transition is incomplete. 
If the spin transition curve shows the presence of hysteresis the complex may undergo a structural 
phase change accompanied by the transition in the spin, from the low-spin to the high-spin state, 
giving rise to the named discontinuous transition.  
The manifestation of a spin transition in a solid state system is subject to the operation of lattice 
forces. So, it is known that the nature of the spin transition curve γHS(T) can be strongly influenced 
by chemical contributions which affect the lattice interactions. These include: 
(i) The nature of the anion or cation associated with the complex cation or complex anion; 
(ii) The extent and nature of solvation of the complex; 
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(iii) Variations in the ligand substituents;  
(iv) Actual ligand replacement.  
Figure 1.5 γHS(T) plots of the possible different types of thermal spin transition curve i) smooth and 
continuous, ii) abrupt, iii) with hysteresis, iv) with steps and v) incomplete. 
 
1.2 Iron(III) spin-crossover 
Since the discovery of the spin-crossover phenomenon was first described, its development has 
offered an insight into the unique process with FeIII coordination compounds. The spin-crossover 
effect was first reported by Cambi and Szegö who in 1931, conveyed the unusual temperature 
dependence of the magnetic susceptibility of various tris(N,N-dialkyl-dithiocarbamato)iron(III) 
compounds [3, 4]. Over the past 80 years spin-crossover coordination compounds have been of major 
interest to many researchers; and to date spin-crossover has been reported for some of the first row 
metal ions i.e. 3d4-d7 configurations.   
Major interest and significance of the thiosemicarbazones and their metal complexes is due to their 
diverse chemical and structural characteristics including their biological and chemical applications 
[5-8]. Particular interest has been developed in the area concerning the thiosemicarbazone being 
condensed with a suitable aldehyde to yield Schiff base-type ligands. This allows for predetermined, 
specific modifications of the ligands making them ideal candidates for generating spin-crossover in 
the FeIII compounds.  
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1.2.1 R-salicylaldehyde 4R’-thiosemicarbazone ligand system 
In solution, the free R-salicylaldehyde 4R’-thiosemicarbazone (H2L) exists in two tautomeric forms, 
i.e. the thione and thiol forms, as illustrated in Figure 1.6. Consequently, in FeIII compounds, the 
ligand may be present in either of the possible tautomers, and may be neutral, anionic or dianionic. 
Referring to the thiol tautomer, neutral H2L has H atoms located on the phenol O atom and the thiol 
S atom. The first deprotonation step involving the phenol group results in the formation of R-
salicylaldehyde 4R’-thiosemicarbazonate(1-) (abbreviated as HL‒). Subsequent deprotonation yields 
R-salicylaldehyde 4R’-thiosemicarbazonate(2-) (abbreviated as L2‒). 
 
Figure 1.6 The two tautomeric forms of R-salicylaldehyde 4R’-thiosemicarbazone, the thione (left) 
and the thiol (right). 
 
It has been observed that in solution thiosemicarbazones may consist of an equilibrium mixture of 
thione and thiol tautomers, as illustrated in Figure 1.6 [6-8]. This class of chelating tridentate R-
salicylaldehyde 4R’-thiosemicarbazone ligands generally coordinates in the anionic thiolate form 
(illustrated in Figure 1.7) [9]. The salts of the anionic bis(ligand) FeIII complexes of this class of 
Schiff base dianion frequently show spin-crossover behaviour. Typically, these FeIII compounds 
contain two doubly deprotonated ligands, and the crystal lattice comprises an associated cation and 
may contain solvent molecules as well. However, FeIII compounds with one-fold deprotonated or 
neutral ligands may also be obtained, and sometimes ligands of different degrees of deprotonation 
may be present in the same FeIII compound. 
 
Figure 1.7 The dianion of R-salicylaldehyde 4R’-thiosemicarbazone, together with the atom 
labelling of the R-salicylaldehyde unit.  
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This particular class of ferric complex, FeIII bis(R-salicylaldehyde 4R’-thiosemicarbazonato) 
systems, is the main focus of the thesis, therefore, in the following sections of this chapter selected 
R-substituted salicylaldehyde 4R’-thiosemicarbazone ferric complex systems are discussed in order 
to describe the factors affecting spin-crossover i.e. the chemical and physical influences. 
Experimental techniques to detect a spin transition are presented together with their application. An 
overview of the progress made in the research field of selected R-substituted salicylaldehyde 4R’-
substituted thiosemicarbazone ferric spin-crossover systems is herein discussed.  
 
1.3 Factors affecting spin-crossover 
The potential of a compound to exhibit a spin transition can be affected by chemical or physical 
influences which consequently can change the characteristics of the material. The conversion from 
the low-spin to the high-spin state gives rise to the increase in the ionic radius of the metal ion 
associated with the increased occupation of the anti-bonding eg orbitals and greater distance of the 
ligand donor atoms from the metal ion. This corresponds to an increase in the metal – ligand donor 
atom bond lengths. It is important to note the important consequences of a spin transition; these 
include the following: 
(i) The size increase of the ionic radius of the metal ion;  
(ii) The change in magnetic properties;  
(iii) The change in the d-d transitions (colour change). 
The main factors affecting the spin transition of a particular compound can be categorised into two 
factors: firstly, the chemical influences and secondly, the physical influences. Chemical 
modifications of spin-crossover systems include: 
(i) The nature of the anion or cation associated with the complex cation or complex anion; 
(ii) The extent and nature of solvation of the complex; 
(iii) Variations in the ligand substituents;  
(iv) Actual ligand replacement.  
Furthermore, the physical influences that affect the spin transition of this type of systems include: 
(i) Sample condition; 
(ii) Effect of temperature; 
(iii) Effect of pressure; 
(iv) Effect of light irradiation;  
(v) Effect of a magnetic field.  
31 
 
For the purpose of this thesis, anion/cation and solvent effect of the chemical influences will be 
discussed, as well as the effect of temperature, effect of pressure, and light irradiation on the spin 
transition of R-salicylaldehyde 4R’-thiosemicarbazone FeIII type compounds.  
 
1.3.1 Chemical Influences 
Anion/Cation and solvent effects 
It has been recognised that for R-salicylaldehyde 4R’-thiosemicarbazone FeIII compounds the spin-
state may be sensitive to changes in the counter-ion, whether that is an anion with respect to an 
[FeIII(HL)2]+ type compound or a cation with respect to an [FeIII(L)2]‒ type compound [9-10]. The 
variation of the associated cation has been investigated for various FeIII compounds of R-
salicylaldehyde 4R’-thiosemicarbazones. In particular, the ferric complexes with the unsubstituted 
dianionic salicylaldehyde thiosemicarbazone (thsa2–) have been extensively researched, whereby the 
outersphere cation has been varied, to give rise to the compounds NH4[Fe(thsa)2] [11], Cs[Fe(thsa)2] 
[12], Li[Fe(thsa)2]∙2H2O [13], Na[Fe(thsa)2]∙3H2O [13] and (C5H5NH)[Fe(thsa)2]∙H2O [14].  
The attempts made to correlate the structural features of these types of systems concluded that 
significant changes in the magnetic behaviour may be due to: 
(i) The replacement of the associated outer-sphere cation in the ferric complex; 
(ii) The introduction of R-substituents into the salicylaldehyde moiety of the 
salicylaldehyde thiosemicarbazone type ligands; 
(iii) The incorporation of the substituents on the terminal amido group of the 
thiosemicarbazone residue; 
(iv) The degree of hydration of the complex system. 
The compound NH4[Fe(thsa)2] [11] was found to be in the low-spin state at 300 K. Replacing the 
NH4+ cation with Cs+, creating the compound Cs[Fe(thsa)2] [12] gave rise to a compound in the high-
spin state at 298 and 103 K. The ferric complex Li[Fe(thsa)2]∙2H2O is in the low-spin state (at both 
measurement temperatures 80 and 300 K), whereas Na[Fe(thsa)2]∙3H2O was found to exhibit a spin 
transition between the low- and high-spin state over the temperature range 80-300 K [13]. 
Furthermore, (C5H5NH)[Fe(thsa)2]∙H2O (C5H5NH = pyridine) was found to exhibit spin-crossover 
behaviour using 57Fe Mössbauer spectroscopy in the temperature range 80 – 280 K [14]. It may be 
considered that the variation of the cation has an indirect influence on the spin state of the FeIII ion, 
with respect to the crystal packing of the ferric complexes and the degree of hydration of the system. 
In addition, the R-substituted ligands 5-bromosalicylaldehyde and 5-chlorosalicylaldehyde 
thiosemicarbazone ferric complexes have also been investigated for the variation of the associated 
cation. The crystal structures determined for NH4[Fe(5-Br-thsa)2] (at 298 K) [15] and NH4[Fe(5-Cl-
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thsa)2] (at 135 and 298 K) [16] show that all three crystal structures contain an FeIII cation in the low-
spin state.  
 
1.3.2 Physical Influences 
Effects of Temperature 
Thermally induced spin transitions are the most widely recognised form of spin-crossover for FeIII 
compounds. Thermally induced discontinuous spin-crossover conversions exist for those systems of 
which the high-spin to low-spin transition occurs abruptly over a minute temperature interval. The 
temperature at which the thermal spin transition is usually described as T1/2, which is considered as 
the temperature at which half of the low-spin (S = 1/2) FeIII cations have transitioned to the high-
spin state (S = 5/2). Furthermore, for those systems which exhibit hysteresis two T1/2 values will be 
observed, one for the transition when measured in the heating mode and the other when decreasing 
the temperature.  
 
Effects of Light Irradiation 
Decurtins et al., discovered for FeII that by irradiating a low-spin solid-state sample with green light 
(λ = 514 nm), the low-spin compound could be promoted to a metastable high-spin state [17]. This 
phenomenon is known as the LIESST effect (Light Induced Excited Spin State Trapping) [17]. The 
LIESST effect has been demonstrated for FeII spin-crossover systems and even though the 
phenomenon appears to be unfavourable for FeIII spin-crossover systems, it has been observed that 
systems which exhibit strong intermolecular interactions such as π-π stacking and hydrogen bonds 
afford cooperative spin transitions with large thermal hysteresis and LIESST effects [18, 19]. In 
particular, this type of behaviour is of great interest as it creates the bistability required for essential 
applications such as optical switches in memory devices.  
At this stage, the process has been described for FeII, however the exact mechanism for FeIII has not 
been entirely clarified thus far, therefore, the mechanism for FeII will now be discussed in detail. The 
LIESST effect is depicted in a schematic mechanism in Figure 1.8 [20]. The process for FeII typically 
allows for the irradiation of a low-spin sample using an Ar+ laser with a wavelength of approximately 
λ = 514 nm (green) and at temperature below 50 K. This causes the sample to become bleached, 
hence results in a colour change. The LIESST effect was first observed for the compound [FeII(1-
propyltetrazole)6](BF4)2, which resulted in the low-spin purple sample becoming colourless (high-
spin). Stimulation due to exposure to the green light causes the complex to be in an excited state 
when undergoing a spin allowed transition from the low-spin, 1A1 state to the 1T1 state. The 
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metastable high-spin state, 5T2, is reached due to a small probability that the excited 1T1 state decays 
by a two stage intersystem crossing process via the intermediate 3T1 spin state. The trapped excited 
spin state, 5T2, has a long lifetime at low temperatures (usually below 50 K).  
 
Figure 1.8 Schematic representation of the mechanism for LIESST (green arrow) and reverse-
LIESST (red arrow) for FeII systems. The solid lines indicate excitation by irradiation while dotted 
lines represent relaxation pathways. (Adapted from reference [20]). 
 
In 1986 Hauser discovered the existence of the reverse process termed reverse-LIESST [21], for 
which the excitation results from using a longer wavelength of light (red light, λ = 980 nm) [22]. The 
metastable high-spin state is converted back to the low-spin state, 1A1, via an intersystem crossing 
resulting in the transformation from 5T2 → 3T1 → 1A1. However, the metastable high-spin state can 
also be converted back to the low-spin state by increasing the temperature above 50 K i.e. thermal 
relaxation.  
The manifestation of the possible photo-control of the spin-state of spin-crossover systems meant 
these type of compounds could be used as optical switches, storage and memory devices [1]. Due to 
the low temperatures required to keep the systems in the photo-induced metastable high-spin state, 
further research was conducted to develop an array of new phenomena.  
Since the discovery of the LIESST effect, many other light-induced spin-crossover techniques have 
been identified. This has mainly been driven by the limitations of the LIESST effect, as this occurs 
at low-temperatures and is incompatible with room temperature applications. The list of discovered 
light induced stimuli for spin-crossover materials is as follows: 
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(i) NIESST – Nuclear induced excited spin state trapping [23-26] 
(ii) LIESST – Light induced excited spin state trapping  
(iii) LD-LISC – Ligand driven light induced spin change [27] 
(iv) LD-CISSS – Light driven coordination induced spin state switching [28] 
(v) SOXIESST – Soft X-ray induced excited spin state trapping [29] 
(vi) SF-LIESST – Strong field light induced excited spin state trapping [30] 
(vii) HAXIESST – Hard X-ray induced excited spin state trapping [31] 
(viii) VUVIESST – Vacuum UV induced excited spin state trapping [32]  
(ix) LITH – Light induced thermal hysteresis [33, 34] 
(x) LIOH – Light induced optical hysteresis [33] 
(xi) LiPTH – Light induced perturbed thermal hysteresis [35] 
(xii) LiPOH – Light induced perturbed optical hysteresis [35, 36] 
(xiii) HAXITH – Hard X-ray induced thermal hysteresis [37] 
LIESST and NIESST are initiated at cryogenic temperatures, this leads to the decay of the meta-
stable states at higher temperatures, thus preventing potential room temperature photo-induced spin 
state switching and their use in molecular switching applications.  
Ligand Driven – Light Induced Spin Changes (LD – LISC) have been reported by Zarembowitch et 
al., [38]. This phenomenon occurs when light irradiation promotes a change in the ligand, e.g. cis-
trans isomerism in the ligand creating a change in the ligand field strength, which triggers a spin 
transition at the metal centre [38]. This may allow for a longer life time of the photo-induced spin 
conversions between spin-states at higher temperatures. An example of the LD – LISC phenomenon 
has been reported for the compound [Fe(trans-stpy)4(NCS)2] (where stpy = 4-styrylpyridine) [38]. 
The 4-styrylpyridine was used as the photo-switchable ligand, giving rise to cis- and trans-4-
styrylpyridine (Figure 1.9). [Fe(trans-stpy)4(NCS)2] exhibits a thermally induced spin transition at 
around 108 K, whereas [Fe(cis-stpy)4(NCS)2] is found to be in the high-spin state at any temperature 
[38]. In general, by irradiating the sample with light of an appropriate wavelength, one should be 
able to induce a spin transition in the system resultant from the photo-conversion of the ligand.  
 
Figure 1.9 Trans (left)/cis (right) isomerisation in 4-styrylpyridine (stpy). 
hν 
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The many mechanisms induced by visible light discovered in recent decades show the differentiation 
between using light irradiation as a single excitation pulse and that of continuous exposure of visible 
light. Most of the aforementioned mechanisms are based on the LIESST phenomena, using 
continuous light irradiation. However, the mechanisms labelled LITH and LIOH are induced at 
cryogenic temperatures, whereas, LiPTH and LiPOH may occur at much higher temperatures [35, 
36]. The LiPTH and LiPOH mechanisms that stimulate spin-state switching are therefore eligible 
candidates for potential applications.  
Létard et al., and Varret et al., both identified hysteretic switchable materials, an FeII mononuclear 
complex [34] and a coordination polymer [33] by the LITH phenomena. After the population of the 
meta-stable high-spin state at low temperature (via the LIESST effect), the LITH effect maintains 
the green light irradiation both in the warming and heating modes. Varret et al., [33] observed a 
similar behaviour to that of the LITH effect, by varying the intensity of the light irradiation at a 
constant temperature, this hysteresis effect is known as LIOH. LIESST, LITH, and LIOH 
mechanisms demonstrate hysteresis effects at cryogenic temperatures, whereas the LiPTH [35] and 
LiPOH [35,36] are spin transition stimuli at higher temperatures. Both the LiPTH and LiPOH 
mechanisms are based on the high-spin state excitation by light and thermal decay, whereby the 
hysteresis behaviour may be manipulated [35,36].  Renz et al., [35] reported the coordination 
compound [Fe(phy)2](BF4)2 (phy = 1,10 phenanthroline-2-carbaldehyde-
phenylhydrazone)demonstrated a thermal hysteresis between 270 K and 280 K, by exposure to 
continuous irradiation with green light the thermal hysteresis shifted to lower temperatures and with 
exposure to red light shifted to higher temperatures [35].  
The previously mentioned effects LITH, LIOH, LiPTH and LIPOH stimulate a spin-crossover by 
visible light, however, spin-crossover can be induced by X-ray excitation. This fairly new stimulus 
was first observed by Collison et al., [29] which discusses the first excitation effects induced by X-
rays, though it should be noted that XPS and XAFS ere used to monitor spin-crossover in 
coordination compounds [39,40]. Collison et al., have evidenced that X-rays with low energy may 
stimulate a spin-crossover at low temperatures, this effect is known as SOXIESST – Soft X-ray 
Induced Excited Spin State Trapping. Similar to the LIESST effect, the SOXIESST effect also traps 
the high-spin state below a certain temperature by irradiation with soft X-rays (instead on light). The 
SOXIESST effect has been observed for the mononuclear complex [Fe(bpz)2(phen)] (where bpz = 
dihydrobis(pyrazolyl)borate) whereby the named complex was in direct contact with a highly 
oriented pyrolytic graphite surface [41] or absorbed on Au(111) [42]. Moreover, the HAXIESST 
effect (Hard X-ray Induced Spin State Trapping) was also discovered in the mononuclear complex 
[Fe(bpz)2(phen)] (where bpz = dihydrobis(pyrazolyl)borate) at low temperatures.  
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This array of mechanisms induced by light irradiation or X-rays, opens the door for potential a new 
array of mononuclear and multinuclear switchable coordination compounds, which could indeed 
stimulate progression in the field owing to the applications of the materials in nanoscience to 
customize future spintronic devices.  
 
Effects of Pressure 
Physical perturbations can either initiate or modify a spin transition. The occurrence of a spin 
transition in a metal complex results in a considerable change in the metal-ligand bond lengths and 
therefore a change in volume of the crystallographic unit cell, provided that the symmetry and hence 
the space group of the unit cell remains unchanged. Due to this feature, the spin-crossover materials 
are sensitive to the application of pressure; this is particularly so for FeII spin-crossover materials. It 
is known that the compound in the high-spin state has a larger volume than that of the respective 
low-spin form of a compound, thus the application of an increased external perturbation, in this case 
pressure to a spin-crossover system in the high-spin state at ambient pressure can result in the 
formation of the low-spin form. Referring to the energy diagram of FeII systems (displayed in Figure 
1.10) the applied (higher) pressure raises the energy of the 5T2 high-spin state potential well [43]. 
This rise in energy results in a decrease in activation energy (∆WHL) and an increase in the difference 
in zero point energy (∆EHL), therefore favouring the low-spin state of FeII, 1A1.  
 
Figure 1.10 Schematic representation of the effect of pressure (p) on FeII spin-crossover systems. 
(Adapted from reference [43]). 
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The effect of an applied external pressure on FeIII spin-crossover materials has not been extensively 
studied. The first studies using high-pressure to initiate a spin transition of spin-crossover materials 
were carried out in the 1960s and primarily focused upon a series of FeIII complexes [44]. In 1969 
Ewald et al., showed that for tris(N,N-disubstituted-dithiocarbamato)iron(III) compounds spin 
transitions may be induced when the pressure on the ferric complexes in solution is increased at 
constant temperature [44]. Butcher et al., studied the effect of an applied external pressure by 
analysing the infrared spectra of these FeIII spin-crossover materials by studying the metal-ligand 
stretching region as a function of pressure (up to 35 kbar) [45]. For the spin-crossover compound 
tris(N-ethyl-N-phenyl-dithiocarbamato)iron(III) it was deduced that the intensity of the metal-sulfur 
band assigned to the low-spin state increases relative to the high-spin state band with increasing 
pressure [45].  
 
Effects of an applied Magnetic Field 
The spin transition alters the magnetic properties of the metal system. It is anticipated that 
perturbation of a spin transition material by an external magnetic field could therefore affect the 
transition. This effect may be predicted by theoretical calculations, in particular based on the 
thermodynamics and the magnitude of the change in transition temperature [1]. In an applied 
magnetic field, B, a decrease in the transition temperature is anticipated, this is caused by the 
decrease in the energy of the molecules in the high-spin state by their magnetic moment μHS = χB [1, 
46]. The theoretical calculations for an FeII system have predicted that the effect of the applied 
magnetic field would be minute whereby a change in the critical temperature of only ‒0.1 K is 
calculated for a field of 5 Tesla. Applied magnetic field studies carried out by Qi et al., measured 
the shift in the transition curve for the compound [FeII(phen)2(NCS)2], the results (‒0.11 ± 0.04 K 
when exposed to fields of between 1 and 5 Tesla) agreed with the predicted values [47]. It was 
concluded from these studies that the effect of the magnetic field on the spin transition temperature 
was weak. More recently, the applied magnetic field studies of the same FeII compound have 
advanced somewhat to yield the spin-crossover transition temperature a change in the critical 
temperature of ‒1.8 K in a pulsed magnetic field of 30 Tesla [48-50].  
 
1.3.3 Detection of spin-crossover 
A spin-crossover in a material can be measured by a variety of techniques due to three key 
consequences of a spin transition: (i) the changes in the metal-donor atom distances, resultant from 
the change in relative occupancies of the t2g and eg orbitals, (ii) changes in d-d transitions give rise 
to different optical properties and (iii) the changes of the magnetic properties. The principal 
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techniques employed in this thesis for detecting a spin transition of 3d4-3d7 metal complexes are 
herein briefly described. 
 
1.3.3.1 Experimental techniques 
Magnetic Measurements 
The principal technique to characterise the spin transition of a 3d4-3d7 metal complex is the 
measurement of the molar magnetic susceptibility as a function of temperature, χM(T). A spin-
crossover transition involves a change in the number of unpaired electrons on the metal ion which is 
evidenced by the magnetic behaviour of the spin-crossover material. The magnetic susceptibility of 
the sample is proportional to the amount of material being in the high-spin and low-spin state; this 
data is used to express a spin transition curve (vide supra). Notably, the magnetism is a property of 
the bulk material whereas the spin transition of these types of compounds is defined by individual 
molecules and so hence the change in magnetism is not sufficient to verify the existence of the spin 
transition [1, 51].  
In order to study the magnetic properties of these type of materials, solid-state measurement 
techniques such as a Faraday balance, a SQUID (Superconducting Quantum Interference Device) or 
a Foner-type magnetometer can be used, whereas for liquids, the Evans NMR method can be 
employed. In recent years, primarily the SQUID measurement technique has been at the fore front 
for measuring the magnetic properties of these materials [1].  
When measuring the magnetic susceptibility of a material as a function of temperature, the material 
is exposed to a homogeneous external magnetic field and a magnetisation is induced in the sample 
material. This degree of magnetisation can be expressed in terms of molar magnetic susceptibility 
(χM), which is comprised of two components (i) the paramagnetic component originating from a 
permanent magnetic dipole moment, which acts in the direction of the applied field and (ii) the 
diamagnetic component which is a distortion causing a small magnetic moment against the applied 
field [52]. For a spin-crossover material, the product of the molar magnetic susceptibility and 
temperature (T) as a function of temperature, χMT(T), can be obtained through Equation 1.1, where 
M is the magnetisation of the sample, H is the applied magnetic field, m is the mass of the sample, 
Mr is the molar mass of the compound and T is the temperature. 
𝜒𝑀T = [
𝑀
H x (
m
𝑀𝑟
)
]  𝑇             (1.1) 
Expected values for χMT for octahedral FeIII spin-crossover compounds are as follows:  
(i) χMT = 0.375 cm3 mol-1 K (for g = 2.0023) for the low-spin state (S = 1/2) material, 
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(ii) χMT = 4.37 cm3 mol-1 K (for g = 2.0023) for the high-spin state (S = 5/2) material.  
 
Crystallographic Studies 
Single crystal X-ray diffraction is used extensively in the study of spin-crossover compounds. The 
existence of a spin transition of a transition metal complex can be confirmed through the 
determination of the difference of the bond distances between the structures of compounds in the 
two spin states, detected both above and below the transition temperature. These variable 
temperature measurements of the structural features of these types of compounds indicate whether 
the spin transition, if present, is associated with a change in the crystallographic space group. It is 
noteworthy, that continuous spin transitions generally only reveal changes in both the metal – ligand 
bond distances and angles, whereas a discontinuous spin transition exhibiting hysteresis in a 
thermally induced spin transition often occurs with a change in the crystallographic space group [1, 
53]. Thus, it can be suggested that the variable temperature structural investigations can be used to 
interpret the effect of intermolecular interactions on the spin-transition and therefore the 
cooperativity property of the sample. The cooperativity displayed by a spin-crossover material is a 
type of behaviour whereby a number of seemingly independent components of the system act 
collectively. The relationship between the structural features and the spin transition of spin-crossover 
compounds allows the directed design and synthesis of these materials to give rise to specific 
physical properties, such as an abrupt spin transition near ambient temperature. Therefore, the 
determination of the crystal structure of these spin-crossover materials is critical, specifically at 
variable temperatures around the spin-transition temperature. Structural investigations of spin-
crossover materials have revealed that in all cases it is expected that the metal-ligand bond distance 
is shorter in the low-spin state than that of the high-spin state, due to the change from S = 1/2 to S = 
5/2; therefore, a restructuring of charge occurs in the system.  
 
Spectroscopic Methods 
Variable temperature near- and far-infrared spectroscopy and UV-Vis spectroscopy can be used to 
detect a spin-transition of a material, as well as obtaining information on the structure of the 
compound. The thermally induced spin transition from the high-spin to low-spin states of FeIII spin-
crossover compounds is accompanied by a depletion of the charge in the antibonding eg orbitals and 
simultaneous increase of charge in the bonding t2g orbitals. As a consequence, a change in the metal-
ligand bond distances on going through the transition makes the vibrational spectroscopies extremely 
useful. As a detection tool UV-Vis spectroscopy can also be used to detect the electronic changes of 
a spin-crossover system. In some cases, one may follow the d-d transitions of the low-spin and the 
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high-spin species individually. For FeIII spin-crossover systems, the 5T2 → 5E transition of the high-
spin species appears as a weak band in the near infrared, while for the low-spin species two bands 
occur, corresponding to the two ligand field transitions 1A1→ 1T1 and 1A1→1T2, both in the visible 
region. In the occurrence of ligands with low-lying π* orbitals, the metal to ligand charge-transfer 
transitions for both spin states appear in the visible region and mask the d-d transitions for the low-
spin state, but for the high-spin state they are generally displaced to higher frequencies and are much 
weaker, so the spin transition can still be followed by the appearance and disappearance of the metal 
to ligand charge-transfer band of the low-spin state. 
 
Mӧssbauer Spectroscopy  
Mӧssbauer spectroscopy is a technique that probes the hyperfine interactions between the nuclei and 
its surrounding electrons to measure information on the magnetic, electronic and structural properties 
within a material. The most common isotope to Mӧssbauer spectroscopy is the 57Fe isotope and 
hence FeII and FeIII containing spin-crossover materials are widely investigated [1, 53]. 57Fe 
Mӧssbauer spectroscopy has proved a useful application in the characterisation of a spin transition 
curve influenced by a variety of conditions such as; variable temperature, pressure and concentration.    
The most significant Mӧssbauer spectral parameters are the isomer shift, δ, and the quadrupole 
splitting, ΔEQ, which are derived from an Mӧssbauer spectrum [1, 53-55]. The hyperfine interactions 
are probed by oscillating gamma rays, when the energy of the gamma ray is equivalent to that of a 
nuclear transition in the 57Fe Mössbauer nucleus, the gamma ray is resonantly absorbed, and a peak 
is observed on the Mössbauer spectrum [53]. The isomer shift (position of the peak), δ, is reported 
relative to a known absorber. The isomer shift is dependent on the screening effect of d-electrons on 
the nucleus i.e. more d-electrons increases the screening effect which results in a large positive 
isomer shift [53]. The isomer shift is proportional to the s-electron density at the nucleus, and hence 
is directly influenced by the s-electron population and indirectly (via shielding effects) by the d-
electron population in the valence shell, i.e. the area of each peak is proportional to the amount of 
species present [54,55]. As a result, when there are multiple peaks the ratio of species present in a 
sample can be determined i.e. the ratio of FeII to FeIII or high-spin to the low-spin state. Therefore, 
variable temperature Mӧssbauer spectroscopy is a very useful technique for observing spin-
crossover, and to examine the proportion of the low-spin to the high-spin states during the spin-
transition [1]. Furthermore, a Mӧssbauer spectrum includes the quadruple splitting, ΔEQ, which is 
observed as a doublet peak on the spectrum. The quadrupole splitting is observed when an 
inhomogeneous electric field at the Mӧssbauer nucleus is present, a nuclear quadrupole moment is 
produced when nuclei have an asymmetrical charge distribution, which interacts with the electric 
field gradient and results in the splitting of the nuclear energy levels [1,54,55]. The quadrupole 
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splitting is the distance between the two peak observed on a spectrum. The data collected from the 
quadrupole splitting gives rise to information on the molecular structure of the materials, as well as, 
together with the isomer shift, can be used to distinguish between different oxidation and spin states 
[1].  
 
Differential Scanning Calorimetry 
Differential Scanning Calorimetry (DSC) can be used to determine the transition temperature of the 
spin transition in addition to the enthalpy (∆H) and entropy (∆S) of the spin transition [56].  
 
1.4 Iron(III) spin-crossover systems with bis(R-salicylaldehyde 4R’-thiosemicarbazone) 
ligands 
Iron(III) occupies a unique position in the development of the spin-crossover area since it was for 
derivatives of this ion that the phenomenon was first discovered. The aim of this section is to 
introduce the class of spin-crossover compounds, iron(III) bis(R-salicylaldehyde 4R’-
thiosemicarbazone), as this type of compound will be the main focus in this thesis.  
 
1.4.1 Structural aspects 
The structures of FeIII bis(ligand) systems consist of a distorted FeO2N2S2 octahedral core, in which 
the two tridentate ligands coordinate meridionally around the FeIII cation [57]. The coordination core 
contains two nitrogen atoms (imine) in trans disposition, two oxygen atoms (phenolate) and two 
sulfur atoms, whereby the S and O atoms are located in cis positions [57]. The crystal structures of 
several R-substituted salicylaldehyde 4R’-thiosemicarbazone FeIII compounds have been determined 
at various temperatures and the iron-donor atom distances are recorded in Table 1.1. 
The details of the FeIII bis(ligand) compounds as displayed in Table 1.1 indicate that it is possible 
for the R-salicylaldehyde 4R’-thiosemicarbazone ligands to coordinate to the FeIII ion in manner of 
different forms. Up to now the following forms have been reported: the FeIII bis(ligand) compounds 
can be comprised of their constituents in one of three ways: (cation+)[Fe(L2‒)2]∙solvent, [Fe(HL‒)(L2‒
)]∙solvent or [Fe(HL‒)2]∙(anion‒)∙solvent. The abbreviated term HL‒ represents the singly 
deprotonated R-salicylaldehyde 4R’-thiosemicarbazonate(1-) ligand (involving the phenolate group) 
and the abbreviated L2‒ term denotes the doubly deprotonated R-salicylaldehyde 4R’-
thiosemicarbazonate(2-) ligand.  
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Table 1.1 Crystallographic data of R-salicylaldehyde 4R’-thiosemicarbazone FeIII bis(ligand) 
compounds. 
Compoundi T  
(K) 
Space 
group  
Fe-S 
(Å) 
Fe-N 
(Å) 
Fe-O 
(Å) 
Spin 
Stateii 
Ref 
Cs[Fe(thsa)2] 298 
103 
Pna21 
Pna21 
 
2.44 
2.44 
2.12 
2.15 
1.96 
1.96 
HS 
HS 
[12] 
NH4[Fe(5-Br-thsa)2]iii 298 Pnca 
 
2.23 1.93 1.95 LS [15] 
NH4[Fe(5-Cl-thsa)2] 298 
135 
Pnca 
Pnca 
2.24 
2.23 
1.95 
1.96 
1.93 
1.94 
LS 
LS 
 
[16] 
NH4[Fe(3,5-Cl-thsa)2]∙1.5H2O 298 
 
 
103 
P21/a 
Site A 
Site B 
P21/a 
Site A 
Site B 
 
2.26 
2.40 
 
2.25 
2.31 
 
1.95 
2.06 
 
1.95 
1.95 
 
1.93 
1.97 
 
1.93 
1.94 
 
LS 
HS-sco  
 
LS  
LS-sco 
 
[58] 
Li[Fe(5-Br-thsa)2]∙H2O 373 
150 
P21/c 
P21/c 
2.35 
2.25 
2.17 
1.98 
1.95 
1.93 
HS 
LS 
 
[59] 
[Fe(H-thsa)(thsa)]∙H2O 295 P21/n 2.406 2.139 1.911 HS [18] 
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Table 1.1 Crystallographic data of R-salicylaldehyde 4R’-thiosemicarbazone FeIII bis(ligand) 
compounds (continued).  
Compoundi T  
(K) 
Space 
group  
Fe-S 
(Å) 
Fe-N 
(Å) 
Fe-O 
(Å) 
Spin 
Stateii 
Ref 
[Fe(H-5-Cl-thsa)(5-Cl-thsa)]∙H2O 295 
 
P21/n 2.367 2.164 1.911 HS [18] 
[Fe(H-5-Br-thsa)(5-Br-thsa)]∙H2O 303 
 
123 
P21/n 
 
P21/n 
2.445 
 
2.259 
2.14 
 
1.95 
1.945 
 
1.96 
HS 
 
LS 
 
[60] 
[Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-
Me)]∙H2O 
293 
 
260 
 
110 
Cc 
 
Cc 
 
Cc 
2.422 
 
2.32 
 
2.24 
2.11 
 
2.00 
 
1.94 
1.92 
 
1.925 
 
1.936 
HS 
 
IS 
 
LS 
[19] 
i The ligands are defined as follows: salicylaldehyde thiosemicarbazone = H2thsa (H2L form), 5-
bromosalicylaldehyde thiosemicarbazone = H2-5-Br-thsa (H2L form), 5-chlorosalicylaldehyde 
thiosemicarbazone = H2-5-Cl-thsa (H2L form), and 5-chlorosalicylaldehyde 4-
methylthiosemicarbazone = H2-5-Cl-thsa-Me (H2L form). 
ii The spin states are defined as low-spin (LS) and high-spin (HS); sco indicates the occurrence of 
spin-crossover. 
iii Determined for crystals of tabular form. 
 
Several compounds reported by Ryabova et al., [12, 15, 16, 58] display coordination of the R-
salicylaldehyde 4R-thiosemicarbazone ligands to the FeIII cation in the dianionic thiol form, giving 
rise to an anionic metal fragment. These systems are usually composed of a cation, an anionic 
[FeIII(L2‒)2]‒ fragment and in the case of the compound NH4[Fe(3,5-Cl-thsa)2]∙1.5H2O [58], water 
solvent molecules. Similarly, Floquet et al., reported the (cation+)[Fe(L2‒)2]∙solvent compound 
Li[Fe(5-Br-thsa)2]∙H2O [59].  
Furthermore, the complexes consistent with the [Fe(HL‒)(L2‒)]∙solvent composition have only been 
reported in the literature for Fe(III) over the past decade [18, 19, 60]. The compounds containing 
both the anionic and dianionic form of the ligand, so in the thione and thiol form of the tautomer, 
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appear more likely to exhibit the spin-crossover phenomenon than the more common 
(cation+)[Fe(L2‒)2]∙solvent compounds.  
The spin state of the metal ion of these FeIII bis(ligand) compounds can be inferred from the metal-
donor atom bond distances. X-ray structural data of this class of FeIII bis(ligand) compounds 
containing FeIIIO2N2S2 geometry, show that the Fe‒S, Fe‒N and Fe‒O bond distances are in the 
ranges 2.23-2.31, 1.93-1.95 and 1.88-1.96 Å, respectively, for low-spin FeIII compounds, and 2.40-
2.44, 1.96-1.99 and 2.05-2.15 Å, respectively, for corresponding high-spin FeIII compounds [9]. 
The non-solvated FeIII bis(ligand) compounds reported by Ryabova et al., [12, 15, 16] (Table 1.1) 
do not exhibit a transition from low-spin to high-spin FeIII, however, similar materials have been 
found to exhibit the spin-crossover phenomenon with increasing temperature, but crystallographic 
data are not available for these non-solvated materials. The FeIII cation in the compound 
Cs[Fe(thsa)2] is in the high-spin state at both 103 and 298 K [12], whereas the FeIII cation in 
NH4[Fe(5-Cl-thsa)2] is in the low-spin state at both 135 and 298 K [16]. Furthermore, in NH4[Fe(5-
Br-thsa)2], the FeIII cation is in the low-spin state at 298 K [15]. For the compounds NH4[Fe(3,5-Cl-
thsa)2]∙1.5H2O [58] and Li[Fe(5-Br-thsa)2]∙H2O [59], with increasing temperature the FeIII cation 
undergoes a spin transition from low-spin (S = 1/2) to high-spin (S = 5/2) state. Furthermore, the 
crystallographic data of NH4[Fe(3,5-Cl-thsa)2]∙1.5H2O indicated that within the unit cell there are 
two different FeIII centres, labelled Site A and Site B (Table 1.1). Only Site B undergoes a spin 
transition upon increasing temperature, whereas Site A remains in the low-spin state [58].  
The structure of Li[Fe(5-Br-thsa)2]∙H2O has been determined at 373 and 103 K [59]. Both the high-
spin and low-spin form of the complex crystallise in the monoclinic system P21/c; this despite the 
occurrence of the crystallographic phase transition at 150 K in the low-spin form where the crystal 
structure preferentially favours the pseudo-orthorhombic system [59]. The structure determined for 
the high-spin form of the [Fe(5-Br-thsa)2]‒ fragment at 373 K shows a distortion from the ideal 
octahedral symmetry with bond angles involving the FeIII ion and the ligand donor atoms deviating 
from the expected 90° [59]. The distortion of the octahedron is due to the strain caused by the 
interconnected five- and six-membered chelate rings. Floquet et al., cited that the determined bond 
angles of the high-spin ferric complex [Fe(5-Br-thsa)2]‒ at 373 K are very similar to those reported 
by Ryabova et al., for the high-spin ferric complex Cs[Fe(thsa)2] [12]. Moreover, van 
Koningsbruggen et al., [9] reported that the FeO2N2S2 geometry of the FeIII atom in the Cs[Fe(thsa)2] 
complex is very close to that reported for the Site B of the NH4[Fe(3,5-Cl-thsa)2]∙1.5H2O. The low-
spin form at 150 K of the compound Li[Fe(5-Br-thsa)2]∙H2O is quite different to the reported high-
spin state compound at 373 K [59]. The crystal structure of the low-spin form gives rise to a distorted 
FeIIIO2N2S2 orthorhombic system which is similar to the FeIII bis(ligand) compound reported by 
Ryabova et al., for the low-spin ferric complexes NH4[Fe(5-Br-thsa)2] [15] and NH4[Fe(5-Cl-thsa)2] 
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[16]. Considering both the FeIIIO2N2S2 geometry and crystal structure of the low-spin [Fe(5-Br-
thsa)2]‒ (at 150 K), both infer that the unit cell parameters and moreover the molecular packing 
display a dramatic change upon temperature decrease [59]. The molecular characteristics determine 
the packing and intermolecular interactions of both the high-spin (373 K) and low-spin (150 K) form 
of [Fe(5-Br-thsa)2]-, illustrated in Figure 1.11 [59]. Generally, the crystal packing and intra/inter-
molecular interactions involve hydrogen bonding and π-π interactions. In particular, attention can be 
focused on the nature of the interactions and how the crystallographic phase transition is modified 
as a consequence of the strength of these interactions. The comparison of these interactions from 
both the high-spin and low-spin forms leads to the indication that the molecular packing of the ferric 
complexes occurs in layers [59]. The low-spin form strongly suggests close packing occurring due 
to hydrogen bonding. The anionic compound in both the low-spin and high-spin state have been 
continuously influenced by the intermolecular interactions involving both the N-atoms and O-atoms 
of the dianionic tridentate ligand, but also the interactions formed with the Br-substituent of the 
salicylaldehyde moiety [59]. The high-spin form displayed no π-π stacking interactions, though it 
was identified that the hydrophobic component of the dianionic ligand, i.e. the bromo-substituted 
aromatic ring, separated the parallel layers of the ferric complex molecular packing [59].  
 
Figure 1.11 The strongest intermolecular contacts between [Fe(5-Br-thsa)2]- complexes at (a) 150 K 
and (b) 373 K, adapted from reference [59].  
 
The FeIII compounds with the [Fe(HL)(L)]∙solvent configuration listed in Table 1.1 show that the 
chelated ligands are bound to the central FeIII atom in two differently charged tautomeric forms, i.e. 
the thione and thiol tautomers. The thione form is the anionic tridentate ligand and bears a proton on 
the hydrazinic nitrogen atom, whereas the dianionic thiol form, does not possess a proton on the 
hydrazinic nitrogen atom. Typically, the compounds of this configuration as displayed in Table 1.1 
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exhibit a distorted octahedral geometry as the Fe-donor atom bond angles deviate from the ideal 90° 
[18, 19, 60].  
Yemeli Tido reported the crystal structures of the isostructural compounds [Fe(H-thsa)(thsa)]∙H2O 
and [Fe(H-5-Cl-thsa)(5-Cl-thsa)]∙H2O at 295 K [18]. Both compounds crystallise in the monoclinic 
P21/n system. The FeIII cation in both compounds was found to be in the high-spin state at 295 K. 
The packing arrangements of [Fe(H-thsa)(thsa)]∙H2O and [Fe(H-5-Cl-thsa)(5-Cl-thsa)]∙H2O 
(displayed in Figure 1.12) are such that 2D sheets are formed, whereby the FeIII entities are packed 
closely together forming a parallel π-π stacking interaction with the water solvent molecules inserted 
within each sheet [18].  
 
Figure 1.12 (a) The molecular packing arrange of [Fe(H-thsa)(thsa)]∙H2O and (b) illustrates the 2D 
networks of [Fe(H-5-Cl-thsa)(5-Cl-thsa)]∙H2O. (c) and (d) illustrate the π-π stacking interactions of 
[Fe(H-thsa)(thsa)]∙H2O and [Fe(H-5-Cl-thsa)(5-Cl-thsa)]∙H2O at 295 K, respectively. (Adapted from 
reference [18]). 
 
Furthermore, the crystal structure of [Fe(H-5-Br-thsa)(5-Br-thsa)]∙H2O reported by Li et al., [60] at 
303 and 123 K was found to be isostructural to the compounds [Fe(H-thsa)(thsa)]∙H2O [18] and 
[Fe(H-5-Cl-thsa)(5-Cl-thsa)]∙H2O [18]. The FeIII atom of [Fe(H-5-Br-thsa)(5-Br-thsa)]∙H2O was 
found to be in the high-spin state at 303 K, and in the low-spin state at 123 K [60]. Interestingly, Li 
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et al., observed upon decreasing the temperature from room temperature the crystallographic data 
revealed a symmetry closer to the triclinic space group P1 (Z = 4), where there were found to be four 
crystallographically independent FeIII complexes in the unit cell, i.e. three in the high-spin state and 
one FeIII complex in the low-spin state [60]. Moreover, Li and co-workers reported the polar space 
group Pn (Z = 4) was more suitable to the crystallographic data recorded due to the lower R1 value 
[60]. At 223 K, it was observed that the two crystallographically independent FeIII complexes 
exhibited different spin states; one in the high-spin state and the other FeIII complex in the low-spin 
state [60]. It was determined that the Pn space group was maintained until the temperature reached 
163 K, by 123 K the P21/n space group is observed where one independent FeIII complex exists in 
the unit cell [60]. The comparison of the high-spin to low-spin state packing arrangements of the 
present FeIII complex reveals that both spin state forms give rise to a two-dimensional supramolecular 
structure (illustrated in Figure 1.13) in which the FeIII entities are linked through hydrogen bonding 
[60]. However, the low-spin FeIII compound showed strong hydrogen bonding interactions between 
the terminal N atoms and the O atom of the phenolate group whereas, in the high-spin form only 
moderate interactions were observed.  
 
Figure 1.13 (a) 1D supramolecular chain connected by the hydrogen bonds N(azomethine)-H···Ow 
and N(amide)-H···O at 123 K. (b) 2D supramolecular packing structure of [Fe(H-5-Br-thsa)(5-Br-
thsa)]∙H2O along the c axis at 183 K. (Adapted from reference [60]).  
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Li et al., reported the neutral FeIIIO2N2S2 compound [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]·H2O, 
where the crystallographic data were collected at 110, 260 and 293 K [19]. The space group for the 
FeIII atom at measurement temperatures 110, 260 and 293 K, was determined to be Cc. The FeIII atom 
was found to be in the high-spin state at 293 K, and in the low-spin state at 110 K, however, at the 
measurement temperature 260 K, the averaged Fe-donor atom bond distances are indicative for the 
FeIII atom being in the process of converting from the low-spin to the high-spin state [19]. The 
packing arrangements (Figure 1.14) of the FeIII entities in the unit cell show hydrogen bonding 
interactions which link the FeIII entities in a chain by an amide nitrogen atom and the phenolate 
oxygen atom of the salicylaldehyde moiety of the ligand [19].  
 
Figure 1.14 Supramolecular hydrogen bonding packing arrangement of [Fe(H-5-Cl-thsa-Me)(5-Cl-
thsa-Me)]·H2O. (Adapted from reference [19]). 
 
Interestingly, a feature that has been recognised throughout the series of [Fe(HL)(L)]·H2O type 
compounds is that the coordinated singly deprotonated and doubly deprotonated ligands’ bond 
distances change significantly when the spin state of the FeIII atom changes from the high-spin to the 
low-spin state. Specifically, the spin transition mainly affects the C‒S and C‒N bond distances that 
involve the electron delocalisation of the FeIII-nitrogen donor atom. This feature causes a change in 
the ligand field strength during the process of the thermally induced spin transition. Furthermore, the 
close packing arrangements and the hydrogen bonding interactions between the FeIII entities of this 
family of compounds reveal that the coordination sphere of the FeIIIO2N2S2 entities is restricted, 
which causes the FeIII complex to rearrange within the unit cell when undergoing a thermal induced 
spin transition. When the thermally induced spin-crossover occurs the FeIII-donor atom bond 
distances change significantly between the low-spin and high-spin forms.  
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1.4.2 Characterisation by Spectroscopic Techniques 
A wide variety of spectroscopic techniques can be used to characterise the spin-state and therefore 
the occurrence of a spin transition of FeIII bis(ligand) type compounds. The most extensively applied 
spectroscopic technique is 57Fe Mössbauer Spectroscopy, where variable temperature 57Fe 
Mössbauer spectral studies of various coordination compounds have revealed the compounds to 
exhibit a spin transition. Floquet et al. [59, 61], Li et al. [19, 60], and Yemeli Tido et al. [18], have 
reported various R-salicylaldehyde 4R’-thiosemicarbazone FeIII bis(ligand) compounds. 57Fe 
Mössbauer spectral measurements showed that the solvated FeIII compounds Li[Fe(5-Br-
thsa)2]∙1.5H2O [59], [Fe(H-thsa)(thsa)]∙H2O [18], [Fe(H-5-Cl-thsa)(5-Cl-thsa)]∙H2O [18] and [Fe(H-
5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O [19] display spin-crossover behaviour. Typical values of the 
quadrupole splitting (∆EQ) and isomer shift (δ) parameters for both the high-spin and low-spin state 
observed for complexes with FeIIIO2N2S2 coordination core are ∆EQ = 0.4-0.8 mm s-1; δ = 0.34-0.54 
mm s-1 and ∆EQ = 2.7-3.1 mm s-1; δ = 0.14-0.34 mm s-1, respectively [62-66].  
The 57Fe Mössbauer spectra recorded between 300 – 77 K of the compounds [Fe(H-5-Cl-thsa)(5-Cl-
thsa)]∙H2O and [Fe(H-thsa)(thsa)]∙H2O both show very similar behaviour in which they reveal 
quadrupole-split absorption lines devoid of magnetic splitting at all measurement temperatures [18]. 
Typically at room temperature the 57Fe Mössbauer spectra of the present compounds exhibit an 
asymmetric doublet, and as the temperature decreases to ca. 270 K and ca. 230 K for [Fe(H-
thsa)(thsa)]∙H2O and [Fe(H-5-Cl-thsa)(5-Cl-thsa)]∙H2O, respectively, there are two distinct 
quadrupole split doublets. The two doublets are indicative for the existence of two different FeIII 
environments, such that one doublet corresponds to the low-spin fraction and the contribution of the 
other doublet is ascribed to the high-spin fraction of FeIII. At 77 K, the corresponding values of the 
isomer shift and quadrupole splitting for [Fe(H-thsa)(thsa)]∙H2O and [Fe(H-5-Cl-thsa)(5-Cl-
thsa)]∙H2O (δ = 0.22-0.53 mm s-1; ∆EQ = 1.37-2.78 mm s-1 and δ = 0.22-0.54 mm s-1; ∆EQ = 0.84-
2.79 mm s-1, respectively) suggest that the FeIIIO2N2S2 core of the two compounds have exhibited a 
spin transition from the high-spin (S = 5/2) to the low-spin (S = 1/2) state. The 57Fe Mössbauer 
isomer shift and quadrupole splitting parameters indicate that the FeIIIO2N2S2 core undergoes a spin 
transition from the high-spin to the low-spin state between 300 and 77 K [18].  
The 57Fe Mössbauer spectrum of the compound Li[Fe(5-Br-thsa)2]∙1.5H2O at 360 K is characterised 
by the isomer shift and quadrupole splitting values of δ = 0.294 mm s-1 and ∆EQ = 0.338 mm s-1, 
which are attributed to the high-spin state of FeIII [61]. Between 160 K and 360 K two distinct 
quadrupole doublets are observed, one being attributed to the fraction of low-spin and the other 
assigned to the contribution of the high-spin fraction of FeIII. With decreasing the temperature to 77 
K, the 57Fe Mössbauer spectrum is characterised by a quadrupole splitting of ∆EQ = 2.584 mm s-1 
and an isomer shift of δ = 0.262 mm s-1; these values are consistent with the low-spin state of FeIII. 
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This indicates that the compound converts from the high-spin to low-spin state over the temperature 
range 360 – 77 K [61].  
The recorded 57Fe Mössbauer spectra of the FeIII compound [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-
Me)]∙H2O corroborate the observed two-step spin transition as supported by the magnetic and the 
crystallographic studies [19]. A quadrupole doublet is observed at 300 K, which is characterised by 
an isomer shift δ = 0.297 mm s-1 and quadrupole splitting ∆EQ = 0.592 mm s-1 [19]. These values are 
consistent with high-spin (S = 5/2) FeIII. At 260 K the isomer shift is equal to δ = 0.091 mm s-1 and 
the quadrupole splitting equals ∆EQ = 2.692 mm s-1 for the low-spin fraction, moreover, for the high-
spin fraction, the isomer shift is equal to δ = 0.326 mm s-1 and the quadrupole splitting, ∆EQ = 0.823 
mm s-1 [19]. The spectrum at the decreased temperature of 110 K reveals the compound has converted 
completely to the low-spin state, with isomer shift and quadrupole splitting values of 0.148 mm s-1 
and 2.735 mm s-1, respectively [19].  
 
1.4.3 Magnetic Studies 
Iron(III) thiosemicarbazone complexes belong to a unique family that potentially exhibit cooperative 
thermal spin-crossover from low-spin, S = 1/2 ↔ S = 5/2, high-spin. The reported ferric complexes’ 
thermal spin-crossover behaviour from high-spin to low-spin state is characterised by minute 
changes in both molecular structure and molecular volume [12, 15, 16, 18, 19, 59-61]. Discontinuous 
and continuous transitions of spin-crossover have been identified as well as the rare two-step 
transition observed by Zelentsov et al., and the multi-step transition reported by Li et al., [19, 60]. 
In particular, this class of ferric bis(R-salicylaldehyde 4R’-thiosemicarbazone) spin-crossover 
compounds may also exhibit a spin-crossover with a thermal hysteresis loop, similar to those 
reported with ferric complexes with protonated forms of pyruvic acid thiosemicarbazones and 
pyridoxal thiosemicarbazones [18]. Variable temperature magnetic measurements are used to study 
the potential of a solid compound to exhibit a thermally induced spin-crossover.  
The compound NH4[Fe(5-Cl-thsa)2] does not exhibit a thermally induced spin transition, however 
the compound NH4[Fe(5-Br-thsa)2] in both the tabular and mica-like crystal forms exhibits a 
thermally induced spin transition, although each crystal form undergoes a spin transition in a 
different temperature region [15, 16]. The mica-like crystal form shows spin-crossover in the region 
around 200 K. The tabular crystalline form of NH4[Fe(5-Br-thsa)2] is in the low-spin state at room 
temperature with a magnetic moment of µeff = 2.16 B.M., however, upon increasing the temperature 
to 400 K the effective magnetic moment increases to reach a value for high-spin FeIII (µeff = 5.84 
B.M.) [15].  
The ferric complex Li[Fe(5-Br-thsa)2]∙H2O showed that the temperature dependence of the χMT 
product indicates a discontinuous S=1/2 ↔ S=5/2 transition with a broad asymmetric hysteresis loop 
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[59], illustrated in Figure 1.15. The associated hysteresis loop is centred at T1/2↓= 292 K and T1/2↑ = 
329 K [59]. 
For the ferric complex, Li[Fe(5-Br-thsa)2]∙H2O reported by Floquet et al., [61] the hysteresis loop is 
centred at T1/2↓= 294 K and T1/2↑ = 333 K. The χMT values 0.63 cm3 mol-1 K at 50 K and 0.46 cm3 
mol-1 K at 10 K correspond to the low-spin form of the ferric complex whereas the χMT values for 
the high-spin form are 3.91 cm3 mol-1 K at 383 K and 3.74 cm3 mol-1 K at 380 K [59]. These reported 
products of temperature dependent magnetic susceptibility values are indicative of a near complete 
spin transition. Floquet et al., detected the spin-crossover by DSC and X-ray powder diffraction 
measurements. Both techniques allowed for the analysis of hysteretic behaviour. It was found that 
the observation of the hysteresis of the χMT product was caused to the first order crystallographic 
phase transition association with spin-crossover [59, 61]. The Li[Fe(5-Br-thsa)2]∙H2O compound 
displayed a discontinuous spin transition; and the magnetic behaviour is influenced by the solvent 
water molecule [59, 61]. The water molecule sets up a hydrogen bonding network resulting in 
cooperative spin-crossover behaviour [59].  
 
Figure 1.15 Temperature dependence of the χMT product for Li[Fe(5-Br-thsa)2]∙H2O. (Adapted from 
reference [59]). 
 
Yemeli Tido reported the two isostructural compounds [Fe(H-thsa)(thsa)]·H2O and [Fe(H-5-Cl-
thsa)(5-Cl-thsa)]·H2O. Both compounds exhibited a thermally induced spin transition over the 
temperature range 50 – 340 K [18]. The temperature dependence of the χMT product for the 
compound [Fe(H-5-Cl-thsa)(5-Cl-thsa)]·H2O (Figure 1.16) reveals an abrupt transition in the 
warming mode which is observed around T1/2↑ = 231 K [18]. Upon cooling the sample the χMT value 
decreases abruptly around T1/2↓ = 230 K. The magnetic properties of [Fe(H-thsa)(thsa)]·H2O (Figure 
1.16) reveal the χMT value at 340 K is equal to 3.80 cm3 K mol-1, which lies in the range expected 
for FeIII in the high-spin state (S = 5/2), with an abrupt transition occurring at T1/2↑ = 274 K, 
indicating a thermally induced spin-crossover from the low-spin to high-spin state [18]. 
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Figure 1.16 Temperature dependence of the χMT product for (a) [Fe(H-thsa)(thsa)]·H2O and (b) 
[Fe(H-5-Cl-thsa)(5-Cl-thsa)]·H2O. (Adapted from reference [18]). 
 
Interestingly, the magnetic measurements upon cooling of the compound [Fe(H-thsa)(thsa)]·H2O, 
showed that the FeIII ion exhibits a rare two step hysteresis; the first and second transition steps are 
centered at temperatures of T1/2↓ = 262 K and T1/2↓ = 232 K, respectively, whereas upon heating the 
sample the FeIII ion undergoes a one-step transition at T1/2↑ = 274 K [18]. Furthermore, the FeIII 
compound [Fe(H-5-Br-thsa)(5-Br-thsa)]·H2O reported by Li et al., shows that the magnetic 
properties reveal a multi-step spin-crossover during both the heating and cooling measurements (5 – 
300 K), illustrated in Figure 1.17 [60].  
 
Figure 1.17 Temperature dependence of the χMT product for [Fe(H-5-Br-thsa)(5-Br-thsa)]·H2O. 
(Adapted from reference [60]). 
 
The conversion of the FeIII spin state from high-spin to low-spin over the temperature range 300 to 
5 K is verified by the χMT values of 4.20 cm3 K mol-1 at 300 K and 0.44 cm3 K mol-1 at 5 K, 
respectively [60]. The first and sixth transition step are centered at temperatures of T1/2↓ = 242 K 
and T1/2↓ = 144 K, respectively, with χMT values of 3.50 cm3 K mol-1 and 0.44 cm3 K mol-1, 
respectively [60]. The second, third, fourth and fifth transition steps are centered at 238 K, 211 K, 
194 K and 170 K, severally. Li et al., determined that upon heating, the spin-crossover is observed 
with hysteresis of about 7 K at the first and sixth step [60]. 
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The magnetic behaviour of the neutral compound [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O 
revealed a two-step spin transition with hysteresis (Figure 1.18) [19]. At 300 K the χMT value is 
equal to 3.89 cm3 K mol-1, which lies in the range expected for high-spin FeIII [19]. On cooling the 
sample, the first transition step is centered at T1/2↓ = 270 K, while decreasing the temperature 
revealed the second transition step centered at T1/2↓ = 245 K [19]. In the warming mode the second 
and first transition steps are centered at the temperatures of T1/2↑ = 249 K and 278 K, respectively, 
creating a hysteresis of 4 K and 8 K for the first and second spin transitions [19].  
 
Figure 1.18 Temperature dependence of the χMT product for [Fe(H-5-Cl-thsa)(5-Cl-thsa)]·H2O. 
(Adapted from reference [19]). 
 
1.5 Applications of Spin Crossover Materials 
In the last 50 years there has been growing interest in spin crossover materials and their possible 
technological applications, which has been reflected through the current advances occurring in this 
field. As molecular-based switchable materials can be tailor made, they provide a unique tool for 
fine-tuning the physical properties, as well as their sensitivity to the external environment in 
combination with measurable effects to the bulk properties [67,68]. This provides a wide range of 
potential applications, which include: 
(i) Data storage devices; 
(ii) Molecular switches; 
(iii) Display devices; 
(iv) Sensors. 
The field of potential applications is influenced by the constant pressures of advancing technology, 
mainly caused by the demand for miniaturisation in current technology which therefore increases 
the interest in molecular materials. Among these materials, molecular switches are transition metal 
complexes (having a dn, where n = 4-7) exhibiting spin-crossover. These materials exhibit reversible 
switching behaviour, i.e. the conversion between two spin states, the low-spin and high-spin 
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electronic configurations. These so-called spin transitions can be caused by various external stimuli 
such as temperature, pressure, light or X-ray irradiation, an intense magnetic field or the inclusion 
of a guest molecule [68]. As discussed in previous sections of this chapter, the low-spin and high-
spin states can be determined by their different magnetic, optical, mechanical, spectroscopic and 
structural properties [68]. The ability of spin-crossover materials to switch between spin-states can 
produce hysteresis phenomena. This aspect of the spin-crossover materials is of interest from a 
technological point of view, as the materials provide molecular bistability; and thus provide a 
promising area of research that spin-crossover materials can potentially be useful molecular 
switches, as well as components in displays [67], data storage [69], sensors [70,71], nano-
thermometers [72], optoelectronic devices [73] and actuators [74].  
Létard et al., [67] reviewed in 2004 the possible applications of spin-crossover materials in molecular 
electronics, data storage, display devices, non-linear optics, and photomagnetism, with emphasis 
towards the design of molecular switches and their shortfalls for possible practical application. 
Switchable molecular materials have been considered since the miniaturisation of silicon based 
devices and magnetic storage devices, together with the technological and physical limitations these 
switches impose on the application phase [68,75-77]. This leads to the question of whether single 
crystals or powder spin-crossover materials are compatible with technological requirements, for the 
construction of possible technological devices. Kahn et al. in the 1990s proposed that spin-crossover 
materials could be incorporated into polymer systems for applications towards spin transition 
polymers for memory devices [69,78]. More recently, Bousseksou et al., have made key 
contributions towards research focused on nano-scale spin-crossover materials, and attempting to 
emphasise the important aspects required to understand before the construction of the applications. 
These aspects include: (i) spin-crossover nano-particles and thin films, (ii) nano-patterning and nano-
scale organisation and (iii) future possibilities of addressable nano-structures for gas sensors, 
displays and switchable photonic devices [79-91].  
The latest review (2016) by Bousseksou et al., [68] gives an overview of several research groups’ 
efforts concerning the studies of electrical properties of spin-crossover materials, including the 
possibilities of utilising the electrical field and/or current. Instead of using temperature, pressure or 
light irradiation as the stimulus or ‘input’, the use of electrical stimuli to activate the spin-state 
interconversion would be more advantageous, not only due to faster dynamics, but for the 
compatibility with current technology and the ability of size reduction [68]. Bousseksou et al., 
reviewed the present studies of electrical properties of spin-crossover materials, this including (i) 
bulk powders and crystals, (ii) reduction of scale to thin films and nano-particles and (iii) single 
molecules.  
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The following sections will discuss the properties required for the application of spin-crossover 
materials in technology and emphasise important aspects required so these materials can become 
functional components of these applications.  
 
Molecular switches 
A molecular switch is defined as possessing two states, the ‘on’ state and ‘off’ state; materials 
exhibiting spin-crossover act as molecular switches, whereby the interconversion between the low-
spin and high-spin states differentiates between the ‘on’ and ‘off’ states. The ability of a material to 
act as a molecular switch is defined as possessing molecular bistability. This can be interpreted as 
binary code i.e. the strings of 0s and 1s that are used for encoding of information in digital computing 
and communication systems. The ‘on’ and ‘off’ states of a molecular switch are corroborative of the 
low-spin and high-spin states. Although, for these systems to be useful in current technology, the 
interconversion between on and off states must be repeatable without deterioration and occur at a 
rapid pace, as well as the individual states being accessible with simple input and readable output 
functions. As previously stated, the simplest stimuli or ‘input’ are temperature, pressure and light 
irradiation. An abrupt spin-crossover is required in response to the input, in order to produce a 
detectable output functions which can be identified by the magnetic moment or the colour absorption 
between the low-spin and high-spin states. Due to the requirement of an abrupt transition for the 
molecular switch to be useful, it has been determined that these materials cannot act as operators in 
logic operations i.e. where one input produces one output.  
There is potential use for multinuclear spin-crossover systems, which would provide a more complex 
molecular switch, whereby more than two states are accessible and therefore more complex uses are 
possible [92]. Another potential use for these materials as reviewed by Bousseksou et al., is using 
their potential as an electrical conductor, hence the spin-transition is measured by passing a current 
through the material and measuring the resistance [68].  This would be more advantageous as 
electrical conductivity is easy to measure and compatible with the current technology [68].  
 
Data storage devices 
Similar to molecular switches, systems with molecular-based memory must have two states, the so-
called ‘on’ and ‘off’ states. Molecular based memory systems also require materials with bistability, 
such as hysteretic spin-crossover compounds exist in two states at a given temperature, hence 
provides potential applications in memory storage devices. For these systems to be utilised in data 
storage, they must remain in a chosen state after the input (stimuli) function has been removed up 
until that information is required [67]. At present, data is stored in a binary format [67].  
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Both the LIESST and reverse-LIESST phenomena in spin-crossover materials, where switching 
between the low-spin and excited high-spin state occurs from the input of light irradiation, has shown 
they are possible candidates for memory storage devices. However, as the excited high-spin state 
lifetime is only seen at cryogenic temperatures, these materials are not ideal in data storage for 
current technologies. Materials with an easily-triggered abrupt hysteretic spin-transition at room 
temperature are ideal systems for memory storage devices. The hysteretic system is resultant from 
cooperative interactions between a series of molecules, hence spin-crossover materials designed for 
data storage devices consist of a range of spin-crossover centres instead of individual sites, as used 
in molecular switches [67]. Interestingly, multifunctional materials which exhibit spin-crossover 
together with electrical conductivity represents another step toward the application of these materials 
in future technologies [68].  
 
Display Devices 
Spin-crossover materials have the potentials to be used in display devices if a number of general 
requirements are fulfilled; the material should have a strong thermochromic response to the spin-
state change, the material must be chemically stable and not be subject to deterioration and the spin-
transitions must be abrupt, exhibiting a wide hysteresis centred at room temperature. This list of 
criteria is not always easily executed due to particular intermolecular interactions which can occur, 
such as π-π stacking interactions, which is frequently a requirement for hysteresis, however this often 
leads to charge transfer transitions which mask any visible colour change upon transition [67].  
Létard et al., created a functioning display device using triazole derivatives [67]. This approach used 
the spin-crossover materials suspended in ink which was printed onto a screen, to which a heating 
element is placed below the screen in combination with a mask incorporating the design of visual 
display and when the temperature is increased the design is revealed [67]. However, display devices 
as created by Létard et al., or presented by Kahn et al., rely on thermal transition and heating, which 
is not a practical method suitable for current display devices [67].  
 
Sensors 
Developments of temperature or pressure sensors are of interest in the field of spin-crossover 
materials due to the temperature and pressure dependence of a spin transitions. The spin-crossover 
behaviour exhibited by a change in pressure has applications as pressure sensors, and thermally 
induced spin-crossover materials can be utilised as temperature sensors [67]. Preferably these spin-
crossover systems would exhibit a visibly pronounced colour change upon interconversion between 
spin-states, hence easily detected. Moreover, it would be highly advantageous to create a sensor 
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which could detect both temperature and pressure, as this would enable materials which have well-
defined phase diagrams to be used to detect temperature changes at a constant pressure, as well as 
pressure changes at a constant temperature [70]. 
 
1.6 Objectives and Scope of Research 
The initial stage of the project was to synthesise a variety of functionalised R-salicylaldehyde 4R’-
thiosemicarbazone ligands. Once obtained, the aim was to design new mononuclear FeIII compounds 
with a view of studying their structural and magnetic properties. The focus of the investigation was 
to design three types of structural configurations of FeIII-bis(ligand) complexes, these include: (i) 
(cation+)[FeIII(L2‒)2]·x(solvent), (ii) [FeIII(HL‒)(L2‒)]·x(solvent) and (iii) [FeIII(HL‒)2](anion‒
)·x(solvent). Dependent upon the structural data interpreted, an attempt would then be made to 
outline correlations between the observed magnetic behaviours of the obtained ferric complexes and 
the structure of the FeIII entities and the packing of the FeIII entities within the crystal lattice, both 
spin-active and in-active.  An in-depth study of these observations and relationships would then be 
compared to similar types of ferric complexes published in this research field. The results of this 
project are detailed in this thesis.  
Chapter II details the synthetic procedures of the obtained ferric complexes and their corresponding 
ligands, in addition to the experimental details for the physical characterisation of the obtained ferric 
complexes. Chapter III describes the research of (cation+)[FeIII(L2‒)2]·xsolvent type complexes 
containing two dianionic R-salicylaldehyde 4R’-thiosemicarbazonate(2-) ligands, with a focus of 
investigating the effect of varying R- and R’-substituents, cations and solvent molecules within the 
lattice on the magnetic properties and crystal packing. Chapter IV provides a study of three 
mononuclear [FeIII(HL‒)(L2‒)]·H2O type complexes, containing one anionic and one dianionic R-
salicylaldehyde 4R’-thiosemicarbazone ligand. Correlations between the steric and electronic effects 
imposed by the R- and R’-substituents of the ligands bound to the FeIII ions and the magnetic 
properties observed will then be discussed. Chapter V investigates [FeIII(HL‒)2](anion‒)·xH2O type 
complexes, with focus upon the effect of varying the anions and the R- and R’-substituents of the 
coordinated one-fold deprotonated ligands within the crystal lattice on the magnetic properties and 
crystal packing of [FeIII(HL‒)2](anion‒)·xH2O type complexes. Chapter VI offers the final 
conclusions and suggested future work based on the results obtained in this thesis. 
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2.0 Materials and Methods 
2.1 Introduction 
This chapter details the materials, techniques and methods used for the synthesis, characterisation 
and determination of the physical properties of the ferric complexes and their corresponding ligands. 
Firstly, the materials used are provided, which is followed by a description of the synthesis of both 
the ligands and ferric complexes presented in this thesis, the syntheses not presented in the thesis are 
displayed in the appendix. Secondly, the standard techniques used to characterise the ligand and 
ferric complexes are herein described. A more detailed description of the single crystal X-ray 
structure solution and refinement can be found in the corresponding chapters. Finally, is followed 
by a brief description of the physical techniques used to determine the magnetic properties of the 
ferric complexes.  
 
2.2 Materials 
The R-salicylaldehyde derivatives, 4R’-thiosemicarbazone derivatives, iron(III) salts and bases used 
in the synthesis of the ferric complexes and their corresponding ligands are displayed in Tables 2.1, 
2.2, 2.3 and 2.4, severally.  
The iron(III) salts were all purchased from Sigma-Aldrich and used without further purification. 
Derivatives of both the R-salicylaldehyde and 4R’-thiosemicarbazide compounds purchased from 
either Sigma-Aldrich or Alfa Aesar were also used without further purification in the R-
salicylaldehyde 4R’-thiosemicarbazone ligand syntheses presented in Section 2.3. Solvents used in 
the synthesis of the ligands and ferric complexes were all purchased from Fisher-Scientific. 
 
Table 2.1 Salicylaldehyde derivatives utilised in the synthesis of the various R-salicylaldehyde 
4R’-thiosemicarbazone ligands. 
Name Structure Supplier 
 
 
Salicylaldehyde, 98% 
 
 
 
 
 
 
 
 
 
 
 
Sigma-Aldrich 
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Table 2.1 Salicylaldehyde derivatives utilised in the synthesis of the various R-salicylaldehyde 
4R’-thiosemicarbazone ligands (continued)  
Name Structure Supplier 
 
5-bromosalicylaldehyde, 
98% 
 
 
Sigma-Aldrich 
 
5-chlorosalicylaldehyde, 98% 
 
 
 
 
 
 
 
 
 
Alfa Aesar 
3-ethoxysalicylaldehyde, 97% 
 
 
Alfa Aesar 
2,4-dihydroxybenzaldehyde, 
98% 
 
 
Alfa Aesar 
 
Table 2.2 Thiosemicarbazone derivatives utilised in the synthesis of the various R-salicylaldehyde 
4R’-thiosemicarbazone ligands  
Name Structure Supplier 
 
 
Thiosemicarbazide, 
99% 
 
 
 
 
 
 
 
 
Alfa Aesar 
4-Methyl-3-
thiosemicarbazide, 
97% 
 
Alfa Aesar 
66 
 
Table 2.2 Thiosemicarbazone derivatives utilised in the synthesis of the various R-salicylaldehyde 
4R’-thiosemicarbazone ligands (continued) 
Name Structure Supplier 
 
4-Ethyl-3-
thiosemicarbazide, 
97% 
 
 
Sigma-
Aldrich 
 
 
Table 2.3 Various FeIII salts used in the synthesis of the FeIII bis(ligand) compounds 
Name Composition Supplier 
 
 
Iron(III) chloride hexahydrate, >98% 
 
 
[FeCl3]·6H2O 
 
 
Sigma-Aldrich 
 
Iron(III) nitrate nonahydrate, >98% 
 
[Fe(NO3)3]·9H2O 
 
 
Sigma-Aldrich 
 
Iron(III) sulfate hydrate, 97% 
 
 
[Fe2(SO4)3]·H2O 
 
 
 
Sigma-Aldrich 
Iron(III) p-toluenesulfonate hexahydrate 
 
[Fe(CH3C6H4SO3)3]·6H2O 
 
 
Sigma-Aldrich 
 
 
Table 2.4 Different bases used in the synthesis of the FeIII bis(ligand) complexes 
Name Composition Supplier 
 
 
Caesium hydroxide monohydrate, >95% 
 
CsOH 
 
Alfa Aesar 
 
 
Ammonium hydroxide solution, 35% in 
water 
 
 
 
NH4OH 
 
 
Fisher Scientific 
 
Dimethylamine, 40% wt in water 
 
 
NH(CH3)2 
 
 
ACROS Organics 
 
Triethylamine, >98% 
 
 
 
N(C2H5)3 
 
 
Sigma-Aldrich 
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2.3 Ligand Synthesis 
2.3.1 Synthesis of R-salicylaldehyde 4R’-thiosemicarbazone (H2L) based ligands 
The preparation of the desired R-salicylaldehyde 4R’-thiosemicarbazone ligands incorporated the 
synthesis between thiosemicarbazide and an R-substituted salicylaldehyde in ethanolic solution. The 
general reaction scheme is illustrated in Scheme 2.1.  
H2O
 
R = -H, 5-Br, 5-Cl, 3-OCH2CH3, 4-OH 
R’ = -H, -CH3, -CH2CH3 
Scheme 2.1 
49 mmol of R-substituted salicylaldehyde was dissolved in 80 mL of ethanol with constant stirring, 
and was added to 49 mmol of the 4R’-thiosemicarbazide dissolved in 40 mL of ethanol. The 
corresponding mixture was refluxed for 120 minutes. The resulting solution was cooled to room 
temperature, the solid isolated by filtration, washed with ether and dried in a vacuum for two days.  
 
Salicylaldehyde thiosemicarbazone (H2thsa) 
The synthesis of H2thsa has been carried out by the general procedure described vide supra. Yield: 
7.75 g (39.70 mmol, 81.0%). Mp: 218°C. H2thsa is soluble in methanol, acetone and DMSO. 1H 
NMR (300 MHz, DMSO-d6) δ (ppm): 11.40 (1H, s, OH), 9.90 (1H, s, S=C−NH), 8.37 (1H, s, 
N=C−H), 7.91−8.12 (2H, m, S=C−NH2), 6.78−7.24 (aromatic 4H, m, C−H). 13C NMR (300 MHz, 
DMSO-d6) δ (ppm): 178.1 (C=S), 156.8 (C−O), 140.0 (C=N), 131.5, 127.2, 120.8, 119.7, 116.5, 
108.2 (C aromatic), 52.9 (C−N). IR (cm-1, KBr): 3444.83 (νOH), 3174.51 (νNH), 3319.44 (νNH2), 
1616.29 (νC=N), 1539.61−1602.70 (νC=C), 1265.82 (νC−N), 1110.84 (νC=S). 
Salicylaldehyde 4-methylthiosemicarbazone (H2thsa-Me)  
The synthesis of H2thsa-Me has been carried out by the general procedure described vide supra. 
Yield: 11.79 g (49.38 mmol, 98.7%). Mp: 208°C. H2-thsa-Me is soluble in methanol, ethanol, 
acetone and DMSO. 1H NMR (300 MHz, DMSO-d6) δ (ppm): 11.40 (1H, s, OH), 9.90 (1H, s, 
S=C−NH), 8.37 (1H, s, N=CH), 8.42-8.44 (1H, m, S=C−NH(CH3)), 6.79-7.97 (aromatic 3H, m, 
C−H), 3.00 (3H, d, NH(CH3)). 13C NMR (300 MHz, DMSO-d6) δ (ppm): 177.4 (C=S), 156.3 (C−O), 
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138.9 (C=N), 131.0, 126.6, 120.4, 119.2, 116.1 (C−C aromatic), 31.1 (CH3). IR (cm-1, KBr): 3362.01 
(νOH), 3256.21 (νNH), 2965.70 (νCH3), 1618.15 (νC=N), 1605.92, 1554.21 (νC=C), 1254.37 
(νC−N), 1100.03 (νC=S). 
5-Bromosalicylaldehyde thiosemicarbazone (H2-5-Br-thsa) 
The synthesis of H2-5-Br-thsa has been carried out by the general procedure described vide supra. 
Yield: 11.58 g (42.24 mmol, 86.2%). Mp: 262°C. H2-5-Br-thsa is soluble in methanol, ethanol, 
acetone and DMSO. 1H NMR (300 MHz, DMSO-d6) δ (ppm): 11.42 (1H, s, OH), 10.25 (1H, s, 
S=C−NH), 8.28 (1H, s, N=C−H), 8.15−8.23 (2H, m, C−NH2), 6.82−7.33 (aromatic 3H, m, C−H). 
13C NMR (300 MHz, DMSO-d6) δ (ppm): 177.7 (C=S), 155.6 (C−O), 137.3 (C=N), 133.29, 128.4, 
122.8 (C−C aromatic) 11.0 (C−Br). IR (cm-1, KBr): 3456.13 (νOH), 3161.84 (νNH), 3248.73 
(νNH2), 1610.08 (νC=N), 1545.34−1602.00 (νC=C), 1264.20 (νC−N), 1191.52 (νC=S). 
5-Bromosalicylaldehyde 4-ethylthiosemicarbazone (H2-5-Br-thsa-Et)  
The synthesis of H2-5-Br-thsa-Et has been carried out by the general procedure described vide supra. 
Yield: 14.32 g (47.55 mmol, 97.0%). Mp: 186°C. H2-5-Br-thsa-Et is soluble in methanol, acetone 
and DMSO. 1H NMR (300 MHz, DMSO-d6) δ (ppm):  11.42 (1H, s, OH), 10.28 (1H, s, S=C−NH), 
8.32 (1H, m, N=CH), 8.66 (1H, t, S=C−NH(CH2CH3)), 6.80-7.38 (aromatic 3H, m, C−H), 3.60 (2H, 
p, NH−CH2), 1.15 (3H t, NHCH2−CH3). 13C NMR (300 MHz, DMSO-d6) δ (ppm): 176.5 (C=S), 
155.5 (C−O), 137.0 (C=N), 133.2, 128.1, 122.9, 118.2 (C−C aromatic), 110.9 (C−Br), 38.2 (CH2), 
14.8 (CH3). IR (cm-1, KBr): 3299.28 (νOH), 3146.02 (νNH), 2990.34 (νCH3), 2936.0 (νCH2), 
1613.36 (νC=N), 1601.19, 1549.90 (νC=C), 1236.91 (νC−N), 1046.78 (νC=S). 
5-Chlorosalicylaldehyde 4-methylthiosemicarbazone (H2-5-Cl-thsa-Me) 
The synthesis of H2-5-Cl-thsa-Me has been carried out by the general procedure described vide 
supra. Yield: 11.79 g (49.38 mmol, 98.7%). Mp: 224°C. H2-5-Cl-thsa-Me is soluble in methanol, 
acetone and DMSO. 1H NMR (300 MHz, DMSO-d6) δ (ppm): 11.49 (1H, s, OH), 10.24 (1H, s, 
S=C−NH), 8.29 (1H, s, N=CH), 8.58-8.59 (2H, m, S=C−NH(CH3)), 6.85-7.23 (aromatic 3H, m, 
C−H), 3.01 (3H, d, NH(CH3)). 13C NMR (300 MHz, DMSO-d6) δ (ppm): 177.8 (C=S), 155.1 (C−O), 
137.3 (C=N), 130.5, 125.5, 122.3, 117.7 (C−C aromatic), 123.4 (C−Cl), 31.1 (CH3). IR (cm-1, KBr):  
3397.86 (νOH), 3254.90, 3124.07 (νNH), 2983.97 (νCH3), 1600.69 (νC=N), 1552.98, 1527.96 
(νC=C), 1270.10 (νC-N), 1182.31 (νC=S). 
3-Ethoxysalicylaldehyde thiosemicarbazone (H2-3-OEt-thsa) 
The synthesis of H2-3-OEt-thsa has been carried out by the general procedure described vide supra. 
Yield: 11.14 g (46.55 mmol, 95.0%). Mp: 224°C. H2-3-OEt-thsa is soluble in methanol, ethanol, 
acetone and DMSO. 1H NMR (300 MHz, DMSO-d6) δ (ppm): 11.39 (1H, s, OH), 9.02 (1H, s, 
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S=C−NH), 8.40 (1H, s, N=C−H), 7.90−8.13 (2H, m, S=C−NH2), 6.72−7.50 (aromatic 3H, m, C−H), 
4.05 (2H, q, O−CH2), 1.35 (3H, t, O−C−CH3). 13C NMR (300 MHz, DMSO-d6) δ (ppm): 182.8 
(C=S), 147.4, 146.7 (C−O), 140.1 (C=N), 119.5, 118.7, 114.5 (C aromatic), 64.6 (C−N), 74.0 
(O−CH2), 15.1 (O−C−CH3). IR (cm-1, KBr): 3400.03 (νOH), 3169.30 (νNH), 3248.73 (νNH2), 
2934.86 (νCH3), 2895.68 (νCH2), 1617.76 (νC=N), 1534.53-1599.81 (νC=C), 1270.18 (νC−N), 
1166.98 (νC=S). 
3-Ethoxysalicylaldehyde 4-methylthiosemicarbazone (H2-3-OEt-thsa-Me)  
The synthesis of H2-3-OEt-thsa-Me has been carried out by the general procedure described vide 
supra. Yield: 11.80 g (46.58 mmol, 95.1%). Mp: 228°C. H2-3-OEt-thsa-Me is soluble in methanol, 
ethanol, acetone and DMSO. 1H NMR (300 MHz, DMSO-d6) δ (ppm): 11.42 (1H, s, OH), 9.02 (1H, 
s, S=C−NH), 8.42 (1H, s, N=CH), 8.39 (2H, m, S=C−NH(CH3)), 6.78–7.54 (aromatic 3H, m, C−H), 
4.10 (2H, q, O−CH2), 1.35 (3H, t, O−C−CH3). 13C NMR (300 MHz, DMSO-d6) δ (ppm): 177.6 
(C=S), 147.0, 146.1 (C−O), 139.0 (C=N), 120.8, 118.9, 118.01 113.8 (C aromatic), 64.3 (O−CH2), 
30.8 (N−CH3), 14.6 (O−C−CH3). IR (cm-1, KBr): 3350.03 (νOH), 3307.61 (νNH), 2977.95, 2926.71 
(νCH3), 2895.74 (νCH2), 1606.79 (νC=N), 1531.75-1581.09 (νC=C), 1221.49 (νC−N), 1107.16 
(νC=S). 
2, 4-Dihydroxybenzaldehyde thiosemicarbazone (H2-4-OH-thsa) 
The synthesis of H2-4-OH-thsa has been carried out by the general procedure described vide supra. 
Yield 9.51 g (45.07 mmol, 92.0%). Mp: 226°C. H2-4-OH-thsa is soluble in ethanol, methanol, 
DMSO and acetone. 1H NMR (300 MHz, DMSO-d6) δ (ppm): 11.19 (1H, s, S=C−NH), 9.76 (2H, s, 
OH), 8.24 (1H, s, N=C−H), 7.66 – 7.97 (2H, m, S=C−NH2), 6.23 – 6.29 (aromatic 3H, m, C−H). 13C 
NMR (300 MHz, DMSO-d6) δ (ppm): 176.9 (C=S), 160.4, 157.9 (C−O), 140.9 (C=N), 128.4, 11.7, 
107.8, 102.2 (C aromatic). IR (cm-1, KBr): 3478.60 (νOH), 3167.12 (νNH), 3338.21 (νNH2), 1631.49 
(νC=N), 1553.56-1578.28 (νC=C ring), 1230.44 (νC−N), 1121.49 (νC=S). 
 
2.4 Synthesis of Iron(III) Coordination Compounds 
2.4.1 (Cation)[FeIII(L)2]∙solvent Complexes 
Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH  
FeCl3∙6H2O (1.0 mmol, 0.27 g) was dissolved in 5 mL of methanol. The ligand H2-3-OEt-thsa-Me 
(1.0 mmol, 0.25 g) was dissolved in 30 mL of methanol with the addition of CsOH.H2O (4.0 mmol, 
0.67 g). To this mixture, the methanolic Fe(III) salt solution was added drop wise on constant stirring. 
The resulting dark green solution was stirred and heated to 80°C for approximately 10 minutes. The 
solution was then allowed to stand at room temperature until crystals were formed. The dark green 
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microcrystals were isolated by filtration and dried. Yield: 0.29 g (0.4 mmol, 40.1%). IR (cm-1, KBr) 
3401.50 (νOH), 3319.35 (νNH), 2967.94, 2931.51 (νCH3), 2885.50 (νCH2), 1636.73, 1593.97 
(νC=N), 1545.79-1509.33 (νC=C ring), 1218.78 (νC−O), 1163.95 (νN−N), 1021.92 (νC−N), 738.02 
(νC−S). 
Cs[Fe(5-Br-thsa)2]  
FeCl3∙6H2O (1.0 mmol, 0.27 g) was dissolved in 10 mL of methanol. The ligand H2-5-Br-thsa (2.0 
mmol, 0.54 g) was dissolved in 60 mL of methanol with the addition of CsOH.H2O (4.0 mmol, 0.67 
g). To this mixture, the methanolic Fe(III) salt solution was added drop wise on constant stirring. 
The resulting dark green solution was stirred and heated to 80°C for approximately 10 minutes. The 
solution was then allowed to stand at room temperature until crystals were formed. The dark green 
microcrystals were isolated by filtration and dried. Yield: 0.43 g (0.57 mmol, 58.7%). IR (cm-1, 
ATR): 3464.82, 3251.42 (νNH), 3075.11 (νNH2), 1611.31, 1590.53 (νC=N), 1538.98-1497.13 
(νC=C ring), 1273.72 (νC−O), 1199.90 (νN−N), 1030.60 (νC−N), 817.71 (νC−S). 
NH4[Fe(thsa)2]  
Fe(p-CH3C6H4SO3)3∙6H2O (1.0 mmol, 0.68 g) was dissolved in 5 mL of methanol. The ligand H2thsa 
(1.0 mmol, 0.20 g) was dissolved in 25 mL of methanol with the addition of 20 mL of NH4OH (35 
wt% in water). To this mixture, the methanolic Fe(III) salt solution was added drop wise on constant 
stirring. The resulting dark green solution was stirred and heated to 80°C for approximately 10 
minutes. The solution was then allowed to stand at room temperature until crystals were formed. The 
dark green microcrystals were isolated by filtration and dried. Yield: 0.10 g (0.22 mmol, 21.7%). IR 
(cm-1, KBr): 3472.47, 3239.56 (νNH), 3015.68 (νNH2), 1595.06 (νC=N), 1546.07-1508.53 (νC=C 
ring), 1277.90 (νC−O), 1203.23 (νN−N), 1027.15 (νC−N), 756.07 (νC−S). 
NH4[Fe(5-Br-thsa)2]  
FeCl3∙6H2O (1.0 mmol, 0.27 g) was dissolved in 5 mL of methanol. The ligand H2-5-Br-thsa (1.0 
mmol, 0.27 g) was dissolved in 30 mL of methanol with the addition of 20 mL of NH4OH (35 wt% 
in water). To this mixture, the methanolic Fe(III) salt solution was added drop wise on constant 
stirring. The resulting dark green solution was stirred and heated to 80°C for approximately 10 
minutes. The solution was then allowed to stand at room temperature until crystals were formed. The 
dark green microcrystals were isolated by filtration and dried. Yield: 0.24 g (0.39 mmol, 38.8%). IR 
(cm-1, ATR): 3461.85 (νNH), 3247.45, 3098.95 (νNH2), 1609.77 (νC=N), 1535.21-1505.30 (νC=C 
ring), 1276.15 (νC−O), 1198.10 (νN−N), 1031.48 (νC−N), 816.65 (νC−S). 
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(CH3)2NH2[Fe(3-OEt-thsa)2]  
Fe(NO3)3∙9H2O (1.0 mmol, 0.40 g) was dissolved in 10 mL of water. The ligand H2-3-OEt-thsa (2.0 
mmol, 0.46 g) was dissolved in 60 mL of methanol with the addition of addition of dimethylamine, 
40wt% in water (10 mmol, 0.51 mL). To this mixture, the Fe(III) salt solution was added drop wise 
on constant stirring. The resulting dark green solution was stirred and heated to 80°C for 
approximately 10 minutes. The solution was then allowed to stand at room temperature until crystals 
were formed. The dark green microcrystals were isolated by filtration and dried. Yield: 0.30 g (0.52 
mmol, 52.0%). IR (cm-1, ATR): 3436, 3413.5 (νNH), 3264.7, 3097.7 (νNH2), 3012 (νCH3), 2971.4 
(νCH2), 1613.5, 1586.1 (νC=N), 1570.2-1541.4 (νC=C ring), 1237.7 (νC−O), 1215.3 (νN−N), 
1077.8 (νC−N), 735.7 (νC−S). 
 
2.4.2 [FeIII(HL)(L)]∙solvent Complexes 
[Fe(Hthsa-Me)(thsa-Me)]∙H2O  
Fe(NO3)3∙9H2O (1.0 mmol, 0.40 g) was dissolved in 5 mL of water. The ligand H2thsa-Me (2.0 
mmol, 0.42 g) was dissolved in an ethanol/methanol/water mixture (v: v: v, 5: 5: 1) with the addition 
of dimethylamine, 40wt% in water (10 mmol, 0.51 mL). To this mixture, the Fe(III) salt solution 
was added drop wise on constant stirring. The resulting dark green solution was stirred and heated 
to 80°C for approximately 10 minutes. The solution was then allowed to stand at room temperature 
until crystals were formed. The dark green microcrystals were isolated by filtration and dried. Yield: 
0.12 g (0.25 mmol, 24.5%). IR (cm-1, ATR) 3558.1, 3481.4, 3149 (νNH), 3017.6 (νCH3), 2973.8, 
2937.3, 2897, 2849.6 (νC−H aromatic), 1604.3 (νC=N), 1589.7, 1542.2 (νC=C ring), 1279.3 
(νC−O), 1323 (νN−N), 749.73 (νC−S).  
[Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O  
Fe(NO3)3∙9H2O (1.0  mmol, 0.40 g) was dissolved in 10 mL of water. The ligand H2-3-OEt-thsa-Me 
(2.0 mmol, 0.50 g) was dissolved in 60 mL of methanol with the addition of dimethylamine, 40wt% 
in water (10 mmol, 0.51 mL). To this mixture, the Fe(III) salt solution was added drop wise on 
constant stirring. The resulting dark green solution was stirred and heated to 80°C for approximately 
10 minutes. The solution was then allowed to stand at room temperature until crystals were formed. 
The dark green microcrystals were isolated by filtration and dried. Yield: 0.60g (0.53 mmol, 53.1%). 
IR (cm-1, ATR) 3423, 3317, 3211.2 (νNH), 3010.3 (νCH3), 2973.8 (νCH2), 2926.3, 2889.8, 2875.2 
(νC−H aromatic), 1597 (νC=N), 1582.4, 1542.2 (νC=C ring), 1213.5 (νC−O), 1239 (νN−N), 1077.8 
(νC−N), 727.82 (νC−S). 
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[Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O  
Fe(NO3)3∙9H2O (1.0 mmol, 0.40 g) was dissolved in 5 mL of methanol. The ligand H2-5-Cl-thsa-Me 
(1.0 mmol, 0.24 g) was dissolved in 25 mL of methanol with the addition of 20 mL of NH4OH (35 
wt% in water). To this mixture, the methanolic Fe(III) salt solution was added drop wise on constant 
stirring. The resulting dark green solution was stirred and heated to 80°C for approximately 10 
minutes. The solution was then allowed to stand at room temperature until crystals were formed. The 
dark green microcrystals were isolated by filtration and dried. Yield: 0.35 g (0.63 mmol, 62.7%). IR 
(cm-1, ATR): 3525.8, 3217.5, 3172.5 (νNH), 3028.6 (νCH3), 2965.6, 2934.1, 2889.2, 2848.7 (νCH 
aromatic), 1604.3 (νC=N), 1586, 1567.8 (νC=C ring), 1315.8 (νC-O), 1286.6, 1188 (νN-N) 815.47 
(νC-S). 
 
2.4.3 [FeIII(HL)2]∙anion∙solvent Complexes 
[Fe(H-5-Br-thsa-Et)2]NO3∙H2O  
Fe(NO3)3∙9H2O (1.0 mmol, 0.40 g) was dissolved in 5 mL of distilled water. The ligand H2-5-Br-
thsa-Et (2.0 mmol, 0.60 g) was dissolved in an ethanol/methanol/water mixture (v: v: v, 5: 5: 1) with 
the addition of dimethylamine, 40wt% in water (10 mmol, 0.51 mL). To this mixture, the Fe(III) salt 
solution was added drop wise on constant stirring. The resulting dark green solution was stirred and 
heated to 120°C for approximately 10 minutes. The solution was then allowed to stand at room 
temperature until crystals were formed. The dark green microcrystals were isolated by filtration and 
dried. Yield: 0.54 g (0.73 mmol, 73.2%). IR (cm-1, ATR): 3313.4, 3225.8 (νNH), 3046.8 (νCH3), 
2997.4 (νCH2), 1600.6 (νC=N), 1582.4, 1542.2 (νC=C ring), 1293.9 (νC−O), 1312.1 (νN−N), 819.12 
(νC−S), 866.6, 1352.3 (νNO). 
[Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O 
Fe2(SO4)4∙H2O (0.5 mmol, 0.21 g) was dissolved in 5 mL of distilled water. The ligand H2-4-OH-
thsa (1.0 mmol, 0.21 g) was dissolved in 25 mL of methanol with the addition of dimethylamine, 
40wt% in water (0.1 mmol, 0.051 mL). To this mixture, the Fe(III) salt solution was added drop wise 
on constant stirring. The resulting dark green solution was stirred and heated to 80°C for 
approximately 10 minutes. The solution was then allowed to stand at room temperature until crystals 
were formed. The dark green microcrystals were isolated by filtration and dried. Yield: 0.43g (0.38 
mmol, 38.1%). IR (cm-1, ATR):  3291.5 (νOH), 3174.7 (νNH), 3068.7 (νNH2), 1597 (νC=N), 1578.7, 
1542.2 (νC=C ring), 1224.5 (νC−O), 1341.4 (νN−N), 1031 (νC−S), 1432.7 (νSO). 
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2.5 Analytical Techniques  
2.5.1 Fourier Transform Infrared Spectroscopy 
Room temperature IR spectra for all ligands and ferric complexes were recorded on a Perkin Elmer 
FT-IR spectrometer Spectrum RXI by using KBr pellets within the range 4000-400 cm-1. Some 
additional IR spectroscopic measurements of the R-salicylaldehyde 4R-thiosemicarbazone ligands 
were carried out (at room temperature) using an ATR (Attenuated Total Reflectance) Perkin Elmer 
FT-IR spectrometer Frontier within the range 4000-600 cm-1.  
 
2.5.2 Nuclear Magnetic Resonance Spectroscopy 
1H and 13C NMR spectra were recorded in DMSO-d6 for the R-salicylaldehyde 4R’-
thiosemicarbazone ligands using a BRUKER cyromagnet BZH 300/52 spectrometer (300 MHz) with 
the recorded chemical shifts in δ (parts per million) relative to an internal standard of TMS 
(tetramethylsilane).  
 
2.5.3 Single Crystal X-ray Diffraction Measurements 
Crystallographic data details on data collection and refinement for all ferric complexes can be found 
in the corresponding chapters of this thesis. The data collection for the compounds Cs[Fe(3-OEt-
thsa-Me)2]∙CH3OH, Cs[Fe(5-Br-thsa)2], (CH3)2NH2[Fe(3-OEt-thsa)2], [Fe(H-thsa-Me)(thsa-
Me)]∙H2O, [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O, [Fe(H-5-Br-thsa-Et)2](NO3)∙H2O and [Fe(H-
4-OH-thsa)2]4(SO4)2∙9H2O were performed on Rigaku AFC12 four-circle κ diffractometer, equipped 
with an enhanced sensitivity (HG) Saturn724+ detector mounted at the window of an FR-E+ 
SuperBright molybdenum rotating anode generator with VHF Varimax optics (70μm focus/100μm 
focus). The data were collected at 100 K for the ferric complexes (vide supra) apart from Cs[Fe(5-
Br-thsa)2], of which the data was collected at 293 K, all with a Mo Kα radiation, λ = 0.71075 Å. Data 
collection was performed using the commercially designed software, CrystalClear-SM Expert [1, 2]. 
Data reduction, cell refinement and absorption correction were performed using CrystalClear-SM 
Expert [1, 2] and CrysAlisPro [3] packages. The structure solution and structure refinement of the 
ferric complexes data were carried out using SUPERFLIP [4] and SHELX programmes [5, 6]. The 
data collection of the compounds Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH, Cs[Fe(5-Br-thsa)2], 
(CH3)2NH2[Fe(3-OEt-thsa)2], [Fe(H-thsa-Me)(thsa-Me)]∙H2O, [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-
Me)]∙H2O, [Fe(H-5-Br-thsa-Et)2](NO3)∙H2O and [Fe(H-4-OH-thsa)2]4(SO4)2∙9H2O were carried out 
at the ESPRC National Crystallography Service, at the University of Southampton.  
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The data collection for the compound [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O was conducted 
at the synchrotron-based facility at the Diamond Light Source, UK national synchrotron science 
facility located at the Harwell Science and Innovation Campus Oxfordshire. The data collection was 
performed on beamline I19 situated on an undulator insertion device with a combination of double 
crystal monochromator, vertical and horizontal focussing mirrors and a series of beam splits (primary 
white beam and either side of the focussing mirrors). The experimental hutch (EH1) is equipped with 
a Crystal Logic four-circle κ geometry goniometer with a Rigaku Saturn 724 CCD detector and an 
Oxford Cryosystems Cyrostream plus cryostat (80-500 K). The crystal data was collected at 100 K, 
with an energy of the X-ray beam of 18 k eV (λ = 0.6889 Å). Cell determination and data collection 
were performed using the program CrystalClear-SM Expert 2.0 r5 [7]. Moreover, the data reduction, 
cell refinement and absorption correction were performed using the program CrystalClear-SM 
Expert 2.0 r5 [7]. The structure solution of [Fe(3-OEt-thsa-Me)(H-3-OEt-thsa-Me)]∙H2O was 
determined using the program SUPERFLIP [4].  
Furthermore, the crystal data collection for the ferric complexes NH4[Fe(thsa)2] and NH4[Fe(5-Br-
thsa)2], were carried out after attaching a single crystal to a glass fibre by using perfluorinated oil 
and mounted on a Bruker KAPPA APEX II diffractometer equipped with a CCD detector. Data were 
collected at 100 K in a dry stream of nitrogen with MoKα radiation (λ=0.71073 Å). Data were 
reduced to intensity values using SAINT-Plus [8] and absorption correction was applied using the 
multi-scan method implemented by SADABS [8]. The structures were solved using charge-flipping 
implemented by SUPERFLIP [4] and refined against F-values with JANA2006 [9].  
 
2.6 Physical Measurements 
2.6.1 Differential Scanning Calorimetry 
DSC experiments were performed with a differential scanning calorimeter Mettler Toledo DSC1 
STARe System. The temperature and enthalpy scales were calibrated with a standard sample of 
indium, using its melting transition (156.6°C, 3296 Jmol-1). The calorimetric measurements were 
carried out in 40 μL aluminium pans, containing ~5-15 mg of the ferric complex sample, which was 
sealed with an aluminium lid and crimped. An empty sealed 40μL aluminium pan and lid was used 
as the reference. The measurements were carried out at a heating rate of 5 K/min under N2 
atmosphere in the temperature range of 123 – 353 K.  
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2.6.2 Magnetic Measurements  
Variable temperature magnetic susceptibility data for the coordination compounds Cs[Fe(3-OEt-
thsa-Me)2]∙CH3OH and Cs[Fe(5-Br-thsa)2] were obtained with a cryogenic vibrating-sample 
magnetometer (VSM) at the Institute of Applied Synthetic Chemistry, Vienna University of 
Technology. The rate of temperature change was at 5 K/min. The magnetometer was calibrated using 
Gd2(SO4)3 and a certified Pd-sample. The data collected from the vibrating sample magnetometer 
(VSM) in the temperature range 10 – 300 K was converted to χMT by equation 1 (Eq 1): 
 
χMT = [M/ (magnetic field*(sample amount/ MW)]*T  (Eq 1) 
 
The different terms displayed in equation 1 and their respective units are defined as: 
Magnetisation (M) emu 
Magnetic field Oe 
Sample amount g 
Sample molecular weight 
(MW) 
g/mol 
Temperature (T) K 
Data were corrected for diamagnetic contributions, which were estimated from Pascal’s constants. 
 
Temperature dependent magnetic measurements of the ferric complexes presented in this thesis were 
carried out at the Physics Department of the University of Warwick, using a Quantum Design 
MPMS-5S SQUID (Superconducting Quantum Interference Device) magnetometer. The magnetic 
measurements were conducted with scan temperatures between 5-320 K with a rate of 2 K/min and 
an applied field of 1 T. The SQUID magnetometer was calibrated against the standard palladium 
sample. Data collected from the SQUID magnetometer was converted to χMT (χM is the molar 
magnetic susceptibility and T the temperature) via equation 1 (vide supra).  
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3.0 Anionic Fe(III) Complexes of R-salicylaldehyde 4R’-thiosemicarbazones 
3.1 Introduction 
It is recognised that octahedral metal complexes with 3d4 – 3d7 electronic configurations with 
specific ligands can exhibit spin-crossover behaviour, the magnetic interconversion between low-
spin and high-spin state, dependent upon external perturbations of temperature, pressure or light 
irradiation [1]. In recent years, particular interest has focused on FeIII (3d5) complexes of substituted 
derivatives of R-salicylaldehyde 4R’-thiosemicarbazone [2-7] for generating FeIII spin-crossover. 
The spin-crossover properties of this class of FeIII bis(ligand) complexes have been found to be 
sensitive to the presence of a particular counter-ion, the degree of solvation and the nature of the 
R,R’-substituted ligands [7, 8]. Furthermore, it has been established that varying the pH during the 
synthesis of the FeIII bis(ligand) entities leads to the formation of FeIII compounds differing in the 
degree of deprotonation of the ligand, whereby the complex unit can be neutral, monocationic or 
monoanionic [4, 6, 9].  
In FeIII compounds, it is possible for the tridentate R-salicylaldehyde 4R’-thiosemicarbazone ligand 
(H2L) to exist in tautomeric forms; moreover, the ligand may also be present in its neutral, anionic 
or dianionic form. The free R-salicylaldehyde 4R’-thiosemicarbazone ligand (H2L) in solution exists 
in two tautomeric forms i.e. the thione and thiol forms, as illustrated in Scheme 3.1.1.  
R
OH
N
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N
H
N
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H
R
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N
H
N N
SH
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Scheme 3.1.1 
 
In this chapter, the synthesis and crystallographic studies of five anionic FeIII compounds of R-
salicylaldehyde 4R’-thiosemicarbazonato(2-) are reported: Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH, 
Cs[Fe(5-Br-thsa)2], NH4[Fe(thsa)2], NH4[Fe(5-Br-thsa)2] and (CH3)2NH2[Fe(3-OEt-thsa)2]; the 
ligands are depicted in Figure 3.1.1. Furthermore, the electronic properties of the FeIII coordination 
compounds are herein investigated, with focus upon the effect of the varied R and R’-substituted 
salicylaldehyde thiosemicarbazone ligands and the effect of the variation of the non-coordinating 
cation.    
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Figure 3.1.1 Structure of H2L R-salicylaldehyde 4R’-thiosemicarbazone ligands  
 
3.2 The crystal structure and magnetic properties of caesium bis(3-ethoxysalicylaldehyde 4-
methylthiosemicarbazonato(2-)-κ3-O2,N1,S)ferrate(III) methanol monosolvate  
The magnetic properties are herein reported of the novel FeIII compound Cs[Fe(3-OEt-thsa-
Me)2]∙CH3OH containing two dianionic tridentate 3-ethoxysalicylaldehyde 4-
methylthiosemicarbazonate(2-) (L2‒) ligands (Scheme 3.2.1) and the determination and description 
of its structure at 100 K.   
The experimental data are reported in Chapter II for the synthesis of Cs[Fe(3-OEt-thsa-
Me)2]∙CH3OH and corresponding ligand, 3-ethoxysalicylaldehyde 4-methylthiosemicarbazone.  
 
Scheme 3.2.1 
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3.2.1 Crystal Data and Structure Refinement Details of Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH  
Crystal data, data collection and structure refinement details are summarised in Table 3.2.1. The 
hydrogen atoms on the secondary amine atoms N13 and N23 were located in difference Fourier maps 
and refined with restrained N–H distances of 0.88(2) Å and with Uiso(H) = 1.2Ueq(N). The hydrogen 
atom attached to atom O3 of the methanol molecule was located in a difference Fourier map and 
refined with an O–H distance restraint of 0.84(2) Å and Uiso(H) = 1.5Ueq(O). The remaining hydrogen 
atoms were included in the refinement in calculated positions and treated as riding on their parent 
atoms, with C–H = 0.95 Å and Uiso(H) = 1.2Ueq(C) for aryl (-CH=) hydrogen atoms, C–H = 0.99 Å 
and Uiso(H) = 1.2Ueq(C) for methylene (-CH2-) hydrogen atoms, C–H = 0.98 Å and Uiso(H) = 
1.5Ueq(C) for methyl (–CH3) hydrogen atoms. The ethoxy group of one of the ligands shows 
positional disorder. Two different sets of positions for the methyl and methylene carbon atoms were 
identified in the difference Fourier synthesis, i.e. C111 and C110; and C113 and C112, respectively, 
which were refined with inversely proportional occupancy factors [0.552(17) and 0.448(17)]. 
Similarity restraints were applied to the chemically equivalent bonds within the two disordered 
conformations. The residual density on a difference Fourier map included a quadrilateral of peaks 
near Cs of height 1.21–1.84 e Å–3. Unreasonably close contacts to some ligand atoms, which 
persisted after refinement, ruled out an attribution of these peaks to disorder of the Cs site. Twinning 
was also considered and rejected; three possible twin laws were provided by ROTAX [10], but 
refinement in SHELXL97 [11] led to a negligible scale factor for each such twin component. 
Therefore, the peaks, which represent a small fraction of the 54 electrons in the Cs+ ion, are assumed 
to arise from limitations of the data. 
 
Table 3.2.1 Crystal data and structure refinement details of Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH 
Crystal data 
Chemical formula Cs[Fe(C11H13O2N3S)2]∙CH3OH 
Mr 723.40 
Crystal system, space group Triclinic, P-1 
Temperature (K) 100 
a, b, c (Å) 8.486 (3), 9.078 (3), 19.875 (7) 
α, β, γ (°) 100.629 (5), 91.549 (5), 113.674 (5) 
V (Å3) 1369.5 (8) 
Z 2 
Radiation type Mo Kα 
µ (mm−1) 2.06 
Crystal size (mm) 0.04 × 0.02 × 0.01 
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Table 3.2.1 Crystal data and structure refinement details of Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH 
(continued) 
Colour Green (plate) 
Data collection 
Diffractometer Rigaku AFC12 four-circle Kappa diffractometer 
Absorption correction Multi-scan (CrystalClear-SM Expert [12]) 
Tmin, Tmax 0.711, 1.000 
No. of measured, independent and  
observed [I > 2σ(I)] reflections 
15188, 4844, 3414  
Rint 0.082 
Refinement 
R[F2 > 2σ(F2)], wR(F2), S 0.052, 0.122, 0.92 
No. of reflections 4844 
No. of parameters 377 
No. of restraints 5 
H-atom treatment H atoms treated by a mixture of independent and 
constrained refinement 
Δρmax, Δρmin (e Å−3) 1.84, −0.62 
 
The program used for data collection, cell refinement and data reduction: CrystalClear-SM Expert 
[12]. The program used for the structure solution: SUPERFLIP [13-15]; the structure refinement 
used the program SHELXL97 [11]. The ORTEP-3 for Windows [16] and OLEX2 [17] programs were 
used to produce the molecular graphics.  
 
3.2.2 Crystallographic study of Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH 
The structure of caesium bis(3-ethoxy-salicylaldehyde-methylthiosemicarbazonato(2-)-
κ3O2,N1S)ferrate(III) methanol (Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH) (Figure 3.2.1) was determined at 
100 K. Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH was found to crystallise in a triclinic system and in the space 
group P-1. The asymmetric unit consists of one formula unit, Cs[Fe(L)2]∙CH3OH, with no atom at a 
special position. The structure of Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH shows that the FeIII ion is 
coordinated by two dianionic tridentate thiosemicarbazonato-O,N,S ligands, displaying an distorted 
octahedral FeIIIO2N2S2 geometry. Selected geometric parameters are listed in Table 3.2.2. The donor 
atoms of the ligands are situated in two perpendicular planes with O and S atoms in cis positions, 
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whereas the N atoms are in trans positions. These features are corroborated by the bond angles 
involving the Fe atom and the donor atoms (Table 3.2.2). 
 
Figure 3.2.1 The molecular structure and atom-numbering scheme for Cs[Fe(3-OEt-thsa-
Me)2]∙CH3OH. The Cs+, CH3OH and an alternative orientation for C110-C111 have been omitted 
for clarity. Displacement ellipsoids are drawn at the 50% probability level. 
 
The bond distances involving the Fe atom and the donor atoms (Table 3.2.2) suggest that the present 
compound contains low-spin FeIII at 100 K. Typical distances for Fe−S, Fe−O and Fe−N bonds are 
2.23–2.31 Å, 1.93–1.95 Å and 1.88–1.96 Å, respectively, for low-spin FeIII compounds of this 
family, and 2.40–2.44 Å, 1.96–1.99 Å and 2.05–2.15 Å, respectively, for the corresponding high-
spin FeIII compounds [8]. It is noteworthy that the Fe−O distances in Cs[Fe(3-OEt-thsa-
Me)2]∙CH3OH are both shorter than the typical values quoted for low-spin FeIII. One reason may be 
invoked for this occurrence; the low-spin Fe−O reference values are mainly taken from X-ray crystal 
structures determined at temperatures higher than that at which the structure of the present compound 
was determined (100 K), hence it may be anticipated that the range of actual low-spin Fe−O distances 
at 100 K will be slightly shorter than the cited values. Furthermore, it is significant to note that the 
Fe−O distances seem to be less sensitive to a change in FeIII spin state than the Fe−N and Fe−S 
distances, which may be related to the π-acceptor capability of the N- and S-donor atoms opposed 
to the π-donor capability of the O-donor atoms. This is of particular significance when FeIII is in the 
low-spin state as increased back-bonding will lead to comparatively more pronounced shortening of 
the Fe−N and Fe−S bonds than of the Fe−O bonds. 
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Table 3.2.2 Selected geometric parameters of Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH (Å, °) 
Fe1–S11  2.2686(19)  Fe1–S21  2.265(2)  
Fe1–O11 1.904(4)  Fe1–O21  1.918(4)  
Fe1–N11  1.933(5)  Fe1–N21  1.939(5)  
    
S11–Fe1–S21  89.61(7)  O11–C12–C11  124.2(6) 
S11–Fe1–N11  85.55(15)  C12–C11–C17 123.6(5) 
S11–Fe1–O11  177.83(14)  C11–C17–N11 125.3(6) 
S11–Fe1–O21  89.34(13)  C17–N11–Fe1 125.4(4) 
S11–Fe1–N21  94.57(15)  Fe1–O21–C22  122.8(4) 
S21–Fe1–O11  92.56(14)  O21–C22–C21  124.3(3) 
S21–Fe1–O21  178.01(13)  C22–C21–C27 122.1(6) 
S21–Fe1–N11  94.17(16)  C21–C27–N21 126.2(6) 
S21–Fe1–N21  84.71(16)  C27–N21–Fe1 123.8(4) 
O11–Fe1–O21  88.49(18)  C18–S11–Fe1 94.6(2) 
O11–Fe1–N11  94.37(19)  N11–N12–C18 113.3(5) 
O11–Fe1–N21  85.55(18)  N12–C18–S11  124.8(5) 
O21–Fe1–N11  87.4(2)  C28–S21–Fe1 94.3(2) 
O21–Fe1–N21  93.7(2)  N21–N22–C28 113.1(5) 
N11–Fe1–N21  178.9(2)  N22–C28–S21  124.3(5) 
Fe1–11–C12  126.14(4)   
 
The tridentate ligands in the present compound coordinate to the FeIII cation by the thiolate-S, 
phenolate-O and the imine-N, forming six- and five-membered chelate rings. As might be expected, 
the six-membered chelate ring involves a significantly less restricted bite angle [O11–Fe–N11 = 
94.37(19)° and O21–Fe–N21 = 93.7(2)°] than the five-membered chelate ring [S11–Fe–N11 = 
85.55(15)° and S21–Fe–N21 = 84.71(16)°]. The conformation of the 5- and 6-membered chelate 
rings of Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH illustrate there is no major strain relief through puckering. 
At 100 K, the root-mean-square deviations from their least-squares plane of atoms comprising the 
6-membered [Fe1 N11 C17 C11 C12 O11] and [Fe1 N21 C27 C21 C22 O21] chelate rings are 0.038 
and 0.123 Å, respectively; corresponding values for the 5-membered [Fe1 N11 N12 C18 S11] and 
[Fe1 N21 N22 C28 S21] chelate rings are 0.012 and 0.083 Å, respectively. The O–Fe–N bite angle 
of the 6-membered chelate rings is deficient by ca. 26° from the ideal 120° angles in a regular 
hexagon. The remaining bite angles (listed in Table 3.2.2) of the 6-membered chelate rings are within 
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3° of 125°. In comparison to the 108° angles of a regular pentagon, the S–Fe–N bite angles are 
deficient by 23°. The C–S–Fe angles are 94.6(2)° and 94.3(2)°, respectively, creating an additional 
deficiency of ca. 14°. The deficiencies of the bite angles can be offset by an increase in the other bite 
angles of the 5-membered chelate ring to ca. 120°. In fact, the N–N–C angles are 113.3(5)° and 
113.1(5)°, respectively, and the N–C–S bite angles are 124.8(5)° and 124.3(5)°, respectively. The C 
and N atoms form bonds which display sp2 hybridisation which is contaminant of the 120° angles. 
Further stabilisation arises from the near alternation of single and double bonds in the different 
electronic forms allowing a high degree of π-electron delocalisation throughout both of the chelate 
rings. Hydrogen atoms could not be located on the phenolate-O and the thiolate-S atoms, which 
implies that both ligands are in the dianionic form. This is concomitant with the presence of a 
trivalent iron ion together with a monovalent caesium cation. Ryabova et al. [18] reported on the 
related compound Cs[Fe(L)2] [where L2‒ = salicylaldehyde thiosemicarbazonato(2-)], although this 
material contains high-spin FeIII.  
The binding of the twofold deprotonated ligand of Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH to the FeIII 
cation involves electron delocalisation within the chelate ring, which is evident from geometric 
parameters. The C18−S11 bond distance of 1.742(7) Å and C28−S21 bond distance of 1.759(6) Å 
suggest a partial electron delocalisation of these bonds. This corresponds well with the C−S bond 
distance of 1.750(6) Å for the low-spin FeIII compound NH4[Fe(L)2] (where L2‒ = 5-
chlorosalicylaldehyde thiosemicarbazonato(2-)) at 135 K [19]. Similarly, a bond order larger than 
one can be inferred for the C−N bond involving the deprotonated hydrazinic nitrogen atom. The 
bond distances for the C17−N11 and C27−N21 bonds in the present FeIII complex are 1.302(7) Å 
and 1.291(8) Å, respectively, which correlates with the value reported by Ryabova et al. [19], i.e. a 
C−N bond distance of 1.265(8) Å for NH4[Fe(L)2] at 135 K. Moreover, for Cs[Fe(3-OEt-thsa-
Me)2]∙CH3OH, the N11−N12 and N21−N22 bond lengths are 1.398(7) Å and 1.406(7) Å, 
respectively, indicating some electron delocalisation.  
The hydrogen bonding interactions of Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH are listed in Table 3.2.3 and 
displayed in Figure 3.2.2. N13–H13∙∙∙S11 (−x + 1, −y + 1, −z + 1) interactions paired about the 
inversion centre at (0.5, 0.5, 0.5) create R22 (8) rings [20], as do N23–H23∙∙∙S21 (−x, −y + 1, −z + 1) 
contacts about (0, 0.5, 0.5). In this manner, successive FeIII entities are linked in the a direction. The 
CH3OH solvent oxygen atom O3 forms an O3–H3∙∙∙N12 contact involving the hydrazinic nitrogen 
atom N12. In turn, the hydrazinic atom N12 is bonded to the imine atom N11, which is coordinated 
to the FeIII cation centre. However, the Fe−N11 bond length [1.933(5) Å] is virtually identical to the 
Fe−N21 bond length [1.939(5) Å] involving the other ligand, which is devoid of hydrogen bonding 
interactions. The Cs+ cations link the anions into chains along [100].  
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Figure 3.2.2 A projection showing the unit cell of Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH. An alternative 
orientation for C110−C111 has been omitted for clarity. Displacement ellipsoids are drawn at the 
50% probability level. [Symmetry codes: (i) –x + 1, –y + 1, –z + 1; (ii) –x, –y + 1, –z + 1.] 
 
Table 3.2.3 Hydrogen bond geometry of Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH (Å, °) 
D–H∙∙∙A D–H  H∙∙∙A  D∙∙∙A  D–H∙∙∙A  
N13−H13∙∙∙S11i 0.87(2) 2.97(6) 3.505(6) 122(5) 
N23−H23∙∙∙S21ii 0.87(2) 2.70(5) 3.416(6) 141(6) 
O3−H3∙∙∙N12 0.85(2) 2.04(4) 2.852(7) 160(8) 
Symmetry codes: (i) –x + 1, –y + 1, –z + 1; (ii) –x, –y + 1, –z + 1. 
 
3.2.3 Magnetic Studies of Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH 
The temperature dependence of the χMT product (χM being the molar magnetic susceptibility and T, 
temperature) for the compound Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH was measured in the temperature 
range 10-300 K and given in Figure 3.2.3. The χMT value for Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH is 
0.664 cm3 mol-1 K at 300 K, which corresponds to the low-spin value expected for FeIII (0.375 cm3 
mol-1 K, g = 2.00), revealing no spin transition within the temperature range 10-300 K. 
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Figure 3.2.3 χMT vs T plot of Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH. [The sample was heated (▲) and 
subsequently cooled (▼).] 
 
3.3 The crystal structure and magnetic properties of caesium bis(5-bromosalicylaldehyde 
thiosemicarbazonato(2-)-κ3-O,N1,S)ferrate(III)  
In this section the magnetic properties of the title FeIII compound, Cs[Fe(5-Br-thsa)2], as illustrated 
in Scheme 3.3.1, are described, as well as the crystal structure at 293 K. The synthesis of Cs[Fe(5-
Br-thsa)2] and the corresponding H2L ligand, 5-bromosalicylaldehyde thiosemicarbazone, are 
described in Chapter II – Materials and Methods.  
 
Scheme 3.3.1 
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3.3.1 Crystal Data and Structure Refinement Details of Cs[Fe(5-Br-thsa)2] 
Crystal data, data collection and structure refinement details are summarised in Table 3.3.1. The 
structure of Cs[Fe(5-Br-thsa)2] was routinely solved by direct methods and refined by least squares 
with hydrogen atoms placed in calculated positions and non-hydrogen atoms given anisotropic 
displacement parameters. However, the refined parameters did not match the quality of the data set 
since the unweighted discrepancy index R1 of 0.0916 was much higher than R(int) of 0.0451. Since 
all 50 of the reflections with the worst discrepancy had F(obs) > F(calc), twinning was suspected; 
and the closeness of the unit cell β angle to 90° suggested a mechanism for pseudo-merohedral 
twinning. Application of ROTAX [10] indicated 180° rotation about the a axis as the likely twin law. 
Repeating the refinement with this twin law drastically reduced the discrepancy indices.  
Now all polar hydrogen atoms were omitted from the model and sought in difference Fourier maps. 
The H atoms on the secondary amine atoms N13 and N23 were located in difference Fourier maps 
at peak heights between 0.60 and 0.70 e Å-3, while no comparable peaks appeared adjacent to N11, 
N12, N21, N22 or any O or S atom. In subsequent refinements the amino hydrogen atoms thus 
established were treated as riding with N–H distances of 0.86 Å and Uiso(H) = 1.2Ueq(N). The 
remaining H atoms were included in the refinement in calculated positions and treated as riding on 
their parent atoms, with C–H = 0.93 Å and Uiso(H) = 1.2Ueq(C) for aryl (-CH=) H atoms. After final 
refinement R1 reached 0.0326 and wR2 = 0.0859, and fractional contribution of 0.1306(8) from the 
minor twin component was indicated.  
 
Table 3.3.1 Crystal data and structure refinement details of Cs[Fe(5-Br-thsa)2]  
Crystal data 
Chemical formula Cs[Fe(C8H6BrON3S)2]  
Mr 733.02 
Crystal system, space group Monoclinic, P21/c 
Temperature (K) 293 
a, b, c (Å) 20.2500(14), 12.0868(8), 9.0389(5) 
α, β, γ (°) 90, 90.337(1), 90 
V (Å3) 2212.3(2) 
Z 4 
Radiation type Mo Kα 
µ (mm−1) 
Crystal size (mm) 
6.13 
0.08 × 0.08 × 0.01 
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Table 3.3.1 Crystal data and structure refinement details of Cs[Fe(5-Br-thsa)2] (continued) 
Colour Green/brown (plate) 
Data collection 
Diffractometer Rigaku AFC12 (Right) diffractometer 
Absorption correction Multi-scan  
CrystalClear-SM Expert 3.1 b27 
No. of measured, independent and 
observed [I > 2σ(I)] reflections 
29088, 5073, 4211  
Rint 0.045 
(sin θ/λ)max (Å−1) 0.649 
Refinement 
R[F2 > 2σ(F2)], wR(F2), S 0.033, 0.086, 1.03 
No. of reflections 5073 
No. of parameters 272 
No. of restraints 0 
H-atom treatment All H atoms treated by a constrained refinement 
Δρmax, Δρmin (e Å−3) 0.88, −0.85 
 
The program used for data collection, cell refinement and data reduction: CrystalClear-SM Expert 
[12]. The program(s) used for the structure solution and the structure refinement: ROTAX [10], 
SHELXS [11] and SHELXL [11].  The ORTEP-3 for Windows [16] program was used to produce the 
molecular graphics.  
 
3.3.2 Crystallographic study of Cs[Fe(5-Br-thsa)2] 
The crystal structure of caesium bis(5-bromosalicylaldehyde thiosemicarbazonato(2-)-κ3-
O,N1,S)ferrate(III) (Figure 3.3.1) was determined at 293 K. Cs[Fe(5-Br-thsa)2] crystallises in the 
monoclinic system in the space group P21/c. The asymmetric unit corresponds to the formula unit, 
Cs[Fe(L)2] where L
2‒ = 5-bromosalicylaldehyde thiosemicarbazonate(2–), with no atom on a special 
position. The central FeIII cation is hexa-coordinated by two dianionic O,N,S-tridentate L2‒ ligands, 
displaying a distorted octahedral FeIIIO2N2S2 geometry. Deprotonation occurs for the phenol O atoms 
and thiol S atoms. Selected geometric parameters are listed in Tables 3.3.2 and 3.3.3. 
The FeIIIO2N2S2 unit is distorted from the ideal octahedral geometry, as indicated by the bond angles 
(Table 3.3.2) of the donor atoms and the Fe1 atom (vide infra). The tridentate L2‒ ligands are 
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coordinated to the FeIII cation by the O- and S-donor atoms, which are situated in two perpendicular 
planes in the cis positions, such that the N-donor atoms are situated in mutually trans positions.  
 
Figure 3.3.1 The molecular structure and atom-numbering scheme for Cs[Fe(5-Br-thsa)2]. 
Displacement ellipsoids are drawn at 50% probability level. 
 
Table 3.3.2 Selected geometric parameters of Cs[Fe(5-Br-thsa)2] (Å, °) 
Fe–S11  2.2321(11) Fe–S21  2.2422(11) 
Fe–O11  1.942(3)  Fe–O21 1.956(3) 
Fe–N11  1.947(3) Fe–N21  1.938(3)  
Cs1–S11i 3.7159(11) Cs1–N12ii  3.326(3) 
Cs1–S21i 3.5564(11) Cs1–N22iii 3.470(3) 
Cs1–O11 3.220(3) Cs1–N23i 3.699(4) 
Cs1–O21 3.129(3)   
    
S11–Fe–S21  93.66(4) O11–Fe–N21  89.20(12) 
S11–Fe–N11  86.01(9) O21–Fe–N11  89.40(11) 
S11–Fe–O11   177.50(9) O21–Fe–N21  93.78(12) 
S11–Fe–O21  89.78(10) N11–Fe–N21  175.33(12) 
S11–Fe–N21  90.57(9) C18–S11–Fe  95.12(13) 
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Table 3.3.2 Selected geometric parameters of Cs[Fe(5-Br-thsa)2] (Å, °) (continued) 
S21–Fe–O11  88.81(9) C28–S21–Fe  94.61(14) 
S21–Fe–O21  176.56(10) N11–N12–C18  113.5(3) 
S21–Fe–N11  90.96(9) N21–N22–C28  113.6(3) 
S21–Fe–N21  86.07(9) N12–C18–S11 124.3(3) 
O11–Fe–O21  87.75(12) N22–C28–S21 124.8(3)  
O11–Fe–N11  94.35(12)   
O11–Cs1–S11i 176.98(5) N12ii–Cs1–S11i 85.01(6) 
O11–Cs1–S21i 129.54(5) N12ii–Cs1–S21i 103.23 6) 
O11–Cs1–N12ii 92.97(7) N12ii–Cs1–N22iii 156.35(8) 
O11–Cs1–N22iii 65.82(7) N12ii–Cs1–N23i 143.33(8) 
O11–Cs1–N23i 100.65(7) N22iii–Cs1–S11i 115.72(6) 
O11–Cs1–O21 50.34(7) N22iii–Cs1–S21i 98.64(6) 
O21–Cs1–S11i 126.82(5) N22iii–Cs1–N23i 56.10(8) 
O21–Cs1–S21i 178.78(5) N23i–Cs1–S11i 82.29(6) 
O21–Cs1–N12ii 75.63(7) N23i–Cs1–S21i 42.99(6) 
O21–Cs1–N22iii 82.42(7) S21i–Cs1–S11i 53.27(2) 
O21–Cs1–N23i 137.96(7)   
Symmetry codes: (i) x, y, z – 1; (ii) x, –y + 1/2, z – 1/2; (iii) x, –y +3/2, z – 1/2. 
 
X-ray structural data of similar FeIII bis(ligand) compounds containing the dianionic 
thiosemicarbazonate(2-) ligands show that the Fe–S, Fe–O and Fe–N bond distances are 2.23–2.31 
Å, 1.93–1.95 Å and 1.88–1.96 Å, respectively, for low-spin FeIII compounds, and 2.40–2.44 Å, 1.96–
1.99 Å and 2.05–2.15 Å, respectively, for corresponding high-spin FeIII compounds [8]. Comparison 
of the bond distances of Cs[Fe(5-Br-thsa)2] involving the FeIII atom and the donor atoms (Table 
3.3.2) suggests that the present compound contains low-spin FeIII at 293 K. 
The distortion of the FeIIIO2N2S2 unit results from the constraints imposed by the five- and six-
membered chelate rings formed. The six-membered chelate ring involves a significantly wider bite 
angle than the ideal octahedral 90° [O11–Fe–N11 = 94.35(12)° and O21–Fe–N21 = 93.78(12)°], 
while the bite angle is narrowed in the five-membered chelate ring [S11–Fe–N11 = 86.01(9)° and 
S21–Fe–N21 = 86.07(9)°]. There is no major strain relief through puckering: the root mean-square 
deviations from their least-squares plane of atoms comprising the six-membered [Fe1 N11 C17 C11 
C12 O11] and [Fe1 N21 C27 C21 C22 O21] chelate rings are 0.034 and 0.038 Å, respectively; 
corresponding values for the five-membered [Fe1 N11 N12 C18 S11] and [Fe1 N21 N22 C28 S21] 
chelate rings are 0.014 and 0.009 Å, respectively. Compared with the 120° angles in a regular 
hexagon, the O–Fe–N bite angle is deficient by ca. 26°; each of the remaining angles in the six-
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membered rings is within 2° of 125°. Because the angle at the vertex of a regular pentagon is 108°, 
the S–Fe–N bite angles are deficient by only 22°. However, the C–S–Fe angles are only about 95°, 
providing an additional deficiency of 13° and a total which could be neatly offset by increasing the 
other angles to ca. 120°. (In fact, the N–N–C angles are <120° and the N–C–S are >120°.) Such 120° 
angles are consistent with sp2 hybridisation at C and N atoms. The stability of the FeIII complex is 
enhanced by the high degree of electron delocalisation throughout the chelated ligands.   
The bond distances of the ligands coordinated to the FeIII cation in Cs[Fe(5-Br-thsa)2] can be related 
to the bond order. The C–S, C–N and N–N bond distances obtained for the present compound show 
characteristics of a bond order between single and double bonds. As expected, the C18–S11 bond 
distance of 1.750(4) Å and C28–S21 bond distance of 1.753(4) Å suggest a partial electron 
delocalisation of these bonds. Ryabova et al., [21] reported the related low-spin compound 
NH4[Fe(5-Br-thsa)2] at 298 K which crystallises in the centrosymmetric space group Pnca with Z’ 
= 0.5 (where Z is the number of formula units per unit cell and Z’ is the number of formula units per 
asymmetric unit). Thus the ligands coordinated around the FeIII cation are related by symmetry. The 
C–S bond distances of Cs[Fe(5-Br-thsa)2] correspond with the C–S bond distance of 1.750(9) Å for 
NH4[Fe(5-Br-thsa)2] suggesting the occurrence of partial electron delocalisation in both compounds. 
Furthermore, the electron delocalisation of the ligands is confirmed by a bond order larger than 1 for 
the C–N bond involving the deprotonated hydrazinic N atom. The bond distances for the C17–N11 
and C27–N21 bonds in the present compound are 1.281(5) Å and 1.296(5) Å, respectively, which 
are similar to the C–N bond distance (1.292(10) Å) reported for NH4[Fe(5-Br-thsa)2] [21]. In 
addition, the N–N bond distances of Cs[Fe(5-Br-thsa)2] are N11–N12 = 1.394(4) Å and N21–N22 = 
1.401(4) Å, respectively, indicating partial electron delocalisation. 
The Cs+ cation of Cs[Fe(5-Br-thsa)2] is at the centre of an irregular seven-donor atom polyhedron, 
the donor atoms of which originate from three symmetry-related equivalents of both symmetry-
independent ligands. Selected geometric parameters are listed in Table 3.3.2.  
Several donor atoms coordinated to the Fe atom of Cs[Fe(5-Br-thsa)2] form interactions with the Cs+ 
ion in the second coordination sphere, modulating the electron density of the Fe-donor atom bonds 
and hence influencing the electronic state of the FeIII cation.  
The phenolate O11 and O21 FeIII donor atoms bind to the Cs+ cation within the same FeIII unit. The 
Cs–O distances are Cs1–O11 = 3.220(3) Å and Cs1–O21 = 3.129(3) Å, which is somewhat longer 
than the mean Cs–O bond distance of 3.074(1) Å in the hydrated Cs+ cation [22]. The small O11–
Cs1–O21 bond angle of 50.34(7)° is a corollary of the closeness of the two ligands bound to FeIII. 
The Cs1∙∙∙Fe separation involving the -diphenolate bridge is 4.2703(6) Å and the Cs–O–Fe bond 
angles are Cs1–O11–Fe = 109.12(11)° and Cs1–O21–Fe = 112.16(11)°. 
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The thiolate S11i and S21i [symmetry code: (i) x, y, z – 1] FeIII-donor atoms coordinate to the Cs+ 
cation with bond distances of 3.7159(11) Å and 3.5564(11) Å, respectively. Moreover, the terminal 
N23i atom of the same FeIII unit forms a bond with the Cs+ cation, with a Cs1–N23i bond distance of 
3.699(4) Å. The proximity of N23 and S21 is shown by the small N23i–Cs1–S21i bond angle of 
42.99(6)°, whereas the small S21i–Cs1–S11i bond angle of 53.27(2)° is related to the vicinity of the 
two ligands bound to FeIII. Furthermore, the thiolate S-donor atoms coordinate to the Cs+ cation, as 
well as to the FeIII cation, which gives rise to the Cs1∙∙∙Fei separation of 4.7695(6) Å [symmetry 
code: (i) x, y, z – 1]. The Cs–S–Fe bond angles involving the -dithiolate bridge are Cs1–S11i–Fe 
= 103.80(4)° and Cs1–S21i–Fe = 108.55(4)°. In addition, the atoms N12ii and N22iii [symmetry 
codes: (ii) x, –y + 1/2, z – 1/2; (iii) x, –y + 3/2, z – 1/2] next to the imine N-donor atoms in the first 
coordination sphere of FeIII are also coordinated to the Cs+ cation. The bond distances for the Cs1–
N12ii and Cs1–N22iii bonds in Cs[Fe(5-Br-thsa)2] are 3.326(3) Å and 3.470(3) Å, respectively. 
The Cs+∙∙∙Cs+ separations of 7.4530(5) Å for Cs1∙∙∙Cs1 (x, ‒y + 3/2, z + 1/2) and 7.6404(5) Å for 
Cs1∙∙∙Cs1 (x, –y + 1/2, z – 1/2) do correlate with the shortest FeIII∙∙∙FeIII separations in Cs[Fe(5-Br-
thsa)2]. These are 7.5369(9) Å for Fe∙∙∙Fe (x, –y + 3/2, z + 1/2) and 7.5559(6) Å for Fe∙∙∙Fe (x, –y + 
1/2, z – 1/2). 
The previously reported compound, Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH, displays FeIII∙∙∙FeIII (x + 1, y, 
z) separations of 8.486 Å (Section 3.2 vide supra). The absence of the solvent molecule in Cs[Fe(5-
Br-thsa)2] allows the FeIII entities to be closer to each other in the crystal lattice compared to those 
in the latter compound. Furthermore, the R-R’-substituents of the ligands coordinated to the FeIII 
atom, 5-bromosalicylaldehyde thiosemicarbazone in the present compound and 3-
ethoxysalicylaldehyde 4-methylthiosemicarbazone in Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH, might have 
some effect as to how the FeIII entities are assembled in the crystal lattice. The size and position of 
the R, R’-substituted groups are different, as Cs[Fe(5-Br-thsa)2] contains the Br-substituent on the 
C15/C25 labelled atom of the salicylaldehyde moiety, whereas Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH 
contains a relatively bulky ethoxy group on the C13/C23 atom of the salicylaldehyde moiety as well 
as a methyl substituent on the terminal nitrogen atom of the thiosemicarbazide moiety. In addition, 
the Br-substituent of one FeIII unit of Cs[Fe(5-Br-thsa)2] provides a hydrogen bonding interaction 
with an amino group of a neighbouring FeIII unit (vide infra). The occurrence of the intermolecular 
hydrogen bonding interactions between the FeIII units in Cs[Fe(5-Br-thsa)2] contributes to the 
arrangement of the FeIII entities in the unit cell.  
The hydrogen bonding interactions of Cs[Fe(5-Br-thsa)2] are listed in Table 3.3.3 and displayed in 
Figure 3.3.2. The main features of the molecular packing of the present compound are the N–H∙∙∙O 
and N–H∙∙∙Br hydrogen bonds. Although the latter are weak, their grip on the bromine atoms is 
augmented by C-H∙∙∙Br interactions at similar H∙∙∙Br contact distances. The N13–H13B∙∙∙Br2v (–x + 
1, –y – 1/2, –z + 3/2) and N13–H13A∙∙∙O21iv (x, –y + 1/2, z + 1/2) contacts form hydrogen bonds to 
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two different ring systems. In turn the O21 atom in the first system and Br2 in the second accept 
hydrogen bonds from inversion-related N13 (–x + 1, –y, –z + 2), giving rise to R44(18) rings [20]. In 
a similar manner, the N23–H23B∙∙∙Br1vii (–x + 2, y + 1/2, –z + 3/2) and N23–H23A∙∙∙O11vi (x, –y + 
3/2, z + 1/2) contacts create R44(18) rings with inversion-related N23 (–x + 2, –y + 2, –z + 2). The 
ring systems created by the hydrogen bonding between the FeIII entities link them in the a and b 
directions. Furthermore, the Cs+ cations link the FeIII complex anions in a chain along [010]. 
 
Figure 3.3.2 A projection showing the unit cell of Cs[Fe(5-Br-thsa)2]. The Cs+ cation has been 
omitted for clarity. Displacement ellipsoids are drawn at the 50% probability level. Dashed lines 
indicate hydrogen bonds. [Symmetry codes: (iv) x, –y + 1/2, z + 1/2; (v) –x + 1, y – 1/2, –z + 3/2; 
(vi) x, –y + 3/2, z + 1/2; (vii) –x + 2, y + 1/2, –z + 3/2; (viii) –x + 2, y + 1/2, –z + 1/2; (ix) –x + 1, y 
– 1/2, –z + 1/2.]  
 
Table 3.3.3 Hydrogen bond geometry of Cs[Fe(5-Br-thsa)2] (Å, °) 
D–H∙∙∙A D–H (Å) H∙∙∙A (Å) D∙∙∙A (Å) D–H∙∙∙A (°) 
N13–H13A∙∙∙O21iv 0.86 2.08 2.908(5) 161 
N13–H31B∙∙∙Br2v 0.86 2.73 3.557(4) 163 
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Table 3.3.3 Hydrogen bond geometry of Cs[Fe(5-Br-thsa)2] (Å, °) (continued) 
D–H∙∙∙A D–H (Å) H∙∙∙A (Å) D∙∙∙A (Å) D–H∙∙∙A (°) 
N23–H23A∙∙∙O11iii 0.86 2.10 2.952(5) 171 
N23–H23B∙∙∙Br1vii 0.86 2.95 3.590(4) 133 
C13–H13∙∙∙Br1viii 0.93 2.83 3.578(5) 139 
C23–H23∙∙∙Br2ix 0.93 2.86 3.623(5) 141 
Symmetry codes: (iv) x, –y + 1/2, z + 1/2; (v) –x + 1, y – 1/2, –z + 3/2; (vi) x, –y + 3/2, z + 1/2; 
(vii) –x + 2, y + 1/2, –z + 3/2; (viii) –x + 2, y + 1/2, –z + 1/2; (ix) –x + 1, y – 1/2, –z + 1/2. 
 
3.3.3 Magnetic Studies of Cs[Fe(5-Br-thsa)2] 
The temperature dependence of the χMT product (χM being the molar magnetic susceptibility and T, 
temperature) for the compound Cs[Fe(5-Br-thsa)2] was measured in the temperature range 10-300 K 
and is given in Figure 3.3.3. Concomitant with the crystallographic study of Cs[Fe(5-Br-thsa)2] at 
293 K, Cs[Fe(5-Br-thsa)2] was found to be low-spin at 300 K as χMT = 0.488 cm3 mol-1 K, which 
corresponds to the low-spin value expected for FeIII (0.375 cm3 mol-1 K, g = 2.00), revealing no spin 
transition within the temperature range 10-300 K. 
 
Figure 3.3.3 χMT vs T plot of Cs[Fe(5-Br-thsa)2]. [The sample was heated (▲) and subsequently 
cooled (▼).] 
 
3.4 The crystal structure and magnetic properties of ammonium bis(salicylaldehyde 
thiosemicarbazonato(2-)-κ3-O,N1,S)ferrate(III)  
It has been recognised that ferric complexes, particularly those formed with R-salicylaldehyde 4R’-
thiosemicarbazone type ligands are of considerable interest due to their magnetic behaviour. The 
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spin-crossover properties for (cation+)[Fe(L2‒)2]·xH2O type compounds are quite sensitive to 
changes in the non-coordinating cation, the number of water molecules, the nature of the R-
substituent attached to the salicylaldehyde moiety, and the introduction of the R’-substituent attached 
to the thiosemicarbazone moiety [2, 3, 6, 8, 18, 19, 21, 25]. 
In the present section, the variable-temperature magnetic properties and the crystal structure 
(determined at 100 K) of the complex NH4[Fe(thsa)2] where thsa is the dianion of salicylaldehyde 
thiosemicarbazone (as illustrated in Scheme 3.4.1) are described. Ryabova et al., reported the 
crystallographic data of the related compound Cs[Fe(thsa)2] [18] at 103 and 298 K. The main 
difference between NH4[Fe(thsa)2]  and Cs[Fe(thsa)2] is the associated outer-sphere cation. The 
influence of the varying cation on the magnetic properties of these compounds will be investigated 
by examining the subtle structural and electronic modifications the cation may cause to the crystal 
packing. 
 
Scheme 3.4.1 
 
3.4.1 Crystal Data and Structure Refinement Details of NH4[Fe(thsa)2] 
Crystal data, data collection and structure refinement details are summarized in Table 3.4.1. The 
position of the hydrogen atoms on the secondary amine nitrogen atoms N3 and N6 were located in 
difference Fourier maps and were allowed to ride in the refinement, with Uiso(H) = 1.2Ueq(N). Other 
hydrogen atoms were included in the refinement in calculated positions, riding on their parent atoms, 
with C‒H = 0.96 Å and Uiso(H) = 1.2Ueq(C). The hydrogen atoms on the NH4+ cation have not been 
located but are included in the molecular formula.  
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Table 3.4.1 Crystal data and structure refinement details of NH4[Fe(thsa)2] 
Crystal data 
Chemical formula NH4[Fe(C8H7N3OS)2]  
Mr 460.30 
Crystal system, space group Monoclinic, P21/n 
Temperature (K) 100 
a, b, c (Å) 8.4393(8), 18.2444(17), 11.7635(11) 
α, β, γ (°) 90, 90.052(4), 90 
V (Å3) 1811.2(3) 
Z 4 
Radiation type Mo Kα 
µ (mm−1) 1.093 
Crystal size (mm) 
Colour 
0.60 × 0.36 × 0.18 
Dark green (rhombic prism) 
Data collection  
Diffractometer Bruker KAPPA APEX II diffractometer  
Absorption correction Multi-scan (SADABS) 
Tmin, Tmax 0.63, 0.82 
No. of measured, independent and  
observed [I > 2σ(I)] reflections 
61584, 5352, 4735 
Rint 0.0411 
Refinement  
R[F2 > 2σ(F2)], wR(F2), S 0.0418, 0.0543, 3.140i 
No. of reflections 5352 
No. of parameters 280 
No. of restraints 40 
H-atom treatment H atoms treated by a mixture of independent and 
constrained refinement 
Δρmax, Δρmin (e Å−3) 0.83, −0.76 
i It should be noted that S (goodness of fit) should be close to 1, the goodness of fit value of 3.140 
has been reported to the crystallographer at Vienna University of Technology.  
 
The program used for data collection, cell refinement and data reduction: SAINT-Plus [23]. The 
program(s) used for the structure solution and the structure refinement: SADABS [23], SUPERFLIP 
[13], JANA2006 [24]. The ORTEP-3 for Windows [16] program was used to produce the molecular 
graphics.  
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3.4.2 Crystallographic study of NH4[Fe(thsa)2] 
The structure of ammonium bis(salicylaldehyde thiosemicarbazonato(2-)-κ3-O,N1,S)ferrate(III) 
(Figure 3.4.1) was determined at 100 K. NH4[Fe(thsa)2] was found to crystallise in the monoclinic 
system in the space group P21/n. The asymmetric unit consists of one formula unit, NH4[Fe(thsa)2], 
with no atom on a special position. The FeIII cation is coordinated by two dianionic O,N,S-tridentate 
salicylaldehyde thiosemicarbazonato ligands, displaying a distorted octahedral FeIIIO2N2S2 
geometry. Selected geometric parameters are listed in Table 3.4.2. The two-fold deprotonated 
ligands are coordinated to the FeIII atom with the phenolate-O, thiolate-S and imine-N atoms. These 
donor atom–FeIII bonds are located in two perpendicular planes, the O and S atoms in the cis 
positions, whereby the S1–Fe–S2 bond angle is 92.06(3)° and O1–Fe–O2 bond angle is 88.53(10)°. 
Also, the N atoms are situated in trans positions which is evidenced by the N1–Fe–N4 bond angle 
of 176.81(10)°. The FeO2N2S2 coordination core is distorted at 100 K, and the Fe-donor atom 
distances fall within the range expected for FeIII in the low-spin state [8].  
 
Figure 3.4.1 The molecular structure and atom-numbering scheme for NH4[Fe(thsa)2]. The N atom 
of the NH4+ cation has been omitted from the figure for clarity. Displacements ellipsoids are drawn 
at the 50% probability level. 
  
The presence of the trivalent iron cation together with the monovalent ammonium cation is supported 
by the coordination of two two-fold deprotonated ligands to the FeIII ion. In addition, the presence 
of both dianionic ligands is confirmed by the C–S, C–N and N–N bond distances (listed in Table 
3.4.2) obtained for NH4[Fe(thsa)2], which show characteristics of a bond order between single and 
double bonds. Ryabova et al., [21] reported the related high-spin compound Cs[Fe(thsa)2] at 103 and 
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298 K which crystallises in the space group Pna21 with an asymmetric unit consisting of a Cs+ cation 
and a [Fe(thsa)2]– unit. The C–S, C–N and N–N bond distances (C–S = 1.749(9) Å and 1.761(9) Å, 
C–N = 1.314(10) Å and 1.303(11) Å and N–N = 1.371(11) Å and 1.380(11) Å at 103 K, severally, 
and C–S = 1.743(14) Å and 1.775(17) Å, C–N = 1.281(19) Å and 1.281(19) Å and N–N = 1.393(18) 
Å and 1.412(18) Å at 103 K, severally) reported by Ryabova and coworkers [21] for Cs[Fe(thsa)2] 
at 103 K, correspond to the bond distances for the reported FeIII complex, NH4[Fe(thsa)2] at 100 K.  
 
Table 3.4.2 Selected geometric parameters of NH4[Fe(thsa)2] (Å, °) 
 
The hydrogen bonding interactions of NH4[Fe(thsa)2] are listed in Table 3.4.3 and are displayed in 
Figure 3.4.2. The terminal N atoms of the tridentate ligands, N3 and N6, form N6−Hn62∙∙∙O2 (x – 
1/2, 1/2 – y, z – 1/2) and N3−Hn32∙∙∙O1 (x – 1/2, 1/2 – y, 1/2 + z) contacts with the phenolate O-
Fe1–S1  2.2366(9)  Fe1–S2  2.2373(9)  
Fe1–O1 1.938(2)  Fe1–O2  1.950(2)  
Fe1–N1  1.930(3)  Fe1–N4  1.948(2)  
C8–S1 1.742(3) C16–S2 1.750(3) 
C7–N1 1.294(4) C15–N4 1.291(4) 
N1–N2 1.405(3) N4–N5 1.409(3) 
S1–Fe1–S2 92.06(3)  O1–C2–C1  124.4(3) 
S1–Fe1–N1  86.53(7)  C2–C1–C7 122.3(3) 
S1–Fe1–O1   177.76(7)  C1–C7–N1 126.8(8) 
S1–Fe1–O2  89.26(7)  C7–N1–Fe1 126.1(2) 
S1–Fe1–N4  91.93(7)  Fe1–O2–C10 126.5(2) 
S2–Fe1–O1  90.15(7)  O2–C10–C9  123.7(3) 
S2–Fe1–O2  178.58(7)  C10–C9–C15 124.1(3) 
S2–Fe1–N1  91.61(7)  C9–C15–N4 126.3(3) 
S2–Fe1–N4  85.65(7)  C15–N4–Fe1 124.99(19) 
O1–Fe1–O2  88.53(10)  C8–S1–Fe1 94.72(10) 
O1–Fe1–N1  93.02(10)  N1–N2–C8  112.9(2) 
O1–Fe1–N4  88.63(10)  N2–C8–S1 124.8(2) 
O2–Fe1–N1  88.99(10)  C16–S2–Fe1 95.48(10) 
O2–Fe1–N4  93.78(10)  N4–N5–C16  113.8(2) 
N1–Fe1–N4  176.81(10)  N5–C16–S2  124.2(2) 
Fe1–O1–C2 126.5(2)   
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donor atoms, O1 and O2, respectively. In this manner, successive FeIII entities are linked in the c 
direction. The ammonium cations are distributed in between the layers of the FeIII entities, with 
alternate separations of the N atoms of the ammonium cation of 3.915(7) Å (1 + x, y, z) and 4.547(7) 
Å (1/2 + x, 1/2 – y, 1/2 + z) in the a direction. The FeIII∙∙∙FeIII separations in the present compound 
are 8.439 Å for FeIII∙∙∙FeIII (x + 1, y, z) and 9.714 Å for FeIII∙∙∙FeIII (–x, –y + 1, –z + 1). The FeIII units 
in NH4[Fe(thsa)2] are linked by hydrogen bonding interactions between the corresponding FeIII units 
phenolate O and amino N atoms. The related compound Cs[Fe(5-Br-thsa)2] (Section 3.3, vide supra) 
displays FeIII∙∙∙FeIII (x, 3/2 – y, 1/2 + z) separations of 7.556 Å and FeIII∙∙∙FeIII (x, 5/2 – y, 3/2 + z) 
separations of 7.537 Å. It appears that the addition of the Br-substituent on the salicylaldehyde 
moiety of the ligand in Cs[Fe(5-Br-thsa)2] may affect how the FeIII units are assembled in the unit 
cell. The Br-substituent of one FeIII unit of Cs[Fe(5-Br-thsa)2] provides a hydrogen bonding 
interaction with an amino group of a neighbouring FeIII unit, creating ring systems.  
 
Figure 3.4.2 A projection showing the unit cell of NH4[Fe(thsa)2]. The N atom of the ammonium 
cation has been omitted for clarity. Displacement ellipsoids are drawn at the 50% probability level. 
Dashed lines indicate hydrogen bonds. [Symmetry codes: (i) x – 1/2, 1/2 – y, z – 1/2; (ii) x – 1/2, 1/2 
– y, 1/2 + z.] 
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Table 3.4.3 Hydrogen bond geometry of NH4[Fe(thsa)2] (Å, °) 
D–H∙∙∙A D–H  H∙∙∙A  D∙∙∙A  D–H∙∙∙A  
N6−Hn62∙∙∙O2i 0.87 (4) 1.97 (4) 2.387 (3) 173 (3) 
N3−Hn32∙∙∙O1ii 0.92 (5) 1.99 (5) 2.880 (4) 160 (4) 
Symmetry codes: (i) x – 1/2, 1/2 – y, z – 1/2; (ii) x – 1/2, 1/2 – y, 1/2 + z. 
 
3.4.3 Magnetic Studies of NH4[Fe(thsa)2] 
The temperature dependence of the χMT product (χM being the molar magnetic susceptibility and T, 
temperature) for the compound NH4[Fe(thsa)2] was measured in the temperature range 10-300 K and 
is given in Figure 3.4.3. At 100 K, the FeIII ion in the crystal structure of NH4[Fe(thsa)2] was found 
to be in the low-spin state. The χMT value for NH4[Fe(thsa)2] corroborates that the FeIII ion is indeed 
in the low-spin state at this temperature with a χMT value of 0.516 cm3 mol-1 K at 100 K. The χMT 
value for NH4[Fe(thsa)2] of 0.535 cm3 mol-1 K at 300 K reveals no spin transition is observed between 
the temperature range 10-300 K.  
 
Figure 3.4.3 χMT vs T plot of NH4[Fe(thsa)2]. [The sample was heated (▲) and subsequently cooled 
(▼).] 
 
3.5 The crystal structure and magnetic properties of ammonium bis(5-bromosalicylaldehyde 
thiosemicarbazonato(2-)-κ3-O,N1,S)ferrate(III)  
Various (cation+)[Fe(ligand2‒)2]∙nH2O type compounds of R-substituted salicylaldehyde 
thiosemicarbazone have been reported over the past decade [2-4, 8, 18, 19, 21, 25]. This series of 
compounds has been extensively studied with respect to their crystallographic data in order to 
attempt to correlate the structural features of these systems with the spin state of FeIII. It is now well 
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established that significant changes in the electronic state of these FeIII systems may occur due to the 
associated cation in the complex system, the R-substituents of the salicylaldehyde moiety and/or the 
R’-substituents of the thioamide group of the thiosemicarbazide moiety and the FeIIIO2N2S2 
geometry. 
In this section, the magnetic behaviour and crystal structure (at 100 K) of NH4[Fe(5-Br-thsa)2] 
(illustrated in Scheme 3.5.1) are described. Ryabova et al., reported the related compound NH4[Fe(5-
Cl-thsa)2] [19], whereby the structure was determined at 103 and 298 K. The X-ray structure of 
NH4[Fe(5-Cl-thsa)2] at 298 K was found to be isostructural to the tabular form of NH4[Fe(5-Br-
thsa)2] [21] at 298 K. Both compounds were found to crystallise in the orthorhombic crystal system 
in the space group Pnca at 298 K. It was determined that the ligands coordinated to the FeIII atom by 
a two-fold rotational symmetry in the FeIII bis(ligand) compounds.  
 
Scheme 3.5.1 
 
In order to attempt to correlate the structures of this family of (cation+)[Fe(L2‒)2] compounds to their 
magnetic properties, it has to be considered that the spin transition is governed by subtle structural 
and electronic modifications tuned by the crystal packing, which determines the ligand field strength 
and the spin-crossover behaviour. These modifications depend on the nature of the ligands, the non-
coordinating cation, the solvent molecules (if any), and the crystal packing. Although, the effects of 
the aforementioned chemical contributions are not always consistent from one material to another. 
Indeed, a more systematic approach is required to investigate these modifications on these types of 
systems. In this regard, comparison of the crystal structure and magnetic properties of NH4[Fe(5-Br-
thsa)2] (at 100 K) to that of tabular form of NH4[Fe(5-Br-thsa)2] (at 298 K) reported by Ryabova et 
al., [21] are herein described.  
 
102 
 
3.5.1 Crystal Data and Structure Refinement Details of NH4[Fe(5-Br-thsa)2] 
Crystal data, data collection and structure refinement details are summarized in Table 3.5.1. The 
position of the hydrogen atoms on the secondary amine nitrogen atoms N3 and N6 were located in 
difference Fourier maps and were allowed to ride in the refinement with Uiso(H) = 1.2Ueq(N). Other 
hydrogen atoms were included in the refinement in calculated positions and riding on their parent 
atoms with C‒H = 0.96 Å and Uiso(H) = 1.2Ueq(C). The hydrogen atoms on the NH4+ cation have not 
been located but are included in the molecular formula. The ligand molecules in NH4[Fe(5-Br-thsa)2] 
are related by a twofold axis of rotation. The ligand shows positional disorder with respect to the 
following atoms: S1, O1, N4, C2, C3, C4, H3 and H4. Two different sets of positions for these atoms 
were identified in the difference Fourier synthesis, i.e. S1 and S1′, O1 and O1′, N4 and N4′, C2 and 
C2′, C3 and C3′, C4 and C4′, H3 and H3′, and H4 and H4′, severally, which were refined with fixed 
site occupancy factors (0.5 and 0.5).  
 
3.5.2 Crystallographic study of NH4[Fe(5-Br-thsa)2] 
The structure of ammonium bis(5-bromosalicylaldehyde thiosemicarbazonato(2-)-κ3-
O,N1,S)ferrate(III) (Figure 3.5.1) was determined at 100 K. NH4[Fe(5-Br-thsa)2] crystallises in the 
orthorhombic system in the centrosymmetric space group Pbcn, Z’ = 0.5 (where Z’ is the number of 
formula units per asymmetric unit). The asymmetric unit consists of one NH4+ cation and 1/2 [Fe(5-
Br-thsa)2], whereby the ligands coordinated to the FeIII cation are related by two-fold rotational 
symmetry (symmetry code: (i) –x, y, –z – 1/2). The FeIII cation is coordinated by two equivalent 
dianionic O,N,S-tridentate 5-bromosalicylaldehyde thiosemicarbazonato ligands, displaying a 
distorted octahedral FeIIIO2N2S2 geometry. Both of the tridentate ligands are found to be in their 
dianionic form, as no hydrogen atoms were located on the phenolate-O and the thiolate-S atoms. 
This is also confirmed by the presence of the trivalent iron cation together with the monovalent 
ammonium cation.  Selected geometric parameters are listed in Table 3.5.2.  
On the basis of the FeO2N2S2 donor bond distances, the spin state of the FeIII ion can be identified. 
At 100 K, the Fe–S1 and Fe–S1i (i = –x, y, –z – 1/2) distances are 2.263(3) Å, the Fe–O1 and Fe–
O1i (i = –x, y, –z – 1/2) distances are 1.938(6) Å, and the Fe–N1 and Fe–N1i (i = –x, y, –z – 1/2) 
distances are 1.9420(18) Å, typical for low-spin FeIII [8]. Furthermore, the donor atoms of the ligands 
are situated in two perpendicular planes with O and S atoms in cis positions, which is corroborated 
by the S1–Fe–S1i bond angle of 82.47(11)° and O1–Fe–O1i bond angle of 73.5(2)°. In addition, the 
N atoms are situated in trans positions which is confirmed by the N1–Fe–N1i bond angle of 
176.44(7)°.  
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Table 3.5.1 Crystal data and structure refinement details of NH4[Fe(5-Br-thsa)2] 
Crystal data 
Chemical formula NH4[Fe(C8H6BrN3OS)2]  
Mr 618.10 
Crystal system, space group Orthorhombic, Pbcn 
Temperature (K) 100 
a, b, c (Å) 11.6901(6), 8.5208(9), 21.0279(15) 
α, β, γ (°) 90, 90, 90 
V (Å3) 2094.6(3) 
Z 4 
Radiation type Mo Kα 
µ (mm−1) 4.765 
Crystal size (mm) 
Colour 
0.41 × 0.32 × 0.04 
Dark green (rhombic prism) 
Data collection  
Diffractometer Bruker KAPPA APEX II diffractometer  
Absorption correction Multi-scan (SADABS) 
Tmin, Tmax 0.18, 0.83 
No. of measured, independent and  
observed [I > 2σ(I)] reflections 
69081, 3066, 2559  
Rint 0.0436 
Refinement  
R[F2 > 2σ(F2)], wR(F2), S 0.0287, 0.0416, 2.47i 
No. of reflections 3066 
No. of parameters 184 
No. of restraints 24 
H-atom treatment H atoms treated by a mixture of independent and 
constrained refinement 
Δρmax, Δρmin (e Å−3) 0.97, −0.64 
i It should be noted that S (goodness of fit) should be close to 1, the goodness of fit value of 2.47 has 
been reported to the crystallographer at Vienna University of Technology.  
 
The program used for data collection, cell refinement and data reduction: SAINT-Plus [23]. The 
program(s) used for the structure solution and the structure refinement: SADABS [23], SUPERFLIP 
[13], JANA2006 [24]. The ORTEP-3 for Windows [16] program was used to produce the molecular 
graphics.  
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Figure 3.5.1 The molecular structure and atom-numbering scheme for NH4[Fe(5-Br-thsa)2]. The N 
atom of the NH4+ cation, and alternative orientation for O1′, S1′, C2′, C3′ and C4′ have been omitted 
from the figure for clarity. Displacements ellipsoids are drawn at the 50% probability level. 
[Symmetry code: (i) –x, y, –z –1/2.]  
 
Table 3.5.2 Selected geometric parameters of NH4[Fe(5-Br-thsa)2] (Å, °)  
Symmetry transformation used to generate equivalent atoms: (i) –x, y, –z – 1/2.  
Fe1–S1i  2.263(3)  C8i–S1i 1.769(4) 
Fe1–O1i 1.938(6)  C7i–N1i 1.292(4) 
Fe1–N1i 1.9420(18)  N1i–N2i 1.401(3) 
    
S1–Fe1–S1i 82.47(11)  O1i–Fe1–N1  89.9(2) 
S1–Fe1–N1  86.10(11)  N1–Fe1–N1i  176.44(7)  
S1–Fe1–O1   175.46(19)  Fe1–O1–C2 125.1(5) 
S1–Fe1–O1i  102.00(18)  O1–C2–C1 124.6(5) 
S1–Fe1–N1i 91.22(11)  C2–C1–C7 122.2(3) 
S1i–Fe1–O1  102.00(18) C1–C7–N1 126.2 (19) 
S1i–Fe1–N1  91.22(11)  C7–N1–Fe1 125.48(15) 
O1–Fe1–O1i  73.5(2)  C8–S1–Fe1 93.58(16) 
O1–Fe1–N1  93.0(2)  N1–N2–C8 113.77(17) 
O1–Fe1–N1i  89.9(2)  N2–C8–S1 124.5(2) 
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Both tridentate ligands are found to be in their dianionic form, as no hydrogen atoms were located 
on the phenolate-O and the thiolate-S atoms. This is also confirmed by the presence of the trivalent 
iron cation together with the monovalent ammonium cation. Furthermore, this is corroborated by the 
C–S, C–N and N–N bond distances (listed in Table 3.5.2) obtained for NH4[Fe(5-Br-thsa)2], which 
show characteristics of a bond order between single and double bonds. Ryabova et al., [21] reported 
the structure of the tabular polymorph of the low-spin compound NH4[Fe(5-Br-thsa)2] at 298 K 
which crystallises in the centrosymmetric space group Pnca with Z’ = 0.5; the ligands are related by 
two-fold rotational symmetry. The C–S, C–N and N–N bond distances (C–S = 1.750(9) Å, C–N = 
1.294(10) Å and N–N = 1.392(9) Å) reported by Ryabova et al., [21] of this compound are in line 
with the bond distances for the reported FeIII complex at 100 K.  
The crystal packing diagram of NH4[Fe(5-Br-thsa)2] at 100 K is displayed in Figure 3.5.2 and the 
hydrogen bonding contacts are listed in Table 3.5.3. The most striking structural feature is the 
interlinking of mononuclear [Fe(L2‒)2]– units by the intermolecular N3−Hn31∙∙∙O1 (1/2 + x, 3/2 – y, 
–1 – z) hydrogen bond between the phenolate O-donor atom, O1, and the terminal N3 atom of the 
symmetry related ligand. A similar intermolecular hydrogen bond is also observed for disordered 
form of the phenolate O-donor atom, O1’, giving rise to the hydrogen bonding contact 
N3−Hn31∙∙∙O1’ (1/2 + x, 3/2 – y, –1 – z). These hydrogen bonding interactions between the FeIII 
entities link them in the a direction. The NH4+ cations are distributed in between the layers of the 
FeIII entities, with alternate separations of the N atoms of the ammonium cation of  4.608(4) Å (1/2 
+ x, 3/2 + y, –1/2 – z) and 3.959(4) Å (1/2 + x, 1/2 + y, –1/2 – z), respectively, in the c direction.  
The shortest FeIII∙∙∙FeIII separations in NH4[Fe(5-Br-thsa)2] are 7.233 Å for FeIII∙∙∙FeIII (–x, y + 1, 1/2 
– z) and 7.233 Å for FeIII∙∙∙FeIII (1 – x, y + 1, 1/2 – z). Additionally, NH4[Fe(5-Br-thsa)2] displays 
longer FeIII∙∙∙FeIII separations of 8.251 Å for FeIII∙∙∙FeIII (1/2 – x, 1/2 – y, 3/2 + z) and 8.251 Å for 
FeIII∙∙∙FeIII (1/2 + x, 3/2 + y, –1/2 – z). The related compound Cs[Fe(5-Br-thsa)2] (Section 3.3), 
displays shortest FeIII∙∙∙FeIII separations of 7.556 Å for FeIII∙∙∙FeIII (x, 3/2 – y, 1/2 + z) and 7.537 Å 
for FeIII∙∙∙FeIII (x, 5/2 – y, 3/2 + z). Both NH4[Fe(5-Br-thsa)2] and Cs[Fe(5-Br-thsa)2] contain the 
dianionic ligand 5-bromosalicylaldehyde thiosemicarbazonato(2-), but differ with respect to the 
monovalent cation in the crystal lattice. Although both compounds contain the same Br-substituted 
ligand, the steric effect of the ligand on the manner in which the FeIII units assemble in the unit cell 
is very different. In NH4[Fe(5-Br-thsa)2], the Br-substituent of one FeIII unit provides a hydrogen 
bonding interaction with an amino group of a neighbouring FeIII unit, giving rise to ring systems. 
However the present compound does not possess hydrogen bonding interactions involving the Br-
substituent, and instead corresponding FeIII units are linked in chains by interactions between the 
phenolate O and imine N atoms (vide infra). It appears the hydrogen bonding ring systems in 
Cs[Fe(5-Br-thsa)2] contribute to the arrangement of the FeIII entities in the unit cell to be closer 
together compared to that of the present compound’s intermolecular hydrogen bonding interactions. 
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In a similar way to the crystal packing of NH4[Fe(5-Br-thsa)2] at 100 K, the crystal structure of the 
tubular polymorph NH4[Fe(5-Br-thsa)2] reported at 298 K by Ryabova and co-workers [22] indicates 
that the structural units are linked by N–H···O contacts, formed from the terminal N-atom and the 
phenolate O-donor atom, along the c axis. This indicates that at both 100 K and 298 K, the crystal 
packing of the FeIII entities are very similar.  
 
Figure 3.5.2 A projection showing the unit cell of NH4[Fe(5-Br-thsa)2]. The N atom of the NH4+ 
cation and alternative orientation for O1’, S1’, C2’, C3’ and C4’ have been omitted for clarity. 
Displacements ellipsoids are drawn at the 50% probability level. Dashed lines indicate hydrogen 
bonds. [Symmetry codes: (i) 1/2 + x, 3/2 – y, –1 – z; (ii) 1/2 + x, 3/2 – y, –1 – z.] 
 
Table 3.5.3 Hydrogen bond geometry of NH4[Fe(5-Br-thsa)2] (Å, °) 
D–H∙∙∙A D–H  H∙∙∙A  D∙∙∙A  D–H∙∙∙A  
N3−Hn31∙∙∙O1i 0.89 (2) 2.06 (3) 2.935 (7) 168 (3) 
N3−Hn31∙∙∙O1’ii 0.89 (2) 1.92 (3) 2.807 (7) 177 (2) 
Symmetry codes: (i) 1/2 + x, 3/2 – y, –1 – z; (ii) 1/2 + x, 3/2 – y, –1 – z. 
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3.5.3 Magnetic Studies of NH4[Fe(5-Br-thsa)2]  
The temperature dependence of the χMT product (χM being the molar magnetic susceptibility and T, 
temperature) for the compound NH4[Fe(5-Br-thsa)2] was measured in the temperature range 10-300 
K and is given in Figure 3.5.3. At 100 K, the FeIII ion in the crystal structure of NH4[Fe(5-Br-thsa)2] 
was found to be in the low-spin state which corroborates with the χMT value for NH4[Fe(5-Br-thsa)2] 
of being 0.65 cm3 mol-1 K at 100 K, which is close to the value expected for a low-spin FeIII ion. 
Around 200 K, there is an abrupt change in the product χMT; the value of χMT for NH4[Fe(5-Br-
thsa)2] increases to 0.85 cm3 mol-1 K at 250 K. At this stage, it is important to note that the sample 
is homogeneous, as the crystals synthesised were found to be in the tabular form. The increase in the 
product of magnetic susceptibility and temperature could be due to only a minute fraction of the FeIII 
ions converting into the high-spin state. The observed χMT value at 250 K of 0.85 cm3 mol-1 K 
corresponds to an estimated high-spin fraction of 12 % and an estimated 88 % low-spin fraction of 
FeIII ions. Thus, observing that the spin transition occurs at T1/2↑ = 200 K and T1/2↓ = 198 K.  
 
Figure 3.5.3 χMT vs T plot of NH4[Fe(5-Br-thsa)2]. [The sample was heated (▲) and subsequently 
cooled (▼).] 
 
Although, it still remains that for the bulk of the FeIII sample, the FeIII ions are in the low-spin state, 
as the value of χMT = 0.85 cm3 mol-1 K at 250 K is higher than that expected for a low-spin compound 
(χMT = 0.374 cm3 mol-1 K, when g = 2.00) and not as expected for high-spin FeIII (χMT = 4.37 cm3 
mol-1 K). It should be noted that the value of χMT = 0.85 cm3 mol-1 K at 100 K, which is also higher 
that the expected value for FeIII ions in the low-spin state, this value slightly higher than expected 
value may be due to some residual high-spin FeIII ions. Moreover, the decrease of the of χMT value 
between 5-20 K may be due to the zero-field splitting of the high-spin FeIII ions. In order to accurately 
measure the percentage of FeIII ions which convert to the high-spin state at 200 K, the measurement 
of the 57Fe Mössbauer spectroscopic data would be advantageous to assess the percentage of the 
high-spin and low-spin FeIII at particular temperatures.  
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The DSC curve of NH4[Fe(5-Br-thsa)2] is displayed in Figure 3.5.4. The DSC curve displays a peak 
at T↓ = 199 K in the cooling mode and T↑ = 201 K in the heating mode. The resultant data 
corroborates with the temperature dependent magnetic susceptibility data that the FeIII entities 
exhibit a spin transition at around 200 K.  
 
Figure 3.5.4 DSC curves obtained for NH4[Fe(5-Br-thsa)2] in the temperature range 100-300 K, 
measured at a scan rate of 5 K min-1. 
 
3.6 The synthesis, structure and magnetic properties of dimethylammonium bis(3-
ethoxysalicylaldehyde thiosemicarbazonato(2-)-κ3-O2,N1,S)ferrate(III)  
In the following section the magnetic properties of the compound (CH3)2NH2[Fe(3-OEt-thsa)2] 
(illustrated in scheme 3.6.1) are described, as well as the crystal structure at 100 K. The synthesis of 
(CH3)2NH2[Fe(3-OEt-thsa)2] and the corresponding H2L ligand, 3-ethoxysalicylaldehyde 
thiosemicarbazone is described in Chapter II – Materials and Methods.  
 
Scheme 3.6.1 
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3.6.1 Crystal Data and Structure Refinement Details of (CH3)2NH2[Fe(3-OEt-thsa)2] 
Crystal data, data collection and structure refinement details are summarised in Table 3.6.1. The H-
atoms of the terminal amine atoms N103 and N3 were located in difference Fourier maps and refined 
with restrained N‒H distances of 0.86(2) Å and with Uiso(H) = 1.2 Ueq(N). The remaining H-atoms 
were included in the refinement in calculated positions and treated as riding on their parent atoms, 
with N‒H distance of 0.91 Å and Uiso(H) = 1.2 Ueq(N) for the amine N atom of the cation, C‒H 
distance of 0.95 Å and Uiso(H) = 1.2 Ueq(C) for aryl (-CH=) H-atoms, C‒H distance of 0.99 Å and 
Uiso(H) = 1.2 Ueq(C) for the secondary (-CH2-) H-atoms and C‒H distance of 0.98 Å and Uiso(H) = 
1.5 Ueq(C) for the methyl (-CH3) H-atoms.  
 
Table 3.6.1 Crystal data and structure refinement details of (CH3)2NH2[Fe(3-OEt-thsa)2] 
Crystal data 
Chemical formula (CH3)2NH2[Fe(C10H11O2N3S)2] 
Mr 576.50 
Crystal system, space group Monoclinic, P21/n 
Temperature (K) 100 
a, b, c (Å) 9.4359(3), 16.0265(5), 17.2333(7) 
α, β, γ (°) 90, 98.668(4), 90 
V (Å3) 2576.35(17) 
Z 4 
Radiation type Mo Kα 
µ (mm−1) 0.79 
Crystal size (mm) 
Colour 
0.08 × 0.05 × 0.01 
Green (plate)  
Data collection 
Diffractometer Rigaku AFC12 four-circle Kappa diffractometer 
Absorption correction Multi-scan (CrystalClear-SM Expert [12]) 
Tmin, Tmax 0.661, 1.000 
No. of measured, independent and  
observed [I > 2σ(I)] reflections 
16969, 5903, 4415  
Rint 0.055 
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Table 3.6.1 Crystal data and structure refinement details of (CH3)2NH2[Fe(3-OEt-thsa)2] 
(continued). 
Refinement 
R[F2 > 2σ(F2)], wR(F2), S 0.044, 0.096, 1.02 
No. of reflections 5903 
No. of parameters 341 
No. of restraints 4 
H-atom treatment H atoms treated by a mixture of independent and 
constrained refinement 
Δρmax, Δρmin (e Å−3) 0.38, −0.38 
 
The program used for data collection, cell refinement and data reduction: CrystalClear-SM Expert 
[12]. The program(s) used for the structure solution and the structure refinement: SUPERFLIP [13], 
SHELXL [11]. The ORTEP-3 for Windows [16] program was used to produce the molecular 
graphics.  
 
3.6.2 Crystallographic study of (CH3)2NH2[Fe(3-OEt-thsa)2] 
The structure of dimethylammonium bis(3-ethoxysalicylaldehyde thiosemicarbazonato(2-)-κ3-
O2,N1,S)ferrate(III) (Figure 3.6.1) was determined at 100 K. The present compound has been found 
to crystallise in the monoclinic system in the space group P21/n with Z = 4. The asymmetric unit 
consists of one formula unit, (CH3)2NH2[Fe(3-OEt-thsa)2], with no atom on a special position. The 
FeIII cation is coordinated by two dianionic O,N,S-tridentate 3-ethoxysalicylaldehyde 
thiosemicarbazonato(2-) ligands, displaying a distorted octahedral FeIIIO2N2S2 coordination sphere. 
Selected geometric parameters are listed in Table 3.6.2 and Table 3.6.3.  
The FeIIIO2N2S2 coordination sphere displays a distorted octahedral geometry, as indicated by the 
bond angles (Table 3.6.2) of the donor atoms and the Fe atom (vide infra). The donor atoms of the 
ligands are situated in two perpendicular planes, with the O and S atoms in cis positions and N atoms 
in trans positions.  
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Figure 3.6.1 The molecular structure and atom-numbering scheme for (CH3)2NH2[Fe(3-OEt-thsa)2]. 
Displacement ellipsoids are drawn at the 50 % probability level.  
 
X-ray structural data of similar FeIII bis(ligand) compounds containing two dianionic 
thiosemicarbazonato(2-) ligands show that the Fe–S, Fe–O and Fe–N bond distances are 2.23–2.31 
Å, 1.93–1.95 Å and 1.88–1.96 Å, severally, for low-spin FeIII compounds and 2.40–2.44 Å, 1.96–
1.99 Å and 2.05–2.15 Å, severally, for corresponding high-spin FeIII compounds [8]. The bond 
distances of (CH3)2NH2[Fe(3-OEt-thsa)2] involving the Fe atoms and the donor atoms (Table 3.6.2) 
suggests that the present compound contains high-spin FeIII at 100 K. Furthermore, the spin state of 
the FeIII cation can also be inferred from the bond angles of the FeO2N2S2 coordination core. The 
bite angle of O–Fe–S is 158.89(5)º and 158.48(5)º, for O1–Fe1–S1 and O101–Fe1–S101, 
respectively, at 100 K, however for the low-spin compound Cs[Fe(3-OEt-thsa-Me)2]·CH3OH, the 
O–Fe–S angle is 177.88(14)° and 178.01(13)°, O11–Fe1–S11 and O21–Fe1–S21, respectively, at 
100 K. This clearly shows that the coordination angles of the FeIII ion in the low-spin state at 100 K 
are closer to those found in a regular octahedron than those of the high-spin form at 100 K.  
The ligands have been found to be in the dianionic form as no hydrogen atoms were located on the 
phenolate-O (O1 and O101) or the thiolate-S (S1 and S101) atoms. This is associated with the 
presence of the monovalent dimethylammonium cation together with the trivalent iron cation. The 
tridentate ligands of the present compound are coordinated to the FeIII cation by the thiolate-S, 
phenolate-O and imine-N atoms, forming six- and five-membered chelate rings. It has been found 
that the six membered chelate ring involves a significantly less restricted bite angle [O1–Fe–N1 = 
82.17(7)° and O101–Fe–N101 = 84.03(7)°] than the five-membered chelate ring [S1–Fe–N1 = 
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78.45(5)° and S101–Fe–N101 = 78.93(5)°]. The root mean-square deviations from their least-
squares plane of atoms involving the 6-membered chelate ring of both coordinated ligands are 0.197 
Å and 0.177 Å, for [Fe1 N11 C17 C11 C12 O11] and [Fe1 N101 C107 C101 C102 O101], 
respectively, and the analogous values for the 5-membered chelate rings are 0.129 Å and 0.102 Å, 
for [Fe1 N11 C12 C18 S11] and [Fe1 N101 C102 C108 S101], respectively. It appears that the metal 
chelate rings deviate slightly from the ideal planar structure. Furthermore, the O–Fe–N and S–Fe–N 
bite angles of the 6- and 5-membered chelates are deficient by ca. 38° and 30°, respectively, 
compared to the angle at the vertex of a regular hexagon (120°) or pentagon (108°), respectively.  
 
Table 3.6.2 Selected geometric parameters of (CH3)2NH2[Fe(3-OEt-thsa)2] (Å, °)  
Fe1–S1 2.4320(6)  Fe1–S101 2.4389(7)  
Fe1–O1 1.9806(16)  Fe1–O101 1.9595(16)  
Fe1–N1 2.167(2)  Fe1–N101 2.131(2)  
    
S1–Fe1–S101  98.98(2)  O1–C2–C1 122.4(2) 
S1–Fe1–N1  78.45(5)  C2–C1–C7 121.2(2) 
S1–Fe1–O1  158.48(5)  C1–C7–N1  125.3(2) 
S1–Fe1–O101  94.31(5)  C7–N1–Fe1 124.80(15) 
S1–Fe1–N101  93.26(5)  Fe1–O101–C102 130.25(16) 
S101–Fe1–O1  91.30(5)  O101–C102–C101 123.1(2) 
S101–Fe1–O101  158.89(5)  C102–C101–C107 121.2(2) 
S101–Fe1–N1  93.18(5)  C101–C107–N101  125.9(2) 
S101–Fe1–N101  78.93(5)  C107–N101–Fe1 123.56(16) 
O1–Fe1–O101  81.91(7)  C8–S1–Fe1 95.87(8) 
O1–Fe1–N1  82.17(7)  N1–N2–C8 113.96(19) 
O1–Fe1–N101  107.31(7)  N2–C8–S1 125.75(17) 
O101–Fe1–N1  105.56(7)  C108–S101–Fe1 95.71(8) 
O101–Fe1–N101  84.03(7)  N101–N102–C108 114.09(19) 
N1–Fe1–N101  167.63(7)  N102–C108–S101 125.65(18) 
Fe1–O1–C2 127.41(14)   
 
In comparison to the other FeIII bis(ligand) compounds reported in this chapter, the deficiency of the 
bite angle in both the 6- and 5-membered chelate rings is larger than expected. It has been recognised 
that the other FeIII bis(ligand) compounds reported contain FeIII in the low-spin state, however the 
present compound contains FeIII in the high-spin state. Subsequently, (CH3)2NH2[Fe(3-OEt-thsa)2] 
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displays longer FeIII-donor atom bond distances which could be associated with the bite angles being 
more restricted. Moreover, the remaining angles of the 6-membered chelate rings (Table 3.7.2) are 
within ca. 5° of 125° as expected. However, the C–S–Fe angles of the 5-membered chelate ring are 
only about 95°, providing an additional deficiency of 13°. The additional deficiency can be offset by 
increasing the other angles to ca. 120°. It has been found that the N–N–C angles are <120° and the 
N–C–S angles are >120°, these values (Table 3.7.2) suggest sp2 hybridisation at C and N atoms. The 
stability of the FeIII complex is enhanced by the high degree of electron delocalisation throughout 
the chelated ligands. 
The dianionic ligands coordinated to the FeIII cation of (CH3)2NH2[Fe(3-OEt-thsa)2] form chelate 
rings which involve electron delocalisation, which is evident from the geometric parameters. The C–
S, C–N and N–N bonds obtained for the present compound, show characteristics of a bond order 
between single and double bonds. The C8–S1 bond length of 1.746(3) Å and C108–S101 bond length 
of 1.752(2) Å, suggest partial electron delocalisation of these bonds. A comparison can be made with 
the related high-spin FeIII compound Cs[Fe(thsa)2] [18] at 103 K which crystallises in the space group 
Pna21. The C–S bond distances of (CH3)2NH2[Fe(3-OEt-thsa)2] correspond with the C–S bond 
distances of 1.749(9) and 1.761(9) Å, respectively, for Cs[Fe(thsa)2], suggesting the occurrence of 
partial electron delocalisation in both compounds. Additionally, the electron delocalisation of the 
O,N,S-tridentate ligands is confirmed by a bond order larger than 1 for the C–N bond involving the 
deprotonated hydrazinic N atom. The bond distances for the C7–N1 and C107–N101, in the present 
compound are 1.301(3) Å and 1.301(3) Å, respectively. Similarly, the C–N bond distances are 
1.314(10) and 1.303(11) Å, respectively, for Cs[Fe(thsa)2] at 103 K. Moreover, the N–N bond 
distances of (CH3)2NH2[Fe(3-OEt-thsa)2] at 100 K, are N1–N2 = 1.395(2) Å and N101–N102 = 
1.399(3) Å, respectively, which indicates partial electron delocalisation within the 5-membered 
chelate. 
The hydrogen bonding interactions of (CH3)2NH2[Fe(3-OEt-thsa)2] are listed in Table 3.6.3 and 
displayed in Figure 3.6.2. The N atom of the dimethylammonium cation forms two hydrogen bonds; 
one contact is formed with the phenolate-O of one ligand. The second contact is formed with the O 
atom of the ethoxy group of the salicylaldehyde moiety of the other ligand. The N201−H20A∙∙∙O102 
and N201−H20B∙∙∙O1 contacts form an intramolecular hydrogen bond ring system, giving rise to a 
R22(9) ring [20].  
The closely assembled FeIII units in the compound (CH3)2NH2[Fe(3-OEt-thsa)2] may be due to the 
size of the R’-substituent groups being different, as (CH3)2NH2[Fe(3-OEt-thsa)2] contains the amino 
group whereas Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH contains a methyl substituent on the terminal N 
atom of the thiosemicarbazide moiety. Furthermore, both compounds differ in the monovalent cation 
and the presence/absence of a solvent molecule in the crystal lattice. In addition, (CH3)2NH2[Fe(3-
OEt-thsa)2] forms intramolecular ring systems through hydrogen bonds (vide infra), whereas 
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Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH forms intermolecular hydrogen bond ring systems which link the 
neighbouring FeIII entities. Subsequently, it appears the intermolecular hydrogen bonding 
interactions of the latter compound contribute to how the FeIII entities are arranged in the unit cell.  
 
Figure 3.6.2 A projection showing the unit cell of (CH3)2NH2[Fe(3-OEt-thsa)2]. Displacement 
ellipsoids are drawn at 50% probability level. Dashed lines indicate hydrogen bonds. 
 
Table 3.6.3 Hydrogen bond geometry of (CH3)2NH2[Fe(3-OEt-thsa)2] (Å, °) 
D–H∙∙∙A D–H  H∙∙∙A  D∙∙∙A  D–H∙∙∙A  
N201−H20A∙∙∙O102 0.91 1.97 2.877(3) 173.5 
N201−H20B∙∙∙O1 0.91 1.86 2.766(3) 172.8 
 
3.6.3 Magnetic Studies of (CH3)2NH2[Fe(3-OEt-thsa)2] 
The magnetic behaviour of (CH3)2NH2[Fe(3-OEt-thsa)2] is shown by the temperature dependence of 
the χMT (χM being the molar magnetic susceptibility and T being the temperature) measured in the 
5-300 K temperature range and is displayed in Figure 3.6.4. The product of magnetic susceptibility 
and the temperature shows a plateau, revealing the compound to be in the high-spin state over the 
temperature range 5-300 K, in both the heating and cooling modes. The value of χMT is 4.36 cm3 K 
mol-1 for (CH3)2NH2[Fe(3-OEt-thsa)2] at 300 K, which is close to the value expected for high-spin 
compounds (S = 5/2) where χMT = 4.37 cm3 K mol-1 for g = 2.00.  
115 
 
 
Figure 3.6.3 χMT vs T plot of (CH3)2NH2[Fe(3-OEt-thsa)2]. [The sample was heated (▲) and 
subsequently cooled (▼).] 
 
As illustrated in Figure 3.6.3, the χMT decreases abruptly below the temperature 50 K; this is a 
consequence of the zero-field splitting of the ground state of the FeIII ion in the high-spin state. This 
feature has been found to be common in high-spin FeIII compounds [26-27]. The zero-field splitting 
was calculated using equation (1) [26]: 
 
χ𝑀 =
𝑁𝑔2 𝛽2
4𝑘𝑇
[
0.14 + 5.12𝑒−3.23𝑋 + 23.85𝑒−6.83𝑋
1 + 𝑒−3.23𝑋 + 𝑒−6.83𝑋
] Eqn (1) 
 
In this equation, X = D/kT, D is the zero-field splitting parameter, g is the average g tensor value and 
the other symbols have their standard meanings (as shown in Chapter I). As reported by Chen et al., 
[26] equation (1) is the theoretical equation for the magnetic susceptibility resulting from the axial 
and rhombic zero-field splitting for a FeIII S = 5/2 ion. The least-squares fit (Figure 3.6.4) within the 
temperature range 5-300 K has been obtained with the parameters D = 0.80 cm-1 and g = 2.20 for 
(CH3)2NH2[Fe(3-OEt-thsa)2], with a coefficient of determination value of 0.97 and a reduced χ2 value 
of 0.000001. The goodness of fit determined for the zero-field splitting parameter can be measured 
by the reduced χ2 value; the value of reduced χ2 is obtained by the following equation: 
 
𝜒2 = (∑
𝜒𝑜𝑏𝑠𝑇−𝜒𝑐𝑎𝑙𝑐𝑇
𝜒𝑜𝑏𝑠𝑇
)2  Eqn (2) 
In equation (2) χobsT and χcalcT represent the observed and calculated product of the magnetic 
susceptibility and temperature, respectively.  
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Figure 3.6.4 Temperature dependence of the molar magnetic susceptibility, χM, for the compound 
(CH3)2NH2[Fe(3-OEt-thsa)2] in the range 5-150 K (▲ represents the heating mode). Points are the 
experimental data; solid red line represents the least-squares fit of the data to Equation (1), where D 
= 0.80 cm-1 and g = 2.20.  
 
3.7 Discussion of FeIII bis(ligand) compounds of R-salicylaldehyde-4R’-thiosemicarbazone 
The structures of the (cation+)[Fe(ligand)2]∙nH2O type systems consist of an FeIIIO2N2S2 
chromophore which is formed by two chelating tridentate dianionic R-salicylaldehyde 4R’-
thiosemicarbazonato(2-) ligands. The FeIIIO2N2S2 chromophore exhibits a distorted octahedral 
geometry, where the O- and S-donor atoms are in the cis positions and the N-donor atoms are in the 
trans positions. The Fe-donor atom distances of the FeIII bis(ligand) compounds described in this 
chapter are listed in Table 3.7.4.  
The FeIII cation in Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH is in the low-spin state at 100 K. Moreover, the 
compounds Cs[Fe(5-Br-thsa)2] at 293 K, NH4[Fe(thsa)2] at 100 K and NH4[Fe(5-Br-thsa)2] at 100 K 
all contain a FeIII cation in the low-spin state, whereas the FeIII cation in (CH3)2NH2[Fe(3-OEt-thsa)2] 
is high-spin at 100 K. 
In the following, the crystallographic data of the various (cation+)[Fe(ligand)2]∙nH2O compounds 
(listed in Table 3.7.4) will be compared to similar FeIII bis(ligand) compounds reported in the 
literature (Table 3.7.5), in an attempt to correlate the structural features of these systems with the 
spin state of the FeIII cation. It has long been established that the associated cation in the complex 
system, the R-substituents of the salicylaldehyde moiety and/or the R’-substituents of the thioamide 
group of the thiosemicarbazide moiety and the FeIII O2N2S2 chromophore may cause significant 
changes in the electronic state of the FeIII bis(ligand) compounds. Moreover, the increased hydration 
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of the FeIII compounds has been associated with the introduction of the R-substituent of the 
salicylaldehyde moiety or the change in outer-sphere cation [8].  
 
Table 3.7.4 Fe-donor atom bond for various (cation+)[Fe(ligand)2]∙n(solvent) compounds of R-
salicylaldehyde thiosemicarbazone described in this chapter 
Compoundi T 
(K) 
Space 
group 
Fe–S 
(Å) 
Fe–N 
(Å) 
Fe–O 
(Å) 
Spin 
Stateii 
 
Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH 100 P-1 2.2686 
2.265 
1.933 
1.939 
1.904 
1.918 
LS 
Cs[Fe(5-Br-thsa)2] 293 P21/c 2.2321 
2.2422 
1.947 
1.938 
1.942 
1.956 
LS 
NH4[Fe(thsa)2] 100 P21/n 2.2366 
2.2373 
1.930 
1.948 
1.938 
1.950 
LS 
NH4[Fe(5-Br-thsa)2]iii 100 Pbcn 2.263 1.942 1.938 LS 
(CH3)2NH2[Fe(3-OEt-thsa)2] 100 P21/n 2.4320 
2.4389 
2.167 
2.131 
1.9806 
1.9595 
HS 
i The geometric parameters for the crystallographically independent ligands are given separately in 
different lines.  
ii The spin states are defined as low-spin (LS) and high-spin (HS). 
iii The FeIII ion in the compound NH4[Fe(5-Br-thsa)2] becomes partially high-spin around 200 K. 
 
It is noteworthy, that the compounds Cs[Fe(5-Br-thsa)2], NH4[Fe(thsa)2], NH4[(Fe(5-Br-thsa)2] and 
(CH3)2NH2[Fe(3-OEt-thsa)2] do not contain any solvent molecules in their crystal lattice. This 
feature has also been observed for the following FeIII compounds: Cs[Fe(thsa)2] [18], NH4[Fe(5-Br-
thsa)2] [21] and NH4[Fe(5-Cl-thsa)2] [19], for which relevant data are compiled in Table 3.7.5. This 
table shows the non-solvated FeIII bis(ligand) compounds together with the spin state of the FeIII 
cation at the temperature at which the crystal structure was determined. Although, this is not the case 
for the low-spin compound Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH at 100 K (Table 3.7.4).  
The FeIII cation in the compound Cs[Fe(thsa)2] is in the high-spin state at both 103 K and 298 K [18], 
whereas the FeIII cation in NH4[Fe(5-Cl-thsa)2] is low-spin at 135 K and 298 K [19]. Furthermore, 
in the compound NH4[Fe(5-Br-thsa)2] the FeIII cation is in the low-spin state at 298 K [21]. The 
FeIII cation in Cs[Fe(5-Br-thsa)2] is in the low-spin state at 293 K. A transition from low-spin to high-
spin FeIII has been detected for similar materials on increasing temperature [25], but crystallographic 
data are not available for these non-solvated materials. Noting that Cs[Fe(5-Br-thsa)2] contains low-
spin FeIII at 293 K, perhaps, the present compound may exhibit a change in spin state above room 
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temperature. Furthermore, the possibility of a change in spin sate may also occur for the other 
compounds listed in Table 3.7.4, excluding (CH3)2NH2[Fe(3-OEt-thsa)2], as the compound is in the 
high-spin state at 100 K.  
 
Table 3.7.5 Selected average Fe-donor atom bond distances for non-solvated FeIII bis(ligand) 
compounds of R-salicylaldehyde thiosemicarbazone described in the literature 
Compoundi T 
(K) 
Space 
group 
and  
Z’ 
Fe–S 
(Å) 
Fe–N 
(Å) 
Fe–O 
(Å) 
Spin 
Stateii 
Ref 
Cs[Fe(thsa)2] 298 
 
103 
Pna21 
Z’ = 1 
Pna21 
Z’ = 1 
2.44 
 
2.44 
2.12 
 
2.15 
1.96 
 
1.96 
HS 
 
HS 
[18] 
NH4[Fe(5-Br-thsa)2]iii 298 Pnca 
Z’ = 0.5 
2.23 1.93 1.95 LS [21] 
NH4[Fe(5-Cl-thsa)2] 298 
 
135 
Pnca 
Z’ = 0.5 
Pnca 
Z’ = 0.5 
2.24 
 
2.23 
1.95 
 
1.96 
1.93 
 
1.94 
LS 
 
LS 
[19] 
i The ligands are defined as follows: H2L = salicylaldehyde thiosemicarbazone = H2thsa, so L2– = 
thsa, H2L = 5-bromosalicylaldehyde thiosemicarbazone = H2-5-Br-thsa, so L2– = 5-Br-thsa and H2L 
= 5-chlorosalicylaldehyde thiosemicarbazone = H2-5-Cl-thsa, so L2– = 5-Cl-thsa. 
ii The spin states are defined as low-spin (LS) and high-spin (HS). 
iii Determined for crystals of tabular form. 
 
The generation of any spin transition is governed by the energy difference between the high-spin and 
low-spin electronic states. This energy gap can be tuned by variation of the ligand field strength. The 
features of the second coordination sphere, such as the arrangement of Fe units within a unit cell 
belonging to a particular crystal system, also influence the ligand field characteristics. The packing 
of Fe units is evidenced by symmetry requirements which are embedded within the space group in 
which the material crystallises. X-Ray structural analysis has revealed that the FeIII bis(ligand) type 
compounds (Table 3.7.5) adopt different crystal systems and space groups in comparison to the 
(cation+)[Fe(ligand)2]∙nH2O compounds listed in Table 3.7.4. The latter compounds display an array 
of crystal systems and space groups, such as Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH exhibits a triclinic 
crystal system and the space group P-1. Furthermore, the compounds NH4[Fe(thsa)2], NH4[Fe(5-Br-
thsa)2] and (CH3)2NH2[Fe(3-OEt-thsa)2] display monoclinic crystal systems at 100 K, however with 
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slightly different orientations of the space group (No. 14) P21/n, P21/c and P21/n, severally. 
Moreover, Cs[Fe(5-Br-thsa)2] displays a monoclinic crystal system (at 293 K) and crystallises in the 
space group P21/c with Z = 4, or alternatively, Z’ = 1 (where Z is the number of formula units per 
unit cell and Z’ is the number of formula units per asymmetric unit). In contrast, the non-solvated 
FeIII bis(ligand) compounds listed in Table 3.7.5, all exhibit an orthorhombic crystal system, however 
in some cases their space groups differ. For example, Cs[Fe(thsa)2] crystallises in the space group 
Pna21 with Z’ = 1 [18], whereas NH4[Fe(5-Br-thsa)2] in the tabular form crystallises in the space 
group Pnca with Z’ = 0.5 [21]. Moreover, the compound NH4[Fe(5-Cl-thsa)2] crystallises in the 
space group Pnca, also with Z’ = 0.5 [19]. The FeIII bis(ligand) entities present variances with respect 
to their symmetry: In some instances, a value for Z’ of 0.5 is encountered which for space group 
Pnca implies that the ligands coordinated to the FeIII atom are related by two-fold rotational 
symmetry. Interestingly, Ryabova et al., [21], reported that NH4[Fe(5-Br-thsa)2] crystallises in two 
different forms, one form crystallising as tabular plates and the other crystallising as mica-like 
crystals. It was established that these two different polymorphs exhibit a spin-crossover at different 
temperature ranges, i.e. the mica-like crystals in the region around 200 K, and the tabular plate 
crystals in the region around 300 K. It appears that the crystallographic data analysed so far for this 
family of materials do not reveal a relation between FeIII spin state and the crystal system and space 
group.  
It is widely recognised that significant changes in the electronic state of the FeIII bis(ligand) 
compounds may arise from the associated cation in the complex system, the R-substituents at the 
benzene ring of the salicylaldehyde moiety and/or the introduction of R’-substituents into the 
thioamide group of the thiosemicarbazide moiety and the FeIIIO2N2S2 geometry. The main difference 
observed between the compounds (Table 3.7.5) in comparison to the (cation+)[Fe(ligand)2]∙nH2O 
compounds reported in this work in Table 3.7.4 is the varying size of the associated cation (either 
NH4+, (CH3)2NH2+ or Cs+) in the crystal lattice and the variation in slight distortions of the octahedral 
FeIIIO2N2S2 coordination sphere. It appears that the variation of the associated cation in the FeIII 
bis(ligand) compounds may have an indirect impact on the spin state of FeIII by influencing the 
crystal packing. In addition to the difference in size between NH4+, (CH3)2NH2+ and Cs+ ions, the 
two former may engage in directed interactions through hydrogen bonding while the latter presents 
a more uniform electrostatic field without a preferred direction for hydrogen bonds. The R,R’-
substituents of the ligand may exhibit steric and electronic effects (including being involved in 
hydrogen bonding, via the R,R- substituents in the (cation+)[Fe(ligand)2]∙nH2O compounds (Table 
3.7.4)), but at this stage it is unclear how these features may be harnessed to induce a particular spin 
state for FeIII.  
The FeIIIO2N2S2 coordination spheres of the compounds are slightly distorted from the ideal 
octahedral geometry. It has been acknowledged that there are subtle differences in the FeIII 
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coordination geometry among the members of this particular type of compound. Clearly, the 
stabilisation of FeIII in a particular spin state is governed by a subtle balance of geometric parameters, 
as is implied by the fact that a single compound (NH4[Fe(5-Br-thsa)2] [21]) exists in slightly different 
polymorphs each with its distinct magnetic behaviour. The latter example shows that it is too early 
for deriving a possible relation between FeIII spin state and FeIIIO2N2S2 geometry and crystal packing 
(the latter evidenced by crystal system and space group). 
The development of a strategy towards the synthesis of FeIII bis(ligand) compounds with a pre-
determined spin state will require the measurement and analysis of crystallographic data of a larger 
number of FeIII compounds of this family, including these having different R and/or R’-substituents 
and a variety of associated cations. Furthermore, other parameters that we are currently considering 
in our studies are the alteration of the degree of solvation and the tuning of the deprotonation 
characteristics of the R-salicylaldehyde R’-thiosemicarbazone ligand.  
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4.0 Neutral Fe(III) Complexes of R-salicylaldehyde 4R’-thiosemicarbazones 
4.1 Introduction 
Transition metal fragments displaying switching behaviour are appealing materials, which may be 
used in a functional way in research and technology [1-5]. It is now established that some molecular 
species containing transition metal ions may exhibit a crossover between states having a different 
magnetic moment. Among these, FeIII occupies a unique position in the development of the spin-
crossover area since it was for FeIII tris(dithiocarbamates) that the temperature induced phenomenon 
was first discovered [6-7]. The magnetic interconversion between the low-spin (S = 1/2) and high-
spin (S = 5/2) state in FeIII systems has now been found to be triggered by a change in temperature, 
pressure or by light irradiation [4, 8-9].  
Generation of FeIII spin-crossover behaviour has been demonstrated for a variety of ligand systems 
[4]. Among these, particular interest is focused on FeIII entities containing two tridentate O,N,S-
thiosemicarbazonato ligands which exhibit a thermal spin transition [10-18]. Previous research by 
Yemeli Tido and co-workers first focused on using derivatives of pyridoxal-4-R-thiosemicarbazone 
for generating FeIII spin-crossover, resulting in the octahedral FeIIIO2N2S2 entity 
[FeIII(HL)(L)]∙2H2O, where HL‒ and L2‒ are the mono- and dianionic form of pyridoxal-4-
methylthiosemicarbazone, respectively [19]. The crystal structure of this compound has been 
determined at 100 K and from the values of the geometric parameters, it could be inferred that the 
FeIII cation is in the low-spin state. Temperature dependent magnetic susceptibility measurements 
(5–300 K) showed that this spin state is retained over this temperature range. Complete dehydration 
of the compound results in an FeIII high-spin material [19]. Furthermore, it appeared that varying the 
pH during the synthesis of the FeIII entities leads to the formation of FeIII compounds differing in the 
degree of deprotonation of the ligand [20]. In addition, Yemeli Tido [20] identified the photo-
induced spin transition through the light-induced excited spin state trapping (LIESST) of FeIII in 
[FeIII(HL)(L)]∙xH2O, where HL‒ = 5-chlorosalicylaldehyde thiosemicarbazonate(1-) and L2‒ = 5-
chlorosalicylaldehyde thiosemicarbazonate(2-) (x = 1), or HL‒ = 5-bromosalicylaldehyde 
thiosemicarbazonate(1-) and L2‒ = 5-bromosalicylaldehyde thiosemicarbazonate(2-) (x = 1/2) [20]. 
The magnetic properties and crystallographic studies (obtained from powder X-ray diffraction) 
reveal the compounds exhibit a one-step spin-transition [20]. In addition, Li et al., reported the single 
crystal X-ray structures of the photo-responsive neutral spin-crossover compounds [FeIII(H-5-Br-
thsa)(5-Br-thsa)]∙H2O [18] (where H-5-Br-thsa, HL− = 5-bromosalicylaldehyde 
thiosemicarbazonate(1-) and 5-Br-thsa, L2− = 5-bromosalicylaldehyde thiosemicarbazonate(2-)) and 
[FeIII(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O [21] (where H-5-Cl-thsa-Me, HL− = 5-
chlorosalicylaldehyde 4-methylthiosemicarbazonate(1-) and 5-Cl-thsa-Me, L2− = 5-
chlorosalicylaldehyde 4-methylthiosemicarbozonate(2-)). In contrast to the one-step spin transition 
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of the neutral compound [FeIII(H-5-Br-thsa)(5-Br-thsa)]∙(H2O)1/2 (reported by Yemeli Tido [20]), the 
compound [FeIII(H-5-Br-thsa)(5-Br-thsa)]∙H2O [18] studied by Li and co-workers revealed a rare 
multi-step spin-transition, which reportedly is accompanied by a two-step reversible crystallographic 
symmetry breaking process. In recent years, it has been suggested in the literature that 
multifunctional spin-crossover compounds which respond to magnetic and electric stimuli are highly 
desirable [21-29]. Li et al., reported the mononuclear ferric compound [FeIII(H-5-Cl-thsa-Me)(5-Cl-
thsa-Me)]∙H2O exhibits a two-step spin transition and dielectric anomalies, also, the material is 
photo-responsive [21].  
The aim of the work described in this research chapter is to design, synthesise and study the magnetic 
behavior of hydrated ferric spin-crossover materials containing both the mono- and dianionic form 
of the R-salicylaldehyde 4R’-thiosemicarbazone type ligand, with emphasis on the variation of the 
R substituent and its position on the salicylaldehyde moiety and the nature of the R’ substituent of 
the thiosemicarbazone moiety. The study of these compounds will be considered in conjunction with 
the structural features of the spin-crossover materials reported by Li et al., [18, 21], Yemeli Tido 
[20] and Floquet et al., [30]. Detailed discussion of how the structural features might influence the 
possibility of the material to exhibit a temperature dependent spin transition will be closely examined 
and compared with the related results published in the literature [18, 20-21, 30].  
Herein, we report the crystallographic studies (at 100 K) and magnetic properties of three novel 
neutral ferric complexes: [FeIII(H-thsa-Me)(thsa-Me)]∙H2O, [FeIII(H-3-OEt-thsa-Me)(3-OEt-thsa-
Me)]∙H2O and [FeIII(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]·H2O. The featured compounds contain both 
the doubly and singly deprotonated forms of the R-salicylaldehyde 4R’-thiosemicarbazone 
derivatives (ligand structures illustrated in Figure 4.1.1.) 
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Figure 4.1.1 Molecular structure of the R-salicylaldehyde 4R’-thiosemicarbazone ligands (i) H2-
thsa-Me, (ii) H2-3-OEt-thsa-Me and (iii) H2-5-Cl-thsa-Me.  
125 
 
4.2 The crystal structure and magnetic properties of [Fe(H-thsa-Me)(thsa-Me)]∙H2O 
In this section the magnetic properties of the compound [Fe(H-thsa-Me)(thsa-Me)]∙H2O are 
described, as well as the crystal structure at 100 K. Furthermore, the infrared spectroscopic studies 
of the free ligand and ferric complex are also discussed. The synthesis of [Fe(H-thsa-Me)(thsa-
Me)]∙H2O and the corresponding H2L ligand, salicylaldehyde 4-methylthiosemicarbazone, is 
described in Chapter II – Materials and Methods.  
 
4.2.1 Crystal Data and Structure Refinement Details of [Fe(H-thsa-Me)(thsa-Me)]∙H2O 
Crystal data, data collection and structure refinement details are summarised in Table 4.2.1. The Fe1 
atom has a site occupancy position of 0.5, whereby the symmetry transformation (i) –x + 1, –y + 1, 
z generates the equivalent atoms of the coordinated anionic ligand salicylaldehyde methyl-
thiosemicarbazone. The H-atoms of the secondary amine atoms N2, N2i, N3 and N3i were located 
in difference Fourier maps and refined with restrained N–H distances of 0.88(2) Å and with Uiso(H) 
= 1.2 Ueq(N). Moreover, the H -atom bound to the N2-atom has a site occupancy factor of 0.5. The 
water solvent molecule has a site occupancy of 0.5. The H-atoms bound to the O-atom of the water 
molecule were located in difference Fourier maps and refined with an O–H distance restraint of 
0.87(2) Å and with Uiso(H) = 1.5 Ueq(O). The remaining H-atoms were included in the refinement in 
calculated positions and treated as riding on their parent atoms, with a C–H distance of 0.95 Å and 
Uiso(H) = 1.2 Ueq(C) for aryl (-CH=) H-atoms and a C–H distance of 0.98 Å and Uiso(H) = 1.5 Ueq(C) 
for the methyl (-CH3) H-atoms.  
 
Table 4.2.1 Crystal data and structure refinement details of [Fe(H-thsa-Me)(thsa-Me)]∙H2O 
Crystal data 
Chemical formula [Fe(C9H9N3OS)(C9H10N3OS)]∙H2O 
Mr 489.38 
Crystal system, space group Orthorhombic, Aea2 
Temperature (K) 100 
a, b, c (Å) 11.354 (3), 19.433 (5), 9.097 (2) 
α, β, γ (°) 90, 90, 90 
V (Å3) 2007.2 (9) 
Z 4 
Radiation type Mo Kα 
µ (mm−1) 0.994 
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Table 4.2.1 Crystal data and structure refinement details of [Fe(H-thsa-Me)(thsa-Me)]∙H2O 
(continued) 
Crystal size (mm)                                   0.06 x 0.06 x 0.01 
Data collection 
Diffractometer Rigaku AFC12 four-circle Kappa diffractometer 
Absorption correction Multi-scan (CrystalClear-SM Expert 3.1 b27 [31]) 
Tmin, Tmax 0.618, 1.000 
No. of measured, independent and 
observed [I > 2σ(I)] reflections 
6620, 2270,  
1741  
Rint 0.096 
Refinement 
R[F2 > 2σ(F2)], wR(F2), S 0.060, 0.188, 1.04 
No. of reflections 2270 
No. of parameters 150 
No. of restraints 6 
H-atom treatment H atoms treated by a mixture of independent or 
constrained refinement 
Δρmax, Δρmin (e Å−3) 0.74, -0.49 
 
The program used for the structure solution: SUPERFLIP [32]; the structure refinement used the 
program SHELXL-2014 [33]. The OLEX2 [34] and ORTEP-3 for Windows [35] programs were used 
to produce the molecular graphics [35].  
 
4.2.2 Crystallographic study of [Fe(H-thsa-Me)(thsa-Me)]∙H2O 
The crystal structure of [Fe(H-thsa-Me)(thsa-Me)]∙H2O (Figure 4.2.1) was determined at 100 K. The 
present compound crystallises in the orthorhombic polar space group Aea2 with Z = 4 and Z’ = 0.5 
(where Z is the number of formula units per unit cell and Z’ is the number of formula units per 
asymmetric unit). The asymmetric unit consists of 1/2 [Fe(H-thsa-Me)(thsa-Me)] unit and half of a 
solvent water molecule. The ligands coordinated around the FeIII cation are related by symmetry 
(symmetry code: (i) –x + 1, –y + 1, z).  
The FeIII cation is coordinated by an anionic O,N,S-tridentate salicylaldehyde 4-
methylthiosemicarbazonate(1-) and a dianionic ligand salicylaldehyde 4-
methylthiosemicarbazonate(2-) which are related by symmetry [(i) –x + 1, –y + 1, z]. The 
crystallographic model for both ligands involves a hydrogen atom bound to the hydrazinic N atom 
of each ligand (N2 and N2i) having a site occupancy factor of 0.5, therefore this hydrogen atom is 
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disordered over both the N2 and N2i sites (50:50). The disorder of the hydrogen atoms of the 
hydrazinic N atoms gives rise to the ferric complex containing a dianionic ligand and an anionic 
ligand (vide infra).  
 
Figure 4.2.1 The molecular structure and atom-numbering scheme of [Fe(H-thsa-Me)(thsa-
Me)]∙H2O, whereby the second ligand bound to Fe1 atom is generated by the symmetry operation: 
(i) –x + 1, –y + 1, z. The hydrogen atom bound to N2 and N2i atoms has a site occupancy factor of 
0.5, i.e. the atom is disordered over the N2 and N2i sites (50:50). Displacement ellipsoids are drawn 
at the 50% probability level.  
 
The FeIII cation forms an FeIIIO2N2S2 octahedral environment with the coordinated O,N,S-donor 
atoms of both ligands. The FeIII-donor atom bond distances are Fe1–S1 and Fe1–S1i = 2.249(2) Å, 
Fe1–O1 and Fe1–O1i = 1.932(5) Å and Fe–N1 and Fe1–N1i = 1.9246(5) Å. Selected geometric 
parameters are displayed in Table 4.2.2.  
X-ray structural data of FeIII bis(ligand) type compounds reveal that the Fe–S, Fe–O and Fe–N 
distances are 2.23 – 2.31 Å, 1.93 – 1.95 Å and 1.88 – 1.96 Å, severally, for low-spin FeIII compounds, 
and 2.40 – 2.44 Å, 1.96 – 1.99 Å and 2.05 – 2.15 Å, severally, for the corresponding high-spin FeIII 
compounds [4]. These details in comparison with the present compound’s Fe-donor atom bond 
distances suggest that the FeIII cation is in the low-spin state at 100 K. In addition, the X-ray structural 
data of the low-spin compound [Fe(H-5-Br-thsa)(5-Br-thsa)]∙H2O at 123 K, reveal that the Fe–S and 
Fe–N bonds distances of are 2.2718(17)/2.2463(17) Å and 1.952(5)/1.955(4) Å, respectively, which 
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too suggests that the FeIII cation is in the low-spin state at 100 K for the compound [Fe(H-thsa-
Me)(thsa-Me)]·H2O.  
 
Table 4.2.2 Selected geometric parameters of [Fe(H-thsa-Me)(thsa-Me)]∙H2O (Å, °) 
Fe1–S1 2.249 (2) Fe1–N1 1.946 (5) 
Fe1–O1 1.932 (5)   
    
S1–Fe1–S1i 90.08 (12) Fe1–O1–C2 127.6 (5) 
S1–Fe1–N1 86.5 (2) O1–C2–C1 123.3 (7) 
S1–Fe1–O1 179.4 (2) C2–C1–C7 123.8 (8) 
S1–Fe1–O1i 89.67 (16) C1–C7–N1 125.4 (7) 
S1–Fe1–N1i 90.2 (2) C7–N1–Fe1 126.7 (7) 
O1–Fe1–O1i 90.6 (3) C8–S1–Fe1 95.9 (3) 
O1–Fe1–N1 92.9 (3) N1–N2–C8 116.1 (6) 
O1–Fe1–N1i 90.4 (3) N2–C8–S1 122.3 (6) 
N1–Fe1–N1i 175.4 (5)   
Symmetry transformation used to generate equivalent atoms: (i) –x + 1, –y + 1, z.  
 
The donor atoms of the salicylaldehyde 4-methylthiosemicarbazonato ligands are located in two 
mutually perpendicular planes with the phenolate-O and thiolate-S in cis positions and the imine-N 
atom in the trans position. The distortion of the FeIIIO2N2S2 octahedral geometry results from the 
constraints imposed by the five- and six-membered chelate rings formed. As expected the six-
membered chelate ring involves a significantly wider bite angle than the ideal octahedral 90° [O1–
Fe1–N1 bite angle of 92.9(3)°] while the bite angle is narrowed in the five-membered chelate ring 
[S1–Fe1–N1 bite angle of 86.5(2)°]; selected geometric parameters are displayed in Table 4.2.2. 
There is no major strain relief through puckering: the root mean-square deviations from their least-
squares plane of atoms comprising the six membered [Fe1 N1 C7 C1 C2 O1] chelate ring are 0.020 
Å and the corresponding values for the five-membered [Fe1 N1 N2 C8 S1] chelate ring are 0.007 Å. 
The FeIII chelating O,N,S-tridentate ligands’ bond distances suggest that there is electron 
delocalisation over the five- and six-membered chelates. It should be noted that the bond distances 
and angles for the [Fe(H-thsa-Me)(thsa-Me)]∙H2O compound are an average for the one-fold and 
two-fold deprotonated ligand forms, due to the ligands being related by symmetry. Furthermore, it 
is significant to note that the ligands are chemically inequivalent i.e. one ligand is anionic and the 
other dianionic, but the ligands are crystallographically equivalent, due to the ligands being related 
by the symmetry operation (i) –x + 1, –y + 1, z. This geometric feature is shown by the bond distances 
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of the C–S, C–N and N–N bonds of the symmetry related ligands. The N1–N2, N2–C8 and C8–S1 
bonds are involved in the structure of the five-membered chelate, in which the bond distances at 100 
K are 1.396(9) Å, 1.340(9) Å and 1.726(7) Å, respectively. This corresponds to the N–N, N–C and 
C–S bond distances reported for the crystallographically independent ligands in the related 
compound [Fe(5-Cl-thsa-Me)(H-5-Cl-thsa-Me)]∙H2O at 110 K, reported by Li et al. [21].    
The salicylaldehyde 4-methylthiosemicarbazonate ligand can coordinate to the FeIII cation in two 
different tautomeric forms, the thione and the thiol form. In this instance, the thione form is a singly 
deprotonated ligand which possesses a hydrogen atom at the hydrazinic nitrogen atoms, whereas the 
thiol form of the tautomer is doubly deprotonated and therefore has no hydrogen atom bound to the 
hydrazinic nitrogen. Each FeIII ion is coordinated by one singly deprotonated ligand, i.e. thione 
tautomer. The other ligand is generated by the symmetry operation (i) –x + 1, –y + 1, z. Considering 
that one ligand is generated from the other by symmetry, the disorder of the hydrazinic proton, with 
a N2 site occupancy of 50% and N2i site occupancy of 50%, suggests that the hydrogen atom can 
take up either N2 or the N2i site, which suggests that both an anionic ligand and dianionic ligand are 
bound to the FeIII cation.  
 
Figure 4.2.2 A projection showing the unit cell of [Fe(H-thsa-Me)(thsa-Me)]∙H2O. The disordered 
H2O molecule has been omitted for clarity. Displacement ellipsoids are drawn at the 50% probability 
level. Dashed lines indicate hydrogen bonds. [Symmetry code: (ii) x – 1/2, –y + 1, z + 1/2] 
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The shortest FeIII∙∙∙FeIII separations for the present compound are 7.2744(13) Å for Fe1∙∙∙Fe1 (x – 
1/2, –y + 1, z + 1/2) and 9.097(2) Å for Fe1∙∙∙Fe1 (–x + 1, –y + 1, z – 1). The FeIII units of [Fe(H-
thsa-Me)(thsa-Me)]∙H2O are linked in the a direction by the N−H∙∙∙O contacts (as displayed in Figure 
4.2.2). The N3−H3∙∙∙O1 (x – 1/2, –y + 1, z + 1/2) contact is formed by the terminal nitrogen atom, 
N3, which hydrogen bonds to the phenolate-O FeIII donor atom, O1. The hydrogen bonding geometry 
of [Fe(H-thsa-Me)(thsa-Me)]∙H2O is listed in Table 4.3.3.  
 
Table 4.3.3 Hydrogen bond geometry of [Fe(H-thsa-Me)(thsa-Me)]∙H2O (Å, °) 
D–H∙∙∙A D–H  H∙∙∙A  D∙∙∙A  D–H∙∙∙A  
N3−H3∙∙∙O1ii 0.880 (3) 1.894 (19) 2.759 (9) 167 (7) 
Symmetry code: (ii) x – 1/2, –y + 1, z + 1/2.  
 
4.2.3 Infrared spectroscopic studies of [Fe(H-thsa-Me)(thsa-Me)]∙H2O and the ligand 
salicylaldehyde 4-methylthiosemicarbazone, H2-thsa-Me 
Several key structural features regarding the ferric complexes and ligands can be drawn from the 
infrared spectra (given in the appendix). In contrast to the infrared spectrum of the ferric complex, 
the infrared spectrum of the ligand salicylaldehyde 4-methylthiosemicarbazone shows a νOH peak 
at 3362 cm-1 which indicates the presence of the OH group of the phenol. As the ligand binds to the 
FeIII ion, it is possible for the tridentate ligand to be present in the anionic or dianionic form. The 
anionic ligand is singly deprotonated at the phenolate-O atom and the dianionic ligand is doubly 
deprotonated thus no hydrogen atom would be located at the phenolate-O and thiolate-S atoms. The 
present ferric complex contains both the anionic and dianionic form of the ligand; subsequently the 
OH group of the phenol is not present in the infrared spectrum of the ferric complex as expected. 
The deprotonation of the phenolate-O atom after complexation to the metal ion is also supported by 
the shift of the frequency of the νC–O band from 1100 cm-1 to 1323 cm-1, in the ligand to the ferric 
complex, respectively [18, 21]. The positive shift of the νC–O band frequency indicates the 
coordination of the FeIII ion to the phenolate-O atom. The azomethine nitrogen atom is confirmed to 
have coordinated to the metal ion due to the shift of the C=N band from 1604 cm-1 in the free ligand 
to 1600 cm-1 in the complex [18, 21, 37]. The absence of the S‒H bond in the range 2600-2800 cm-1 
in the infrared spectrum of the ligand, indicates the ligand is present in the thione form, which is 
confirmed by the vibration at 1201 cm-1 which corresponds to the C=S band [18, 21, 37]. 
Furthermore, the coordination of the S atom to the FeIII ion is corroborated by the shift of the C–S 
band to 815 cm-1 in the ferric complex from 1020 cm-1 (νC=S) with regard to the free ligand [37].  
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4.2.4 Magnetic properties of [Fe(H-thsa-Me)(thsa-Me)]·H2O  
The temperature dependence of the χMT value (χM being the molar magnetic susceptibility and T 
being the temperature) of [Fe(H-thsa-Me)(thsa-Me)]∙H2O was measured in the 5-300 K temperature 
range and is displayed in Figure 4.2.3. The magnetic behaviour of the present compound reveals that 
the FeIII ion is in the low-spin state over the temperature range 5-300 K, in both the heating and 
cooling modes. The product of magnetic susceptibility and the temperature clearly indicates a plateau 
with the low-spin value (0.55 cm3 K mol-1) for [Fe(H-thsa-Me)( thsa-Me)]∙H2O being slightly higher 
than the value expected for low-spin compounds (S = 1/2) where χMT = 0.375 cm3 K mol-1 for g = 
2.00. The χMT value slowly increases at temperatures above ca. 280 K, this will be further 
investigated (vide infra).  
  
Figure 4.2.3 χMT vs T plot of [Fe(H-thsa-Me)(thsa-Me)]·H2O (left). The sample was warmed (▲) 
and then subsequently cooled (▼) in the temperature region of 5-300 K, at a rate of 2 K min-1. DSC 
curves (right) obtained for [Fe(H-thsa-Me)(thsa-Me)]∙H2O at a scan rate of 5 K min-1.  
 
As observed from Figure 4.2.3 the χMT vs T plot of [Fe(H-thsa-Me)(thsa-Me)]·H2O (5-300 K) shows 
that the value of the χMT slightly increases in the temperature range 250-300 K. In order to investigate 
this increase of χMT, higher temperature magnetic measurements were conducted and are displayed 
in Figure 4.2.4. At 400 K, χMT = 2.52 cm3 K mol-1 for the FeIII complex, however, this is much lower 
than the expected χMT value (4.37 cm3 K mol-1, S = 5/2, g = 2.0023) for the corresponding FeIII ion 
in the high-spin state. The increase in the product of magnetic susceptibility and temperature may be 
due to the FeIII ion exhibiting in an incomplete spin transition, whereby only a fraction of the FeIII 
ions convert into the high-spin state. The observed χMT values at 300 K and 400 K are 0.66 cm3 K 
mol-1 and 2.52 cm3 K mol-1, which correspond to the estimated high-spin fractions of 7 % and 54 %, 
respectively.  
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The DSC curve (125-350 K) of [Fe(H-thsa-Me)(thsa-Me)]∙H2O, as displayed in Figure 4.2.3, shows 
a slight increase in the curve above ca. 280 K in both the heating and cooling mode, which confirms 
the onset of the spin-crossover in this temperature range. This result correlates with the temperature 
dependent magnetic data recorded from 5 to 300 K.  
 
Figure 4.2.4 χMT vs T plot of [Fe(H-thsa-Me)(thsa-Me)]·H2O. The sample was warmed (▲) in the 
temperature region of 200-400 K, at a rate of 2 K min-1. 
 
4.3 The structure and magnetic properties of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O 
In this section the crystallographic data and magnetic properties of the ferric complex [Fe(H-3-OEt-
thsa-Me)(3-OEt-thsa-Me)]∙H2O are reported. Furthermore, the infrared spectroscopic studies of the 
free ligand and ferric complex are also discussed.  
The synthesis of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O and corresponding H2L ligand, 3-
ethoxysalicylaldehyde 4-methylthiosemicarbazone (H2-3-OEt-thsa-Me), are detailed in Chapter II – 
Materials and Methods.  
 
4.3.1 Crystal Data and Structure Refinement Details of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-
Me)]∙H2O 
Data was collected on the Beamline I19 situated on an undulator insertion device with a combination 
of double crystal monochromator, vertical and horizontal focussing mirrors and a series of beam slits 
(primary white beam and either side of the focussing mirrors). The experimental hutch (EH1) is 
equipped with a Crystal Logic 4-circle kappa geometry goniometer with a Rigaku Saturn 724 CCD 
detector and an Oxford Cryosystems Cryostream plus cryostat (80-500 K). For conventional service 
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crystallography the beamline operates at a typical energy of 18 k eV (Zr K absorption edge). The 
cell determination and data collection were carried out on the software CrystalClear-SM Expert 2.0 
r5 [38]. The data reduction, cell refinement and absorption correction were made using CrystalClear-
SM Expert 2.0 r5 [38] and the structure solution was made using the program SUPERFLIP [32]. 
OLEX2 [34] and ORTEP-3 for Windows [35] programs were used to produce the molecular graphics 
[35]. 
The crystal data, data collection and structure refinement details are summarised in Table 4.3.1. All 
H-atoms were included in the refinement in calculated positions and treated as riding on their parent 
atoms, with N–H distance of 0.86 Å and Uiso(H) = 1.2 Ueq(C) for amide H-atoms, C–H distance of 
0.93 Å and Uiso(H) = 1.2 Ueq(C) for aryl (-CH=) H-atoms, C–H distances of 0.97 Å and Uiso(H) = 1.2 
Ueq(C) for secondary (-CH2-) H-atoms and C–H distance of 0.92 Å and Uiso(H) = 1.5 Ueq(C) for the 
methyl (-CH3) H-atoms. The remaining non-hydrogen atoms have been refined as a rigid body, using 
the rigid body restraint RIGU, with the sigma for 1-2 distances of 0.004 and sigma for 1-3 distances 
of 0.0004. The O401 and O501 atoms of the H2O solvent molecules, both have a site occupancy 
factor of 0.5; due to the disorder associated with the H2O solvent molecules, the H-atoms have not 
been located explicitly, although they are included in the sum formula of the ferric complex. The 
large residual density (Δρmax = 0.892 e Å−3) on the difference Fourier map included peaks near the 
Fe atom and the largest peak being near the O atom; a fraction of the large residual density may be 
due to the positional disorder of the ethoxy group of one of the ligands. Thus, the peaks which 
represent a fraction of the electrons in ethoxy group, were assumed to arise from limitations of the 
data. 
 
4.3.2 Crystallographic study of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O 
The structure of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O (Fig. 4.3.1) was determined at 100 K. 
The present compound crystallises in the triclinic system in the space group P-1, with Z = 2. The 
asymmetric unit of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O contains two crystallographically 
independent FeIII entities, defined as sites Fe1 and Fe11, respectively. Both FeIII cations are 
coordinated by a dianionic O,N,S-tridentate ligand, 3-ethoxysalicylaldehyde 4-
methylthiosemicarbazonato(2-) (L2‒) and an anionic O,N,S-tridentate ligand, 3-
ethoxysalicylaldehyde 4-methylthiosemicarbazonato(1-) (HL‒).   
Examination of the structure of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O revealed that both the 
FeIII ions (Fe1 and Fe11) have octahedral coordination with an FeIIIO2N2S2 geometry. The bond 
distances of the FeIII-donor atoms are given in Table 4.3.2 and are consistent with those typical for 
high-spin FeIII bis(ligand) compounds containing both the anionic and dianionic form of the R-
salicylaldehyde 4R’-thiosemicarbazonate ligand [18, 20-21]. The FeIIIO2N2S2 coordination spheres 
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of Fe1 and Fe11 display slightly distorted octahedral geometries, as indicated by the bond angles 
(Table 4.3.2) of the donor atoms and the Fe1 and Fe11 atoms (vide infra). The distorted FeIIIO2N2S2 
geometry is evidenced by the two mutually perpendicular ligand planes whereby the donor atoms O 
and S are in the cis positions and N atoms in trans positions.  
 
Table 4.3.1 Crystal data and structure refinement details of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-
Me)]∙H2O 
Crystal data 
Chemical formula [[Fe(C11H13N3O2S)(C11H14N3O2S)]∙H2O]2 
Mr 1136.44 
Crystal system, space group Triclinic, P-1 
Temperature (K) 100 
a, b, c (Å) 12.264 (2), 12.829 (2), 17.214 (2) 
α, β, γ (°) 91.768 (8), 90.822 (6), 104.854 (9) 
V (Å3) 2615.9 (7) 
Z 2 
Radiation type Mo Kα 
µ (mm−1) 0.721 
Crystal size (mm) 0.04 x 0.04 x 0.04 
Data collection 
Diffractometer Beamline I19 (Synchrotron) 
Absorption correction Multi-scan (CrystalClear-SM Expert 2.0 r5 [38]) 
Tmin, Tmax 0.445, 1.000 
No. of measured, independent and 
observed [I > 2σ(I)] reflections 
21479, 9060,  
4095 
Rint 0.1949 
Refinement 
R[F2 > 2σ(F2)], wR(F2), S 0.1253, 0.2922, 1.053 
No. of reflections 9060 
No. of parameters 649 
No. of restraints 19 
H-atom treatment H atoms treated by constrained refinement 
Δρmax, Δρmin (e Å−3) 0.892, -0.710 
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Figure 4.3.1 The molecular structure and atom-numbering scheme for the asymmetric unit of [Fe(H-
3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O. The two H2O molecules have been omitted for clarity. 
Displacement ellipsoids are drawn at the 50% probability level. 
 
The single crystal structure of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O has revealed that the 
FeIII ion is in the high-spin state at 100 K, whereas the FeIII ion of the complex [Fe(H-thsa-Me)(thsa-
Me)]∙H2O (vide supra) is in the low-spin state at 100 K. It is recognised that there is a difference in 
the bond distances of the FeIII-donor atoms between the high-spin and low-spin forms [20, 21]. Bond 
distances between the FeIII atom and the O,N,S-donor atoms for selected [FeIII(HL)(L)]∙H2O type 
spin-crossover compounds are summarised in Table 4.3.3.  
 
Table 4.3.2 Selected geometric parameters of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O (Å, °) 
Fe1–S1 2.473 (4) Fe1–S101 2.442 (4) 
Fe1–O1 1.939 (9) Fe1–O101 1.996 (9) 
Fe1–N1 2.168 (10) Fe1–N101 2.085 (10) 
Fe11–S201 2.482 (4) Fe11–S301 2.417 (4) 
Fe11–O201 1.958 (9) Fe11–O301 1.994 (8) 
Fe11–N201 2.146 (5) Fe11–N301 2.096 (11) 
    
S1–Fe1–S101 95.02 (13) S201–Fe11–S301 95.75 (13) 
S1–Fe1–N1 79.5 (3) S201–Fe11–N201 79.1 (3) 
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Table 4.3.2 Selected geometric parameters of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O (Å, °) 
(continued) 
S1–Fe1–O1 160.2 (3) S201–Fe11–O201 159.7 (3) 
S1–Fe1–O101 86.4 (3) S201–Fe11–O301 88.0 (3) 
S1–Fe1–N101 100.1 (3) S201–Fe11–N301 97.7 (4) 
S101–Fe1–O1 95.8 (3) S301–Fe11–O201 94.8 (3) 
S101–Fe1–O101 165.3 (3) S301–Fe11–O301 166.2 (3) 
S101–Fe1–N1 87.3 (3) S301–Fe11–N201 84.9 (3) 
S101–Fe1–N101 78.9 (3) S301–Fe11–N301 80.5 (3) 
O1–Fe1–O101 87.3 (4) O201–Fe11–O301 85.8 (4) 
O1–Fe1–N1 84.4 (4) O201–Fe11–N201 84.7 (4) 
O1–Fe1–N101 98.3 (4) O201–Fe11–N301 101.1 (4) 
O101–Fe1–N1 107.3 (3) O301–Fe11–N201 108.9 (3) 
O101–Fe1–N101 86.4 (4) O301–Fe11–N301 85.8 (4) 
N1–Fe1–N101 166.2 (4) N201–Fe11–N301 164.6 (4) 
 
In the high-spin compound [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O, the Fe–O, Fe–S and Fe–
N bond distances of the anionic ligand (H-3-OEt-thsa-Me) are Fe1–O1 = 1.939(4) Å and Fe11–O201 
= 1.958(5) Å; Fe1–S1 = 2.473(4) Å and Fe11–S201 = 2.482(2) Å; and Fe1–N1 = 2.168(10) Å and 
Fe11–N201 = 2.146(5) Å, severally. Furthermore, the Fe–O, Fe–S and Fe–N bond distances of the 
dianionic ligand (3-OEt-thsa-Me) are Fe1–O101 = 1.996(9) Å and Fe11–O301 = 1.994(8) Å; Fe1–
S101 = 2.442(4) Å and Fe11–S301 = 2.417(4) Å; and Fe1–N101 = 2.085(10) Å and Fe11–N301 = 
2.096(11) Å, severally. In the low-spin compound [Fe(H-thsa-Me)(thsa-Me)]∙H2O, the Fe–O, Fe–S 
and Fe–N bond distances are Fe1–O1i = 1.932(5) Å, Fe1–S1i = 2.249(2) Å and Fe1–Ni1 = 1.946(5) 
Å ((i) –x + 1, –y + 1, z), severally. It should be noted that the bond distances for the [Fe(H-thsa-
Me)(thsa-Me)]∙H2O compound are an average for the one-fold and two-fold deprotonated ligand 
forms, as the ligands are crystallographically equivalent, due to the ligands being related by the 
symmetry operation (i) –x + 1, –y + 1, z. These differences between the high-spin and low-spin form 
result in the bond distances of the anionic ligands (HL‒) of ∆Fe–O = 0.01 Å, ∆Fe–S = 0.22 Å and 
∆Fe–N = 0.21 Å, severally, and for the dianionic ligand (L2‒) of ∆Fe–O = 0.06 Å, ∆Fe–S = 0.17 Å 
and ∆Fe–N = 0.15 Å, severally, for the reported compounds [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-
Me)]∙H2O and [Fe(H-thsa-Me)(thsa-Me)]∙H2O. The FeIII-donor atom bond distances of the 
compounds [Fe(H-5-Br-thsa)(5-Br-thsa)]∙H2O and [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O 
(displayed in Table 4.3.3) differences for the anionic ligand are ∆Fe–O = 0.004-0.028 Å, ∆Fe–S = 
0.196-0.213 Å and ∆Fe–N = 0.176-0.201 Å, severally, the corresponding differences between the 
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FeIII-donor atom bond distances for the dianionic ligand are ∆Fe–O = 0.003-0.024 Å, ∆Fe–S = 0.152-
0.171 Å and ∆Fe–N = 0.118-0.176 Å, severally.  
 
Table 4.3.3 The Fe–O, Fe–N and Fe–S bond distances (Å), and the bond distances differences 
between the low-spin and high-spin state for selected [FeIII(HL)(L)]·H2O spin-crossover compounds 
FeIII compoundsi Fe–O 
LS/HSii 
Fe–N 
LS/HSii 
Fe–S 
LS/HSii 
∆Fe–O ∆Fe–N ∆Fe–S 
[Fe(H-5-Br-thsa)(5-Br-thsa)]∙H2O
iii 
[18] 
1.941(4) 
1.949(4) 
/ 
1.969(4) 
1.952(4) 
1.952(5) 
1.955(4) 
/ 
2.153(4) 
2.131(4) 
2.2718(17) 
2.2463(17) 
/ 
2.4845(18) 
2.4177(19) 
0.028 
0.003 
0.201 
0.176 
0.213 
0.171 
[Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-
Me)]∙H2O
iii [21] 
1.933(4) 
1.940(4) 
/ 
1.937(9) 
1.916(9) 
1.948(5) 
1.993(5) 
/ 
2.124(9) 
2.111(10) 
2.2566(16) 
2.2389(15) 
/ 
2.453(4) 
2.391(4) 
0.004 
0.024 
0.176 
0.118 
0.196 
0.152 
i The H2L ligands are defined as follows: 5-bromosalicylaldehyde thiosemicarbazone = H2-5-Br-
thsa and 5-chlorosalicylaldehyde 4-methylthiosemicarbazone = H2-5-Cl-thsa-Me.  
ii HS and LS represent high-spin and low-spin states, respectively. 
iii The geometric parameters of the HL and L ligands are given on subsequent lines.  
 
 
It is significant to note that the Fe–O distances seem to be less sensitive to change in FeIII spin state 
than the Fe–N and Fe–S distances, which may be related to the π-acceptor capability of the N- and 
S-donor atoms opposed to the π-donor capability of the O-donor atoms. This is of particular 
significance when FeIII is in the low-spin state, as increased back-bonding will lead to comparatively 
more pronounced shortening of the Fe–N and Fe–S bonds than of the Fe–O bonds. Furthermore, the 
changes in the FeIII-donor atoms’ bond distances are due to the FeIII ion switching from the low-spin 
to the high-spin state, as it is recognised that with a spin transition the size of the ionic radius of the 
metal ion changes. 
The packing diagram of the high-spin compound [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O is 
given in Figure 4.3.2. The FeIII∙∙∙FeIII separations of the Fe1 units of the compound [Fe(H-3-OEt-
thsa-Me)(3-OEt-thsa-Me)]∙H2O are 9.942(4) Å for Fe1∙∙∙Fe1 (–x + 1, –y + 1, –z + 1) and 12.829(2) 
Å for Fe1∙∙∙Fe1 (x, y + 1, z). The Fe11∙∙∙Fe11 separations of 17.555(4) Å for Fe11∙∙∙Fe11 (–x + 1, –
y + 1, –z + 1) and 12.829(2) Å for Fe11∙∙∙Fe11 (x, y + 1, z) correlate with the Fe1∙∙∙Fe1 separations 
in [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O. The Fe1 and Fe11 units are assembled with 
Fe1∙∙∙Fe11 (–x + 1, –y + 1, –z + 1) separations of 9.644(3) Å and Fe1∙∙∙Fe11 (–x + 2, –y + 1, –z + 1) 
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10.371(3) Å. The hydrogen bonding interactions of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O 
are listed in Table 4.3.4. The terminal N atom N3 of the anionic ligand coordinated to Fe1 forms an 
N3–H3∙∙∙O401 contact involving the water solvent oxygen atom O401. 
 
Figure 4.3.2 A projection of the unit cell of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O. 
Displacement ellipsoids are drawn at the 50% probability level.  
 
Table 4.3.4 Hydrogen bond geometry of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]·H2O (Å, °) 
D–H∙∙∙A D–H  H∙∙∙A  D∙∙∙A  D–H∙∙∙A  
N3−H3∙∙∙O401 0.86  2.01 2.82 (3) 155.0 
 
4.3.3 Infrared spectroscopic studies of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O and the 
ligand 3-ethoxysalicylaldehyde 4-methylthiosemicarbazone, H2-3-OEt-thsa-Me 
Similarly to compound [Fe(H-thsa-Me)(thsa-Me)]∙H2O, the infrared spectrum of [Fe(H-3-OEt-thsa-
Me)(3-OEt-thsa-Me)]∙H2O  displays  the relevant bands corresponding to the typical peaks expected 
for a ferric complex containing both a thione and thiol tautomeric form of the ligand. The 
assignments of the main infrared spectroscopic bands of the FeIII complex and corresponding ligand, 
3-ethoxysalicylaldehyde 4-methylthiosemicarbazone, are listed in Table 4.3.5. The infrared 
spectrum of the free ligand exhibits bands in the regions 1606 cm-1 and 1107 cm-1, which are assigned 
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to νC=N and νCS bands, respectively, indicating the free ligand is in the thione form. The 
coordination of the ligand to the FeIII is accompanied by negative shifts of the νC=N and νCS 
bands and a positive shift of the νCO band with regards to the free ligand, therefore indicating 
the coordination of the FeIII ion to the O,N,S-donor atoms.  
 
Table 4.3.5 Selected infrared spectroscopic bands (cm-1) with assignments of [Fe(H-3-OEt-thsa-
Me)(3-OEt-thsa-Me)]∙H2O and H2L ligand, 3-ethoxysalicylaldehyde 4-methylthiosemicarbazone. 
Compound νC=N νN=C νNN νCS νCO 
H2L 1606 - 1167 1107 1061 
[Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O 1597 1582 1239 727 1213 
 
4.3.4 Magnetic properties of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O 
The magnetic behaviour of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O is shown by the 
temperature dependence of the χMT value (χM being the molar magnetic susceptibility and T being 
the temperature) measured in the 5-300 K temperature range and is displayed in Figure 4.3.3. The 
product of magnetic susceptibility and the temperature shows a plateau, revealing the compound to 
be in the high-spin state over the temperature range 5-300 K, in both the heating and cooling modes. 
The value of χMT is 4.09 cm3 K mol-1 for [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O at 300 K, 
which is close to the value expected for high-spin compounds (S = 5/2) where χMT = 4.37 cm3 K 
mol-1 for g = 2.00. The lower than expected value of χMT of 4.09 cm3 K mol-1 for [Fe(H-3-OEt-thsa-
Me)(3-OEt-thsa-Me)]∙H2O at 300 K, may be due to residual low-spin FeIII, with a corresponding 
low-spin fraction estimated at 6%.  
  
Figure 4.3.3 χMT vs T plot of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]·H2O in the temperature range 
of 5 – 300 K, measured at a rate of 2 K min-1. (i) The heating mode is shown on the left and 
represented by the symbol (∆) and (ii) the cooling mode on the right is represented by the symbol 
(▼). 
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The DSC curves of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O, as displayed in Figure 4.3.4, 
correlates with the temperature dependent magnetic susceptibility data that a phase transition in the 
temperature range 5-300 K is absent.  
 
Figure 4.3.4 DSC curves obtained for [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O in the 
temperature range 150-350 K, measured at a scan rate of 5 K min-1. 
 
As illustrated in Figure 4.3.3, the χMT value decreases abruptly below the temperature 50 K; this is 
a consequence of the significant zero-field splitting of the ground state FeIII ion in the high-spin state. 
This feature has been found to be common in high-spin FeIII compounds [39-40]. The zero-field 
splitting was calculated using equation (1) [39]: 
 
χ𝑀 =
𝑁𝑔2 𝛽2
4𝑘𝑇
[
0.14 + 5.12𝑒−3.23𝑋 + 23.85𝑒−6.83𝑋
1 + 𝑒−3.23𝑋 + 𝑒−6.83𝑋
] Eqn (1) 
 
In this equation, X = D/kT, D is the zero-field splitting parameter, g is the average g tensor value and 
the other symbols have their standard meanings (as shown in Chapter I). As reported by Chen et al., 
[39] equation (1) is the theoretical equation for the magnetic susceptibility resulting from the axial 
and rhombic zero-field splitting for a FeIII S = 5/2 ion. The least squares fit (Figure 4.3.5) between 
the temperature range 5-150 K has been obtained with the parameters D = 2.85 cm-1 and g = 2.18, 
for [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O, with a coefficient of determination value of 0.99 
and a reduced χ2 value of 0.0001.  
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Figure 4.3.5 Temperature dependence of the molar magnetic susceptibility, χM, for the compound 
[Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]·H2O in the range 5-150 K. Points represent the cooling 
mode experimental data; solid red line represents the least-squares fit of the data to Equation (1), 
where D = 2.85 cm-1 and g = 2.18. 
 
4.4 The crystal structure and magnetic properties of [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-
Me)]∙H2O1 
In this section the crystallographic data and magnetic properties of the ferric complex [Fe(H-5-Cl-
thsa-Me)(5-Cl-thsa-Me)]∙H2O are reported. Furthermore, the infrared spectroscopic studies of the 
free ligand and ferric complex are also discussed. The synthesis of [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-
Me)]∙H2O and corresponding H2L ligand, 5-chlorosalicylaldehyde 4-methylthiosemicarbazone (H2-
5-Cl-thsa-Me), is detailed in Chapter II – Materials and Methods.  
 
4.4.1 Crystal Data and Structural Refinement Details of [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-
Me)]∙H2O 
Crystal data, data collection and structure refinement details are summarised in Table 4.4.1. The Fe1 
atom has a site occupancy of 0.5, whereby the symmetry transformation (i) –x + 1, –y + 1, z generates 
the equivalent atoms of the coordinated ligand 5-chlorosalicylaldehyde methylthiosemicarbazone. 
The position of the hydrogen atoms on the secondary amine nitrogen atoms N2, N2i, N3 and N3i 
were located in difference Fourier maps and refined with restrained N–H distances of 0.88(2) Å and 
with Uiso(H) = 1.2 Ueq(N). The hydrogen atoms attached to the O1W of the water molecule were 
                                                     
1 An article was published during the preparation of this thesis regarding the compound [Fe(H-5-Cl-thsa-
Me)(5-Cl-thsa-Me)]·H2O. Reference: Li, Z.-Y., Dai, J.-W., Gagnon, K. J., Cai, H.-L., Yamamoto, T., 
Einaga, Y., Zhao, H.-H., Kanegawa, S., Sato, O., Dunbar, K. R. and Xiong, R.-R. (2013). Dalton. Trans. 42, 
pp. 14685-14688.  
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located in a difference Fourier map and refined with restrained O–H distances of 0.87(2) Å and with 
Uiso(H) = 1.5 Ueq(O). Moreover, the H2 atom bound to the N2 atom has a site occupancy factor of 
0.5. The water solvent molecule has a site occupancy of 0.5. The remaining hydrogen atoms were 
included in the refinement in calculated positions, riding on their parent atoms, with C–H = 0.95 Å 
and Uiso(H) = 1.2 Ueq(C) for aryl H atoms.  
 
Table 4.4.1 Crystal data and structure refinement details of [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-
Me)]∙H2O 
Crystal data 
Chemical formula [Fe(C9H8ClN3OS)(C9H9ClN3OS)]∙H2O 
Mr 558.26 
Crystal system, space group Orthorhombic, Aea2 
Temperature (K) 100 
a, b, c (Å) 11.4264 (8), 22.6178 (16), 8.7809 (6) 
α, β, γ (°) 90, 90, 90 
V (Å3) 2269.3 (3) 
Z 4 
Radiation type Mo Kα 
µ (mm−1) 1.12 
Crystal size (mm) 0.09 x 0.09 x 0.01 
Data collection 
Diffractometer Rigaku AFC12 four-circle Kappa diffractometer 
Absorption correction Multi-scan (CrystalClear-SM Expert  [31]) 
Tmin, Tmax 0.663, 1.000 
No. of measured, independent and  
observed [I > 2σ(I)] reflections 
14234, 2541, 1877  
Rint 0.114 
Refinement 
R[F2 > 2σ(F2)], wR(F2), S 0.077, 0.173, 0.95 
No. of reflections 2541 
No. of parameters 159 
No. of restraints 6 
H-atom treatment H atoms treated by a mixture of independent and 
constrained refinement 
Δρmax, Δρmin (e Å−3) 1.20, -0.39 
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The program used for the structure solution: CrystalClear-SM Expert 2.1 b29 [31]; the structure 
refinement used the programs SUPERFLIP [32] and SHELXL-2014 [33]. The OLEX2 [34] and 
ORTEP-3 for Windows [35] programs were used to produce the molecular graphics [35].  
 
4.4.2 Crystallographic study of [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O 
The crystal structure of the compound [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O was determined at 
100 K, and is illustrated in Figure 4.4.1. It crystallises in the orthorhombic crystal system in the space 
group Aea2, where Z = 4 and Z’ = 0.5 (where Z is the number of formula units per unit cell and Z’ 
is the number of formula units per asymmetric unit). The asymmetric unit consists of 1/2 [Fe(HL)(L)] 
fragment and half of a solvent water molecule. The ligands coordinated around the FeIII cation are 
related by symmetry, and are generated by the symmetry transformation (–x + 1, –y + 1, z). The FeIII 
atom of the present compound is coordinated to two O,N,S-tridentate ligands, a two-fold 
deprotonated ligand [L = 5-chlorosalicylaldehyde 4-methylthiosemicarbazonato(2-)] and a one-fold 
deprotonated ligand [HL = 5-chlorosalicylaldehyde 4-methylthiosemicarbazonato(1-)]. However, 
due to the disorder of the H-atom on the imine N-atoms, N2 and N2i, within each FeIII unit it is not 
clear which ligand is (-2) or (-1) charged. The compound [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O 
has been found to be isostructural to [Fe(H-thsa-Me)(thsa-Me)]∙H2O.  
 
Figure 4.4.1 The molecular structure and atom-numbering scheme for [Fe(H-5-Cl-thsa-Me)(5-Cl-
thsa-Me)]∙H2O, whereby the second ligand bound to Fe1 atom is generated by the symmetry 
operation (i) –x + 1, –y + 1, z. The hydrogen atom bound to N2 and N2i atoms has a site occupancy 
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factor of 0.5, i.e. the atom is disordered over the N2 and N2i sites (50:50). The H2O molecule has 
been omitted for clarity. Displacement ellipsoids are drawn at the 50% probability level.  
 
The dianionic and anionic O,N,S-tridentate ligands coordinate to the FeIII cation to form an distorted 
octahedral FeO2N2S2 geometry. The dianionic ligand is deprotonated at the phenolate-O and the 
thiolate-S, whereas the anionic ligand is deprotonated at the phenolate-O atom, only. The donor 
atoms of the ligands are orientated in two perpendicular planes, with the O and S atoms in the cis 
positions [O1–Fe1–O1i = 89.6 (4)° and S1–Fe1–S1i = 92.02 (15)°] and the N atoms in the trans 
positions [N1–Fe1–N1i = 175.2 (5)°]. Selected geometric parameters are listed in Table 4.4.2. 
 
Table 4.4.2 Selected geometric parameters of [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O (Å, °) 
Fe1–S1i 2.255 (3) Fe1–N1i 1.969 (6) 
Fe1–O1i 1.951 (7)   
    
S1–Fe1–S1i 92.02 (15) O1i–Fe1–N1 90.5 (3) 
S1–Fe1–N1 86.2 (2) N1–Fe1–N1i 175.2 (5) 
S1–Fe1–O1 178.5 (2) Fe1–O1–C2 125.4 (6) 
S1–Fe1–O1i 89.2 (2) O1–C2–C1 125.2 (8) 
S1–Fe1–N1i 90.5 (2) C2–C1–C7 123.2 (8) 
S1i–Fe1–O1 89.2 (2) C1–C7–N1 126.1 (8) 
S1i–Fe1–N1 90.5 (2) C7–N1–Fe1 126.1 (6) 
O1–Fe1–O1i 89.6 (4) C8–S1–Fe1 95.8 (3) 
O1–Fe1–N1 92.9 (3) N1–N2–C8 116.2 (7) 
O1–Fe1–N1i 90.5 (3) N2–C8–S1 122.5 (7) 
Symmetry transformation used to generate equivalent atoms: (i) –x + 1, –y + 1, z.  
 
The Fe-donor atom bond distances suggest that the FeIII cation in the present compound is in the 
low-spin state at 100 K. Typical distances for Fe–S, Fe–O and Fe–N bonds are 2.23-2.31, 1.93-1.95 
and 1.88-1.96 Å, respectively, for low-spin FeIII compounds of this family, and 2.40-2.44, 1.96-1.99 
and 2.05-2.15 Å, respectively, for the corresponding high-spin FeIII compounds [4]. Comparison of 
the bond distances of the present compound involving the FeIII atom and the donor atoms (Table 
4.4.2) suggests that the present compound contains low-spin FeIII at 100 K.  
The FeIIIO2N2S2 chromophore is formed by two six-membered chelates and two five-membered 
chelates via the two-fold and one-fold deprotonated tridentate 5-chlorosalicylaldehyde 4-
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methylthiosemicarbazone ligands. The five-membered chelate rings bite angle is significantly 
restricted [S1–Fe1–N1 = S1i–Fe1–N1i = 86.2 (2)°] in comparison to the wider bite angles of the six-
membered chelate rings [O1–Fe1–N1 = O1i-Fe1-N1i = 92.9 (3)°]. The ligands coordinated to the 
FeIII cation show no major strain relief through puckering of the five- and six-membered chelate 
rings. The five-membered chelate ring shows root-mean-square deviations of 0.08 Å; the 
corresponding values are 0.045 Å for the six-membered chelate ring. In comparison to the bite angle 
of the regular hexagon of 120°, the O–Fe1–N bite angles of the six-membered chelate rings are 
deficient by ca. 27°. The remaining bite angles (listed in Table 4.4.2) of the six-membered chelate 
are within 2° of 125°. Moreover, the five-membered chelate S–Fe1–N bite angles are deficient by 
ca. 23° of the vertex angle (108°) expected for the regular pentagon. The C–S–Fe1 angles form an 
additional deficiency of 13°, which suggests the remaining bite angles (listed in table 4.2.2) of the 
5-membered chelate ring would be expected to be ca. 120°. However, the N–N–C angle is 115.9 (7)° 
and the N–C–S angles are 123.0 (7)°. The chelating O,N,S-tridentate ligands allows for further 
stabilisation of the present compound through the near alternation of the single and double bonds, 
giving rise to a high degree of π-electron delocalisation throughout the chelate rings. 
Li et al., reported the structure of the compound [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O at 110, 
260 and 293 K [26]. Single crystal X-ray structure determination revealed the compound to 
crystallise in the monoclinic system and the polar Cc space group at 110, 260 and 293 K. The 
noticeable difference between the compound [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O reported by 
Li et al., and in this thesis, is the space group the compound crystallises. Li et al., reported the 
monoclinic space group Cc, whereas the present work reports orthorhombic space group, Aea2. The 
major difference between the unit cells is the β angle, for the space group Cc the β angle is 91.301(3)° 
(at 110 K) whereas for Aea2 the β angle = 90.00°.  
Tthe FeIII cation was found to be in the low-spin state at 110 K and in the high-spin state at 293 K. 
The compound [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O [26] displays an FeIIIO2N2S2 octahedral 
environment which is comprised of both the anionic and dianionic ligand, therefore the 5-
chlorosalicylaldehyde 4-methylthiosemicarbazone ligands are in the thione and thiol tautomeric 
form, respectively. In the present compound [Fe(5-Cl-thsa-Me)(H-5-Cl-thsa-Me)]∙H2O, it should be 
noted that the bond distances are an average for the anionic and dianionic deprotonated ligand forms, 
due to the ligands being related by symmetry. This geometric feature is shown by the bond distances 
of the C–S, C–N and N–N bonds of the symmetry related ligands. The N1–N2, N2–C8 and C8–S1 
bonds distances at 100 K are 1.395(10) Å, 1.328(11) Å and 1.748(8) Å, respectively. This 
corresponds to the N–N, N–C and C–S bond distances the compound [Fe(H-5-Cl-thsa-Me)(5-Cl-
thsa-Me)]∙H2O at 110 K, reported by Li et al., [26].   
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The packing of [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O is displayed in Figure 4.4.2 and the 
hydrogen bonding interactions are listed in Table 4.4.3 and displayed in Figure 4.4.3. [Fe(H-5-Cl-
thsa-Me)(5-Cl-thsa-Me)]∙H2O displays FeIII∙∙∙FeIII (x – 1/2, –y + 1, z – 1/2) separations of 7.1829(18) 
Å; 8.747(3) Å for Fe∙∙∙Fe (–x + 1, –y + 1, z – 1) and 12.093(4) Å for Fe∙∙∙Fe (–x + 1, –y + 1/2, z – 
1/2). The FeIII units are linked together by N−H∙∙∙O hydrogen bonds in the a direction. The 
N3−H3∙∙∙O1iii (x + 1/2, –y + 1, z + 1/2) contact is formed between the terminal amide nitrogen atom, 
N3 and the phenolate-O atom O1. The water solvent molecule is involved in hydrogen bonding with 
the metal complex units within the unit cell. Firstly, the hydrazinic nitrogen atom, N2 forms the 
contact N2−H2∙∙∙O1Wii (–x + 3/2, y, z + 1/2) with the oxygen atom of the water molecule, O1W.  
 
Figure 4.4.2 A projection showing the unit cell of [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O. The 
disordered H2O molecule has been omitted for clarity. The displacement ellipsoids are drawn at the 
50% probability level.  
 
The O1W atom of the water solvent molecule also forms a hydrogen bond with the phenolate-O1 
and O1i atoms, O1W−H1WB∙∙∙O1 and O1W−H1WB∙∙∙O1i (–x + 1, –y + 1, z). A ring system is 
created by the following hydrogen bonds: N3−H3∙∙∙O1iii (x + 1/2, –y + 1, z + 1/2), N2−H2∙∙∙O1Wii 
and O1W−H1WB∙∙∙O1. This particular ring system is formed by two acceptor atoms [the phenolate 
O1 and solvent oxygen O1W atoms] and 3 donors atoms, thus forming a R23(8) system [27]. 
Furthermore, the O1W−H1WB∙∙∙O1 and O1W−H1WB∙∙∙O1i (–x + 1, –y + 1, z) contacts form a 
hydrogen bonding ring system. In turn, the phenolate O1 and symmetry related phenolate O1i atoms  
acts as a hydrogen acceptor of the H-atom, H1WB, from the solvent water oxygen atom O1W, giving 
rise to a R21(4) ring [27]. It should be noted that the hydrogen bond ring system involving the 
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phenolate-O atoms (O1 and O1i) which are coordinated to the FeIII atom, could affect the Fe-O donor 
atom bond distances, and therefore the spin state of FeIII. 
 
Figure 4.4.3 Hydrogen bonding system of [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O in the a 
direction. An alternative orientation for H1WA and H1WB has been omitted for clarity. The 
displacement ellipsoids are drawn at the 50% probability level. [Symmetry codes: (i) –x + 1, –y + 1, 
z; (ii) –x + 3/2, y, z + 1/2; (iii) x + 1/2, –y + 1, z + 1/2; (iv) –x + 3/2, y, z – 1/2.]  
 
Table 4.4.3 Hydrogen bond geometry of [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O (Å, °) 
D–H∙∙∙A D–H  H∙∙∙A  D∙∙∙A  D–H∙∙∙A  
N2−H2∙∙∙O1Wii 0.88 (3) 2.22 (6) 3.085 (7) 166 (18) 
N3−H3∙∙∙O1iii 0.87 (3) 1.94 (3) 2.807 (11) 176 (10) 
O1W−H1WA∙∙∙N2iv 0.86 (3) 2.28 (14) 3.085 (7) 157 (32) 
O1W−H1WB∙∙∙O1i 0.85 (3) 2.3 (3) 3.008 (14) 135 (33) 
O1W−H1WB∙∙∙O1 0.85 (3) 2.3 (4) 3.008 (14) 140 (49) 
Symmetry codes: (i) –x + 1, –y + 1, z; (ii) –x + 3/2, y, z + 1/2; (iii) x + 1/2, –y + 1, z + 1/2; (iv) –x 
+ 3/2, y, z – 1/2.  
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4.4.3 Infrared spectroscopic study of [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O and the 
corresponding ligand 5-chlorosalicylaldehyde 4-methylthiosemicarbazone, H2-5-Cl-thsa-Me 
Similarly, to compound [Fe(H-thsa-Me)(thsa-Me)]∙H2O, the infrared spectrum of [Fe(H-5-Cl-thsa-
Me)(5-Cl-thsa-Me)]∙H2O  displays  the relevant bands to give rise the typical peaks expected for a 
ferric complex containing both a thione and thiol tautomeric form of the ligand. The infrared spectra 
of [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O and the corresponding free ligand, 5-
chlorosalicylaldehyde 4-methylthiosemicarbazone, are given in the appendix. In contrast to the ferric 
complex spectrum, the infrared spectrum of the ligand 5-chlorosalicylaldehyde 4-
methylthiosemicarbazone shows a νOH peak at 3397 cm-1 which indicates the presence of the OH 
group of the phenol. As the ligand binds to the central metal FeIII ion, it is possible for the tridentate 
ligand to be present in the anionic and dianionic form. The anionic ligand is singly deprotonated at 
the phenolate-O atom and the dianionic ligand is doubly deprotonated thus no hydrogen atom would 
be located at the phenolate-O or thiolate-S atoms. The present ferric complex contains both the 
anionic and dianionic form of the ligand, subsequently the vibration of the OH group of the phenol 
is not present in the ferric complex spectrum as expected. The deprotonation of the phenolate-O atom 
after complexation to the metal ion is also supported by the shift of the frequency of the νC–O band 
from 1100 cm-1 to 1315 cm-1, in the ligand to the ferric complex, respectively [18, 21]. The positive 
shift of the νC–O band frequency indicates the coordination of the FeIII ion to the phenolate-O atom. 
The azomethine nitrogen atom is confirmed to have coordinated to the metal ion due to the shift of 
the C=N band from 1604 cm-1 in the free ligand to 1600 cm-1 in the complex [18, 21, 37]. The absence 
of the S–H bond in the range 2600-2800 cm-1 in the infrared spectrum of the ligand, indicates the 
ligand is present in the thione form, which is confirmed by the vibration at 1182 cm-1 which 
corresponds to the CS band [18, 21, 37]. Furthermore, the coordination of the S atom to the FeIII ion 
is corroborated by the shift of the C–S band to 815 cm-1 in the ferric complex from 1028 cm-1 νCS 
with regards to the free ligand [37].  
 
4.4.4 Magnetic properties of [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O 
The temperature dependence of the χMT product (χM being the molar magnetic susceptibility and T, 
the temperature) for [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O was measured in the temperature 
range 5-320 K and is presented in Figure 4.4.4. The magnetic properties of the present compound 
reveal a rare two-step spin transition between low-spin (S = 1/2) and high-spin (S = 5/2) states of the 
FeIII ion, with an observed hysteresis effect. The value of χMT is 3.80 cm3 mol-1 K at 320 K, which 
corresponds to the expected value of high-spin FeIII, χMT = 4.37 cm3 mol-1 K (g = 2.00). Furthermore, 
at 100 K, the magnetic properties of [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O indicate that the 
value of χMT (0.65 cm3 mol-1 K) is slightly higher than the value expected for a low-spin FeIII ion, 
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χMT = 0.375 cm3 mol-1 K for g = 2.00. The transition temperatures of the two steps are centered at 
temperatures of T1/2(S1)↑ = 249 K and T1/2(S2)↑ = 277 K (where S1 and S2 represent the spin transition 
temperature of step 1 and step 2, respectively), respectively, and T1/2(S1)↓ = 240 K and T1/2(S2)↓ = 271 
K, respectively. These values give rise to a thermal hysteresis for T1/2(S1) and T1/2(S2) of about 9 K and 
6 K, respectively. 
 
Figure 4.4.4 χMT vs T plot of [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]·H2O. The sample was warmed 
(▲) and then subsequently cooled (▼) in the temperature region of 5–320 K, at a rate of 2 K min-1. 
 
The DSC curves of [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]·H2O is displayed in Figure 4.4.5. The DSC 
curves displays a peak at T↓ = 242 and 269 K in the cooling mode and T↑ = 247 and 274 K in the 
heating mode. The data corroborates with the temperature dependent magnetic susceptibility data in 
that the ferric complex exhibits a two-step spin transition.  
 
Figure 4.4.5 DSC curves obtained for [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]·H2O in the temperature 
range  200-350 K, measured at a scan rate of 5 K min-1. 
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4.5 Discussion 
This chapter reported the structural characterisation and magnetic behaviour of three novel 
mononuclear FeIII compounds, containing a one-fold and a two-fold deprotonated R-salicylaldehyde 
4R’-thiosemicarbazone ligand. The aim of this study is to attempt to construct correlations between 
the steric and electronic effects imposed by the R- and R’-substituents of the ligands to the FeIII ions 
and the magnetic properties observed. The structures of [Fe(H-thsa-Me)(thsa-Me)]·H2O, [Fe(H-3-
OEt-thsa-Me)(3-OEt-thsa-Me)]·H2O and [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]·H2O consist of an 
FeIIIO2N2S2 chromophore which is formed by a chelating tridentate anionic R-salicylaldehyde 4R’-
thiosemicarbazonato(1-) ligand and a dianionic R-salicylaldehyde 4R’-thiosemicarbazonato(2-) 
ligand. The FeIIIO2N2S2 chromophore exhibits a distorted octahedral geometry, where the O- and S-
donor atoms are in the cis positions and the N-donor atoms are in the trans positions. It should be 
noted that for the isostructural compounds, [Fe(H-thsa-Me)(thsa-Me)]·H2O and [Fe(H-5-Cl-thsa-
Me)(5-Cl-thsa-Me)]·H2O the ligands coordinated to the FeIII atom are related by symmetry. 
Interestingly, the two compounds [Fe(H-thsa-Me)(thsa-Me)]·H2O and [Fe(H-5-Cl-thsa-Me)(5-Cl-
thsa-Me)]·H2O are chiral, although this is a rare occurrence due to the fact that no chiral compounds 
were used in the synthesis of the ferric complexes to induce chirality. The Fe-donor atom bond 
distances of the [Fe(HL)(L)]·H2O compounds described in this chapter are listed in Table 4.5.1. 
The compounds [Fe(H-thsa-Me)(thsa-Me)]·H2O and [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]·H2O at 
100 K both contain a FeIII cation in the low-spin state, whereas the FeIII cation in [Fe(H-3-OEt-thsa-
Me)(3-OEt-thsa-Me)]·H2O is high-spin at 100 K.  
In the following, the crystallographic data of [Fe(H-thsa-Me)(thsa-Me)]·H2O, [Fe(H-3-OEt-thsa-
Me)(3-OEt-thsa-Me)]·H2O and [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]·H2O will be compared to 
similar FeIII bis(ligand) compounds reported in the literature (listed in Table 4.5.2) in an attempt to 
correlate the structural features of these materials with the spin state of the FeIII cation. Table 4.5.2 
shows the Fe-donor atom bond distances of the [Fe(HL)(L)]∙H2O type compounds together with the 
spin state of the FeIII cation at the temperature at which the crystal structure was determined.  
The compounds [Fe(H-thsa)(thsa)]·H2O and [Fe(H-5-Cl-thsa)(5-Cl-thsa)]·H2O at 293 K both 
contain a FeIII cation in the high-spin state [20]. The FeIII cation in [Fe(H-5-Br-thsa)(5-Br-thsa)]·H2O 
is high-spin at 303 K and low-spin at 123 K [18]. Furthermore, in the compound [Fe(H-5-Cl-thsa-
Me)(5-Cl-thsa-Me)]·H2O the FeIII cation is in the low-spin state at 110 K and in the high-spin state 
at 293 K [21]. 
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Table 4.5.1 Selected crystallographic data and spin state for [Fe(HL)(L)]∙H2O type complexes of R-
salicylaldehyde 4R’-thiosemicarbazone ligands described in this chapter. 
Compoundi Tii 
(K) 
Space 
group  
Fe–S 
(Å) 
Fe–N 
(Å) 
Fe–O 
(Å) 
Spin 
Stateiii 
[Fe(H-thsa-Me)(thsa-Me)]·H2Oiv 
 
100 Aea2 2.249(2) 
2.249(2) 
 
1.946(5) 
1.946(5) 
1.932(5) 
1.932(5) 
LS 
[Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]·H2Ov 
 
100 P-1 2.473(4) 
2.442(4) 
2.482(2) 
2.417(4) 
2.168(10) 
2.085(10) 
2.416(5) 
2.096(11) 
1.939(4) 
1.996(9) 
1.958(5) 
1.994(8) 
 
Fe1 
HS 
Fe11 
HS 
[Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]·H2Oiv 100 Aea2 2.255(3) 
2.255(3) 
1.969(6) 
1.969(6) 
1.951(7) 
1.951(7) 
LS 
i The ligands are defined as follows: salicylaldehyde 4-methylthiosemicarbazone = H2-thsa-Me (H2L 
form), 3-ethoxysalicylaldehyde 4-methylthiosemicarbazone = H2-3-OEt-thsa-Me (H2L form) and 5-
chlorosalicylaldehyde 4-methylthiosemicarbazone = H2-5-Cl-thsa-Me (H2L form); in the case that 
there are different ligands coordinated to the Fe atom, the geometric parameters involving each 
ligand (HL and L) are given in separate lines. 
ii T represents the measurement temperature.  
iii The spin states are defined as low-spin (LS) and high-spin (HS). 
iv FeIII donor atom bond distances are an average for the one-fold and two-fold deprotonated ligand 
forms, due to the ligands being related by the symmetry operation: –x + 1, –y + 1, z. 
v Compound contains two crystallographically independent Fe sites (Fe1 and Fe11). 
 
As significant changes in the electronic state of FeIII bis(ligand) compounds may arise from the 
associated R- and R’-substituents of the ligand; in addition to the steric effects we may consider the 
electronic effects imposed by the position on a particular R-group on the salicylaldehyde moiety. 
Dependent upon the R-group and the position of the R-group on the benzene ring, the R-group may 
be electron withdrawing or an electron donating group, which may affect the phenolate C–O bond 
length, whereby the phenolate O-atom is bound to the central metal ion, FeIII. As the bond distances 
of the Fe-donor atoms may reveal what spin state the FeIII cation may exhibit (in a specific 
temperature range), it may be stated that the position of the R-group and the type of R-group of the 
benzene ring may affect whether the ferric complexes exhibit an spin transition. Although, it must 
be duly noted that the Fe–O bond distances seem to be less sensitive to change in FeIII spin state than 
Fe–N and Fe–S bond distances, which may be related to the π-acceptor capability of the N- and S-
donor atoms opposed to the π-donor capability of the O-donor atoms. This is of particular 
significance when the FeIII is in the low-spin state, as increased π back-bonding will lead to 
comparatively more pronounced shortening of the Fe–N and Fe–S bonds than of the Fe–O bonds.  
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Table 4.5.2 Selected Fe-donor atom bond distances and spin state for [Fe(HL)(L)]∙H2O type 
complexes of R-salicylaldehyde 4R’-thiosemicarbazone ligands described in the literature. 
Compoundi Tii 
(K) 
Space 
group  
Fe‒S 
(Å) 
Fe‒N 
(Å) 
Fe‒O  
(Å) 
Spin 
Stateiii 
[Fe(H-thsa)(thsa)]∙H2O [20] 293 
 
P21/n 2.444(7) 
2.370(7) 
 
2.111(6) 
2.166(6) 
1.927(5) 
1.894(5) 
HS 
[Fe(H-5-Cl-thsa)(5-Cl-thsa)]∙H2O [20] 293 
 
P21/n 2.386(13) 
2.346(13) 
 
2.210(11) 
2.118(12) 
1.920(17) 
1.902(16) 
HS 
[Fe(H-5-Br-thsa)(5-Br-thsa)]∙H2O [18] 303 
 
123 
P21/n 
 
P21/n 
2.4845(18) 
2.4177(19) 
2.2718(17) 
2.2463(17) 
2.153(4) 
2.131(4) 
1.952(5) 
1.955(4) 
1.969(4) 
1.952(4) 
1.941(4) 
1.949(4) 
 
HS 
 
LS 
 
[Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O 
[21] 
293 
 
110 
Cc 
 
Cc 
2.453(4) 
2.391(4) 
2.2566(16) 
2.2389(150 
2.124(9) 
2.11(10) 
1.948(5) 
1.993(5) 
1.937(9) 
1.916(9) 
1.933(4) 
1.940(4) 
HS 
 
LS 
i The ligands are defined as follows: salicylaldehyde thiosemicarbazone = H2thsa (H2L form), 5-
chlorosalicylaldehyde thiosemicarbazone = H2-5-Cl-thsa (H2L form), 5-bromosalicylaldehyde 
thiosemicarbazone = H2-5-Br-thsa (H2L form) and 5-chlorosalicylaldehyde 4-
methylthiosemicarbazone = H2-5-Cl-thsa-Me (H2L form); in the case that there are different ligands 
coordinated to the Fe atom, the geometric parameters involving each ligand (HL and L) are given in 
separate lines. 
ii T represents the measurement temperature.  
iii The spin states are defined as low-spin (LS) and high-spin (HS). 
 
In the following, the electronic and steric effects of the R and R’-substituents of the R-
salicylaldehyde 4R’-thiosemicarbazone ligand on the magnetic properties of the ferric complexes 
will be discussed, as well as the affects imposed by the R, R’-substituents intermolecular interactions 
formed between the FeIII units.  
 
4.5.1 Electronic effects of R and R’-substituents of the R-salicylaldehyde 4R’-
thiosemicarbazone ligand 
Studies conducted by Zelentsov et al., [10] revealed that replacing the H atom (R-substituent) of 
carbon atom 5 (illustrated in Figure 4.5.1) of the benzene ring of salicylaldehyde may lead to 
significant changes in the magnetic properties of the ferric bis(ligand) compounds. The transition 
from the low-spin (S = 1/2) to the high-spin (S = 5/2) state is governed by the energy difference 
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between these two electronic states; this energy gap can be tuned by the variation of the ligand field 
strength, which can be influenced by the R-group of the benzene ring, as the transfer of electronic 
properties of the substituent through the benzene ring is enabled by the π-delocalisation in this ring 
[10].  
If one considers the influence of the inductive effect caused by various R-substituents, the R-
substituents can be organised according to the magnitude of electron density that is withdrawn or 
donated to the benzene ring via electron withdrawing groups and electron donating groups, 
respectively. The following list of groups show the magnitude of inductive effects in different 
substituents: 
(i) Decreasing order of electron withdrawing effect of these substituents: 
R3N+ > NO2 > CN > F > Cl > OH > OCH3 > Br > I > -CH=CH2 
(ii) Decreasing order of electron donating effect of these substituents: 
-O > (CH3)3C- > (CH3)2CH- > CH3CH2- > CH3- 
 
Figure 4.5.1 Atom labelling of the benzene ring of the R-salicylaldehyde 4R’-thiosemicarbazone 
ligand. 
 
Zelentsov and co-workers found that the substituents studied for FeIII bis(ligand) compounds 
containing two dianionic R-salicylaldehyde 4R’-thiosemicarbazone(2-) ligands, whereby the R-
substituent replaces the H atom of the carbon atom 5 (illustrated in Figure 4.5.1), have been 
categorised in the following sequence according to the capability of favouring low-spin state of FeIII: 
NO2 > H > CH3 > Cl > Br [10].  
The compounds reported in this chapter, [Fe(H-thsa-Me)(thsa-Me)]·H2O, [Fe(H-3-OEt-thsa-Me)(3-
OEt-thsa-Me)]·H2O and [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]·H2O (listed in Table 4.5.1), contain 
the R-substituents, R = H, R = 3-OEt and R = 5-Cl, respectively, and all of the compounds contain 
the R’-substituent, R’ = Me. In accordance with the sequence of the capability of favouring low-spin 
state of FeIII in ferric bis(R-salicylaldehyde 4R’-thiosemicarbazone) compounds, the three novel 
compounds reported have been categorised in the following sequence: H > Cl > -OEt. An attempt to 
reveal the electronic effect of the R-substituents are accounted for by the Hammett constants (normal 
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σn values) of the R group of the R-salicylaldehyde 4R’-thiosemicarbazone ligand system, R = H 
where σn = 0.00, R = 3-OEt where σn = 0.10, and R = 5-Cl where σn = 0.37 []. Typically it has been 
found that for coordination complexes the higher the spin transition temperature, the larger the 
electron withdrawing effect, which is corroborated by the linear relationship between the Hammett 
parameter (σn) and the spin-transition temperature (T1/2). For the series of compounds containing 
both the anionic and dianionic R-salicylaldehyde 4R’-thiosemicarbazone ligand, the complex with 
R = 3-OEt remains in the high-spin state, where R = H no spin transition is observed and for the 
compound containing R = 5-Cl, the complex exhibits a rare two-step spin transition. It could be 
suggested that electron donating groups could stabilise the high spin state with the addition of the 
steric hindrance the ortho-OEt R-substituents presents, i.e. the π-back bonding decreases, whilst the 
electron withdrawing groups (R = H, or Cl) results in increasing π-back bonding and decreasing in 
the σ-bonding in the Fe-O(R-thsa-R’) bond. As a result of increased π-back bonding, the larger the 
π-acceptor properties of the Fe-donor atom bonds are, subsequently giving rise to softer acidity of 
the FeIII ion. Consequently, the FeIII ion is more likely to adopt the low-spin FeIII electronic 
configuration, as well as a higher spin-crossover temperature (T1/2)  dependent upon the R-
substituent. Similar compounds reported in the literature such as [Fe(H-thsa)(thsa)]∙H2O [20], [Fe(H-
5-Cl-thsa)(5-Cl-thsa)]∙H2O [20] and [Fe(H-5-Br-thsa)(5-Br-thsa)]∙H2O [18] (spin state and T1/2 
displayed in Table 4.5.2 and 4.5.3, respectively), also show the similar trend between the Hammett 
parameter and the electron withdrawing effect, with respect to favouring the low-spin state. In this 
series of compounds and similar FeIII compounds reported in the literature [18,20], the electronic 
effect on the spin-crossover behaviour of the R-groups suggests that the larger the electron 
withdrawing effect the lower the T1/2 which is corroborated by the linear relationship between T1/2 
and the Hammett parameters H (0.00) > 5-Cl (0.37) > 5-Br (0.39).  
 
4.5.2 Steric effects of R- and R’-substituents of the R-salicylaldehyde 4R’-thiosemicarbazone 
ligand 
In an attempt to correlate the structural features of the R-salicylaldehyde 4R’-thiosemicarbazone 
ligands to the FeIII spin-state, one needs to consider the introduction of the substituents into the 
benzene ring of the salicylaldehyde moiety or the integration of a substituent into the thioamide of 
the thiosemicarbazone moiety. The compounds reported in this chapter, [Fe(H-thsa-Me)(thsa-
Me)]·H2O, [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]·H2O and [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-
Me)]·H2O (listed in Table 4.5.1), contain the R-substituents, R = H, R = 3-OEt and R = 5-Cl, 
respectively, and all of the compounds contain the R’-substituent, R’ = Me. The related FeIII 
bis(ligand) compounds displayed in Table 4.5.2 contain the following R- and R’-substituents, [Fe(H-
thsa)(thsa)]·H2O, R and R’ = H, [Fe(H-5-Cl-thsa)(5-Cl-thsa)]·H2O, R = 5-Cl and R’ = H, [Fe(H-5-
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Br-thsa)(5-Br-thsa)]·H2O, R = 5-Br and R’ = H, [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]·H2O, R = 5-
Cl and R’ = Me. Firstly, we consider the influence of the substituent R-group on the benzene ring on 
the magnetic behaviour of the ferric complexes, as this is the main difference between the 
compounds discussed in this chapter and the compounds listed in Table 4.5.2. The R-substituents 
present in the ferric complexes listed in Tables 4.5.1 and 4.5.2, R = H, -5-Cl, -5-Br or –3-OEt all 
have an electron withdrawing effect on the benzene ring of the salicylaldehyde moiety. It would 
appear that the R-substituents R = –H, -5-Cl or -5-Br, facilitate an increase in ∆o (octahedral crystal 
field splitting parameter) and assist the FeIII cation to exhibit a spin transition, as shown by 
compounds [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]·H2O (Chapter IV), [Fe(H-thsa)(thsa)]∙H2O [20], 
[Fe(H-5-Cl-thsa)(5-Cl-thsa)]∙H2O [20] and [Fe(H-5-Br-thsa)(5-Br-thsa)]∙H2O [18]. The presence of 
the R-substituent at the 5-position of the salicylaldehyde moiety impacts the operating temperature 
of the spin transition, in this case the ability of the R-substituents R = –H, -5-Cl or -5-Br to increase 
Δo can be arranged in the following sequence: -H > -5-Cl > -5-Br [18, 20]. However, the presence 
of the R-substituent (R = H or –3-OEt) does not facilitate an increase in the Δo in order to generate 
a spin transition for the reported spin-crossover inactive compounds [Fe(H-thsa-Me)(thsa-Me)]·H2O 
and [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]·H2O. It could be suggested that the replacement of the 
H atom with the methyl group on the terminal nitrogen atom of the thiosemicarbazone moiety has 
both electronic and steric effects on the spin-crossover behaviour of these two compounds. The 
integration of the R’ = Me within the thiosemicarbazone moiety for the spin-crossover compound 
[Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]·H2O [Chapter IV, 21] reveals that the temperature at which the 
transition occurs is much higher than that observed for spin-crossover compounds with R’ = H; the 
spin-transition temperatures are listed in Table 4.5.3. Furthermore, the obvious steric interactions 
induced by the presence of the halogen at 5-position of the R-salicylaldehyde fragment causes the 
spin-state transition to operate at lower temperature, thereby affecting the temperature at which the 
spin transition occurs.  
By comparison, for the low-spin [Fe(H-thsa-Me)(thsa-Me)]·H2O, the FeIII-donor atom bond 
distances are 2.249(2) Å (Fe–S), 1.946(5) Å (Fe–N) and 1.932(5) Å (Fe–O) at 100 K, while at the 
same temperature, for [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]·H2O the coordination bond distances 
for the anionic ligand (H-3-OEt-thsa-Me) are Fe1–O1 = 1.939(4) Å and Fe11–O201 = 1.958(5) Å; 
Fe1–S1 = 2.473(4) Å and Fe11–S201 = 2.482(2) Å; and Fe1–N1 = 2.168(10) Å and Fe11–N201 = 
2.146(5) Å, severally. Furthermore, the Fe–O, Fe–S and Fe–N bond distances for the dianionic ligand 
(3-OEt-thsa-Me) are Fe1–O101 = 1.996(9) Å and Fe11–O301 = 1.994(8) Å; Fe1–S101 = 2.442(4) 
Å and Fe11–S301 = 2.417(4) Å; and Fe1–N101 = 2.085(10) Å and Fe11–N301 = 2.096(11) Å, 
severally.2.455 Å (Fe–S), 2.125 Å (Fe–N) and 1.975 Å (Fe–O), which are characteristic of a high-
spin species. It appears that the R-group could sterically prohibit the corresponding system [Fe(H-
3-OEt-thsa-Me)(3-OEt-thsa-Me)]·H2O to exhibit spin-crossover properties: it may be that the 3-
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ethoxy substituent group does not allow the contraction of the octahedron typically observed during 
the high-spin to low-spin transition. The hindered contraction of the octahedron could be caused by 
the positioning of the ethoxy group on the benzene ring, as the ethoxy group is bound at the carbon 
3 atom, which is next to the carbon atom bound to the phenolate-O donor atom. Moreover, the strong 
steric interactions of the “bulky” ethoxy group in the complex apparently prevents such shortening 
in the Fe-donor atom distances, so the FeIII ion remains in the high-spin state.  
 
Table 4.5.3 Transition temperatures (K) for selected spin-crossover [Fe(HL)(L)]·H2O compounds. 
Compoundi T½↑ii T½↓iii Ref 
[Fe(H-thsa)(thsa)]∙H2O 275 (1) 262 
(2) 232 
[20] 
[Fe(H-5-Cl-thsa)(5-Cl-thsa)]∙H2O 231 230 [20] 
[Fe(H-5-Br-thsa)(5-Br-thsa)]∙H2O (1) 148 
(2) 173 
(3) 194 
(4) 212 
(5) 245 
(1) 242 
(2) 238 
(3) 211 
(4) 194 
(5) 170 
(6) 144 
[18] 
[Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O (1) 249 
(2) 278 
(1) 270 
(2) 245 
[21] 
i The ligands are defined as follows: salicylaldehyde thiosemicarbazone = H2thsa (H2L form), 5-
chlorosalicylaldehyde thiosemicarbazone = H2-5-Cl-thsa (H2L form), 5-bromosalicylaldehyde 
thiosemicarbazone = H2-5-Br-thsa (H2L form) and 5-chlorosalicylaldehyde 4-
methylthiosemicarbazone = H2-5-Cl-thsa-Me (H2L form). 
ii Transition temperature in heating mode (K). NB: Multiple step transitions are numbered. 
iii Transition temperature in cooling mode (K). NB: Multiple step transitions are numbered. 
 
 
4.5.3 R- and R’-substituents as hydrogen bonding donor or acceptor atoms and π-π stacking 
interactions 
It would appear the steric and electronic features of either the R or R’-substituent may have an impact 
on the spin state of FeIII cations, and affect at which temperature the spin transition occurs. Moreover, 
the steric and electronic features may affect the degree of cooperativity between FeIII entities due to 
the packing arrangement of the FeIII units within the unit cell imposed by intermolecular interactions 
of the coordinated R-salicylaldehyde 4R’-thiosemicarbazone ligands. The R and/or R’-substituent 
may assist the intricate formation of hydrogen bonding networks as well as the possibility of the 
benzene rings forming π-π stacking interactions between the FeIII entities. It is evidenced throughout 
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that spin-crossover materials reported in the literature reveal that the symmetry and packing 
arrangements within the unit cell of these types of materials influence whether the materials exhibit 
a spin transition. It is recognised that in these type of spin-crossover systems strong cooperativity 
can be influenced by the packing arrangements of the FeIII entities within the unit cell. There are two 
possible features that may cause the behaviour of strong cooperativity: (i) the intermolecular π-π 
stacking interactions between the benzene rings of the salicylaldehyde fragment and (ii) the hydrogen 
bonding networks. In comparison to the low-spin compounds [Fe(H-thsa-Me)(thsa-Me)]∙H2O and 
[Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O and the high-spin compound [Fe(H-3-OEt-thsa-Me)(3-
OEt-thsa-Me)]∙H2O, it appears that the compounds listed in Table 4.5.2 exhibit π-π stacking and 
have extensive hydrogen bonding networks [18, 20-21]. In addition, if the hydrogen bonding 
network connecting the FeIII entities, involves a coordinating donor atom and/or an atom next to the 
FeIII donor atom, may cause an electronic effect, which could then prohibit the ferric complex to 
generate the spin conversion from the low- to high-spin state for FeIII. However, it is unclear at this 
stage how these particular features can be harnessed to induce a particular spin-state for FeIII.  
 
4.6 Conclusion 
In this chapter, three neutral ferric complexes, [Fe(H-thsa-Me)(thsa-Me)]∙H2O, [Fe(H-3-OEt-thsa-
Me)(3-OEt-thsa-Me)]∙H2O and [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O, were synthesised with 
the aim of ligand modification in an approach to tune spin-crossover properties of 
[FeIII(HL)(L)]∙xH2O type compounds. Single crystal X-ray crystallographic measurements at 100 K 
determined that the FeIII cations of the compounds [Fe(H-thsa-Me)(thsa-Me)]∙H2O and [Fe(H-5-Cl-
thsa-Me)(5-Cl-thsa-Me)]∙H2O were in the low-spin state and [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-
Me)]∙H2O was in the high-spin state. Magnetic measurements performed on these compounds 
evidenced that the two neutral compounds [Fe(H-thsa-Me)(thsa-Me)]∙H2O and [Fe(H-3-OEt-thsa-
Me)(3-OEt-thsa-Me)]∙H2O do not exhibit a temperature dependent spin transition in the temperature 
range 5-300 K, which was corroborated by the DSC measurements. A rare two-step spin-crossover 
was observed for the compound [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O in the temperature range 
5-320 K. Similar compounds have been reported in the literature by Yemeli Tido [20], Li et al., [18, 
21] and Floquet et al. [30] and have been compared to the three neutral compounds reported in this 
chapter. In an attempt to correlate the structural properties of these FeIII compounds and their 
corresponding R-salicylaldehyde 4R’-thiosemicarbazone ligands and the magnetic behaviours, the 
discussion’s main focus considered the ligand modification in terms of the electronic and steric 
effects caused by the variation of the R- and R’-substituents and how these features influenced the 
crystal packing and the magnetic behaviour exhibited by the ferric complexes. It has been recognised 
that the increased steric interactions induced by the presence of the R-substituents, R = -5-Cl or -5-
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Br of the R-salicylaldehyde moiety cause the spin-state transition to operate at lower temperature. 
Moreover, the introduction of R’ = Me to the thiosemicarbazone moiety for the spin-crossover 
compound [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]·H2O reveals the spin-state transition operates at a 
higher temperature than the transition temperature observed for spin-crossover compounds with R’ 
= H. The low-spin compound [Fe(H-thsa-Me)(thsa-Me)]·H2O exhibits an incomplete spin-transition 
in the temperature range 5-400 K; it could be suggested that the presence of the R’ = Me causes 
electronic and steric effects which prevent the full spin-state conversion from the low-spin to the 
high-spin state.  Furthermore, for the spin-crossover inactive compound [Fe(H-3-OEt-thsa-Me)(3-
OEt-thsa-Me)]∙H2O, the electronic effects and the steric interactions of both the R and R’-
substituents (R = -3-OEt and R’ = Me) do not allow the contraction of the FeO2N2S2 octahedron 
typically observed during the high-spin to low-spin transition, so as observed in the magnetic 
behaviour,  the ferric complex remains in the high-spin state in temperature range 5-300 K. In order 
to develop a strategy to tune this type of ferric complex to exhibit a temperature dependent spin 
transition, it is evident a larger number of magnetic measurements and analysis of crystallographic 
data will be required.  
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5.0 Cationic Fe(III) Complexes of R-salicylaldehyde 4R’-thiosemicarbazones 
5.1 Introduction 
In the preceding chapters, the magnetic behaviour of (cation+)[Fe(L2‒)2]·x(solvent) (Chapter III) and 
[Fe(HL‒)(L2‒)]·H2O (Chapter IV) type compounds were investigated on the basis of the structural 
data collected for each reported system. The structural and magnetic studies of the (cation+)[Fe(L2‒
)2]·x(solvent) and [Fe(HL‒)(L2‒)]·H2O compounds demonstrated that the nature of the spin state of 
FeIII ion is strongly influenced by different structural parameters. Thus far, studies focused on the 
FeIII bis(R-salicylaldehyde 4R’-thiosemicarbazone) compounds have shown that the spin-crossover 
behaviour, the conversion from the low-spin (S = 1/2) state to the high-spin (S = 5/2) state, may be 
harnessed by the following structural parameters: the variation of the counter cation, the degree of 
deprotonation of the ligand, the integration of different R- and R’-substituents to the salicylaldehyde 
and thiosemicarbazone moieties, respectively, and the solvation of the FeIII bis(ligand) complexes 
[1-12]. Furthermore, comparing the crystal structures of the (cation+)[Fe(L2‒)2]·x(solvent)  and 
[Fe(HL‒)(L2‒)]·H2O type compounds reported in Chapter III and Chapter IV, respectively, to similar 
compounds reported in this research area [1-12], revealed that the different behaviours in magnetic 
properties of the FeIII bis(R-salicylaldehyde 4R’-thiosemicarbazone) compounds may be due to the 
variation of significant intermolecular interactions such as hydrogen bonding in the system and 
whether the complexes are linked by π-π stacking interactions, thus  giving rise to the modulation of 
the cooperativity in the R-salicylaldehyde 4R’-thiosemicarbazone containing compounds.  
In this context, changing the degree of deprotonation of the ligand, the type of R- and R’-substituents 
of the ligand, and the type of anion present in the crystal lattice, may alter the supramolecular 
assembly of the FeIII entities in the lattice and therefore the cooperativity of the spin-crossover 
behaviour of the FeIII entities, and with it the magnetic behaviour of the FeIII bis(ligand) complexes.  
In this chapter, the crystallographic structures (at 100 K) and magnetic properties of [Fe(H-5-Br-
thsa-Et)2](NO3)·H2O and [Fe(H-4-OH-thsa)2]4·(SO4)2·9H2O are reported. The ligands used to 
generate these ferric compounds are displayed in Figure 5.1.1. The effect of the anion, the R- and 
R’-substituents and the degree of solvation on the magnetic properties of the two [Fe(HL‒)2](anion‒
)·xH2O type compounds will be discussed, and will propose the structural impact of the ligand 
modification, anion variation and degree of solvation on the magnetic behaviour of these two 
[Fe(HL‒)2](anion‒)·xH2O type compounds.  
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Figure 5.1.1 Molecular structure of the R-salicylaldehyde 4R’-thiosemicarbazone ligands (i) H2-5-
Br-thsa-Et and (ii) H2-4-OH-thsa  
 
5.2 The crystal structure and magnetic properties of [Fe(H-5-Br-thsa-Et)2](NO3)∙H2O 
The magnetic properties are herein reported of the novel FeIII compound [Fe(H-5-Br-thsa-
Et)2](NO3)∙H2O containing two anionic tridentate 5-bromosalicylaldehyde 4-
ethylthiosemicarbazonate(1−) (HL─) ligands and the determination and description of its structure at 
100 K. Furthermore, the infrared spectroscopic studies of the free ligand and ferric complex are 
discussed. 
The experimental data is reported in Chapter II for the synthesis of [Fe(H-5-Br-thsa-Et)2](NO3)∙H2O 
and corresponding ligand, 5-bromosalicylaldehyde 4-ethylthiosemicarbazone.  
 
5.2.1 Crystal Data and Structure Refinement Details of [Fe(H-5-Br-thsa-Et)2](NO3)∙H2O 
Crystal data, data collection and structure refinement details are summarised in Table 5.2.1. The 
hydrogen atoms H10B and H10A of the water solvent molecule form hydrogen bonds with the O202 
atom of the nitrate anion and the O11 phenolate donor atom, respectively; these bond distances were 
restrained by using the DFIX command to fix the geometry of the unbound nitrate anion and the 
solvent water molecule. The other hydrogen atoms were included in the refinement in calculated 
positions, and riding on their parent atoms, with N‒H = 0.88 Å and Uiso(H) = 1.2Ueq(N), C‒H = 0.95 
Å and Uiso(H) = 1.2Ueq(C), C‒H = 0.99 Å and Uiso(H) = 1.2Ueq(C), C‒H = 0.98 Å and Uiso(H) = 
1.5Ueq(C) for the amide (N‒H), methine  (-CH=), methylene (-CH2-) and methyl (-CH3) hydrogen 
atoms, severally. Additional details towards the structure refinement of [Fe(H-5-Br-thsa-
Et)2](NO3)∙H2O are as follows: SMTBX solvent masking routine as implemented within Olex2 was 
used to mask residual electron density from unidentified solvent [13].  
The program used for the structure solution: SUPERFLIP [15]; the structure refinement used the 
program SHELXL-2014 [16]. The OLEX2 [13] and ORTEP-3 for Windows [17] programs were 
used to produce the molecular graphics. 
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Table 5.2.1 Crystal data and structure refinement details of [Fe(H-5-Br-thsa-Et)2](NO3)∙H2O 
Crystal data 
Chemical formula [Fe(H-5-Br-thsa-Et)2](NO3)∙H2O 
Mr 738.35 
Crystal system, space group Orthorhombic, Pnna 
Temperature (K) 100 
a, b, c (Å) 12.3654(4), 23.2809(6), 19.6468(7) 
α, β, γ (°) 90, 90, 90 
V (Å3) 5655.9(3) 
Z 8 
Radiation type Mo Kα 
µ (mm−1) 3.555 
Crystal size (mm) 0.19 x 0.01 x 0.01 
Data collection 
Diffractometer Rigaku AFC12 four-circle Kappa 
diffractometer 
Absorption correction Multi-scan (CrysAlisPro [14]) 
Tmin, Tmax 0.67549, 1.000 
No. of measured, independent and  
observed [I > 2σ(I)] reflections 
13173, 6540, 4299 
Rint 0.0888 
Refinement 
R[F2 > 2σ(F2)], wR(F2), S 0.0599, 0.1397, 1.045 
No. of reflections 6540 
No. of parameters 348 
No. of restraints 2 
H-atom treatment H atoms treated by a mixture of 
independent and constrained refinement 
Δρmax, Δρmin (e Å−3) 0.647, -0.847 
 
5.2.2 Crystallographic study of [Fe(H-5-Br-thsa-Et)2](NO3)∙H2O 
The crystal structure of bis(5-bromosalicylaldehyde 4-ethylthiosemicarbazonato(1-)-κ3-
O,N1,S)ferrate(III) nitrate monohydrate, [Fe(H-5-Br-thsa-Et)2](NO3)∙H2O (Figure 5.2.1), was 
determined at 100 K. The present compound crystallises in the orthorhombic system in the space 
group Pnna. The asymmetric unit is comprised from the [Fe(H-5-Br-thsa-Et)2]+ fragment, nitrate 
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anion and a water solvent molecule. Selected geometric parameters are given in Table 5.2.2. The 
FeIII cation is coordinated by two singly deprotonated thione O,N,S-ligands. The FeIIIO2N2S2 unit 
displays a distorted octahedral geometry, as corroborated by the bond angles of the donor atoms and 
Fe1 atom. The 5-bromosalicylaldehyde 4-ethylthiosemicarbazonate(1-) ligands are deprotonated at 
the phenolate-O atoms.  
 
Figure 5.2.1 The molecular structure and atom-numbering scheme for [Fe(H-5-Br-thsa-
Et)2](NO3)∙H2O. Displacement ellipsoids are drawn at the 50% probability level.  
 
Table 5.2.2 Selected geometric parameters of [Fe(H-5-Br-thsa-Et)2](NO3)∙H2O (Å, °) 
Fe1–S11 2.4406(15) Fe1–S21 2.4635(15) 
Fe1–O11 1.958(4) Fe1–O21 1.945(3) 
Fe1–N11 2.175(4) Fe1–N21 2.162(4) 
    
S11–Fe1–S21 98.78(5) O11–C12–C11 123.1(5) 
S11–Fe1–N11 78.94(11) C12–C11–C17 123.9(5) 
S11–Fe1–O11 158.08(11) C11–C17–N11 125.3(5) 
S11–Fe1–O21 89.97(11) C17–N11–Fe1 126.5(3) 
S11–Fe1–N21 88.36(11) Fe1–O21–C22 134.6(3) 
S21–Fe1–O11 92.88(11) O21–C22–C21 121.1(4) 
S21–Fe1–O21 160.34(11) C22–C21–C27 123.6(4) 
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Table 5.2.2 Selected geometric parameters of [Fe(H-5-Br-thsa-Et)2](NO3)∙H2O (Å, °) (continued) 
S21–Fe1–N11 84.91(11) C21–C27–N21 125.7(4) 
S21–Fe1–N21 78.97(11) C27–N21–Fe1 126.1(3) 
O11–Fe1–O21 84.98(15) C18–S11–Fe1 99.87(18) 
O11–Fe1–N11 83.71(15) N11–N12–C18 120.2(4) 
O11–Fe1–N21 112.17(15) N12–C18–S11 121.4(4) 
O21–Fe1–N11 114.18(15) C28–S21–Fe1 99.53(18) 
O21–Fe1–N21 83.74(14) N21–N22–C28 121.1(4) 
N11–Fe1–N21 157.72(15) N22–C28–S21 121.1(4) 
Fe1–O11–C12 134.9(3)   
 
The Fe1 donor atom distances involving the two tridentate anionic H-5-Br-thsa-Et ligands are Fe1–
S11 = 2.4406(15) Å, Fe1–S21 = 2.4635(15) Å, Fe1–O11 = 1.958(4) Å, Fe1–O21 = 1.945(3) Å, Fe1–
N11 = 2.175(4) Å and Fe1–N21 = 2.162(4) Å. The Fe-donor atom bond distances suggest that the 
FeIII cation in the present compound is in the high-spin state at 100 K. Typical distances for Fe–S, 
Fe–O and Fe–N bonds are 2.23-2.31, 1.93-1.95 and 1.88-1.96 Å, respectively, for low-spin FeIII 
compounds of this family, and 2.40-2.44, 1.96-1.99 and 2.05-2.15 Å, respectively, for the 
corresponding high-spin FeIII compounds [18].  
The tridentate ligands in the present compound coordinate to the FeIII cation to give rise to a 
FeIIIO2N2S2 octahedral environment, forming six- and five-membered chelate rings. The values of 
the root-mean-square deviations from the least-squares planes of the atoms comprising the five 
membered [Fe1 N11 N12 C18 S11] and [Fe1 N21 N22 C28 S21] chelate rings are 0.072 Å and 0.007 
Å, respectively; the corresponding values for the six-membered [Fe1 N11 C17 C11 C12 O11] and 
[Fe1 N21 C27 C21 C22 O21] chelate rings are 0.073 Å and 0.103 Å, respectively. These geometric 
features are associated with O11–Fe1–N11 and O21–Fe1–N21 bite angles of 83.71(15)° and 
83.74(14)°, respectively; as expected the six-membered chelate ring’s bite angles are larger than the 
values of the five-membered chelate ring’s bite angles of S11–F1–N11 = 78.94(11)° and S21–Fe1–
N21 = 78.97(11)°. The conformation of the five- and six-membered chelate rings of [Fe(H-5-Br-
thsa-Et)2](NO3)∙H2O illustrates there is no major puckering. 
5-Bromosalicylaldehyde 4-ethylthiosemicarbazone appears to be in its thione form, i.e. it is 
deprotonated at the phenolate-O atoms (O11 and O21) and possesses a hydrogen atom on the 
hydrazinic nitrogen atoms (N12 and N22). The protonation of the hydrazinic N atoms (N12 and N22) 
confirms the presence of the thione form of the tautomer which is corroborated by the C=S bond 
distances of the 5-bromosalicylaldehyde 4-ethylthiosemicarbazonate(1-) ligands, as they are closer 
to a bond order of two. The C–S bond distances are C18–S11 = 1.686(5) Å and C28–S21 = 1.696(5) 
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Å. Furthermore, the N–N and C–N bond distances indicate there is electron delocalisation over the 
5-membered chelate in both ligands coordinated to the FeIII cation.  These bond distances give rise 
to a bond order more than one, i.e. the N11–N12 and N21–N22 bond distances are 1.395(6) Å and 
1.374(5) Å, respectively, and the N12–C18 and N22–C28 bond distances are 1.351(6) Å and 
1.352(6) Å, respectively.  
The hydrogen bonding interactions of [Fe(H-5-Br-thsa-Et)2](NO3)∙H2O are listed in Table 5.2.3 and 
displayed in Figure 5.2.2. The nitrate anion is involved in hydrogen bonding interactions with the 5-
bromosalicylaldehyde 4-ethylthiosemicarbazonate(1-) ligand.  These hydrogen bonding interactions 
include the terminal nitrogen atoms N13 and N23 forming contacts with the oxygen atoms of the 
nitrate anion, O203i (i = x + 1, –y + 1/2, –z + 3/2) and O201 atoms, respectively. The nitrogen atom 
N12 forms a contact N12–H12···O202i (i = x + 1, –y + 1/2, –z + 3/2) with the oxygen atom O202i 
of the nitrate anion. Also, the nitrate anion forms a hydrogen bonding interaction with the oxygen 
atom O101 of the water solvent molecule. The nitrate anion is involved in two hydrogen bonding 
ring systems which connect the FeIII units. The first ring system is formed between two FeIII units, 
two water solvent molecules and a nitrate anion. The ring system is formed by the following contacts 
N12–H12∙∙∙O202i (i = x + 1, –y + 1/2, –z + 3/2), O101–H10B∙∙∙O202iii (iii = x, –y + 1/2, –z + 3/2), 
O101–H10A∙∙∙O11ii (ii = x – 1/2, y, –z + 1), and N22–H22∙∙∙O101, giving rise to a R54(18) ring 
system. Furthermore, the second ring system is created by the contacts N12–H12∙∙∙O202i and N13–
H13∙∙∙O203i (i = x + 1, –y + 1/2, –z + 3/2), giving rise to a R22(8) ring system.  
 
Figure 5.2.2 A projection showing the hydrogen bonding interactions of [Fe(H-5-Br-thsa-
Et)2](NO3)∙H2O. Displacement ellipsoids are drawn at the 50% probability level. Dashed lines 
indicate hydrogen bonds. [Symmetry codes: (i) x + 1, –y + 1/2, –z + 3/2; (ii) x – 1/2, y, –z + 1; (iii) 
x, –y + 1/2, –z + 3/2]. 
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Table 5.2.3 Hydrogen bond geometry of [Fe(H-5-Br-thsa-Et)2](NO3)∙H2O (Å, °) 
D–H∙∙∙A D–H  H∙∙∙A  D∙∙∙A  D–H∙∙∙A  
N12–H12∙∙∙O202i 0.88 1.89 2.737(6) 161.5 
N13–H13∙∙∙O203i 0.88 2.01 2.892(6) 176.3 
N22–H22∙∙∙O101 0.88 1.83 2.695(6) 167.3 
N23–H23∙∙∙O201 0.88 2.24 2.898(6) 131.6 
O101–H10A∙∙∙O11ii 0.87 2.09 2.811(6) 139.7 
O101–H10B∙∙∙O202iii 0.87 1.89 2.692(6) 152.6 
Symmetry codes: (i) x + 1, –y + 1/2, –z + 3/2; (ii) x – 1/2, y, –z + 1, (iii) x, –y + 1/2, –z + 3/2.  
 
The assembly of the FeIII units of the present compound is displayed in Figure 5.2.3. The presence 
of both the NO3‒ anion and the water solvent molecule of [Fe(H-5-Br-thsa-Et)2](NO3)∙H2O, might 
have some effect on how the FeIII units are packed in the crystal lattice. [Fe(H-5-Br-thsa-
Et)2](NO3)∙H2O displays FeIII∙∙∙FeIII (1/2 + x, y, –z + 1) separations of 6.788(7) Å and FeIII∙∙∙FeIII (x, 
1/2 – y, 3/2 – z) separations of 7.2135(16) Å. Despite the presence of the water solvent molecule and 
the nitrate anion the FeIII units are packed relatively close together within the crystal lattice. This 
feature could be due to the hydrogen bonding ring systems (vide supra), which link the FeIII units 
together using the hydrogen bonding interactions of the water solvent molecule and the nitrate anion.   
 
Figure 5.2.3 A projection showing the unit cell of [Fe(H-5-Br-thsa-Et)2](NO3)∙H2O. Displacement 
ellipsoids are drawn at the 50% probability level. 
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5.2.3 Infrared spectroscopic study of [Fe(H-5-Br-thsa-Et)2](NO3)∙H2O and the free ligand 5-
bromosalicylaldehyde 4-ethylthiosemicarbazone, H2-5-Br-thsa-Et 
The infrared spectra of the ferric compound bis(5-bromosalicylaldehyde 4-
ethylthiosemicarbazonato(-1)-κ3-O,N1,S)ferrate nitrate monohydrate and the corresponding free 
ligand 5-bromosalicylaldehyde 4-ethylthiosemicarbazone are given in the appendix. The infrared 
spectrum of the free ligand, 5-bromosalicylaldehyde 4-ethylthiosemicarbazone (H2-5-Br-thsa-Et), 
exhibits a strong band at 1613 cm-1, which is assigned to the imine resulting from the condensation 
from the salicylaldehyde moiety and the thiosemicarbazone moiety. Furthermore, the infrared 
spectrum of the ligand exhibits a medium band at 3146 cm-1, which is assigned to the νN–H vibration. 
The presence of the νN–H band in the spectrum of [Fe(H-5-Br-thsa-Et)2](NO3)∙H2O shows evidence 
that the ligand is coordinated to the central FeIII cation in the thione form of the tautomer. Upon 
coordination of the imine nitrogen, the νC=N band shifts from 1613 cm-1 in the free ligand to 1600 
cm-1 in the complex. The νN–N band of the thiosemicarbazone moiety of the free ligand is found at 
1105 cm-1; the wavenumber increases to 1312 cm-1 for the νN–N band in the ferric complex. In 
comparison to the free ligand, the ferric complex does not show the presence of the νOH vibration; 
this is due to the phenolic oxygen having been deprotonated in order to coordinate the O,N,S-
tridentate chelating ligand to the FeIII cation in the [Fe(H-5-Br-thsa-Et)2]+ fragment. The 
corresponding νOH band for the free ligand is found at 3299 cm-1. The FeIII cation is also coordinated 
to the sulfur atom of the thiosemicarbazone moiety of the ligand. The νCS band of the FeIII 
coordinated ligand is assigned at 819 cm-1 in the ferric complex, but it is at a larger wavenumber in 
the free ligand, i.e. νCS at 1046 cm-1. The decrease in the frequency of the νCS band in the 
thiosemicarbazone upon complexation of the ligand indicates coordination of the thione S atom to 
the FeIII cation. In the infrared spectrum of the ferric complex there are two bands which represent 
the presence of the nitrate anion within the crystal lattice, the νNO bands of the NO3‒ anion are 
assigned at 866 and 1352 cm-1, respectively. Furthermore, as evidenced from the crystallographic 
study of the complex [Fe(H-5-Br-thsa-Et)2](NO3)∙H2O there is hydrogen bonding within the crystal 
lattice; which is supported by the broad peaks observed for the νNH bands assigned to the 
azomethine and terminal nitrogen atoms of the thiosemicarbazone moiety of the coordinated ligand.  
 
5.2.4 Magnetic properties of [Fe(H-5-Br-thsa-Et)2](NO3)·H2O 
The temperature dependence of the χMT product (χM being the molar magnetic susceptibility, T being 
the temperature) for [Fe(H-5-Br-thsa-Et)2](NO3)·H2O is given in Figure 5.2.4 over the 5-300 K 
temperature range. The plot reveals the value of χMT varies from 4.17 cm3 mol-1 K at 300 K to 3.23 
cm3 mol-1 K at 5 K. The temperature dependence of the χMT product clearly shows a plateau equal 
to 4.17 cm3 mol-1 K at high temperatures (300-50 K), which is close to the expected value of 4.37 
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cm3 mol-1 K (g = 2.00) for FeIII in its high-spin state (S=5/2). As can been seen in Figure 5.2.4, the 
value of χMT drops rapidly below 20 K, reflecting the significant zero-field splitting of the (S = 5/2) 
ground state [19]. 
 
Figure 5.2.4 χMT vs T plot of [Fe(H-5-Br-thsa-Et)2](NO3)·H2O in the temperature range 5-300 K. 
The data were measured at a rate of 2 K min-1.  
 
The magnetic susceptibility, χM, data for [Fe(H-5-Br-thsa-Et)2](NO3)·H2O between the temperature 
range 5-300 K shown in Figure 5.2.5, were least-squares ﬁtted to equation (1) to give the ﬁtting 
parameters D = 2.12 cm-1 and g = 2.22, with a coefficient of determination value of 0.99 and a 
reduced χ2 value of 0.00004. 
 
χ𝑀 =
𝑁𝑔2 𝛽2
4𝑘𝑇
[
0.14 + 5.12𝑒−3.23𝑋 + 23.85𝑒−6.83𝑋
1 + 𝑒−3.23𝑋 + 𝑒−6.83𝑋
]  Eqn (1) 
 
Where, X = D/kT, D is the zero-field splitting parameter, g is the average g tensor value and the other 
symbols have their standard meanings (as shown in Chapter I). As reported by Chen et al., [19] 
equation (1) is the theoretical equation for the magnetic susceptibility resulting from the axial and 
rhombic zero-field splitting for a FeIII S = 5/2 ion. 
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Figure 5.2.5 Temperature dependence of the molar magnetic susceptibility, χM, for the compound 
[Fe(H-5-Br-thsa-Et)2](NO3)·H2O in the range 5-300 K. Points are the experimental data; solid red 
line represents the least-squares fit of the data to Equation (1), where D = 2.12 cm-1 and g = 2.22. 
 
5.3 The structure and magnetic properties of [Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O 
In this section the crystallographic data (at 100 K) and magnetic properties of the ferric complex 
[Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O are herein reported. Furthermore, the infrared spectroscopic 
studies of the free ligand, 2,4-dihydroxybenzaldehyde thiosemicarbazone, and the ferric complex, 
[Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O are discussed.  
The experimental data is reported in Chapter II for the synthesis of [Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O 
and corresponding ligand, 2,4-dihydroxybenzaldehyde thiosemicarbazone.  
 
5.3.1 Crystal Data and Structure Refinement Details of [Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O 
Crystal data, data collection and structure refinement details are summarised in Table 5.3.1. The 
hydrogen atoms on all N‒H and NH2 groups were located in difference Fourier maps and refined 
with restrained N–H distances of 0.88(2) Å and with Uiso(H) = 1.2Ueq(N). The hydrogen atoms 
attached to hydroxy O atoms, i.e. O112, O122, O212, O222, O312, O322, as well as O412 and O422 
positioned on the C4 atoms, i.e. C114, C124, C214, C224, C314, C324, C414 and C424, 
respectively, of the salicylaldehyde moiety were located in a difference Fourier map and refined with 
an O–H distance restraint of 0.84(2) Å and Uiso(H) = 1.5Ueq(O). The remaining hydrogen atoms were 
included in the refinement in calculated positions, and treated as riding on their parent atoms, with 
C–H = 0.95 Å and Uiso(H) = 1.2Ueq(C) for aryl (-CH=) hydrogen atoms.  
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Table 5.3.1 Crystal data and structure refinement details of [Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O 
Crystal data 
Chemical formula 4(C16H16FeN6O4S2)·2(O4S)·9(H2O) 
Mr 2259.53 
Crystal system, space group Triclinic, P-1 
Temperature (K) 100 
a, b, c (Å) 12.1491(3), 19.4997(4), 19.6086(5) 
α, β, γ (°) 85.8400(19), 88.3058(18), 84.3168(18) 
V (Å3) 4609.14(18) 
Z 2 
Radiation type Mo Kα 
µ (mm−1) 0.94 
Crystal size (mm) 
Colour 
0.03 × 0.02 × 0.01 
Black (plate) 
Data collection 
Diffractometer Rigaku AFC12 four-circle Kappa diffractometer 
Absorption correction Multi-scan (CrystalClear-SM Expert [20]) 
Tmin, Tmax 0.838, 1.000 
No. of measured, independent and 
observed [I > 2σ(I)] reflections 
60573, 21184, 14525 
Rint 0.053 
Refinement 
R[F2 > 2σ(F2)], wR(F2), S 0.055, 0.141, 1.05 
No. of reflections 21184 
No. of parameters 1339 
No. of restraints 32 
H-atom treatment H atoms treated by a mixture of independent and 
constrained refinement 
Δρmax, Δρmin (e Å−3) 1.04, -0.48 
 
The CrystalClear-SM Expert [20] program was used for the unit cell determination and data 
collection. The CrysAlisPro [14] program was used for the data reduction, cell refinement and 
absorption correction. The program used for the structure solution: ShelXT [21]; the structure 
refinement used the program SHELXL [16]. The OLEX2 [13] and ORTEP-3 for Windows [17] 
programs were used to produce the molecular graphics. 
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5.3.2 Crystallographic study of [Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O 
The crystal structure of [Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O (Figure 5.3.1) was determined at 100 K. 
The present compound crystallises in the triclinic space group P-1. The asymmetric unit (Figure 
5.3.2) consists of four [Fe(HL)2]+ fragments, two sulfate anions and nine water molecules, with no 
atoms in special positions. The four FeIII units within the asymmetric unit display appreciably 
distorted octahedral geometries, created by two coordinating anionic tridentate 2,4-
dihydroxybenzaldehyde thiosemicarbazonato(1-) ligands. Selected bond angles and bond lengths are 
listed in Table 5.3.2.  
 
Figure 5.3.1 The molecular structure and atom-numbering scheme of the Fe1 unit for [Fe(H-4-OH-
thsa)2]4∙(SO4)2∙9H2O. Displacement ellipsoids are drawn at the 50% probability level.  
 
The atom-numbering scheme of Fe2 unit of one of the HL fragments adopts the numbering scheme 
with a “21” in front of all numbers, i.e. O1 would become O211. For the second HL fragment adopts 
the numbering scheme with a “22” in front of all numbers, i.e. O1 would become O221. The atom-
numbering scheme of Fe3 unit of one of the HL fragments adopts the numbering scheme with a “31” 
in front of all numbers, i.e. O1 would become O311. For the second HL fragment adopts the 
numbering scheme with a “32” in front of all numbers, i.e. O1 would become O321. The atom-
numbering scheme of Fe4 unit of one of the HL fragments adopts the numbering scheme with a “41” 
in front of all numbers, i.e. O1 would become O411. For the second HL fragment adopts the 
numbering scheme with a “42” in front of all numbers, i.e. O1 would become O421.  
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Each FeIII cation is coordinated by two anionic O,N,S-ligands, giving a FeO2N2S2 octahedron. The 
donor atoms are located in mutually normal planes, the S and O-donor atoms being in the cis 
positions and the N-donor atoms in the trans positions. It has been acknowledged throughout the 
literature that the Fe-donor atom bond distances can be categorised into whether the FeIII cation is in 
the high-spin or low-spin state at the measurement temperature.  It is recognised that typical distances 
for Fe‒S, Fe‒O and Fe‒N bonds are 2.23‒2.31 Å, 1.93‒1.95 Å and 1.88‒1.96 Å, respectively, for 
low-spin FeIII compounds of this family, and 2.40‒2.44 Å, 1.96‒1.99 Å and 2.05‒2.15 Å, 
respectively, for the corresponding high-spin FeIII compounds [18]. It can then be determined that 
for the four FeIII units of the present compound, each FeIII cation is in the high-spin state at 100 K. 
 
Figure 5.3.2 The molecular structure of the asymmetric unit of [Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O. 
Displacement ellipsoids are drawn at the 50% probability level. 
 
The 2,4-dihydroxybenzaldehyde thiosemicarbazonate(1-) is in the thione form of the tautomer when 
coordinated to the central FeIII cation, i.e. deprotonation only occurs at the phenolate O-donor atoms, 
O111, O121, O211, O221, O311, O321, O411 and O421. Additionally, the protonation of the 
azomethine nitrogen atoms (N112, N122, N212, N222, N312, N322, N412 and N422) also indicates 
that the ligand is coordinated to the FeIII cation in the thione form. This is further corroborated by 
the C=S distances of the ligand in each of the FeIII units, which are closer to a bond order of two and 
that the adjacent C–N bonds are within the range expected for a bond order of one. Selected ligand 
bond distances are given in Table 5.3.2. 
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Table 5.3.2 Selected bond lengths and angles of [Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O (Å, °) 
Fe1–S111 2.4391(10) Fe1–S121 2.4422(11) 
Fe1–O111 1.946(2) Fe1–O121 1.945(2) 
Fe1–N111 2.160(3) Fe1–N121 2.173(3) 
Fe2–S211 2.4331(10) Fe2–S221 2.4369(11) 
Fe2–O211 1.952(2) Fe2–O221 1.935(2) 
Fe2–N211 2.166(3) Fe2–N221 2.175(3) 
Fe3–S311 2.4655(11) Fe3–S321 2.4268(12) 
Fe3–O311 1.957(2) Fe3–O321 1.929(2) 
Fe3–N311 2.155(3) Fe3–N321 2.182(3) 
Fe4–S411 2.4587(10) Fe4–S421 2.4506(11) 
Fe4–O411 1.926(2) Fe4–O421 1.950(2) 
Fe4–N411 2.142(3) Fe4–N421 2.143(3) 
N111–C117 1.304(5) N311–C317 1.307(4) 
N121–C127 1.292(5) N321–C327 1.300(4) 
N112–C118 1.336(5) N312–C318 1.340(5) 
N122–C128 1.333(5) N322–C328 1.337(5) 
S111–C118 1.718(4) S311–C318 1.690(4) 
S121–C128 1.697(4) S321–C328 1.707(4) 
N211–C217 1.308(4) N411–C417 1.302(4) 
N221–C227 1.300(4) N421–C427 1.301(4) 
N212–C218 1.328(4) N412–C418 1.344(4) 
N222–C228 1.330(5) N422–C428 1.321(4) 
S211–C118 1.701(3) S411–C418 1.702(3) 
S221–C228 1.709(3) S421–C428 1.706(3) 
    
    
S111–Fe1–S121 101.08(3) S211–Fe2–S221 97.85(4) 
O111–Fe1–S121 84.51(10) O211–Fe2–O221 83.68(9) 
N111–Fe1–N121 155.09(10) N211–Fe2–N221 153.16(10) 
S311–Fe3–S321 101.90(4) S411–Fe4–S421 94.92(4) 
O311–Fe3–O321 85.66(10) O411–Fe4–O421 84.91(10) 
N311–Fe3–N321 153.64(10) N411–Fe4–N421 155.72(10) 
 
The four inequivalent FeIII units are held together by a complex hydrogen bonding system involving 
both the sulfate anions and water molecules present in the crystal lattice. The hydrogen bond 
geometries for [Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O are listed in Table 5.3.3. The hydrogen bond 
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contacts among the FeIII compound, sulfate anion and the water molecules form intramolecular ring 
systems in the lattice. Within the asymmetric unit of [Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O there are 
three different hydrogen bonding ring systems involving the Fe2 unit, as illustrated in Figure 5.3.3. 
The first ring system is formed by the contacts O212–H212∙∙∙O7, O7–H7B∙∙∙O501, O11–H11E∙∙∙502 
and O11–H11D∙∙∙O221 giving rise to a R43(16) ring system. The ring system includes the phenolate-
O atom, O221, of one of the coordinated ligands which is an Fe-donor atom; due to the interaction 
of the hydrogen bonding system with the Fe–O-donor atom, the ligand field strength of the ligand 
may be modified and this is determining the spin state of FeIII ion. However, the hydrogen bonding 
interactions with the Fe–O donor atom have revealed that the Fe–O bond distances (displayed in 
Table 5.3.2) are shorter than expected for a high-spin compound (1.96-1.99 Å [18]).   
 
Table 5.3.3 Hydrogen bond geometry of [Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O (Å, º) 
D–H···A D–H H···A D···A D–H···A 
O112–H112···O9i 0.82(2) 1.90(2) 2.711(4) 171(5) 
O122–H122···O7 0.85(2) 1.86(2) 2.706(4) 175(5) 
N112–H11A···O603ii 0.90(2) 1.96(2) 2.846(4) 173(4) 
N113–H11B···O312iii 0.88(2) 2.12(3) 2.891(4) 145(4) 
O212–H212···O7 0.84(2) 1.85(2) 2.681(4) 173(4) 
O222–H222···O9 0.84(2) 1.91(2) 2.745(4) 175(5) 
N212–H21A···O502ii 0.87(2) 2.00(2) 2.859(4) 169(4) 
N213–H21B···O412iii 0.85(2) 2.31(4) 2.889(4) 126(4) 
N222–H22A···O11iv 0.86(2) 2.03(2) 2.879(3) 170(3) 
O312–H312···O601v 0.82(2) 1.85(2) 2.661(3) 169(4) 
O322–H322···O501v 0.85(2) 1.87(2) 2.716(3) 177(4) 
N312–H31A···O504ii 0.84(2) 2.10(3) 2.845(4) 148(4) 
N322–H32A···O503iv 0.88(2) 1.89(2) 2.769(4) 177(4) 
O412–H412···O501v 0.82(2) 1.96(2) 2.738(3) 158(4) 
O422–H422···O601vi 0.81(2) 1.92(2) 2.720(3) 169(4) 
N412–H41A···O17i 0.89(2) 1.95(2) 2.821(3) 163(3) 
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Table 5.3.3 Hydrogen bond geometry of [Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O (Å, º) (continued) 
N422–H42A···O604iv 0.86(2) 1.92(2) 2.782(3) 172(4) 
O7–H7A···O8 0.87 1.88 2.726(4) 164 
O7-H7B···O501 0.87 1.81 2.676(4) 175 
O8–H8A···O12ii 0.87 1.90 2.766(4) 175 
O9–H9A···O601 0.87 1.88 2.745(3) 173 
O9–H9B···O10 0.87 1.85 2.700(4) 166 
O10–H10A···O14 0.87 1.88 2.751(4) 175 
O10–H10B···O11 0.87 1.93 2.777(4) 163 
O11–H11D···O221 0.87 2.17 2.849(3) 135 
O11–H11E···O502 0.87 1.92 2.791(3) 174 
O12–H12E···O121ii 0.87 1.88 2.717(3) 161 
O14–H14A···O311vii 0.87 1.95 2.801(3) 166 
O14–H14B···O504 0.87 1.94 2.752(4) 154 
O16–H16B···O212ii 0.87 1.98 2.847(4) 173 
O17–H17B···O604viii 0.87 1.85 2.698(3) 164 
Symmetry codes: (i) x, y, z − 1; (ii) –x + 1, −y + 1, −z + 1; (iii) –x + 1, −y, −z + 1; (iv) −x, −y + 1, 
−z + 1; (v) x, y − 1, z; (vi) x, y − 1, z − 1; (vii) x, y + 1, z; (viii) –x + 1, −y + 1, −z + 2. 
 
Furthermore, the second hydrogen bonding ring system formed with the Fe2 unit is created by the 
contacts O11–HD···O221, O222–H222···O9, O9–H9b···O10 and O10–H10b···O11, giving rise to 
a R34(12) ring system. The third hydrogen bonding system is formed between the O502 and O504 
atoms of the sulfate anion and three of the solvent water molecules via the contacts O11–
H11e···O502, O14–H14b···O504, O10–H10a···O14 and O10–H10b···O11, creating a R43(10) ring 
system. The Fe2 unit is linked to the Fe1 unit by the hydrogen bonds formed via the water molecule 
with the labelled O-atom, O7.  
178 
 
 
Figure 5.3.3 A projection of selected hydrogen bonding ring systems within the asymmetric unit of 
[Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O. Displacement ellipsoids are drawn at the 50% probability level.  
 
5.3.3 Infrared Spectroscopic studies of [Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O and the ligand 2,4-
dihydroxybenzaldehyde thiosemicarbazone, H2-4-OH-thsa  
The infrared spectrum of [Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O displays the typical bands expected for 
a ferric complex containing the one-fold deprotonated form of the ligand, 2,4-
dihydroxybenzaldehyde thiosemicarbazone. The assignments of selected infrared spectroscopic 
bands of the FeIII complex and corresponding ligand are listed in Table 5.3.4.  
 
Table 5.3.4 Selected infrared spectroscopic bands (cm-1) with assignments of [Fe(H-4-OH-
thsa)2]4∙(SO4)2∙9H2O and H2L ligand, 2,4-dihydroxybenzaldehyde thiosemicarbazone. 
Compound νOH νC=N νN=C νNN νCS νCO 
H2L 3167 1631 - 1167 1165 1121 
4[Fe(H-4-OH-thsa)2]·2(SO4)∙9H2O 3174 1597 1578 1341 1031 1224 
 
The spectrum of the free ligand exhibits bands in the regions 1631 cm-1 and 1165 cm-1, which are 
assigned to νC=N and νCS bands, respectively, indicating the free ligand is in the thione form. The 
coordination of the ligand to the FeIII is accompanied a by negative shift of the νC=N and νCS bands 
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and a positive shift of the νCO band with regards to the free ligand, therefore indicating the 
coordination of the FeIII ion to the O,N,S-donor atoms. In the infrared spectrum of the ferric complex 
there is a band which represents the presence of the sulfate anion within the crystal lattice; the νSO 
band of the SO42‒ anion is assigned at 1432 cm-1. 
 
5.3.4 Magnetic properties of [Fe(H-4-OH-thsa)2]4∙(SO4)2∙9H2O 
The product of the magnetic susceptibility and the temperature (χMT) measured in the temperature 
range 5-300 K is shown in Figure 5.3.4. At 300 K, the χMT value is 4.08 cm3 mol-1 K, which is close 
to the spin-only value (4.37 cm3 mol-1 K, g = 2.00) for the high-spin FeIII ion (S = 5/2).  
 
Figure 5.3.4 χMT vs T plot of [Fe(H-4-OH-thsa)2]4·(SO4)2·9H2O in the temperature range 5-300 K. 
The data were measured at a rate of 2 K min-1. 
 
Below 50 K, the value of χMT decreases abruptly reaching a value of 1.94 cm3 mol-1 K at 5 K. This 
behaviour is due to the presence of zero-field splitting of the high-spin FeIII [19]. The magnetic data 
were least-squares fitted using equation (1):  
 
χ𝑀 =
𝑁𝑔2 𝛽2
4𝑘𝑇
[
0.14 + 5.12𝑒−3.23𝑋 + 23.85𝑒−6.83𝑋
1 + 𝑒−3.23𝑋 + 𝑒−6.83𝑋
] Eqn (1) 
 
In this equation, X = D/kT, D is the zero-field splitting parameter, g is the average g tensor value and 
the other symbols have their standard meanings (as shown in Chapter I). Equation (1) is the 
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theoretical equation for the magnetic susceptibility resulting from the axial and rhombic zero-field 
splitting for a FeIII S = 5/2 ion [19]. The temperature dependence of the molar paramagnetic 
susceptibility, χM, was least-squares fitted (Figure 5.3.5) between the temperature range 5-300 K and 
yielded the parameters D = 2.78 cm-1 and g = 2.10, for [Fe(H-4-OH-thsa)2]4∙(SO4)2·9H2O, with a 
coefficient of determination value of 0.97 and a reduced χ2 value of 0.000002. 
 
Figure 5.3.5 Temperature dependence of the molar magnetic susceptibility, χM, for the compound 
[Fe(H-4-OH-thsa)2]4·(SO4)2·9H2O in the range 5-300 K. Points are the experimental data; solid red 
line represents the least-squares fit of the data to Equation (1), where D = 2.78 cm-1 and g = 2.10. 
 
5.4 Discussion 
This chapter reports the structural characterisation and magnetic properties of two novel 
mononuclear FeIII complexes based on R-salicylaldehyde 4R’-thiosemicarbazone, [Fe(HL‒
)2]X·nH2O, where X = NO3‒ or SO42‒. The aim of this comparative study is to attempt to explain in 
which manner the spin state of the [Fe(HL‒)2]+ cation appears to be dependent on the accompanying 
non-coordinating anion, the R- and R’-substituent and the solvent molecules. It is noteworthy to 
mention, to the best of our knowledge, that the reported compounds [Fe(H-5-Br-thsa-
Et)2](NO3)·H2O and [Fe(H-4-OH-thsa)2]4·(SO4)2·9H2O are the first type of [Fe(HL‒)2](anion‒)·nH2O 
compound to be described containing the R-salicylaldehyde 4R’-thiosemicarbazone ligand.  
It is difficult to correlate the structure and the magnetic properties of spin-crossover systems, 
therefore studies of spin-crossover materials are essential for understanding how to govern the 
generation of a spin-transition. In the following, the crystallographic data of [Fe(H-5-Br-thsa-
Et)2](NO3)·H2O and [Fe(H-4-OH-thsa)2]4·(SO4)2·9H2O will be compared. The Fe-donor atom 
distances of the FeIII bis(ligand) compounds in this chapter are listed in Table 5.4.1. The structures 
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of [Fe(H-5-Br-thsa-Et)2](NO3)·H2O and [Fe(H-4-OH-thsa)2]4·(SO4)2·9H2O consist of an FeIIIO2N2S2 
chromophore which is formed by two chelating tridentate anionic R-salicylaldehyde 4R’-
thiosemicarbazonato(1-) ligands. The FeIIIO2N2S2 chromophore exhibits a distorted octahedral 
geometry, where the O- and S-donor atoms are in the cis positions and the N-donor atoms are in the 
trans positions. The FeIII cation in both [Fe(H-5-Br-thsa-Et)2](NO3)·H2O and [Fe(H-4-OH-
thsa)2]4·(SO4)2·9H2O is in the high-spin state at 100 K.  
 
Table 5.4.1 Fe-donor atom bonds for high-spin (HS) [Fe(HL‒)2](anion‒)·nH2O type compounds of 
R-salicylaldehyde 4R-thiosemicarbazone. 
Compoundi T 
(K) 
Space 
group 
Fe‒S 
(Å) 
Fe‒N 
(Å) 
Fe‒O 
(Å) 
[Fe(H-5-Br-thsa-Et)2](NO3)·H2O 100 Pnna 2.4406(15) 
2.4635(15) 
2.175(4) 
2.162(4) 
1.958(4) 
1.945(3) 
[Fe(H-4-OH-thsa)2]4·(SO4)2·9H2Oii 100 P-1 2.4391(10) 
2.4422(11) 
2.4331(10) 
2.4369(11) 
2.4655(11) 
2.4268(12) 
2.4587(10) 
2.4506(11) 
2.160(3) 
2.173(3) 
2.166(3) 
2.175(3) 
2.155(3) 
2.182(3) 
2.142(3) 
2.143(3) 
1.946(2) 
1.945(2) 
1.952(2) 
1.935(2) 
1.957(2) 
1.929(2) 
1.926(2) 
1.950(2) 
i In the case that there are different ligands coordinated to the Fe atom, the geometric parameters 
involving each ligand are given in separate lines. 
ii Compound contains four crystallographically independent Fe sites (Fe1, Fe2, Fe3 and Fe4). 
 
It has long been discussed that the nature of the spin transition can be strongly influenced by chemical 
contributions which affect the lattice interactions [1-12, 18, 25]. In this instance, several influences 
on the structural and magnetic properties of the reported [Fe(HL‒)2](anion‒)·nH2O compounds will 
be considered, these include: the nature of the non-coordinating anion associated with the complex 
system, the extent and nature of solvation of the complex and the variations in the ligand substituents. 
The variation of the R and R’-substituent groups of the R-salicylaldehyde 4R’-thiosemicarbazone 
type ligand has been utilised with the aim of finely tuning the spin-crossover behaviours in FeIII 
complexes. In FeIII complexes, the R-salicylaldehyde 4R’-thiosemicarbazone type ligand has been 
known to form π-π stacking interactions which enhances the cooperativity and interactions between 
the FeIII units and leads to the possibility to create an abrupt spin-transition [1-12, 18, 25]. In the case 
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of [Fe(H-5-Br-thsa-Et)2](NO3)·H2O, the ligand contains the R-substituent, 5-bromo on the 
salicylaldehyde moiety, and an ethyl group as the R’-substituent on the thiosemicarbazone moiety, 
whereas, [Fe(H-4-OH-thsa)2]4·(SO4)2·9H2O contains R = 4-hydroxy group and R’ = H. As stated, 
[Fe(H-5Br-thsa-Et)2](NO3)·H2O and [Fe(H-4-OH-thsa)2]4·(SO4)2·9H2O are both in the high-spin 
form over the temperature range 5-300 K. The R,R’-substituents of the ligand may exhibit steric and 
electronic effects, including being involved in hydrogen bonding , via the R,R’-substituents in the 
[Fe(HL‒)2](anion‒)·nH2O compounds (Table 5.4.1), these features may be harnessed to induce a 
particular spin state for FeIII. The introduction of the alkyl chain into the ligand should slightly 
increase the ligand field strength of the ligand because of alkyl chains having a weak tendency to 
donate electrons. However, this may be outbalanced by the alkyl group in close proximity to the 
donating S atom, being able to bind less efficiently to FeIII, elongating the Fe–S bond and hence 
decreasing the ligand field strength. Perhaps the latter effect is larger and the compound has FeIII in 
the high-spin state, but that is difficult to conclude as many parameters are involved. Furthermore, 
the addition of the alkyl group would add steric bulk to the thiosemicarbazone moiety of the ligand, 
which may cause less efficient packing in the within the crystal lattice, in comparison to the ligand, 
2,4-dihydroxybenzaldehyde thiosemicarbazone, which contains R’ = H. The most significant of 
interactions found in the spin-crossover systems include π-π stacking and hydrogen bonding 
interactions. It has been determined that both high-spin compounds, [Fe(H-5Br-thsa-Et)2](NO3)·H2O 
and [Fe(H-4-OH-thsa)2]4·(SO4)2·9H2O do not exhibit π-π stacking interactions, but exhibit extensive 
hydrogen bonding interactions between the solvent molecules, non-coordinating anions and the 
coordinating ligands.  
Over the past few decades, the influence of the non-coordinating anion on the spin-crossover process 
has included research on an abundance of FeII, FeIII and CoII spin-crossover salts [22-26]. Particular 
focus has been paid to the singly deprotonated form of the pyridoxal 4R-thiosemicarbazone ligand, 
which has been found to generate FeIII spin-crossover [27-28]. Previous work by Yemeli Tido [8] 
focused on using derivatives of pyridoxal-4R-thiosemicarbazone for generating FeIII spin-crossover, 
resulting in the three octahedral FeIIIO2N2S2 entities of the molecular formula [FeIII(HL‒)]X·nH2O, 
where HL‒ is the monoanionic form of pyridoxal thiosemicarbazone (Hthpy) or pyridoxal-4-
methylthiosemicarbazone (Hmthpy), respectively, and X = sulfate, nitrate or tosylate anion [8]. It 
was recognised that the magnetic behaviour of these salts was sensitive to the non-coordinating anion 
and the solvent molecules, both of which were involved in hydrogen bonding [8]. For instance, for 
the compounds [Fe(Hthpy)2](SO4)1/2·3.5H2O and [Fe(Hthpy)2]NO3·3H2O where the ligand and its 
degree of deprotonation are identical, completely different magnetic behaviour is encountered. 
[Fe(Hthpy)2](SO4)1/2·3.5H2O shows an abrupt spin transition above room temperature upon release 
of its water solvent molecules on heating, whereas for [Fe(Hthpy)2]NO3·3H2O, the FeIII ion remains 
in the low-spin state, even upon dehydration of the complex [8]. The variation of the non-
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coordinating anion associated with the spin-crossover active complex cation [Fe(Hthpy)2]+, SO42‒ 
and NO3‒ apparently results in the spin-crossover behaviour being suppressed [8].  
The main difference observed between the present compounds [Fe(H-5Br-thsa-Et)2](NO3)·H2O and 
[Fe(H-4-OH-thsa)2]4·(SO4)2·9H2O is the varying size, shape and charge of the associated non-
coordinating anion. The two anions present in the two reported compounds [Fe(H-5Br-thsa-
Et)2](NO3)·H2O and [Fe(H-4-OH-thsa)2]4·(SO4)2·9H2O are different such that NO3‒ anion having a 
trigonal planar configuration whereas the SO42‒ anion has a tetrahedral configuration. Their 
differences are mainly in the aspects of size and electronic properties. It could be suggested that the 
size and the electronic properties of the non-coordinating anions exert an influence on the crystal 
packing and the cooperativity of the FeIII units. Perhaps, investigating these compounds with smaller 
anions such as Cl‒ to tune the spin-crossover is worth performing at a later stage, in order increase 
cooperativity between the FeIII units. It should be duly noted that the effect of the R and R’-
substituents of the salicylaldehyde and thiosemicarbazone moieties, respectively, cannot be 
excluded. 
It is possible that the magnetic behaviour of [Fe(H-5Br-thsa-Et)2](NO3)·H2O and [Fe(H-4-OH-
thsa)2]4·(SO4)2·9H2O may be caused by the intermolecular interactions created by the solvent 
molecules present in the crystal lattice. For instance, it is recognised that hydrogen bonding has been 
found to play a significant role in changes in the spin-crossover behaviour accompanying hydration 
or dehydration processes [25]. It has been suggested that hydration of the metal complex will 
generally result in a stabilisation of the low-spin state, through hydrogen bonding of the water with 
the ligand [25, 26, 29-32]. This does seem to be the case for most hydrates, but in a cationic spin-
crossover system where the ligand is hydrogen bonded to the associated anion only and this in turn 
is hydrogen bonded to the water, the effect can be the reverse, i.e., loss of water can also result in 
stabilisation of the low-spin state [25, 26, 29-32]. However, this turns out not to be the case, as for 
both compounds, [Fe(H-5Br-thsa-Et)2](NO3)·H2O and [Fe(H-4-OH-thsa)2]4·(SO4)2·9H2O, the 
ligands form intermolecular interactions with both the non-coordinating anions and the water solvent 
molecules, therefore does not comply with the suggestion that the loss of water could result in the 
stabilisation of the low-spin state. The involvement of hydrogen bonding also plays an important 
role in the changes in the spin-crossover behaviour accompanying the hydration and/or dehydration 
processes, as reported by Yemeli Tido [8], Mohan et al. [28], and Timken et al. [33]. It is likely that 
the highly cooperative nature of the spin-transition of [Fe(HL‒)2](anion‒)·nH2O type compounds is 
due to the extended interaction of the metal ion units through intermolecular hydrogen bonds and π-
π interactions.  
To conclude, the rationalisation of the factors (i.e. the effect of the R,R’-substituents of the ligand, 
the non-coordinating anion, the degree of solvation and intermolecular interactions) that govern the 
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spin-crossover process in cationic FeIII complexes, such as [Fe(H-5Br-thsa-Et)2](NO3)·H2O and 
[Fe(H-4-OH-thsa)2]4·(SO4)2·9H2O, is rather difficult as they are not always consistent from one 
system to another. The development of a strategy towards the synthesis of [Fe(HL‒)2](anion‒)·nH2O 
type compounds containing R-salicylaldehyde 4R’-thiosemicarbazone ligand, with a pre-determined 
spin state will require the measurement and analysis of crystallographic data of a larger number of 
cationic FeIII complexes, including these having different R and/or R’-substituents and a variety of 
associated anions.  
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6.0 Conclusions and Outlook 
6.1 Conclusions 
The motivation of this work was to synthesise a variety of functionalised R-salicylaldehyde 4R’-
thiosemicarbazone ligands to obtain novel FeIII compounds with the potential to display spin-
crossover behaviour. The design of the derivatives was driven by the aim to successfully crystallise 
single crystalline systems, so that the interpretation of the magnetic properties could be supported 
with structural evidence. In this thesis, several ligands have been prepared based on R-
salicylaldehyde 4R’-thiosemicarbazone, by varying the R- and R’-substituents appended to the 
salicylaldehyde and thiosemicarbazone moieties, respectively. Using these tridentate chelating 
ligands, ten FeIII based compounds have been crystallised and structures have been elucidated, 
adding to this family of FeIII bis(ligand) compounds found in the literature. The thermal magnetic 
behaviour of these compounds has been studied in detail, together with a study of the structural 
features that form the crystal lattice and the determination of the magnetic properties of this family 
of materials.  
The investigation into the family of R-salicylaldehyde 4R’-thiosemicarbazone FeIII compounds 
yielded three types of differently charged moieties of FeIII bis(ligand) complexes (listed in Table 
6.1), these include: (i) (cation+)[FeIII(L2‒)2]·x(solvate), (ii) [FeIII(HL‒)(L2‒)]·x(solvate) and (iii) 
[FeIII(HL‒)2](anion‒)·x(solvate), reported in Chapters 3, 4 and 5, respectively.  
The manifestation of a spin transition in a solid state system is subject to the operation of lattice 
forces. It has long been established that the nature of the spin transition can be strongly influenced 
by chemical contributions which affect the lattice interactions. In this instance, several influences on 
the structural features and the magnetic properties of the reported FeIII compounds were considered 
throughout this thesis. These include: 
(v) The nature of the anion or cation associated with the metal fragment; 
(vi) The extent and nature of solvation of the complex; 
(vii) Variations in the ligand substituents. 
The study of (cation+)[FeIII(L2‒)2]·x(solvate) type complexes (Chapter III) containing two dianionic 
R-salicylaldehyde 4R’-thiosemicarbazonate(2-) ligands, focused upon investigating the effect of 
varying R- and R’-substituents, cations and solvent molecules within the lattice on the crystal 
packing and magnetic properties. Chapter IV provided a study of three mononuclear [FeIII(HL‒)(L2‒
)]·H2O type complexes, containing one anionic and one dianionic R-salicylaldehyde 4R’-
thiosemicarbazone ligand. Correlations between the steric and electronic effects imposed by the R- 
and R’-substituents of the ligands bound to the FeIII ions and the magnetic properties observed were 
discussed. Chapter V investigated [FeIII(HL‒)2](anion‒)·xH2O type complexes, with focus upon the 
188 
 
effect of varying the anions and the R- and R’-substituents of the coordinated one-fold deprotonated 
ligands within the crystal lattice on the magnetic properties and crystal packing of FeIII units. 
 
Table 6.1 Selected crystallographic data and spin state of the FeIII bis(R-salicylaldehyde 4R’-
thiosemicarbazone) compounds 
Compoundi T 
(K) 
Space 
group 
Fe‒S 
(Å) 
Fe‒N 
(Å) 
Fe‒O 
(Å) 
Spin 
Stateii 
Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH 100 P-1 2.2686 
2.265 
1.933 
1.939 
1.904 
1.918 
LS 
Cs[Fe(5-Br-thsa)2] 293 P21/c 2.2321 
2.2422 
1.947 
1.938 
1.942 
1.956 
LS 
NH4[Fe(thsa)2] 100 P21/n 2.2366 
2.2373 
1.930 
1.948 
1.938 
1.950 
LS 
NH4[Fe(5-Br-thsa)2] 100 Pbcn 2.263 1.942 1.938 LS 
(CH3)2NH2[Fe(3-OEt-thsa)2] 100 P21/n 2.4320 
2.4389 
2.167 
2.131 
1.9806 
1.9595 
HS 
[Fe(H-thsa-Me)(thsa-Me)]·H2O 100 Aea2 2.249 1.946 1.932 LS 
[Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-
Me)]·H2Oiii 
100 P-1 2.473 
2.442 
2.482 
2.417 
2.168 
2.085 
2.146 
2.096 
1.939 
1.996 
1.958 
1.994 
Fe1 
HS 
Fe11 
HS 
[Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-
Me)]·H2O 
100 
 
Aea2 2.255 1.969 1.951 LS sco 
[Fe(H-5-Br-thsa-Et)2](NO3)·H2O 100 Pnna 2.4406 
2.4635 
2.175 
2.162 
1.958 
1.945 
HS 
[Fe(H-4-OH-thsa)2]4·(SO4)2·9H2Oiv 100 P-1 2.4391 
2.4422 
2.4331 
2.4369 
2.4655 
2.4268 
2.4587 
2.4506 
2.160 
2.173 
2.166 
2.175 
2.155 
2.182 
2.142 
2.143 
1.946 
1.945 
1.952 
1.935 
1.957 
1.929 
1.926 
1.950 
Fe1 
HS 
Fe2  
HS 
Fe3  
HS 
Fe4  
HS 
i In the case that there are different ligands coordinated to the Fe atom, the geometric parameters 
involving each ligand are given in separate lines. 
ii The spin states are defined as low-spin (LS) and high-spin (HS); sco defines spin-crossover. 
iii Compound contains two crystallographically independent Fe sites (Fe1 and Fe11). 
iv Compound contains four crystallographically independent Fe sites (Fe1, Fe2, Fe3 and Fe4). 
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These studies have shown that all of the reported FeIII bis(ligand) systems (listed in Table 6.1) consist 
of an FeIIIO2N2S2 chromophore which is formed by two chelating tridentate R-salicylaldehyde 4R’-
thiosemicarbazonato ligands. Furthermore, it has been found that the FeIIIO2N2S2 chromophore 
exhibits a distorted octahedral geometry, where the O- and S-donor atoms are in the cis positions 
and N-donor atoms are in the trans positions.  
 
6.1.1 Anionic FeIII complexes of R-salicylaldehyde 4R’-thiosemicarbazones 
The correlations between the structural features and magnetic behaviour of the (cation+)[Fe(L2‒
)2]·x(solvate) type compounds revealed two major effects which influence the magnetic properties 
of this family of compounds: (i) the associated non-coordinating cation in the complex system and 
(ii) the R-substituents at the benzene ring of the salicylaldehyde moiety and/or the introduction of 
R’-substituents into the thioamide group of the thiosemicarbazide moiety. The variation of the cation 
(either NH4+, Cs+ or (CH3)2NH2+) in the crystal lattice may have an indirect impact on the spin state 
of FeIII ion by influencing the crystal packing. In addition to the difference in the size between NH4+, 
(CH3)2NH2+ and Cs+ ions, the two former may engage in directed interactions through hydrogen 
bonding, while the Cs+ ion presents a more uniform electrostatic field without a preferred direction 
for hydrogen bonds. The R,R’-substituents of the ligand may exhibit steric and electronic effects as 
well as being involved in hydrogen bonding, via the R,R’-substituents in the (cation+)[Fe(L2‒
)2]·x(solvate) type compounds. It appears the steric effect induced by the R-substituent was more 
pronounced in the systems containing the bulkier 3-ethoxysalicylaldehyde 4R’-thiosemicarbazone 
ligand, especially with respect to the compound (CH3)2NH2[Fe(3-OEt-thsa)2], in which the FeIII ion 
was found to be in the high-spin state at 100 K. Furthermore, an important feature of spin-crossover 
materials is cooperativity, which is a measure of the degree to which a spin transition in one FeIII 
unit affects neighbouring FeIII units. The Δo required for the FeIII units to exhibit thermal spin-
crossover does not seem have been reached for the reported (cation+)[Fe(L2‒)2]·x(solvate) type 
compounds (as listed in Table 6.1), as these compounds do not exhibit spin-crossover. However, the 
magnetic behaviour of NH4[Fe(5-Br-thsa)2] proved interesting as the magnetic properties revealed 
an estimated fraction of about 12% of FeIII ions converting into the high-spin state at 200 K.  
 
6.1.2 Neutral FeIII complexes of R-salicylaldehyde 4R’-thiosemicarbazones 
The [Fe(HL‒)(L2‒)]·H2O compounds are an interesting example of how the R and R’-substituents of 
the R-salicylaldehyde 4R’-thiosemicarbazonato ligand may influence the nature of the spin transition 
of the FeIII ion. The three compounds reported in Chapter IV, [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-
Me)]·H2O, [Fe(H-thsa-Me)(thsa-Me)]·H2O and [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]·H2O, all 
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contain the R’-substituent, R’ = Me, whereas their R-substituents differ, giving R = 5-Cl, R = H and 
R = 3-OEt, respectively. The isostructural compounds [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]·H2O 
and [Fe(H-thsa-Me)(thsa-Me)]·H2O, were found to be chiral, although this is a rare occurrence due 
to the fact no chiral compounds were used in the synthesis of the ferric complexes to induce chirality.  
It is clear that the electronic and steric implications of the R-substituents affect the spin state of the 
FeIII complex, and also whether the compound exhibits spin-crossover or remains in either the low-
spin or high-spin state. A rare two-step spin transition with hysteresis was observed for the 
compound [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]·H2O. Upon changing the R-group from R = 5-Cl to 
R = -H, the isostructural compound [Fe(H-thsa-Me)(thsa-Me)]·H2O was obtained, however, the 
latter material exhibits very different magnetic behaviour in comparison to [Fe(H-5-Cl-thsa-Me)(5-
Cl-thsa-Me)]·H2O. The value of χMT (χM being the molar magnetic susceptibility and T the 
temperature) for [Fe(H-thsa-Me)(thsa-Me)]·H2O indicated that the FeIII ion was in the low-spin state 
between the temperature range 5-300 K, however, higher temperature magnetic measurements 
between 200-400 K revealed an incomplete spin transition, whereby the χMT value at 400 K is 2.52 
cm3 mol-1 K, which corresponds to an estimated high-spin fraction of 54%. Moreover, replacing the 
R-group with a sterically bulky group, R = 3-OEt, yielded the high-spin compound [Fe(H-3-OEt-
thsa-Me)(3-OEt-thsa-Me)]·H2O. It may be proposed that the strong steric bulkiness of the 3-ethoxy 
group on the benzene ring of the salicylaldehyde moiety in the complex causes the compound to 
remain in the high-spin state between the temperature range 5-300K, as the bulky substituents are 
close to the donor atoms of the FeIII entities, so prevents the shortening of the Fe-donor atom bond 
distances. Furthermore, for this series of compounds, the electronic effect on the spin-crossover 
behaviour of the R-groups suggests that the larger the electron withdrawing effect the lower the T1/2 
which is corroborated by the linear relationship between T1/2 and the Hammett parameters, (σ).   
 
6.1.3 Cationic FeIII complexes of R-salicylaldehyde 4R’-thiosemicarbazones 
Structural studies of [Fe(HL‒)2]·(anion‒)·xH2O type compounds, where HL‒ is the one-fold 
deprotonated R-salicylaldehyde 4R’-thiosemicarbazonato(1-) ligand,  are still an unexploited avenue 
with regards to the synthesis of spin-crossover compounds with this type of ligand. However, [Fe(H-
5-Br-thsa-Et)2](NO3)·H2O and [Fe(H-4-OH-thsa)2]4·(SO4)2·9H2O are particularly interesting first 
examples of this type of material. The spin state of the FeIII ions of [Fe(H-5-Br-thsa-Et)2](NO3)·H2O 
and [Fe(H-4-OH-thsa)2]4·(SO4)2·9H2O may have been influenced by the non-coordinating anion, the 
R,R’-substituents of the ligand and/or the solvent effect. The NO3‒ and SO42‒ anions are different in 
size and electronic properties, such that NO3- has a trigonal planar configuration whereas the SO42‒ 
anion has a tetrahedral configuration. The R,R’-substituents of the ligand may exhibit steric and 
electronic effects as well as being involved in hydrogen bonding via the R,R’-substituents in the 
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[Fe(HL‒)2]·(anion-)·x(solvate) type compounds. The crystal packing and cooperativity of the FeIII 
units may be influenced by both the size and electronic properties of the non-coordinating anion, in 
addition to the electronic and steric effects due to the R and R’-substituents of the coordinated 
ligands. An interesting structural feature of [Fe(H-5-Br-thsa-Et)2](NO3)·H2O and [Fe(H-4-OH-
thsa)2]4·(SO4)2·9H2O is how the hydrogen bonding interactions involving the water molecules and 
the non-coordinating anions within the crystal lattice of each compound may induce the stabilisation 
of the high-spin state. Hydrogen bonding has been found to play a significant role in the changes in 
the spin-crossover behaviour accompanying hydration or dehydration processes [1-6]. It has been 
suggested that hydration will generally result in a stabilisation of the low-spin state, through 
hydrogen bonding of the water with the ligand [1-6]. This does seem to be the case for most hydrates, 
but in a cationic spin-crossover system where the ligand is hydrogen bonded to the associated anion 
only and this in turn is hydrogen bonded to the water, the effect can be the reverse, i.e., loss of water 
can also result in stabilisation of the low-spin state [1-6]. The study of the high-spin [Fe(HL‒
)2]·(anion‒)·xH2O type systems has revealed that this is not the case for this family of compounds. 
The structural features of the [Fe(H-5-Br-thsa-Et)2](NO3)·H2O and [Fe(H-4-OH-
thsa)2]4·(SO4)2·9H2O compounds has revealed that the ligands form intermolecular interactions with 
both the non-coordinating anions and water solvent molecules, it may be suggested that these 
intermolecular interactions do not comply with the evidence that the loss of water could result in the 
stabilisation of the low-spin state.  
The work described in this thesis provides an in depth study of the structural and magnetic properties 
of a wide range of FeIII bis(R-salicylaldehyde 4R’-thiosemicarbazonato) compounds with the 
following configurations: (i) (cation+)[FeIII(L2‒)2]·x(solvate), (ii) [FeIII(HL‒)(L2‒)]·x(solvate) and (iii) 
[FeIII(HL‒)2](anion‒)·x(solvate). This study includes the unique two step transition observed in the 
compound [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]·H2O, in addition to the study of the two novel 
solvated [FeIII(HL‒)2](anion‒) complexes, [Fe(H-5-Br-thsa-Et)2](NO3)·H2O and [Fe(H-4-OH-
thsa)2]4·(SO4)2·9H2O, this latter type of configuration of FeIII complex containing the R-
salicylaldehyde 4R’-thiosemicarbazone ligand are the first of this type and are still relatively 
unexploited in the literature.  
 
6.2 Outlook 
Although the spin-crossover phenomenon was first discovered in the 1930s, it has only been in recent 
decades that interest has been shown in the potential of FeIII bis(R-salicylaldehyde 4R’-
thiosemicarbazonato) compounds as spin-crossover systems. It has been realised that the most 
important features which are manifested in the nature of a spin transition are influenced by the 
chemical contributions which affect the crystal lattice interactions formed by the anion or cation 
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associated with the complex cation or complex anion, the extent and nature of solvation of the 
complex and/or the variations in the ligand substituents. The results of the studies herein provide a 
platform to devise further derivatives of R-salicylaldehyde 4R’-thiosemicarbazone type ligands, in 
order to design a library of FeIII bis(R-salicylaldehyde 4R’-thiosemicarbazonato) compounds to 
increase the knowledge of the possible correlations between the structural and magnetic properties 
which lies behind our current understanding of this family of compounds. There are a number of 
ways in which the relationship between the structural and magnetic behaviour studies described here 
can be continued. The continuation of structural studies of this family of compounds is essential in 
the development of the strategy to predict the switching capabilities associated with the structural 
and electronic features. However, structural studies only are not sufficient for the complete 
understanding of spin-crossover, this leads to the approach of continued detailed crystallographic 
studies alongside detailed analysis of the magnetic properties of the ferric complexes by SQUID 
magnetometry measurements. 
At this stage, it would appear that this family of compounds represents a unique and extremely 
versatile FeIII model system that will allow for the target of further systematic and detailed 
modifications of the FeIII system. This is especially true for the [Fe(HL‒)(L2‒)]·xH2O type compound, 
as this configuration of the FeIII systems with the R-salicylaldehyde 4R’-thiosemicarbazone ligand 
has been shown to exhibit spin-crossover frequently [7-9]. Furthermore, a systematic approach into 
the research of the structural and magnetic properties of the [Fe(HL‒)2]·(anion‒)·xH2O type 
compounds containing the R-salicylaldehyde 4R’-thiosemicarbazone ligand would be of great 
interest, as the two compounds reported in this thesis, are the first of this configuration. The next 
stage of the study would investigate several derivatives of the R-substituted salicylaldehyde moiety 
and the R’-substituted thiosemicarbazone moiety, as well as the unsubstituted salicylaldehyde 
thiosemicarbazone. In addition, investigate the variation of the non-coordinating anion, starting with 
a smaller anion i.e. Cl‒, then continue the research by increasing the size of the anion. Therefore, 
within the process to synthesise numerous [Fe(HL‒)2]·(anion‒)·xH2O type compounds comprising a 
combination of varied ligands and non-coordinating anions,  will not only add to the library of FeIII 
bis(R-salicylaldehyde 4R’-thiosemicarbazonato) compounds, but will allow further understanding 
of the interactions of the ligand and the non-coordinating anions, and how these influence the nature 
of the spin transition. The nature of the different R,R’-substituents incorporated in the various R-
salicylaldehyde 4R’-thiosemicarbazone ligands allows us to tune the steric and electronic features 
of the organic moiety. More precisely, this enables the selective tuning of the intra- and inter-
molecular interactions between the FeIII bis(ligand) entities. It is fair to say, that their true potential 
is yet to be unlocked, and that future research will reveal the full potential of this variously tuneable 
class of FeIII systems.  
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After the aforementioned FeIII systems have been subjected to an extensive characterisation focusing 
on obtaining information on the structural and electronic features associated with their unique 
magnetic behaviour, there have been very few systematic studies into the phenomenon in metal 
centres other than FeII and CoII systems. Extension of this research to use other metal ions i.e. CrIII, 
as this would create analogues of the FeIII systems which would be a valuable addition to the work 
being performed in this area at present. This idea stems from the premise that one may use the CrIII 
analogue instead of the FeIII bis(R-salicylaldehyde 4R’-thiosemicarbazone) compound to assess the 
prospect of the FeIII system displaying spin-crossover, simply by measuring the UV-Vis spectrum 
(thus determine Δo) of the CrIII analogue. There is evidence of CrIII salts bound to thiosemicarbazone 
type ligand systems being characterised with the purpose to understand the coordination of the 
ligands to the metal centres, as in this case for the analogous compounds [FeIII(Hthpu)(thpu)]·H2O 
and [CrIII(Hthpu)(thpu)]·H2O [10]. It should be duly noted that some CrIII compounds may have 
ligands in an alternative orientation with respect to another, hence the CrIII and FeIII compounds are 
not isomorphous. The further study of the other 3d5 metal centres containing the R-salicylaldehyde 
4R’-thiosemicarbzone ligand is likely to yield a wide range of compounds with interesting 
correlations between the structural and magnetic properties.  
The advancement of experimental techniques over the next few decades will greatly widen the areas 
of research in which the electronic state can be detected. It is already recognised that for many spin 
transition systems, spin-crossover behaviour can be examined by solution NMR spectroscopy using 
the Evans Method [11-12]. It has been proposed that 13C solid state NMR spectroscopy could be 
used in an attempt to determine what spin state the metal centre exhibits at measurement temperature, 
although not without difficulty due to the paramagnetic behaviour of FeIII. It has also been postulated 
that dependent upon spin state, either the low-spin state or the high-spin state, the signals observed 
would shift up or down field depending upon the electronic state of the metal ion. If this would be 
the case, it would be an interesting new technique to utilise in the determination of the spin state of 
the metal compound in question.  
In conclusion, a continuation of the research into this family of FeIII bis(R-salicylaldehyde 4R’-
thiosemicarbazone) compounds is likely to provide new and exciting insights into the theory behind 
the nature of the spin-crossover phenomenon. Furthermore, it may be suggested that detailed 
crystallographic studies coupled with corresponding magnetic measurements will play a critical role 
in the future research and development of this field. Moreover, the discovery of coordination 
compounds with the ability to switch spin state, which is accompanied by the modification of the 
macroscopic properties of the material, such as those materials belonging to the family of FeIII bis(R-
salicylaldehyde 4R’-thiosemicarbazone) compounds, will gain more and more interest due to their 
potential applications in spintronics, display devices and sensors [13-19]. It is well documented that 
despite their great potential these type of materials present a number of problems such as chemical 
instability on a molecular level. Further research is required to solve these issues, which currently 
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involves the field of nanoscience with an aim to customize future spintronic devices. Thus the 
research into this family of FeIII bis(R-salicylaldehyde 4R’-thiosemicarbazone) compounds on the 
macroscopic level must be continued not only on the macroscopic level but also on the nano-scale, 
inorder to discover their full potential as molecular switches and for applications in spintronic, 
display devices and sensors.    
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Appendix B 
Infrared Spectra of R-salicylaldehyde 4R’-thiosemicarbazone ligands and ferric complexes 
B1. Infrared spectrum of 3-ethoxysalicylaldehyde 4-methylthiosemicarbazone, H2-3-OEt-thsa-Me 
 
B2. Infrared spectrum of Cs[Fe(3-OEt-thsa-Me)2]∙CH3OH
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B3. Infrared spectrum of 5-bromosalicylaldehyde thiosemicarbazone, H2-5-Br-thsa 
 
 
B4. Infrared spectrum of Cs[Fe(5-Br-thsa)2] 
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B5. Infrared spectrum of salicylaldehyde thiosemicarbazone, H2-thsa 
 
 
B6. Infrared spectrum of NH4[Fe(thsa)2] 
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B7. Infrared spectrum of NH4[Fe(5-Br-thsa)2] 
 
 
B8. Infrared spectrum of 3-ethoxysalicylaldehyde thiosemicarbazone, H2-3-OEt-thsa 
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B9. Infrared spectrum of (CH3)2NH2[Fe(3-OEt-thsa)2] 
 
 
B10. Infrared spectrum of salicylaldehyde 4-methylthiosemicarbazone, H2-thsa-Me 
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B11. Infrared spectrum of [Fe(H-thsa-Me)(thsa-Me)]∙H2O 
 
 
B12. Infrared spectrum of [Fe(H-3-OEt-thsa-Me)(3-OEt-thsa-Me)]∙H2O 
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B13. Infrared spectrum of 5-chlorosalicylaldehyde 4-methylthiosemicarbazone, H2-5-Cl-thsa-Me 
 
 
B14. Infrared spectrum of [Fe(H-5-Cl-thsa-Me)(5-Cl-thsa-Me)]∙H2O 
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B15. Infrared spectrum of 5-bromosalicylaldehyde 4-ethylthiosemicarbazone, H2-5-Br-thsa-Et 
 
 
B16. Infrared spectrum of [Fe(H-5-Br-thsa-Et)2](NO3)∙H2O 
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B17. Infrared spectrum of 2,4-dihydroxybenzaldehyde thiosemicarbazone, H2-4-OH-thsa 
 
 
B18. Infrared spectrum of [Fe(H-4-OH-thsa)2]4·(SO4)2∙H2O 
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Appendix C. 
1H NMR Spectra of R-salicylaldehyde 4R’-thiosemicarbazone ligands in DMSO-d6 
 
C1. 1H NMR spectrum of 3-ethoxysalicylaldehyde 4-methylthiosemicarbazone, H2-3-OEt-thsa-Me 
 
 
C2. 1H NMR spectrum of 5-bromosalicylaldehyde thiosemicarbazone, H2-5-Br-thsa 
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C3. 1H NMR spectrum of salicylaldehyde thiosemicarbazone, H2-thsa 
 
 
C4. 1H NMR spectrum of 3-ethoxysalicylaldehyde thiosemicarbazone, H2-3-OEt-thsa 
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C5. 1H NMR spectrum of salicylaldehyde 4-methylthiosemicarbazone, H2-thsa-Me 
 
 
C6. 1H NMR spectrum of 5-chlorosalicylaldehyde 4-methylthiosemicarbazone, H2-5-Cl-thsa-Me 
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C7. 1H NMR spectrum of 5-bromosalicylaldehyde 4-ethylthiosemicarbazone, H2-5-Br-thsa-Et 
 
 
C8. 1H NMR spectrum of 2,4-dihydroxybenzaldehyde thiosemicarbazone, H2-4-OH-thsa 
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Appendix D. 
13C NMR Spectra of R-salicylaldehyde 4R’-thiosemicarbazone ligands in DMSO-d6 
 
D1. 13C NMR spectrum of 3-ethoxysalicylaldehyde 4-methylthiosemicarbazone, H2-3-OEt-thsa-Me 
 
 
 
D2. 13C NMR spectrum of 5-bromosalicylaldehyde thiosemicarbazone, H2-5-Br-thsa 
 
  
212 
 
D3. 13C NMR spectrum of salicylaldehyde thiosemicarbazone, H2-thsa 
 
 
 
D4. 13C  NMR spectrum of 3-ethoxysalicylaldehyde thiosemicarbazone, H2-3-OEt-thsa 
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D5. 13C NMR spectrum of salicylaldehyde 4-methylthiosemicarbazone, H2-thsa-Me 
 
 
 
D6. 13C NMR spectrum of 5-chlorosalicylaldehyde 4-methylthiosemicarbazone, H2-5-Cl-thsa-Me 
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D7. 13C NMR spectrum of 5-bromosalicylaldehyde 4-ethylthiosemicarbazone, H2-5-Br-thsa-Et 
 
 
 
D8. 13C NMR spectrum of 2,4-dihydroxybenzaldehyde thiosemicarbazone, H2-4-OH-thsa 
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Appendix E. 
Synthesis of R-salicylaldehyde 4R’-thiosemicarbazone and FeIII compounds not presented in 
the thesis 
 
E1. Synthesis of R-salicylaldehyde 4R’-thiosemicarbazone (H2L) based ligands 
The preparation of the desired R-salicylaldehyde 4R’-thiosemicarbazone ligands incorporated the 
synthesis between thiosemicarbazide and an R-substituted salicylaldehyde in ethanolic solution. The 
general reaction scheme is illustrated in Scheme E1.1.  
H2O
Scheme E1.1 
49 mmol of R-substituted salicylaldehyde was dissolved in 80 mL of ethanol with constant stirring, 
and was added to 49 mmol of the 4R’-thiosemicarbazide dissolved in 40 mL of ethanol. The 
corresponding mixture was refluxed for 120 minutes. The resulting solution was cooled to room 
temperature, the solid isolated by filtration, washed with ether and dried in a vacuum for two days.  
 
E1.1 List of Ligands 
Salicylaldehyde thiosemicarbazone, H2-thsa (Data reported in Chapter II, Section 2.3)  
5-Bromosalicylaldehyde thiosemicarbazone, H2-5-Br-thsa (Data reported in Chapter II, Section 
2.3)  
3-Ethoxysalicylaldehyde thiosemicarbazone, H2-3-OEt-thsa (Data reported in Chapter II, Section 
2.3)  
2,4-Dihydroxybenzaldehyde thiosemicarbazone, H2-4-OH-thsa (Data reported in Chapter II, 
Section 2.3)  
2-Hydroxy-5-methoxybenzaldehyde thiosemicarbazone, H2-5-OMe-thsa Yield: 2.94 g (13.05 
mmol, 79.9%). IR (cm-1, KBr): 3413.63 (νOH), 3122.52 (νNH), 3309.05 (νNH2), 1626.69 (νC=N), 
1580.46−1602.41 (νC=C), 1267.19 (νC−N), 1112.29 (νC=S), 2835.58 (νCH3). 1H NMR (300 MHz, 
DMSO-d6) δ (ppm): 11.38 (1H, s, OH), 9.47 (1H, s, S=C−NH), 8.34 (1H, s, N=C−H), 8.03−8.15 
(2H, m, S=C−NH2), 6.76−7.49 (aromatic 3H, m, C−H), 3.72 (3H, s, C-H3). 
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2-Hydroxy-4-methoxybenzaldehyde thiosemicarbazone, H2-4-OMe-thsa Yield: 4.78 g (21.22 
mmol, 86.6%). IR (cm-1, KBr): 3471.72 (νOH), 3152.99 (νNH), 3361.18 (νNH2), 1631.09 (νC=N), 
1546.92−1611.33 (νC=C), 1273.68 (νC−N), 1164.12 (νC=S), 2833.97 (νCH3). 1H NMR (300 MHz, 
DMSO-d6) δ (ppm): 11.25 (1H, s, OH), 9.95 (1H, s, S=C−NH), 8.27 (1H, s, N=C−H), 7.80−8.04 
(2H, m, S=C−NH2), 6.40−6.45 (aromatic 3H, m, C−H), 3.73 (3H, s, C-H3). 
5-Chlorosalicylaldehyde thiosemicarbazone, H2-5-Cl-thsa Yield: 10.20 g (44.41 mmol, 90.6%). IR 
(cm-1, KBr): 3404.08 (νOH), 3165.92 (νNH), 3237.35 (νNH2), 1611.73 (νC=N), 1598.37, 1542.13 
(νC=C), 1264.20 (νC−N), 1188.90 (νC=S). 1H NMR (300 MHz, DMSO-d6) δ (ppm): 11.42 (1H, s, 
OH), 10.23 (1H, s, S=C−NH), 8.29 (1H, s, N=C−H), 8.10−8.17 (2H, m, C−NH2), 6.85−7.24 
(aromatic 3H, m, C−H).  
Salicylaldehyde 4-methylthiosemicarbazone, H2-thsa-Me (Data reported in Chapter II, Section 2.3)  
5-Bromosalicylaldehyde 4-methylthiosemicarbazone, H2-5-Br-thsa-Me Yield: 11.37 g (39.46 
mmol, 80.5%). IR (cm-1, KBr):  3455.54 (νOH), 3248.86, 3161.64 (νNH), 2997.51 (νCH3), 1610.40 
(νC=N), 1601.43, 1545.49 (νC=C), 1263.71 (νC-N), 1190.95 (νC=S). 1H NMR (300 MHz, DMSO-
d6) δ (ppm): 11.42 (1H, s, OH), 10.25 (1H, s, S=C−NH), 8.65 (1H, s, N=CH), 8.15−8.30 (1H, m, 
S=C−NH(CH3)), 6.82−7.35 (aromatic 3H, m, C−H), 4.50 (3H, d, NH(CH3)). 
3-Ethoxysalicylaldehyde 4-methylthiosemicarbazone, H2-3-OEt-thsa-Me (Data reported in 
Chapter II, Section 2.3)  
2,4-Dihydroxybenzaldehyde 4-methylthiosemicarbazone, H2-4-OH-thsa-Me Yield: 8.19 g (36.36 
mmol, 74.2%). IR (cm-1, KBr):  3381.61 (νOH), 3276.27 (νNH), 2976.05 (νCH3), 1631.14 (νC=N), 
1580.94, 1546.91 (νC=C), 1256.89 (νC-N), 1127.84 (νC=S). 1H NMR (300 MHz, DMSO-d6) δ 
(ppm): 11.20 (1H, s, OH), 9.70 (1H, s, S=C−NH), 8.22 (1H, s, N=CH), 6.24−7.68 (aromatic 3H, m, 
C−H), 3.02 (3H, d, NH(CH3)). 
5-Chlorosalicylaldehyde 4-methylthiosemicarbazone, H2-5-Cl-thsa-Me (Data reported in Chapter 
II, Section 2.3)  
Salicylaldehyde 4-ethylthiosemicarbazone, H2-thsa-Et Yield: 10.27 g (45.99 mmol, 93.9%). IR 
(cm-1, KBr):  3355.41 (νOH), 3251.74 (νNH), 2974.19 (νCH3), 2870.50 (νCH2), 1618.14 (νC=N), 
1601.56, 1551.55 (νC=C), 1233.98 (νC-N), 1156.25 (νC=S). 1H NMR (300 MHz, DMSO-d6) δ 
(ppm):  11.42 (1H, s, OH), 10.28 (1H, s, S=C−NH), 8.32 (1H, m, N=CH), 8.66 (1H, t, 
S=C−NH(CH2CH3)), 6.80-7.38 (aromatic 3H, m, C−H), 3.60 (2H, p, NH−CH2), 1.15 (3H t, 
NHCH2−CH3). 
5-Bromosalicylaldehyde 4-ethylthiosemicarbazone, H2-5-Br-thsa-Et (Data reported in Chapter II, 
Section 2.3)  
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3-Ethoxysalicylaldehyde 4-ethylthiosemicarbazone, H2-3-OEt-thsa-Et (Data reported in Chapter 
II, Section 2.3)  
2,4-Dihydroxybenzaldehyde 4-ethylthiosemicarbazone, H2-4-OH-thsa-Et Yield: 5.75 g (24.03 
mmol, 98.1%). IR (cm-1, KBr): 3410.70, 3400.98 (νOH), 3140.10 (νNH), 2976.79 (νCH3), 2888.27 
(νCH2), 1637.77 (νC=N), 1612.22, 1542.04 (νC=C ring), 1246.05 (νC−N), 1157.02 (νC=S). 1H 
NMR (300 MHz, DMSO-d6) δ (ppm): 11.16 (1H, s, S=C−NH), 9.78–9.75 (2H, s, OH), 8.24 (1H, s, 
N=C−H), 8.33–8.29 (1H, t, S=C−NH), 6.30–7.72 (aromatic 3H, m, C−H), 3.56 (2H, m, C-H2), 1.12 
(3H, t, C-H3). 
5-Chlorosalicylaldehyde 4-ethylthiosemicarbazone, H2-5-Cl-thsa-Et Yield: 5.00 g (19.39 mmol, 
79.2%). IR (cm-1, KBr): 3228.01 (νOH), 3301.00 (νNH), 2990.00 (νCH3), 2936.00 (νCH2), 1602.10 
(νC=N), 1537.90 (νC=C), 1236.21 (νC−N), 1269.80 (νC=S). 1H NMR (300 MHz, DMSO-d6) δ 
(ppm):  11.38 (1H, s, OH), 10.33 (1H, s, S=C−NH), 8.15-8.32 (1H, m, N=CH), 8.66 (1H, t, 
S=C−NH(CH2CH3)), 6.85-7.24 (aromatic 3H, m, C−H), 3.61 (2H, m, NH−CH2), 1.15 (3H t, 
NHCH2−CH3). 
Salicylaldehyde 4-phenylthiosemicarbazone, H2-thsa-Ph Yield: 12.21 g (45.00 mmol, 91.80%). IR 
(cm-1, KBr): 3148.64 (νOH), 2990.54 (νNH), 1620.46 (νC=N), 1604.68, 1592.78, 1571.96, 1540.53 
(νC=C), 1271.56 (νC−N), 1150.80 (νC=S). 1H NMR (300 MHz, DMSO-d6) δ (ppm): 11.80 (1H, s, 
OH), 10.04 (1H, s, S=C−NH), 8.48 (1H, s, N=CH), 10.19 (1H, t, S=C−NH(C6H5)), 6.83-8.04 
(aromatic 9H, m, C−H). 
5-Bromosalicylaldehyde 4-phenylthiosemicarbazone, H2-5-Br-thsa-Ph Yield: 16.51 g (47.14 
mmol, 96.2%). IR (cm-1, KBr): 3445.60 (νOH), 3256.00 (νNH), 1618.5 (νC=N), 1605.92, 1581.09, 
1554.21, 1546.90 (νC=C), 1221.49 (νC−N), 1117.00 (νC=S). 1H NMR (300 MHz, DMSO-d6) δ 
(ppm): 11.85 (1H, s, OH), 10.10 (1H, s, S=C−NH), 8.30 (1H, s, N=CH), 8.40 (1H, t, 
S=C−NH(C6H5)), 6.80-7.60 (aromatic 9H, m, C−H). 
3-Ethoxysalicylaldehyde 4-phenylthiosemicarbazone, H2-3-OEt-thsa-Ph Yield: 7.22 g (22.89 
mmol, 93.4%). IR (cm-1, KBr): 3301.18 (νOH), 3061.43 (νNH), 1615.82 (νC=N), 1595.59, 1581.43, 
1551.59, 1519.67 (νC=C), 1281.41 (νC−N), 1192.04 (νC=S). 1H NMR (300 MHz, DMSO-d6) δ 
(ppm): 9.10 (1H, s, OH), 11.70 (1H, s, S=C−NH), 8.50 (1H, s, N=CH), 10.00 (1H, s, 
S=C−NH(C6H5)), 6.80-7.60 (aromatic 9H, m, C−H), 4.10 (2H, q, CH2), 3.25 (3H, t, CH3). 
2,4-Dihydroxybenzaldehyde 4-phenylthiosemicarbazone, H2-4-OH-thsa-Ph Yield: 3.98 g (13.85 
mmol, 84.8%). IR (cm-1, KBr): 3200.00 (νOH), 3152.07 (νNH), 1629.18 (νC=N), 1555.00, 1550.00, 
1546.56, 1514.05 (νC=C), 1211.91 (νC−N), 1126.20 (νC=S). 1H NMR (300 MHz, DMSO-d6) δ 
(ppm): 8.60 (1H, s, OH), 11.70 (1H, s, S=C−NH), 8.30 (1H, s, N=CH), 9.90 (1H, s, S=C−NH(C6H5)), 
6.80-7.60 (aromatic 9H, m, C−H). 
218 
 
5-Chlorosalicylaldehyde 4-phenylthiosemicarbazone, H2-5-Cl-thsa-Ph Yield: 4.97 g (16.25 mmol, 
66.3%). IR (cm-1, KBr): 3273.70 (νOH), 3142.90 (νNH), 1600.00 (νC=N), 1590.00, 1581.50, 
1550.40, 1525.25 (νC=C), 1266.20 (νC−N), 1085.70 (νC=S). 1H NMR (300 MHz, DMSO-d6) δ 
(ppm): 11.90 (1H, s, OH), 10.20 (1H, s, S=C−NH), 8.50 (1H, s, N=CH), 8.35 (1H, s, 
S=C−NH(C6H5)), 6.80-7.60 (aromatic 9H, m, C−H). 
 
E2 Attempted syntheses of FeIII compounds containing the ligand system: R-salicylaldehyde 4R’-
thiosemicarbazone (H2-R-thsa-R’) 
Various FeIII compounds were synthesised throughout the preparation of this work, the details of the 
synthesis are displayed in Table E2.1, Table E2.1 includes the quantities of FeIII salt, H2L ligand, 
solvent and cation/anion used in the synthesis, and the state the compound is in, i.e. powder or 
crystalline.  
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP1:63:1 80 MeOH  
35 
H2-3OEt-thsa 
0.24, 1.0 
CsOH 
0.67, 4.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP1:63:2 80 MeOH  
35 
H2-3OEt-thsa-Me 
0.25, 1.0 
CsOH 
0.67, 4.0 
FeCl3·6H2O 
0.27, 1.0 
40.1 Crystalline 
RP1:64:1 80 MeOH  
35 
H2-3OEt-thsa-Et 
0.28, 1.0 
CsOH 
0.67, 4.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP1:64:2 80 MeOH 
35 
H2-3OEt-thsa-Ph 
0.32, 1.0 
CsOH 
0.67, 4.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP1:65:1 80 MeOH  
35 
H2-3OEt-thsa-Me 
0.48, 2.0 
CsOH 
1.63, 8.0 
FeCl3·6H2O 
0.54, 2.0 
54.9 Crystalline 
RP1:70:1 80 MeOH 
30 
H2-3OEt-thsa 
0.24, 1.0 
CsOH 
0.67, 4.0 
Fe(CH3C6H4SO3)3·6H2O 
0.68, 1.0 
62.1 Powder 
RP1:70:2 80 MeOH 
35 
H2-3OEt-thsa-Me 
0.25, 1.0 
CsOH 
0.67, 4.0 
Fe(CH3C6H4SO3)3·6H2O 
0.68, 1.0 
34.5 Crystalline 
RP1:71:1 80 MeOH  
35 
H2-3OEt-thsa-Et 
0.28, 1.0 
CsOH 
0.67, 4.0 
Fe(CH3C6H4SO3)3·6H2O 
0.68, 1.0 
- No result 
RP1:71:2 80 MeOH  
35 
H2-3OEt-thsa-Ph 
0.32, 1.0 
CsOH 
0.67, 4.0 
Fe(CH3C6H4SO3)3·6H2O 
0.68, 1.0 
44.6 Crystalline  
RP1:72:1 80 MeOH 
30 
H2-3OEt-thsa 
0.24, 1.0 
CsOH 
0.67, 4.0 
Fe(ClO4)3·6H2O 
0.35, 1.0 
- No result 
RP1:72:2 80 MeOH  
30 
H2-3OEt-thsa-Me 
0.25, 1.0 
CsOH 
0.67, 4.0 
Fe(ClO4)3·6H2O 
0.35, 1.0 
- No result 
RP1:73:1 80 MeOH  
30 
H2-3OEt-thsa-Et 
0.28, 1.0 
CsOH 
0.67, 4.0 
Fe(ClO4)3·6H2O 
0.35, 1.0 
- No result 
RP1:73:2 80 MeOH  
30 
H2-3OEt-thsa-Ph 
0.32, 1.0 
CsOH 
0.67, 4.0 
Fe(ClO4)3·6H2O 
0.35, 1.0 
53.8 Crystalline  
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP1:74:1 80 MeOH 
30 
H2-3OEt-thsa 
0.24, 1.0 
CsOH 
0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
76.7 Crystalline product + 
brown powder 
RP1:74:2 80 MeOH  
30 
H2-3OEt-thsa-Me 
0.25, 1.0 
CsOH 
0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
67.4 Crystalline product + 
brown powder 
RP1:75:1 80 MeOH  
30 
H2-3OEt-thsa-Et 
0.28, 1.0 
CsOH 
0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
56.9 Crystalline product + 
brown powder 
RP1:75:2 80 MeOH  
30 
H2-3OEt-thsa-Ph 
0.32, 1.0 
CsOH 
0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
67.0 Powder 
RP1:76:1 80 MeOH 
30 
H2-thsa 
0.20, 1.0 
NH4OH 
20 mL 
Fe(CH3C6H4SO3)3·6H2O 
0.68, 1.0 
34.6 Crystalline  
RP1:76:2 80 MeOH 
 30 
H2-3,5-Br-thsa 
0.35, 1.0 
NH4OH 
20 mL 
Fe(CH3C6H4SO3)3·6H2O 
0.68, 1.0 
62.3 Powder 
RP1:77:1 80 MeOH  
30 
H2-5-Br-thsa 
0.27, 1.0 
NH4OH 
20 mL 
Fe(CH3C6H4SO3)3·6H2O 
0.68, 1.0 
44.2 Crystalline product  
RP1:77:2 80 MeOH  
30 
H2-4-OH-thsa 
0.21, 1.0 
NH4OH 
20 mL 
Fe(CH3C6H4SO3)3·6H2O 
0.68, 1.0 
55.2 Powder 
RP1:78:1 80 MeOH 
30 
H2-thsa 
0.20, 1.0 
NH4OH 
20 mL 
FeCl3·6H2O 
0.27, 1.0 
- No result  
RP1:78:2 80 MeOH  
30 
H2-3,5-Br-thsa 
0.35, 1.0 
NH4OH 
20 mL 
FeCl3·6H2O 
0.27, 1.0 
 No result 
RP1:79:1 80 MeOH  
30 
H2-5-Br-thsa 
0.27, 1.0 
NH4OH 
20 mL 
FeCl3·6H2O 
0.27, 1.0 
27.9 Crystalline product  
RP1:79:2 80 MeOH  
30 
H2-4-OH-thsa 
0.21, 1.0 
NH4OH 
20 mL 
FeCl3·6H2O 
0.27, 1.0 
61.9 Crystalline product + 
brown powder 
RP1:80:2 80 MeOH 
35 
H2-3OEt-thsa-Ph 
0.32, 1.0 
CsOH 
0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
57.3 Crystalline product + 
brown powder 
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP1:80:3 80 MeOH  
70 
H2-3OEt-thsa-Ph 
0.64, 2.0 
CsOH 
0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
33.7 Crystalline 
RP1:81:4 80 MeOH  
35 
H2-3OEt-thsa-Ph 
0.32, 1.0 
CsOH 
0.34, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result  
RP1:81:5 80 MeOH  
70 
H2-3OEt-thsa-Ph 
0.64, 2.0 
CsOH 
0.50, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
55.0 Powder  
RP1:82:6 80 MeOH  
70 
H2-3OEt-thsa-Ph 
0.64, 2.0 
CsOH 
0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
41.6 Crystalline 
RP1:82:2 80 MeOH 
 70 
H2-3OEt-thsa-Et 
0.27, 1.0 
CsOH 
0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
66.2 Crystalline product + 
brown powder 
RP1:83:3 80 MeOH  
70 
H2-3OEt-thsa-Et 
0.54, 2.0 
CsOH 
0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
38.9 Crystalline needles 
RP1:83:1 80 MeOH  
35 
H2-thsa-Ph 
0.27, 1.0 
CsOH 
0.34, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
33.1 Brown powder 
RP1:84:2 80 MeOH  
70 
H2-thsa-Ph 
0.54, 2.0 
CsOH 
0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
22.7 Crystalline 
RP1:84:3 80 MeOH  
35 
H2-thsa-Ph 
0.27, 1.0 
NH4OH 
20 mL 
Fe(NO3)3·9H2O 
0.40, 1.0 
36.7 Crystalline 
RP1:86:1 80 MeOH  
35 
H2-4-OH-thsa-Ph 
0.29, 1.0 
CsOH 
0.34, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP1:87:2 80 MeOH  
35 
H2-4-OH-thsa-Ph 
0.58, 2.0 
CsOH 
0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
45.6 Brown powder 
RP1:87:3 80 MeOH  
35 
H2-4-OH-thsa-Ph 
0.29, 1.0 
NH4OH 
 20 mL 
Fe(NO3)3·9H2O 
0.40, 1.0 
55.2 Brown powder 
RP1:88:1 80 MeOH 
 35 
H2-thsa-Ph 
0.27, 1.0 
NH4OH 
 20 mL 
Fe(CH3C6H5SO3)3·6H2O 
0.68, 1.0 
- No result 
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP1:88:2 80 MeOH 
 70 
H2-thsa-Ph 
0.54, 2.0 
NH4OH 
 20 mL 
Fe(CH3C6H5SO3)3·6H2O 
0.68, 1.0 
- No result 
RP1:89:1 80 MeOH  
35 
H2-4-OH-thsa-Ph 
0.29, 1.0 
NH4OH 
 20 mL 
Fe(CH3C6H5SO3)3·6H2O 
0.68, 1.0 
- No result 
RP1:89:2 80 MeOH  
70 
H2-4-OH-thsa-Ph 
0.58, 2.0 
NH4OH 
 20 mL 
Fe(CH3C6H5SO3)3·6H2O 
0.68, 1.0 
- No result 
RP1:90:2 80 MeOH  
30 
H2-thsa 
0.20, 1.0 
NH4OH 
 20 mL 
Fe(CH3C6H5SO3)3·6H2O 
0.68, 1.0 
29.1 Crystalline 
RP1:90:3 80 MeOH  
70 
H2-thsa 
0.40, 2.0 
NH4OH 
 20 mL 
Fe(CH3C6H5SO3)3·6H2O 
0.68, 1.0 
41.7 Crystalline  
RP1:91:2 80 MeOH 
 35 
H2-5-Br-thsa 
0.27, 1.0 
NH4OH 
 20 mL 
FeCl3·6H2O 
0.27, 1.0 
62.8 Crystalline + brown 
powder 
RP1:91:3 80 MeOH  
70 
H2-5-Br-thsa 
0.54, 2.0 
NH4OH 
20 mL 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP1:92:1 80 MeOH  
70 
H2-3-OEt-thsa-Ph 
0.64, 2.0 
CsOH 
0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
42.4 Crystalline 
RP1:92:4 80 MeOH  
70 
H2-3-OEt-thsa-Et 
0.54, 2.0 
CsOH 
0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP1:95:1 80 MeOH 
 70 
H2-3-OEt-thsa-Et 
0.54, 2.0 
CsOH 
 0.67, 4.0 
Fe(CH3C6H5SO3)3·6H2O 
0.68, 1.0 
38.5 Crystalline  
RP1:96:1 80 MeOH  
30 
H2-5-Br-thsa 
0.27, 1.0 
CsOH 
0.67, 4.0 
Fe(CH3C6H5SO3)3·6H2O 
0.68, 1.0 
48.5 Powder  
RP1:96:2 80 MeOH  
70 
H2-5-Br-thsa 
0.54, 2.0 
CsOH 
 0.67, 4.0 
Fe(CH3C6H5SO3)3·6H2O 
0.68, 1.0 
56.2 Crystalline product + 
brown powder 
RP1:97:3 80 MeOH 
 30 
H2-5-Br-thsa 
0.27, 1.0 
CsOH 
 0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
49.1 Powder  
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP1:97:4 80 MeOH  
70 
H2-5-Br-thsa 
0.54, 2.0 
CsOH 
 0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
28.8 Crystalline  
RP1:98:5 80 MeOH  
30 
H2-5-Br-thsa 
0.27, 1.0 
CsOH 
0.67, 4.0 
FeCl3·6H2O 
0.27, 1.0 
35.8 Powder  
RP1:98:6 80 MeOH 
 70 
H2-5-Br-thsa 
0.54, 2.0 
CsOH 
 0.67, 4.0 
FeCl3·6H2O 
0.27, 1.0 
48.2 Crystalline  
RP1:99:1 80 MeOH  
30 
H2-5-Br-thsa-Me 
0.29, 1.0 
CsOH 
 0.67, 4.0 
Fe(CH3C6N5SO3)3·6H2O 
0.68, 1.0 
52.1 Powder  
RP1:99:2 80 MeOH  
70 
H2-5-Br-thsa-Me 
0.58, 2.0 
CsOH 
 0.67, 4.0 
Fe(CH3C6N5SO3)3·6H2O 
0.68, 1.0 
58.3 Powder 
 
RP1:100:3 80 MeOH  
30 
H2-5-Br-thsa-Me 
0.29, 1.0 
CsOH 
 0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
62.8 Crystalline product  + 
brown powder  
RP1:100:4 80 MeOH  
70 
H2-5-Br-thsa-Me 
0.58, 2.0 
CsOH 
 0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
45.8 Powder 
 
RP1:101:5 80 MeOH  
30 
H2-5-Br-thsa-Me 
0.29, 1.0 
CsOH 
0.67, 4.0 
FeCl3·6H2O 
0.27, 1.0 
44.6 Crystalline product  + 
brown powder  
RP1:101:6 80 MeOH  
70 
H2-5-Br-thsa-Me 
0.58, 2.0 
CsOH 
0.67, 4.0 
FeCl3·6H2O 
0.27, 1.0 
54.3 Powder 
 
RP1:102:7 80 MeOH 
30 
H2-5-Br-thsa-Me 
0.29, 1.0 
NH4OH 
20 mL 
Fe(CH3C6H5SO3)3·6H2O 
0.68, 1.0 
38.1 Crystalline product  + 
brown powder  
RP1:102:8 80 MeOH 
70 
H2-5-Br-thsa-Me 
0.58, 2.0 
NH4OH 
20 mL 
Fe(CH3C6H5SO3)3·6H2O 
0.68, 1.0 
- No result 
 
RP1:103:9 80 MeOH 
30 
H2-5-Br-thsa-Me 
0.29, 1.0 
NH4OH 
20 mL 
Fe(NO3)3·9H2O 
0.40, 1.0 
32.8 Crystalline  
RP1:103:10 80 MeOH 
70 
H2-5-Br-thsa-Me 
0.58, 2.0 
NH4OH 
20 mL 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP1:104:11 80 MeOH 
30 
H2-5-Br-thsa-Me 
0.29, 1.0 
NH4OH 
20 mL 
FeCl3·6H2O 
0.27, 1.0 
28.7 Crystalline  
RP1:104:12 80 MeOH 
70 
H2-5-Br-thsa-Me 
0.58, 2.0 
NH4OH 
20 mL 
FeCl3·6H2O 
0.27, 1.0 
- No result 
 
RP1:106:1 80 MeOH 
30 
H2-5-Br-thsa-Ph 
0.35, 1.0 
CsOH 
 0.67, 4.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP1:106:2 80 MeOH 
70 
H2-5-Br-thsa-Ph 
0.70, 2.0 
NH4OH 
20 mL 
FeCl3·6H2O 
0.27, 1.0 
- No result 
 
RP1:107:3 80 MeOH 
30 
H2-5-Br-thsa-Ph 
0.35, 1.0 
CsOH 
 0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP1:107:4 80 MeOH 
70 
H2-5-Br-thsa-Ph 
0.70, 2.0 
NH4OH 
20 mL 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
 
RP1:108:5 80 MeOH 
30 
H2-5-Br-thsa-Ph 
0.35, 1.0 
CsOH 
 0.67, 4.0 
Fe(CH3C6H5SO3)3·6H2O 
0.68, 1.0 
37.6 Brown powder 
RP1:108:6 80 MeOH 
70 
H2-5-Br-thsa-Ph 
0.70, 2.0 
CsOH 
 0.67, 4.0 
Fe(CH3C6H5SO3)3·6H2O 
0.68, 1.0 
- No result 
 
RP1:109:7 80 MeOH 
30 
H2-5-Br-thsa-Ph 
0.35, 1.0 
NH4OH 
20 mL 
FeCl3·6H2O 
0.27, 1.0 
28.2 Brown powder 
RP1:109:8 80 MeOH 
70 
H2-5-Br-thsa-Ph 
0.70, 2.0 
NH4OH 
20 mL 
FeCl3·6H2O 
0.27, 1.0 
33.6 Brown/black powder 
 
RP1:110:9 80 MeOH 
30 
H2-5-Br-thsa-Ph 
0.35, 1.0 
NH4OH 
20 mL 
Fe(NO3)3·9H2O 
0.40, 1.0 
45.2 Brown/black powder 
 
RP1:110:10 80 MeOH 
70 
H2-5-Br-thsa-Ph 
0.70, 2.0 
NH4OH 
20 mL 
Fe(NO3)3·9H2O 
0.40, 1.0 
51.2 Crystalline product + 
brown powder 
RP1:111:11 80 MeOH 
30 
H2-5-Br-thsa-Ph 
0.35, 1.0 
NH4OH 
20 mL 
Fe(CH3C6H5SO3)3·6H2O 
0.68, 1.0 
21.9 Brown powder 
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP1:111:12 80 MeOH 
70 
H2-5-Br-thsa-Ph 
0.70, 2.0 
NH4OH 
20 mL 
Fe(CH3C6H5SO3)3·6H2O 
0.68, 1.0 
28.3 Brown/black powder 
RP1:112:1 80 MeOH 
30 
H2-5-Br-thsa-Et 
0.30, 1.0 
NH4OH 
20 mL 
FeCl3·6H2O 
0.27, 1.0 
34.2 Crystalline  
 
RP1:112:2 80 MeOH 
70 
H2-5-Br-thsa-Et 
0.60, 2.0 
NH4OH 
20 mL 
FeCl3·6H2O 
0.27, 1.0 
38.5 Crystalline 
RP1:113:3 80 MeOH 
30 
H2-5-Br-thsa-Et 
0.30, 1.0 
NH4OH 
20 mL 
Fe(NO3)3·9H2O 
0.40, 1.0 
43.6 Crystalline product + 
brown powder 
RP1:113:4 80 MeOH 
70 
H2-5-Br-thsa-Et 
0.60, 2.0 
NH4OH 
20 mL 
Fe(NO3)3·9H2O 
0.40, 1.0 
29.2 Crystalline 
RP1:114:5 80 MeOH 
 30 
H2-5-Br-thsa-Et 
0.30, 1.0 
NH4OH 
20 mL 
Fe(CH3C6H5SO3)3·6H2O 
0.68, 1.0 
43.2 Crystalline product + 
brown powder 
RP1:114:6 80 MeOH 
70 
H2-5-Br-thsa-Et 
0.60, 2.0 
NH4OH 
20 mL 
Fe(CH3C6H5SO3)3·6H2O 
0.68, 1.0 
39.1 Crystalline product + 
brown powder 
RP1:118:1 80 MeOH  
30 
H2-5-Cl-thsa 
0.23, 1.0 
CsOH 
0.67, 4.0 
FeCl3·6H2O 
0.27, 1.0 
45.2 Powder  
 
RP1:118:2 80 MeOH  
70 
H2-5-Cl-thsa 
0.46, 2.0 
CsOH 
0.67, 4.0 
FeCl3·6H2O 
0.27, 1.0 
57.3 Powder  
RP1:119:3 80 MeOH  
30 
H2-5-Cl-thsa 
0.23, 1.0 
CsOH 
0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
38.9 Powder  
 
RP1:119:4 80 MeOH  
70 
H2-5-Cl-thsa 
0.46, 2.0 
CsOH 
0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
66.1 Powder  
RP1:120:5 80 MeOH  
30 
H2-5-Cl-thsa 
0.23, 1.0 
CsOH 
0.67, 4.0 
Fe(CH3C6H5SO3)3·6H2O 
0.68, 1.0 
47.8 Powder  
 
RP1:120:6 80 MeOH  
70 
H2-5-Cl-thsa 
0.46, 2.0 
CsOH 
0.67, 4.0 
Fe(CH3C6H5SO3)3·6H2O 
0.68, 1.0 
55.7 Powder  
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP1:121:7 80 MeOH  
30 
H2-5-Cl-thsa 
0.23, 1.0 
NH4OH 
20 mL 
FeCl3·6H2O 
0.27, 1.0 
45.2 Crystalline product + 
brown powder 
RP1:121:8 80 MeOH  
70 
H2-5-Cl-thsa 
0.46, 2.0 
NH4OH 
20 mL 
FeCl3·6H2O 
0.27, 1.0 
34.2 Crystalline 
RP1:122:9 80 MeOH  
30 
H2-5-Cl-thsa 
0.23, 1.0 
NH4OH 
20 mL 
Fe(NO3)3·9H2O 
0.40, 1.0 
46.2 Crystalline product + 
brown powder 
RP1:122:10 80 MeOH  
70 
H2-5-Cl-thsa 
0.46, 2.0 
NH4OH 
20 mL 
Fe(NO3)3·9H2O 
0.40, 1.0 
28.3 Crystalline  
RP1:123:11 80 MeOH  
30 
H2-5-Cl-thsa 
0.23, 1.0 
NH4OH 
20 mL 
Fe(CH3C6H5SO3)3·6H2O 
0.68, 1.0 
66.5 Powder  
 
RP1:123:12 80 MeOH  
70 
H2-5-Cl-thsa 
0.46, 2.0 
NH4OH 
20 mL 
Fe(CH3C6H5SO3)3·6H2O 
0.68, 1.0 
25.4 Crystalline  
RP1:124:1 80 MeOH  
30 
H2-5-Cl-thsa-Me 
0.24, 1.0 
CsOH 
0.67, 4.0 
FeCl3·6H2O 
0.27, 1.0 
38.2 Crystalline 
 
RP1:124:2 80 MeOH  
70 
H2-5-Cl-thsa-Me 
0.48, 2.0 
CsOH 
0.67, 4.0 
FeCl3·6H2O 
0.27, 1.0 
55.3 Powder  
RP1:125:3 80 MeOH  
30 
H2-5-Cl-thsa-Me 
0.24, 1.0 
NH4OH 
20 mL 
FeCl3·6H2O 
0.27, 1.0 
27.4 Crystalline  
RP1:125:4 80 MeOH  
70 
H2-5-Cl-thsa-Me 
0.48, 2.0 
NH4OH 
20 mL 
FeCl3·6H2O 
0.27, 1.0 
48.7 Crystalline product + 
brown powder 
RP1:132:5 80 EtOH  
65 
H2-thsa 
0.40, 2.0 
NH4OH 
0.035, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP1:132:6 80 MeOH  
65 
H2-thsa 
0.46, 2.0 
NH4OH 
0.035, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result  
RP1:133:7 80 H2O  
65 
H2-thsa 
0.40, 2.0 
NH4OH 
0.07, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP1:133:8 80 EtOH  
65 
H2-thsa 
0.46, 2.0 
NH4OH 
0.07, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
54.7 Crystalline  
RP1:134:9 80 MeOH 
65 
H2-thsa 
0.46, 2.0 
NH4OH 
0.07, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
  
RP1:134:10 80 H2O  
65 
H2-thsa 
0.40, 2.0 
NH4OH 
0.07, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
  
RP1:135:11 80 EtOH  
65 
H2-thsa 
0.40, 2.0 
NH4OH 
0.105, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
62.1 Crystalline 
  
RP1:135:12 80 MeOH  
65 
H2-thsa 
0.40, 2.0 
NH4OH 
0.105, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
  
RP1:49:5 80 MeOH  
30 
H2-5Cl-thsa-Me 
0.24, 1.0 
CsOH 
0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
78.2 Powder   
RP1:49:6 80 MeOH  
30 
H2-5Cl-thsa-Me 
0.48, 2.0 
CsOH 
0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
69.2 Powder   
RP1:50:7 80 MeOH  
30 
H2-5Cl-thsa-Me 
0.24, 1.0 
NH4OH 
20 mL 
Fe(NO3)3·9H2O 
0.40, 1.0 
37.1 Crystalline  
RP1:50:8 80 MeOH  
65 
H2-5Cl-thsa-Me 
0.48, 2.0 
NH4OH 
20 mL 
Fe(NO3)3·9H2O 
0.40, 1.0 
66.5 Powder   
RP1:54:1 80 EtOH  
70 
H2-4OH-thsa 
0.42, 2.0 
- Fe(NO3)3·9H2O 
0.40, 1.0 
34.7 Crystalline 
RP1:54:2 80 EtOH  
70 
H2-4OH-thsa 
0.42, 2.0 
NH4OH 
0.035, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
28.8 Crystalline   
RP1:55:3 80 EtOH  
70 
H2-4OH-thsa 
0.42, 2.0 
NH4OH 
0.70, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
37.2 Crystalline  
RP1:55:4 80 EtOH  
70 
H2-4OH-thsa 
0.42, 2.0 
NH4OH 
0.105, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
42.8 Crystalline 
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP1:56:5 80 EtOH  
70 
H2-4OH-thsa 
0.42, 2.0 
CsOH 
0.17, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
43.6 Crystalline 
RP1:56:6 80 EtOH  
70 
H2-4OH-thsa 
0.42, 2.0 
CsOH 
0.34, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
34.5 Crystalline   
RP1:57:7 80 EtOH  
70 
H2-4OH-thsa 
0.42, 2.0 
CsOH 
0.51, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
36.4 Crystalline  
RP1:57:1 20 EtOH  
70 
H2-5OMe-thsa 
0.42, 2.0 
- Fe(NO3)3·9H2O 
0.40, 1.0 
66.3 Powder 
RP1:58:2 80 EtOH  
70 
H2-5OMe-thsa 
0.42, 2.0 
NH4OH 
0.035, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
56.2 Mixture of crystals + 
powder 
RP1:58:3 80 EtOH  
70 
H2-5OMe-thsa 
0.42, 2.0 
NH4OH 
0.7, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
58.4 Mixture of crystals + 
powder 
RP1:59:4 80 EtOH  
70 
H2-5OMe-thsa 
0.42, 2.0 
NH4OH 
0.105, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
28.3 Crystalline 
RP1:59:1 80 MeOH  
35 
H2-3OEt-thsa-Ph 
0.32, 1.0 
CsOH 
0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
34.4 Crystalline 
RP2:4:1 80 EtOH 
70 
H2-thsa-Me 
0.42, 2.0 
- Fe(NO3)3·9H2O 
0.40, 1.0 
26.7 Crystalline 
RP2:4:2 80 EtOH 
70 
H2-thsa-Me 
0.42, 2.0 
NH4OH 
0.035, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
29.4 Crystalline 
RP2:5:3 80 EtOH 
70 
H2-thsa-Me 
0.42, 2.0 
NH4OH 
0.7, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
34.5 Crystalline 
RP2:5:4 80 EtOH 
70 
H2-thsa-Me 
0.42, 2.0 
NH4OH 
0.105, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
36.9 Crystalline 
RP2:6:1 80 EtOH 
70 
H2-thsa-Et 
0.44, 2.0 
- Fe(NO3)3·9H2O 
0.40, 1.0 
42.3 Crystalline 
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP2:6:2 80 EtOH 
70 
H2-thsa-Et 
0.44, 2.0 
NH4OH 
0.035, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
34.6 Crystalline 
RP2:7:3 80 EtOH 
70 
H2-thsa-Et 
0.44, 2.0 
NH4OH 
0.7, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
54.4 Crystalline 
RP2:7:4 80 EtOH 
70 
H2-thsa-Et 
0.44, 2.0 
NH4OH 
0.105, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
48.6 Crystalline 
RP2:8:1 80 EtOH 
70 
H2-thsa-Ph 
0.54, 2.0 
- Fe(NO3)3·9H2O 
0.40, 1.0 
28.9 Crystalline 
RP2:8:2 80 EtOH 
70 
H2-thsa-Ph 
0.54, 2.0 
NH4OH 
0.035, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
45.3 Powder 
RP2:9:3 80 EtOH 
70 
H2-thsa-Ph 
0.54, 2.0 
NH4OH 
0.7, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
34.8 Crystalline 
RP2:9:4 80 EtOH 
70 
H2-thsa-Ph 
0.54, 2.0 
NH4OH 
0.105, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
56.1 Crystalline 
RP2:10:1 80 MeOH 
70 
H2-thsa 
0.40, 2.0 
- Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:10:2 80 MeOH 
70 
H2-thsa 
0.40, 2.0 
Et3N 
0.10, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:11:3 80 MeOH 
70 
H2-thsa 
0.40, 2.0 
Et3N 
0.20, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:11:4 80 MeOH 
70 
H2-thsa 
0.40, 2.0 
Et3N 
0.30, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
66.9 Powder 
RP2:12:1 80 MeOH 
35 
H2-5Cl-thsa-Ph 
0.31, 1.0 
CsOH 
0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:12:2 80 MeOH 
70 
H2-5Cl-thsa-Ph 
0.62, 2.0 
CsOH 
0.67, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
  
 
2
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP2:13:3 80 MeOH 
70 
H2-5Cl-thsa-Ph 
0.31, 1.0 
NH4OH 
20 mL 
Fe(NO3)3·9H2O 
0.40, 1.0 
37.8 Crystalline 
RP2:13:4 80 MeOH 
70 
H2-5Cl-thsa-Ph 
0.62, 2.0 
NH4OH 
20 mL 
Fe(NO3)3·9H2O 
0.40, 1.0 
52.1 Crystalline 
RP2:14:1 80 MeOH 25 
EtOH 25 
H2O 10 
H2-thsa 
04.0, 2.0 
(CH3)2NH 
0.45, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:14:2 80 MeOH 25 
EtOH 25 
H2O 10 
H2-thsa-Me 
0.42, 2.0 
(CH3)2NH 
0.45, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
34.8 Crystalline 
RP2:15:3 80 MeOH 25 
EtOH 25 
H2O 10 
H2-thsa-Et 
0.44, 2.0 
(CH3)2NH 
0.45, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
62.3 Powder 
RP2:15:4 80 MeOH 25 
EtOH 25 
H2O 10 
H2-thsa-Ph 
0.54, 2.0 
(CH3)2NH 
0.45, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:16:5 80 MeOH 60 
H2O 10 
H2-thsa 
0.40, 2.0 
NH4OH 
0.16, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:16:6 80 MeOH 60 
H2O 10 
H2-thsa-Me 
0.42, 2.0 
NH4OH 
0.16, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:17:7 80 MeOH 60 
H2O 10 
H2-thsa-Et 
0.44, 2.0 
NH4OH 
0.16, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:17:8 80 MeOH 60 
H2O 10 
H2-thsa-Ph 
0.54, 2.0 
NH4OH 
0.16, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:18:1 80 MeOH 25 
EtOH 25 
H2O 10 
H2-5Br-thsa 
0.54, 2.0 
(CH3)2NH 
0.45, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP2:18:2 80 MeOH 25 
EtOH 25 
H2O 10 
H2-5Br-thsa-Me 
0.58, 2.0 
(CH3)2NH 
0.45, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
44.7 Crystalline 
RP2:19:3 80 MeOH 25 
EtOH 25 
H2O 10 
H2-5Br-thsa-Et 
0.60, 2.0 
(CH3)2NH 
0.45, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
34.9 Crystalline 
RP2:19:4 80 MeOH 25 
EtOH 25 
H2O 10 
H2-5Br-thsa-Ph 
0.70, 2.0 
(CH3)2NH 
0.45, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
66.7 Powder 
RP2:20:5 80 MeOH 60 
H2O 10 
H2-5Br-thsa 
0.54, 2.0 
NH4OH 
0.16, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:20:6 80 MeOH 60 
H2O 10 
H2-5Br-thsa-Me 
0.58, 2.0 
NH4OH 
0.16, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:21:7 80 MeOH 60 
H2O 10 
H2-5Br-thsa-Et 
0.60, 2.0 
NH4OH 
0.16, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
22.7 Crystalline 
RP2:21:8 80 MeOH 60 
H2O 10 
H2-5Br-thsa-Ph 
0.70, 2.0 
NH4OH 
0.16, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
45.2 Crystalline 
RP2:23:1 80 MeOH 25 
EtOH 25 
H2O 10 
H2-3OEt-thsa 
0.48, 2.0 
(CH3)2NH 
0.45, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:23:2 80 MeOH 25 
EtOH 25 
H2O 10 
H2-3OEt-thsa-Me 
0.50, 2.0 
(CH3)2NH 
0.45, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
55.3 Powder 
RP2:24:3 80 MeOH 25 
EtOH 25 
H2O 10 
H2-3OEt-thsa-Et 
0.54, 2.0 
(CH3)2NH 
0.45, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
  
  
 
2
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP2:24:4 80 MeOH 25 
EtOH 25 
H2O 10 
H2-3OEt-thsa-Ph 
0.64, 2.0 
(CH3)2NH 
0.45, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:25:1 80 MeOH 60 
H2O 10 
H2-3OEt-thsa 
0.48, 2.0 
(CH3)2NH 
0.45, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
34.7 Crystalline 
RP2:25:2 80 MeOH 60 
H2O 10 
H2-3OEt-thsa-Me 
0.50, 2.0 
(CH3)2NH 
0.45, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
55.4 Crystalline 
RP2:26:3 80 MeOH 60 
H2O 10 
H2-3OEt-thsa-Et 
0.54, 2.0 
(CH3)2NH 
0.45, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:26:4 80 MeOH 60 
H2O 10 
H2-3OEt-thsa-Ph 
0.64, 2.0 
(CH3)2NH 
0.45, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:27:1 80 MeOH 60 
H2O 10 
H2-3OEt-thsa 
0.48, 2.0 
NH4OH 
0.04, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
65.8 Powder 
RP2:27:2 80 MeOH 60 
H2O 10 
H2-3OEt-thsa 
0.48, 2.0 
NH4OH 
0.08, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
58.6 Powder 
RP2:28:3 80 MeOH 60 
H2O 10 
H2-3OEt-thsa 
0.48, 2.0 
NH4OH 
0.12, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
58.7 Powder 
RP2:28:4 80 MeOH 60 
H2O 10 
H2-3OEt-thsa 
0.48, 2.0 
NH4OH 
0.16, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
67.2 Powder 
RP2:29:1 80 MeOH 60 
H2O 10 
H2-3OEt-thsa-Me 
0.50, 2.0 
NH4OH 
0.04, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
45.8 Powder 
RP2:29:2 80 MeOH 60 
H2O 10 
H2-3OEt-thsa-Me 
0.50, 2.0 
NH4OH 
0.08, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
52.1 Powder 
RP2:30:3 80 MeOH 60 
H2O 10 
H2-3OEt-thsa-Me 
0.50, 2.0 
NH4OH 
0.12, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
68.3 Crystalline product + 
powder 
RP2:30:4 80 MeOH 60 
H2O 10 
H2-3OEt-thsa-Me 
0.50, 2.0 
NH4OH 
0.16, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
65.8 Crystalline product + 
powder 
  
  
 
2
3
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP2:31:1 80 MeOH 60 
H2O 10 
H2-3OEt-thsa-Et 
0.54, 2.0 
NH4OH 
0.04, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
38.2 Crystalline 
RP2:31:2 80 MeOH 60 
H2O 10 
H2-3OEt-thsa-Et 
0.54, 2.0 
NH4OH 
0.08, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
41.3 Crystalline 
RP2:32:3 80 MeOH 60 
H2O 10 
H2-3OEt-thsa-Et 
0.54, 2.0 
NH4OH 
0.12, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:32:4 80 MeOH 60 
H2O 10 
H2-3OEt-thsa-Et 
0.54, 2.0 
NH4OH 
0.16, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:33:1 80 MeOH 60 
H2O 10 
H2-3OEt-thsa-Ph 
0.64, 2.0 
NH4OH 
0.04, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:33:2 80 MeOH 60 
H2O 10 
H2-3OEt-thsa-Ph 
0.64, 2.0 
NH4OH 
0.08, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:34:3 80 MeOH 60 
H2O 10 
H2-3OEt-thsa-Ph 
0.64, 2.0 
NH4OH 
0.12, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:34:4 80 MeOH 60 
H2O 10 
H2-3OEt-thsa-Ph 
0.64, 2.0 
NH4OH 
0.16, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:36:1 80 MeOH 60 
H2O 10 
H2-5Cl-thsa 
0.46, 2.0 
- Fe(NO3)3·9H2O 
0.40, 1.0 
22.8 Powder 
RP2:36:2 80 MeOH 60 
H2O 10 
H2-5Cl-thsa 
0.46, 2.0 
NH4OH 
0.04, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
28.4 Powder 
RP2:37:3 80 MeOH 60 
H2O 10 
H2-5Cl-thsa 
0.46, 2.0 
NH4OH 
0.08, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
33.5 Powder 
RP2:37:4 80 MeOH 60 
H2O 10 
H2-5Cl-thsa 
0.46, 2.0 
NH4OH 
0.12, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
34.8 Powder 
RP2:38:5 80 MeOH 60 
H2O 10 
H2-5Cl-thsa 
0.46, 2.0 
NH4OH 
0.16, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
28.7 Powder 
  
  
 
2
3
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP2:38:1 80 MeOH 60 
H2O 10 
H2-5Cl-thsa-Me 
0.48, 2.0 
- Fe(NO3)3·9H2O 
0.40, 1.0 
34.6 Crystalline 
RP2:39:2 80 MeOH 60 
H2O 10 
H2-5Cl-thsa-Me 
0.48, 2.0 
NH4OH 
0.04, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
35.8 Crystalline 
RP2:39:3 80 MeOH 60 
H2O 10 
H2-5Cl-thsa-Me 
0.48, 2.0 
NH4OH 
0.08, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
38.5 Crystalline 
RP2:40:4 80 MeOH 60 
H2O 10 
H2-5Cl-thsa-Me 
0.48, 2.0 
NH4OH 
0.12, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
41.2 Crystalline 
RP2:40:5 80 MeOH 60 
H2O 10 
H2-5Cl-thsa-Me 
0.48, 2.0 
NH4OH 
0.16, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
38.7 Crystalline 
RP2:41:1 80 MeOH 60 
H2O 10 
H2-5Cl-thsa-Ph 
0.62, 2.0 
- Fe(NO3)3·9H2O 
0.40, 1.0 
43.1 Crystalline 
RP2:41:2 80 MeOH 60 
H2O 10 
H2-5Cl-thsa-Ph 
0.62, 2.0 
NH4OH 
0.04, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
45.6 Crystalline 
RP2:42:3 80 MeOH 60 
H2O 10 
H2-5Cl-thsa-Ph 
0.62, 2.0 
NH4OH 
0.08, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
42.8 Crystalline 
RP2:44:1 80 MeOH  
70 
H2-thsa-Me 
0.42, 2.0 
Et3N 
0.137 mL, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
43.6 Powder 
RP2:44:2 80 MeOH  
70 
H2-thsa-Me 
0.42, 2.0 
Et3N 
0.275 mL, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
54.7 Powder 
RP2:45:3 80 MeOH  
70 
H2-thsa-Me 
0.42, 2.0 
Et3N 
0.41 mL, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
41.2 Crystalline 
RP2:45:1 80 MeOH  
70 
H2-thsa-Et 
0.44, 2.0 
Et3N 
0.137 mL, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
38.7 Crystalline 
RP2:46:2 80 MeOH  
70 
H2-thsa-Et 
0.44, 2.0 
Et3N 
0.275 mL, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
48.7 Crystalline 
  
  
 
2
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP2:46:3 80 MeOH  
70 
H2-thsa-Et 
0.44, 2.0 
Et3N 
0.41 mL, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
54.2 Crystalline 
RP2:47:1 80 MeOH  
70 
H2-thsa-Ph 
0.54, 2.0 
Et3N 
0.137 mL, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:47:2 80 MeOH  
70 
H2-thsa-Ph 
0.54, 2.0 
Et3N 
0.275 mL, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
72.1 Black powder 
RP2:48:3 80 MeOH  
70 
H2-thsa-Ph 
0.54, 2.0 
Et3N 
0.41 mL, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
66.5 Powder 
RP2:48:1 80 MeOH  
70 
H2-5Cl-thsa 
0.46, 2.0 
(CH3)2NH 
0.45, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:49:2 80 MeOH  
70 
H2-5Cl-thsa-Me 
0.48, 2.0 
(CH3)2NH 
0.45, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
56.4 Powder 
RP2:49:3 80 MeOH  
70 
H2-5Cl-thsa-Ph 
0.62, 2.0 
(CH3)2NH 
0.45, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
64.8 Powder 
RP2:50:1 80 MeOH  
70 
H2-5Cl-thsa-Ph 
0.62, 2.0 
NH4OH 
0.105 mL, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
45.2 Powder 
RP2:50:2 80 MeOH  
70 
H2-5Cl-thsa-Ph 
0.62, 2.0 
NH4OH 
0.14 mL, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
42.8 Powder 
RP2:51:1 80 MeOH  
70 
H2-3,5Br-thsa 
0.70, 2.0 
NH4OH 
0.035 mL, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
38.8 Brown powder 
RP2:51:2 80 EtOH  
85 
H2-3,5Br-thsa 
0.70, 2.0 
NH4OH 
0.035 mL, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
45.6 Powder 
RP2:52:3 80 H2O 
70 
H2-3,5Br-thsa 
0.70, 2.0 
NH4OH 
0.035 mL, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:53:1 80 MeOH  
70 
H2-4OH-thsa 
0.42, 2.0 
NH4OH 
0.035 mL, 1.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
  
  
 
2
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP2:53:2 80 MeOH  
70 
H2-4OH-thsa 
0.42, 2.0 
NH4OH 
0.07 mL, 2.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:54:3 80 MeOH  
70 
H2-4OH-thsa 
0.42, 2.0 
NH4OH 
0.105 mL, 3.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:54:4 80 MeOH  
70 
H2-4OH-thsa 
0.42, 2.0 
NH4OH 
0.14 mL, 4.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:55:5 80 MeOH  
70 
H2-4OH-thsa 
0.42, 2.0 
Et3N 
0.137 mL, 1.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:55:6 80 MeOH  
70 
H2-4OH-thsa 
0.42, 2.0 
Et3N 
0.275 mL, 2.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:56:7 80 MeOH  
70 
H2-4OH-thsa 
0.42, 2.0 
Et3N 
0.41 mL, 3.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:56:8 80 MeOH  
70 
H2-4OH-thsa 
0.42, 2.0 
Et3N 
0.548 mL, 4.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:57:9 80 MeOH  
70 
H2-4OH-thsa 
0.42, 2.0 
(CH3)2NH 
0.05 mL, 1.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:57:10 80 MeOH  
70 
H2-4OH-thsa 
0.42, 2.0 
(CH3)2NH 
0.10 mL, 2.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:58:11 80 MeOH  
70 
H2-4OH-thsa 
0.42, 2.0 
(CH3)2NH 
0.15 mL, 3.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:58:12 80 MeOH  
70 
H2-4OH-thsa 
0.42, 2.0 
(CH3)2NH 
0.20 mL, 4.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:59:1 80 MeOH  
70 
H2-4OH-thsa-Me 
0.45, 2.0 
Et3N 
0.137 mL, 1.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:59:2 80 MeOH  
70 
H2-4OH-thsa-Me 
0.45, 2.0 
Et3N 
0.275 mL, 2.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP2:60:3 80 MeOH  
70 
H2-4OH-thsa-Me 
0.45, 2.0 
Et3N 
0.41 mL, 3.0 
FeCl3·6H2O 
0.27, 1.0 
45.7 Powder 
RP2:60:4 80 MeOH  
70 
H2-4OH-thsa-Me 
0.45, 2.0 
Et3N 
0.548 mL, 4.0 
FeCl3·6H2O 
0.27, 1.0 
57.8 Powder 
RP2:61:5 80 MeOH  
70 
H2-4OH-thsa-Me 
0.45, 2.0 
(CH3)2NH 
0.05 mL, 1.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:61:6 80 MeOH  
70 
H2-4OH-thsa-Me 
0.45, 2.0 
(CH3)2NH 
0.10 mL, 2.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:62:7 80 MeOH  
70 
H2-4OH-thsa-Me 
0.45, 2.0 
(CH3)2NH 
0.15 mL, 3.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:62:8 80 MeOH  
70 
H2-4OH-thsa-Me 
0.45, 2.0 
(CH3)2NH 
0.20 mL, 4.0 
FeCl3·6H2O 
0.27, 1.0 
34.6 Crystalline 
RP2:63:9 80 MeOH  
70 
H2-4OH-thsa-Me 
0.45, 2.0 
NH4OH 
0.035 mL, 1.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:63:10 80 MeOH  
70 
H2-4OH-thsa-Me 
0.45, 2.0 
NH4OH 
0.07 mL, 2.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:64:11 80 MeOH  
70 
H2-4OH-thsa-Me 
0.45, 2.0 
NH4OH 
0.105 mL, 3.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:64:12 80 MeOH  
70 
H2-4OH-thsa-Me 
0.45, 2.0 
NH4OH 
0.14 mL, 4.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:65:1 80 MeOH  
70 
H2-4OH-thsa-Et 
0.48, 2.0 
Et3N 
0.137 mL, 1.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:65:2 80 MeOH  
70 
H2-4OH-thsa-Et 
0.48, 2.0 
Et3N 
0.275 mL, 2.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:66:3 80 MeOH  
70 
H2-4OH-thsa-Et 
0.48, 2.0 
Et3N 
0.41 mL, 3.0 
FeCl3·6H2O 
0.27, 1.0 
55.8 Powder 
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP2:66:4 80 MeOH  
70 
H2-4OH-thsa-Et 
0.48, 2.0 
Et3N 
0.548 mL, 4.0 
FeCl3·6H2O 
0.27, 1.0 
65.9 Powder 
RP2:67:5 80 MeOH  
70 
H2-4OH-thsa-Et 
0.48, 2.0 
NH4OH 
0.035 mL, 1.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:67:6 80 MeOH  
70 
H2-4OH-thsa-Et 
0.48, 2.0 
NH4OH 
0.07 mL, 2.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:68:7 80 MeOH  
70 
H2-4OH-thsa-Et 
0.48, 2.0 
NH4OH 
0.105 mL, 3.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:68:8 80 MeOH  
70 
H2-4OH-thsa-Et 
0.48, 2.0 
NH4OH 
0.14 mL, 4.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:69:9 80 MeOH  
70 
H2-4OH-thsa-Et 
0.48, 2.0 
(CH3)2NH 
0.05 mL, 1.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:69:10 80 MeOH  
70 
H2-4OH-thsa-Et 
0.48, 2.0 
(CH3)2NH 
0.10 mL, 2.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:70:11 80 MeOH  
70 
H2-4OH-thsa-Et 
0.48, 2.0 
(CH3)2NH 
0.15 mL, 3.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:70:12 80 MeOH  
70 
H2-4OH-thsa-Et 
0.48, 2.0 
(CH3)2NH 
0.20 mL, 4.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:72:1 80 MeOH  
70 
H2-4OH-thsa-Ph 
0.57, 2.0 
Et3N 
0.137 mL, 1.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:72:2 80 MeOH  
70 
H2-4OH-thsa-Ph 
0.57, 2.0 
Et3N 
0.275 mL, 2.0 
FeCl3·6H2O 
0.27, 1.0 
66.5 Powder 
RP2:73:3 80 MeOH  
70 
H2-4OH-thsa-Ph 
0.57, 2.0 
Et3N 
0.41 mL, 3.0 
FeCl3·6H2O 
0.27, 1.0 
57.8 Powder 
RP2:73:4 80 MeOH  
70 
H2-4OH-thsa-Ph 
0.57, 2.0 
Et3N 
0.548 mL, 4.0 
FeCl3·6H2O 
0.27, 1.0 
62.4 Powder 
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued.  
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP2:76:1 80 MeOH  
70 
H2-5Cl-thsa-Et 
0.52, 2.0 
Et3N 
0.137 mL, 1.0 
FeCl3·6H2O 
0.27, 1.0 
28.7 Crystalline 
RP2:76:2 80 MeOH  
70 
H2-5Cl-thsa-Et 
0.52, 2.0 
Et3N 
0.275 mL, 2.0 
FeCl3·6H2O 
0.27, 1.0 
33.5 Crystalline 
RP2:77:3 80 MeOH  
70 
H2-5Cl-thsa-Et 
0.52, 2.0 
Et3N 
0.41 mL, 3.0 
FeCl3·6H2O 
0.27, 1.0 
32.9 Crystalline 
RP2:77:4 80 MeOH  
70 
H2-5Cl-thsa-Et 
0.52, 2.0 
Et3N 
0.548 mL, 4.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:79:1 80 MeOH  
70 
H2-4OH-thsa-Ph 
0.57, 2.0 
(CH3)2NH 
0.05 mL, 1.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:79:2 80 MeOH  
70 
H2-4OH-thsa-Ph 
0.57, 2.0 
(CH3)2NH 
0.10 mL, 2.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:80:3 80 MeOH  
70 
H2-4OH-thsa-Ph 
0.57, 2.0 
(CH3)2NH 
0.15 mL, 3.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:80:4 80 MeOH  
70 
H2-4OH-thsa-Ph 
0.57, 2.0 
(CH3)2NH 
0.20 mL, 4.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:81:5 80 MeOH  
70 
H2-4OH-thsa-Ph 
0.57, 2.0 
NH4OH 
0.035 mL, 1.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:81:6 80 MeOH  
70 
H2-4OH-thsa-Ph 
0.57, 2.0 
NH4OH 
0.07 mL, 2.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:82:7 80 MeOH  
70 
H2-4OH-thsa-Ph 
0.57, 2.0 
NH4OH 
0.105 mL, 3.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:82:8 80 MeOH  
70 
H2-4OH-thsa-Ph 
0.57, 2.0 
NH4OH 
0.14 mL, 4.0 
FeCl3·6H2O 
0.27, 1.0 
- No result 
RP2:84:4 80 MeOH  
70 
H2-5Cl-thsa-Et 
0.52, 2.0 
NH4OH 
0.035 mL, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
  
  
 
2
4
0
 
Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP2:84:5 80 MeOH  
70 
H2-5Cl-thsa-Et 
0.52, 2.0 
NH4OH 
0.07 mL, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:85:6 80 MeOH  
70 
H2-5Cl-thsa-Et 
0.52, 2.0 
NH4OH 
0.105 mL, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
48.7 Powder 
RP2:85:7 80 MeOH  
70 
H2-5Cl-thsa-Et 
0.52, 2.0 
NH4OH 
0.14 mL, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
52.5 Powder 
RP2:92:1 80 MeOH  
70 
H2-4OMe-thsa 
0.45, 2.0 
Et3N 
0.137 mL, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:92:2 80 MeOH  
70 
H2-4OMe-thsa 
0.45, 2.0 
Et3N 
0.275 mL, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
65.2 Powder 
RP2:93:3 80 MeOH  
70 
H2-4OMe-thsa 
0.45, 2.0 
Et3N 
0.41 mL, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
43.7 Crystalline 
RP2:93:4 80 MeOH  
70 
H2-4OMe-thsa 
0.45, 2.0 
Et3N 
0.548 mL, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:95:5 80 MeOH  
70 
H2-4OMe-thsa 
0.45, 2.0 
NH4OH 
0.035 mL, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:95:6 80 MeOH  
70 
H2-4OMe-thsa 
0.45, 2.0 
NH4OH 
0.07 mL, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
52.6 Crystalline 
RP2:96:7 80 MeOH  
70 
H2-4OMe-thsa 
0.45, 2.0 
NH4OH 
0.105 mL, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:96:8 80 MeOH  
70 
H2-4OMe-thsa 
0.45, 2.0 
NH4OH 
0.14 mL, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:97:9 80 MeOH  
70 
H2-4OMe-thsa 
0.45, 2.0 
(CH3)2NH 
0.05 mL, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:97:10 80 MeOH  
70 
H2-4OMe-thsa 
0.45, 2.0 
(CH3)2NH 
0.10 mL, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
54.8 Powder 
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued.  
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP2:98:1 80 MeOH  
70 
H2-5Cl-thsa-Me 
0.48, 2.0 
NH4OH 
0.035 mL, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
32.7 Crystalline 
RP2:98:2 80 MeOH  
70 
H2-5Cl-thsa-Me 
0.48, 2.0 
NH4OH 
0.07 mL, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
43.5 Crystalline 
RP2:99:3 80 MeOH  
70 
H2-5Cl-thsa-Me 
0.48, 2.0 
NH4OH 
0.105 mL, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
45.2 Crystalline 
RP2:99:4 80 MeOH  
70 
H2-5Cl-thsa-Me 
0.48, 2.0 
NH4OH 
0.14 mL, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
52.8 Crystalline 
RP2:100:8 80 MeOH  
70 
H2-5Cl-thsa-Et 
0.52, 2.0 
(CH3)2NH 
0.05 mL, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
55.4 Powder 
RP2:100:9 80 MeOH  
70 
H2-5Cl-thsa-Et 
0.52, 2.0 
(CH3)2NH 
0.10 mL, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
58.6 Powder 
RP2:101:10 80 MeOH  
70 
H2-5Cl-thsa-Et 
0.52, 2.0 
(CH3)2NH 
0.15 mL, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
62.5 Powder 
RP2:101:12 80 MeOH  
70 
H2-5Cl-thsa-Et 
0.52, 2.0 
(CH3)2NH 
0.20 mL, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
61.9 Powder 
RP2:106:1 80 MeOH  
70 
H2-3OEt-thsa-Et 
0.54, 2.0 
Et3N 
0.137 mL, 1.0 
FeCl3·6H2O 
0.27, 1.0 
32.7 Crystalline 
RP2:106:2 80 MeOH  
70 
H2-3OEt-thsa-Et 
0.54, 2.0 
Et3N 
0.275 mL, 2.0 
FeCl3·6H2O 
0.27, 1.0 
43.2 Crystalline 
RP2:107:3 80 MeOH  
70 
H2-3OEt-thsa-Et 
0.54, 2.0 
Et3N 
0.41 mL, 3.0 
FeCl3·6H2O 
0.27, 1.0 
42.1 Crystalline 
RP2:107:4 80 MeOH  
70 
H2-3OEt-thsa-Et 
0.54, 2.0 
Et3N 
0.548 mL, 4.0 
FeCl3·6H2O 
0.27, 1.0 
38.7 Crystalline 
RP2:108:5 80 MeOH  
70 
H2-3OEt-thsa-Et 
0.54, 2.0 
(CH3)2NH 
0.05 mL, 1.0 
FeCl3·6H2O 
0.27, 1.0 
28.6 Crystalline 
  
  
 
2
4
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP2:108:6 80 MeOH  
70 
H2-3OEt-thsa-Et 
0.54, 2.0 
(CH3)2NH 
0.10 mL, 2.0 
FeCl3·6H2O 
0.27, 1.0 
36.3 Crystalline 
RP2:109:7 80 MeOH  
70 
H2-3OEt-thsa-Et 
0.54, 2.0 
(CH3)2NH 
0.15 mL, 3.0 
FeCl3·6H2O 
0.27, 1.0 
38.7 Crystalline 
RP2:109:8 80 MeOH  
70 
H2-3OEt-thsa-Et 
0.54, 2.0 
(CH3)2NH 
0.20 mL, 4.0 
FeCl3·6H2O 
0.27, 1.0 
26.4 Crystalline 
RP2:110:1 80 MeOH  
30 
H2-3OH-thsa 
0.21, 1.0 
(CH3)2NH 
0.05 mL, 1.0 
Fe(NO3)3·9H2O 
0.20, 0.5 
28.5 Crystalline 
RP2:110:2 80 MeOH  
30 
H2-3OH-thsa 
0.21, 1.0 
(CH3)2NH 
0.10 mL, 2.0 
Fe(NO3)3·9H2O 
0.20, 0.5 
55.7 Powder 
RP2:111:3 80 MeOH  
30 
H2-3OH-thsa 
0.21, 1.0 
(CH3)2NH 
0.15 mL, 3.0 
Fe(NO3)3·9H2O 
0.20, 0.5 
45.9 Powder 
RP2:111:4 80 MeOH  
30 
H2-3OH-thsa 
0.21, 1.0 
(CH3)2NH 
0.20 mL, 4.0 
Fe(NO3)3·9H2O 
0.20, 0.05 
62.3 Powder 
RP2:112:5 80 MeOH  
30 
H2-3OH-thsa 
0.21, 1.0 
NH4OH 
0.035 mL, 1.0 
Fe(NO3)3·9H2O 
0.20, 0.5 
45.8 Crystalline 
RP2:112:6 80 MeOH  
30 
H2-3OH-thsa 
0.21, 1.0 
NH4OH 
0.07 mL, 2.0 
Fe(NO3)3·9H2O 
0.20, 0.5 
32.6 Crystalline 
RP2:113:7 80 MeOH  
30 
H2-3OH-thsa 
0.21, 1.0 
NH4OH 
0.105 mL, 3.0 
Fe(NO3)3·9H2O 
0.20, 0.5 
42.7 Crystalline 
RP2:113:8 80 MeOH  
30 
H2-3OH-thsa 
0.21, 1.0 
NH4OH 
0.14 mL, 4.0 
Fe(NO3)3·9H2O 
0.20, 0.5 
- No result 
RP2:114:1 80 MeOH  
30 
H2-3OH-thsa-Me 
0.23, 1.0 
NH4OH 
0.035 mL, 1.0 
Fe(NO3)3·9H2O 
0.20, 0.5 
66.4 Powder 
RP2:114:2 80 MeOH  
30 
H2-3OH-thsa-Me 
0.23, 1.0 
NH4OH 
0.07 mL, 2.0 
Fe(NO3)3·9H2O 
0.20, 0.5 
26.5 Crystalline 
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP2:115:3 80 MeOH  
30 
H2-3OH-thsa-Me 
0.23, 1.0 
NH4OH 
0.105 mL, 3.0 
Fe(NO3)3·9H2O 
0.20, 0.5 
32.8 Crystalline 
RP2:115:4 80 MeOH  
30 
H2-3OH-thsa-Me 
0.23, 1.0 
NH4OH 
0.14 mL, 4.0 
Fe(NO3)3·9H2O 
0.20, 0.5 
28.7 Crystalline 
RP2:116:1 80 MeOH  
30 
H2-3OH-thsa-Et 
0.24, 1.0 
NH4OH 
0.035 mL, 1.0 
Fe(NO3)3·9H2O 
0.20, 0.5 
55.8 Powder 
RP2:116:2 80 MeOH  
30 
H2-3OH-thsa-Et 
0.24, 1.0 
NH4OH 
0.07 mL, 2.0 
Fe(NO3)3·9H2O 
0.20, 0.5 
47.6 Crystalline 
RP2:117:3 80 MeOH  
30 
H2-3OH-thsa-Et 
0.24, 1.0 
NH4OH 
0.105 mL, 3.0 
Fe(NO3)3·9H2O 
0.20, 0.5 
57.5 Crystalline 
RP2:117:4 80 MeOH  
30 
H2-3OH-thsa-Et 
0.24, 1.0 
NH4OH 
0.14 mL, 4.0 
Fe(NO3)3·9H2O 
0.20, 0.5 
48.9 Crystalline 
RP2:120:1 80 MeOH 25 
EtOH 25 
H2O 10 
H2-5Cl-thsa-Et 
0.52, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
39.8 Crystalline 
RP2:120:2 80 MeOH  
60 
H2-5Cl-thsa-Et 
0.52, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
43.7 Crystalline 
RP2:121:3 80 MeOH 25 
EtOH 25 
H2O 10 
H2-5Cl-thsa-Ph 
0.62, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
68.2 Powder 
RP2:121:4 80 MeOH  
60 
H2-5Cl-thsa-Ph 
0.62, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
56.8 Powder 
RP2:122:1 80 MeOH 25 
EtOH 25 
H2O 10 
H2-thsa-Et 
0.44, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
65.8 Powder 
RP2:122:2 80 MeOH  
60 
H2-thsa-Et 
0.44, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
61.4 Powder 
  
  
 
2
4
4
 
Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP2:123:3 80 MeOH 25 
EtOH 25 
H2O 10 
H2-thsa-Ph 
0.54, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
64.5 Powder 
RP2:123:4 80 MeOH  
60 
H2-thsa-Ph 
0.54, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
67.8 Powder 
RP2:124:5 80 MeOH 25 
EtOH 25 
H2O 10 
H2-thsa-Ph 
0.54, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
63.7 Powder 
RP2:124:6 80 MeOH  
60 
H2-thsa-Ph 
0.54, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
65.0 Powder 
RP2:125:1 80 MeOH 25 
EtOH 25 
H2O 10 
H2-5Br-thsa 
0.54, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
56.7 Crystalline 
RP2:125:2 80 MeOH  
60 
H2-5Br-thsa 
0.54, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:126:3 80 MeOH 25 
EtOH 25 
H2O 10 
H2-5Br-thsa-Me 
0.58, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
54.9 Crystalline 
RP2:126:4 80 MeOH  
60 
H2-5BR-thsa-Me 
0.58, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:127:5 80 MeOH 25 
EtOH 25 
H2O 10 
H2-5Br-thsa-Et 
0.60, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
48.7 Crystalline 
RP2:127:6 80 MeOH  
60 
H2-5Br-thsa-Et 
0.60, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
38.9 Crystalline 
  
  
 
2
4
5
 
Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP2:128:7 80 MeOH 25 
EtOH 25 
H2O 10 
H2-5Br-thsa-Ph 
0.70, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
47.5 Powder 
RP2:128:8 80 MeOH  
60 
H2-5Br-thsa-Ph 
0.70, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:131:1 80 MeOH  
30 
H2-4OH-thsa 
0.21, 1.0 
(CH3)2NH 
0.05 mL, 1.0 
Fe(NO3)3·9H2O 
0.20, 0.5 
57.8 Crystalline 
RP2:131:2 80 MeOH  
30 
H2-4OH-thsa-Et 
0.54, 2.0 
(CH3)2NH 
0.05 mL, 1.0 
Fe(NO3)3·9H2O 
0.20, 0.5 
63.4 Crystalline 
RP2:134:1 80 MeOH 25 
EtOH 25 
H2O 10 
H2-3OEt-thsa 
0.48, 2.0 
(CH3)2NH 
0.05 mL, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:134:2 80 MeOH 25 
EtOH 25 
H2O 10 
H2-3OEt-thsa 
0.48, 2.0 
(CH3)2NH 
0.10 mL, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:135:3 80 MeOH 25 
EtOH 25 
H2O 10 
H2-3OEt-thsa 
0.48, 2.0 
(CH3)2NH 
0.15 mL, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:135:4 80 MeOH 25 
EtOH 25 
H2O 10 
H2-3OEt-thsa 
0.48, 2.0 
(CH3)2NH 
0.20 mL, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:136:5 80 MeOH 25 
EtOH 25 
H2O 10 
H2-3OEt-thsa 
0.48, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:136:1 80 MeOH 25 
EtOH 25 
H2O 10 
H2-3OEt-thsa-Me 
0.50, 2.0 
(CH3)2NH 
0.05 mL, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP2:137:2 80 MeOH 25 
EtOH 25 
H2O 10 
H2-3OEt-thsa-Me 
0.50, 2.0 
(CH3)2NH 
0.10 mL, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:137:3 80 MeOH 25 
EtOH 25 
H2O 10 
H2-3OEt-thsa-Me 
0.50, 2.0 
(CH3)2NH 
0.15 mL, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:140:4 80 MeOH 25 
EtOH 25 
H2O 10 
H2-3OEt-thsa-Me 
0.50, 2.0 
(CH3)2NH 
0.20 mL, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:140:5 80 MeOH 25 
EtOH 25 
H2O 10 
H2-3OEt-thsa-Me 
0.50, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:141:1 80 MeOH 25 
EtOH 25 
H2O 10 
H2-3OEt-thsa-Et 
0.54, 2.0 
(CH3)2NH 
0.05 mL, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:141:2 80 MeOH 25 
EtOH 25 
H2O 10 
H2-3OEt-thsa-Et 
0.54, 2.0 
(CH3)2NH 
0.10 mL, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:142:3 80 MeOH 25 
EtOH 25 
H2O 10 
H2-3OEt-thsa-Et 
0.54, 2.0 
(CH3)2NH 
0.15 mL, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:142:4 80 MeOH 25 
EtOH 25 
H2O 10 
H2-3OEt-thsa-Et 
0.54, 2.0 
(CH3)2NH 
0.20 mL, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:143:5 80 MeOH 25 
EtOH 25 
H2O 10 
H2-3OEt-thsa-Et 
0.54, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP2:149:1 80 MeOH 60 
H2O 10 
H2-5Br-thsa-Ph 
0.70, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:155:1 80 MeOH 50 
H2O 10 
H2-5Br-thsa-Ph 
0.35, 1.0 
(CH3)2NH 
0.05 mL, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:155:2 80 MeOH 50 
H2O 10 
H2-5Br-thsa-Ph 
0.35, 1.0 
(CH3)2NH 
0.10 mL, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:156:3 80 MeOH 50 
H2O 10 
H2-5Br-thsa-Ph 
0.35, 1.0 
(CH3)2NH 
0.15 mL, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:156:4 80 MeOH 50 
H2O 10 
H2-5Br-thsa-Ph 
0.35, 1.0 
(CH3)2NH 
0.20 mL, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:157:5 80 MeOH 50 
H2O 10 
H2-5Br-thsa-Ph 
0.35, 1.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:157:1 80 MeOH 50 
H2O 10 
H2-thsa-Ph 
0.27, 1.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
55.4 Powder  
RP2:158:2 80 MeOH 50 
H2O 10 
H2-thsa-Ph 
0.27, 1.0 
(CH3)2NH 
0.05 mL, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:158:3 80 MeOH 50 
H2O 10 
H2-thsa-Ph 
0.27, 1.0 
(CH3)2NH 
0.10 mL, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:159:4 80 MeOH 50 
H2O 10 
H2-thsa-Ph 
0.27, 1.0 
(CH3)2NH 
0.15 mL, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:159:5 80 MeOH 50 
H2O 10 
H2-thsa-Ph 
0.27, 1.0 
(CH3)2NH 
0.20 mL, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
- No result 
RP2:160:1 80 MeOH 50 
H2O 10 
H2-3,5Br-thsa-Ph 
0.43, 1.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
55.4 Powder  
RP2:160:2 80 MeOH 50 
H2O 10 
H2-3,5Br-thsa-Ph 
0.43, 1.0 
(CH3)2NH 
0.05 mL, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
52.6 Powder 
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP2:161:3 80 MeOH 50 
H2O 10 
H2-3,5Br-thsa-Ph 
0.43, 1.0 
(CH3)2NH 
0.10 mL, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
43.7 Powder 
RP2:161:4 80 MeOH 50 
H2O 10 
H2-3,5Br-thsa-Ph 
0.43, 1.0 
(CH3)2NH 
0.15 mL, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
62.7 Powder 
RP2:162:5 80 MeOH 50 
H2O 10 
H2-3,5Br-thsa-Ph 
0.43, 1.0 
(CH3)2NH 
0.20 mL, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
61.2 Powder 
RP2:172:5 80 MeOH 50 
H2O 10 
H2-5Br-thsa-Ph 
0.35, 1.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(SO4)3·H2O 
0.40, 1.0 
- No result  
RP2:172:6 80 MeOH 25 
H2O 10 
H2-3,5Br-thsa-Ph 
0.43, 1.0 
NH4OH 
0.04 mL, 1.0 
Fe(SO4)3·H2O 
0.40, 1.0 
- No result 
RP2:173:7 80 MeOH 25 
H2O 10 
H2-5Br-thsa-Ph 
0.35, 1.0 
NH4OH 
0.08 mL, 2.0 
Fe(SO4)3·H2O 
0.40, 1.0 
- No result 
RP2:173:8 80 MeOH 25 
H2O 10 
H2-5Br-thsa-Ph 
0.35, 1.0 
NH4OH 
0.12 mL, 3.0 
Fe(SO4)3·H2O 
0.40, 1.0 
47.6 Powder 
RP2:174:9 80 MeOH 25 
H2O 10 
H2-5Br-thsa-Ph 
0.35, 1.0 
NH4OH 
0.16 mL, 4.0 
Fe(SO4)3·H2O 
0.40, 1.0 
56.3 Powder 
RP2:174:10 80 MeOH 25 
H2O 10 
H2-5Br-thsa-Ph 
0.35, 1.0 
NH4OH 
0.4 mL, 10.0 
Fe(SO4)3·H2O 
0.40, 1.0 
65.7 Powder 
RP2:175:11 80 MeOH 25 
H2O 10 
H2-5Br-thsa-Ph 
0.35, 1.0 
Et3N 
0.14 mL, 1.0 
Fe(SO4)3·H2O 
0.40, 1.0 
45.6 Powder 
RP2:176:12 80 MeOH 25 
H2O 10 
H2-5Br-thsa-Ph 
0.35, 1.0 
Et3N 
0.28 mL, 2.0 
Fe(SO4)3·H2O 
0.40, 1.0 
56.3 Crystalline 
RP2:176:13 80 MeOH 25 
H2O 10 
H2-5Br-thsa-Ph 
0.35, 1.0 
Et3N 
0.42 mL, 3.0 
Fe(SO4)3·H2O 
0.40, 1.0 
56.4 Crystalline 
RP2:177:14 80 MeOH 25 
H2O 10 
H2-5Br-thsa-Ph 
0.35, 1.0 
Et3N 
0.56 mL, 4.0 
Fe(SO4)3·H2O 
0.40, 1.0 
34.2 Brown powder 
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP2:177:15 80 MeOH 25 
H2O 10 
H2-5Br-thsa-Ph 
0.35, 1.0 
Et3N 
1.4 mL, 10.0 
Fe(SO4)3·H2O 
0.40, 1.0 
55.1 Crystalline 
RP2:178:1 80 MeOH 50 
H2O 10 
H2-thsa-Ph 
0.54, 2.0 
Et3N 
0.14 mL, 1.0 
Fe(SO4)3·H2O 
0.40, 1.0 
62.1 Black powder 
RP2:178:2 80 MeOH 50 
H2O 10 
H2-thsa-Ph 
0.54, 2.0 
Et3N 
0.28 mL, 2.0 
Fe(SO4)3·H2O 
0.40, 1.0 
65.3 Black powder 
RP2:179:3 80 MeOH 50 
H2O 10 
H2-thsa-Ph 
0.54, 2.0 
Et3N 
0.42 mL, 3.0 
Fe(SO4)3·H2O 
0.40, 1.0 
52.8 Black powder 
RP2:179:4 80 MeOH 50 
H2O 10 
H2-thsa-Ph 
0.54, 2.0 
Et3N 
0.56 mL, 4.0 
Fe(SO4)3·H2O 
0.40, 1.0 
44.8 Black powder 
RP2:180:5 80 MeOH 50 
H2O 10 
H2-thsa-Ph 
0.54, 2.0 
Et3N 
1.4 mL, 10.0 
Fe(SO4)3·H2O 
0.40, 1.0 
32.7 Crystalline 
RP2:182:6 80 MeOH 50 
H2O 10 
H2-thsa-Ph 
0.54, 2.0 
NH4OH 
0.04 mL, 1.0 
Fe(SO4)3·H2O 
0.40, 1.0 
43.7 Black powder 
RP2:182:7 80 MeOH 50 
H2O 10 
H2-thsa-Ph 
0.54, 2.0 
NH4OH 
0.08 mL, 2.0 
Fe(SO4)3·H2O 
0.40, 1.0 
53.8 Black powder 
RP2:183:8 80 MeOH 250 
H2O 10 
H2-thsa-Ph 
0.54, 2.0 
NH4OH 
0.12 mL, 3.0 
Fe(SO4)3·H2O 
0.40, 1.0 
44.2 Black powder 
RP2:183:9 80 MeOH 50 
H2O 10 
H2-thsa-Ph 
0.54, 2.0 
NH4OH 
0.16 mL, 4.0 
Fe(SO4)3·H2O 
0.40, 1.0 
46.5 Black powder 
RP2:184:10 80 MeOH 50 
H2O 10 
H2-thsa-Ph 
0.54, 2.0 
NH4OH 
0.4 mL, 10.0 
Fe(SO4)3·H2O 
0.40, 1.0 
62.7 Black powder 
RP2:184:11 80 MeOH 50 
H2O 10 
H2-thsa-Ph 
0.54, 2.0 
(CH3)2NH 
0.05 mL, 1.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
52.6 Powder 
RP2:185:12 80 MeOH 50 
H2O 10 
H2-thsa-Ph 
0.54, 2.0 
(CH3)2NH 
0.10 mL, 2.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
43.7 Powder 
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Table E2.1 Quantities used in the synthesis of FeIII complexes with R-salicylaldehyde 4R’-thiosemicarbazone (H2-R-thsa-R’) ligands continued. 
Experimental 
code for 
FeIII Complex 
synthesis 
T 
(°C) 
Solvent 
(mL) 
H2-R-thsa-R’ Ligand 
(g, mmol) 
Cation 
(g, mmol) 
 
FeIII(salt) 
(g, mmol) 
 
Product 
Yield 
% 
State of material 
RP2:185:13 80 MeOH 50 
H2O 10 
H2-thsa-Ph 
0.54, 2.0 
(CH3)2NH 
0.15 mL, 3.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
62.7 Powder 
RP2:186:14 80 MeOH 50 
H2O 10 
H2-thsa-Ph 
0.54, 2.0 
(CH3)2NH 
0.20 mL, 4.0 
Fe(NO3)3·9H2O 
0.40, 1.0 
57.2 Powder 
RP2:186:15 80 MeOH 50 
H2O 10 
H2-thsa-Ph 
0.54, 2.0 
(CH3)2NH 
0.51 mL, 10.0 
Fe(SO4)3·H2O 
0.40, 1.0 
59.4 Powder  
 
 
 
 
 
